Download September 2015 CURRICULUM VITAE A

September 2015
CURRICULUM VITAE
A. PERSONAL INFORMATION
Name in Full
Leslie Bernstein, Ph.D.
Business Address
Division of Cancer Etiology
Department of Population Sciences
City of Hope National Medical Center and Comprehensive
Cancer Center
1500 East Duarte Road, Bldg 173
Duarte, CA 91010
(626) 256-HOPE (extension 61411) or (626) 471-7315
(626) 471-7308
[email protected]
Business Phone
Busisness Fax
Business Email
B. EDUCATION
Undergraduate
University of California, Los Angeles, BA with Highest Honors in Mathematics, 1965
Graduate
University of Southern California, Los Angeles, M.S. in Gerontology
(Masters Thesis: Stroke Rehabilitation, Factors Related to Outcome. Committee
Chairman: Steven Zarit, Ph.D.), 1978
University of Southern California, Los Angeles, Ph.D. in Biometry
(Dissertation: Carcinogenic and Mutagenic Potency: Statistical Methods for
Analysis of Salmonella Test Data and Development of a Potency Index for
Animal Bioassay Results. Committee Chairman: Malcolm C. Pike, Ph.D.),
1981
Leslie Bernstein, PhD
C. PROFESSIONAL BACKGROUND
Current Appointments:
Administrative Appointments at City of Hope National Medical Center:
Interim Chair, Department of Population Sciences
Director, Division of Cancer Etiology
Academic Appointments
Professor, Division of Cancer Etiology, Department of Population Sciences, City
of Hope National Medical Center/Beckman Research Institute, 2007
-present
Professor Emerita, Department of Preventive Medicine, Keck School of Medicine,
University of Southern California, 2007-present
Adjunct Professor, School of Community and Global Health, Claremont Graduate
University, Claremont Colleges, 2008-effective through 6/30/2017.
Past Appointments – City of Hope
Administrative Appointments at City of Hope National Medical Center:
Dean for Faculty Affairs (2007-2014)
Past Appointments - University of Southern California
Administrative Appointments
University Vice Provost for Medical Affairs, 2003-2004
Senior Associate Dean for Faculty Affairs, Keck School of Medicine, 1996-2003.
Program leader (with Michael Press, MD, PhD), Women’s Cancer Program,
USC/Norris Comprehensive Cancer Center 2003-2007
Academic Appointments
Professor, Department of Preventive Medicine 1991-2007
First holder of the AFLAC, Incorporated, Chair in Cancer Research, 1998-2007
Scientific Director, Cancer Surveillance Program of Los Angeles County,
1988-present.
Associate Professor, Department of Preventive Medicine (with tenure), 1988-1991
Assistant Professor, Department of Preventive Medicine, 1985-1988
Assistant Professor of Research, Department of Preventive Medicine, 1982-1985
Research Associate, Department of Preventive Medicine, 1981-1982
Research Assistant, (Dr. Malcolm Pike). Department of Preventive Medicine,
1978-1981
Research Assistant, Division of Community Programs and Social Policy, Andrus
Gerontology Center, University of Southern California, 1977-1978
Adjunct Professor, School of Public Health, University of Texas, Houston, 2009
-2011
2
Leslie Bernstein, PhD
Honors and Awards
Alumni Regent's Scholarships, University of California, Los Angeles, 1956-1957 and
1957-1958
DHEW Undergraduate Fellowship in Biostatistics, University of California, Los Angeles,
1958-1959.
Highest Honors in Mathematics, University of California, Los Angeles, 1965
Outstanding Student Award, Leonard Davis School of Gerontology, University of
Southern California, Los Angeles, 1977
Second prize, Western North American Region of the Biometric Society Student Paper
Competition, 1982
USNC/UICC Travel Grant Award to participate in the XVth International Cancer
Congress, Hamburg, Germany, 1990
Phi Kappa Phi, All-University Honor Society, University of Southern California Chapter,
elected to membership, 1998
Recipient of the Presidential Medallion, University of Southern California’s highest
honor, 2000.
Recipient, Elaine Stevely Hoffman Achievement Award, in recognition of
extraordinary dedication and service to the Keck School of Medicine, 2001.
Presenter, Third Annual Advances in Cancer Prevention Lecture, National Cancer
Institute, 2003.
Recipient, American Society for Preventive Oncology Distinguished Achievement Award, 2003.
Presenter, First EGRP Visiting Scholar Lecture, Epidemiology and Genetics Research
Program, National Cancer Institute, 2005.
Nominee, Los Angeles Business Journal Executive of the Year award, 2005.
Cutter Lectureship, Harvard University, 2005.
Meadow Brook Lecture, Wayne State and Oakland universities, 2006.
Slone Memorial Lecture, Boston University, 2006.
Recipient, Brinker Award for Scientific Distinction in the Field of Clinical Science,
Susan G. Komen for the Cure Foundation, 2007.
Recipient, AACR-Cancer Research and Prevention Foundation Award for Excellence in
Cancer Prevention, 2007.
Judith P. Schlager Lecture, Breast Cancer: Current Controversies and New Horizons,
Harvard Medical School, Boston, MA 2008.
Recipient, 9th Rosalind E. Franklin Award for Women in Science, National Cancer Institute,
National Institutes of Health, 2010.
Ruell A. Stallones Memorial Lecturer , University of Texas School of Public Health,
Houston TX 2010
Recipient, Abraham Lilienfeld Award for Lifetime Contributions to Epidemiology,
American College of Epidemiology, 2010.
First Geoffrey Howe Memorial Lecture. Columbia University School of Public Health, New
York City, NY, 2011
Named to Gallery of Medical and Scientific Achievement, City of Hope, 2011.
Recipient, Scientific Leadership Award, National Breast Cancer Coalition, 2014.
First Mentor of the Year Award, Beckman Research Institute, City of Hope, 2015.
Ron Ross Oration and Award, International Pacific Rim Breast and Prostate Cancer Symposium,
Stevenson Washington , 2015
3
Leslie Bernstein, PhD
Teaching Responsibilities – City of Hope
Lecturer/discussant – Course for molecular biology graduate students: Responsible conduct of
Research: A Successful Mentoring Experience: Finding a mentor and responsibilities
of mentee and mentor, 2008-present.
Lecturer – Clinical Investigations Training Program: Practical applications in epidemiology
observational studies, 2009-present.
Teaching Responsibilities – University of Southern California
Graduate and Medical School
Chair committees for Masters Degree and PhD students, 1982-present.
Lecturer, INTD 505, The Molecular Biology of Cancer, Spring 2006.
Lecturer, Pathology 599: Frontiers in Basic and Applied Science, 1998.
Lecturer, Preventive Medicine 517A: Research Methods in Cancer Epidemiology,
1991-1996.
Instructor, Preventive Medicine 516A & 516B: Methods and Practice of Statistical
Consulting, 1988.
Coordinator of Year 3 Medical School Curriculum in Preventive Medicine (6 week review
of biostatistics and epidemiology) 1986-1990.
Instructor, Years 1 and 3 Medical School Curriculum in Preventive Medicine (Review of
Biostatistics, How to Critically Evaluate the Medical Literature, Medical Screening,
Introduction to Statistical Analyses on Personal Computers, Introduction to
Epidemiologic Methods) 1985-1990.
Instructor, Preventive Medicine 512: Introduction to Epidemiologic and Demographic
Methods, 1981-1986.
Teaching Assistant 1977-1979:
Preventive Medicine 510: Introduction to Biometry;
Preventive Medicine 513: Experimental Designs;
School of Gerontology: 1) Aging and Social Policy,
2) Administrative Practice and Political Processes,
3) Ethnicity and Aging.
Pharmacy School
Lecturer. School of Pharmacy, Year II Course in Public Health (Introduction to
Epidemiologic Methods), 1988-1996.
Undergraduate Level
Teaching Assistant: Mathematics (Calculus, Dr. David Siegel), University of Southern
California, 1978.
Other Teaching Resposibilities
International Course
Faculty Member, Advanced Course: Quantitative Methods in Cancer Epidemiology,
International Agency for Research on Cancer, WHO, Lyon, France, August 26 September 6, 1985.
4
Leslie Bernstein, PhD
Short Course
Instructor, Summer Institute on Gerontology Two Week Intensive Course, Abolition of
Mandatory Retirement Impact and Implications, Andrus Gerontology Center,
University of Southern California, 1978.
Lecturer, Cancer and Aging, Short Course in Geriatric Medicine, Pacific Geriatric
Education Center, University of Southern California School of Medicine, 1984.
Seminar Director and Faculty Member. Biostatistics for the Occupational Medicine
Physician American Occupational Medicine Association, Los Angeles, 1984.
Lecturer. Orthopedic residency program, Martin Luther King Hospital, Charles Drew
Medical School. (Review of biostatistics; how to critically appraise the medical
literature), 1987-1989.
Faculty. USC Postgraduate Division Course, "Family Practice Intensive Refresher.
(Lecture Title: "Epidemiology for the Family Physician"), 1987.
Faculty. Doheny Eye Institute/Jules Stein Eye Institute First Annual Practical Course in
Epidemiology and Biostatistics for Ophthalmologists. February 1991.
Coordinator and instructor. Course in biostatistics and epidemiology for Obstetrics and
Gynecology Fellows at USC/Women's Hospital, Harbor General Hospital and
UCLA. 1993-1995.
Faculty, Medical and Surgical Aspects of Esophageal and Foregut Disorders:
Pathophysiology and Treatment, USC School of Medicine Postgraduate Division
and Department of Surgery.
Lecture: Changing epidemiology of esophageal and gastric cancer. 1998.
Lecture: Epidemiology of Barrett’s esophagus and its complications. 2001.
Graduate Student Committees
PhD Guidance and Dissertation Committee Chair
Carol Koprowski. RD: The effects of diet, body mass index and height on age at
menarche. (USC, Preventive Medicine: Health Behavior - American Cancer
Society pre-doctoral fellowship 1995-1996; Completed, 1998) Published in British
J Cancer, 1999; Obesity Research, 2000.
Jackie Stoddard: Can exercise reduce the frequency and intensity of mood disturbances
of premenopausal women? (USC, Preventive Medicine: Health Behavior,
Completed, 1998) Published in Eur J Appl Physiol, 2006.
Rebecca Nelson: Epidemiologic studies of non-Hodgkin’s lymphoma (USC, Preventive
Medicine: Epidemiology; Completed, 1999) Published in JNCI, 1998; JAIDS,
1999; Journal of Clinical Oncology, 2001.
Alpa Patel: Physical activity and postmenopausal breast cancer risk (USC, Preventive
Medicine: Epidemiology, completed 2002) Published in Cancer Causes
Control, 2003, Cancer, 2003.
Kathleen Ann Meeske, MSN: Fatigue in long-term survivors of lymphoblastic leukemia
(USC, Preventive Medicine: Epidemiology, Completed 2003) Published in J Clin
Oncol, 2005,
Lei Duan, MD: Impact of NSAIDS, treatment for upper gastrointestinal conditions and
passive smoke exposure on risk of adenocarcinomas of the esophagus, gastric ardia
and stomach (USC, Preventive Medicine: IPR, completed 2008) Published in
Cancer Epidemiol, Biomarkers Prev, 2008, 2009 and Br J Cancer, 2009.
5
Leslie Bernstein, PhD
Yani Lu, MD: Risk factors for non-Hodgkin’s lymphoma in the California Teachers
Study (USC, Preventive Medicine: Epidemiology, completed 2009).
Published Br J Cancer, 2009; Am J Epidemiol, 2009, PLoS ONE, 2009.
Jessica Clague, MPH: Influence of hormone therapy and physical activity on lung cancer risk
and survival (University of Texas and MD Anderson, Epidemiology, completed 2010).
Published in Cancer Epidemiol, Biomarkers Prev 2011 and PLoS One 2014.
Kayo Togawa, MPH: Impact of lymphedema in breast cancer survivors (USC, Preventive
Medicine: Epidemiology, completed 2014) Published in Breast Cancer Res 2014.
First Opponent
Inger Thune, MD, PhD: Physical activity and risk of cancer (University of Tromsø School
of Medicine (Epidemiology), Norway, completed 1997).
Tahere Moradi, MD, PhD: Risk of breast and endometrial cancer in relation to physical
activity. (Karolinska Institute, Stockholm, Sweden, completed, 2000.)PMC2813675
MS Thesis Chairman
Jeanne Kordic Emry: The association between breast cancer and meningiomas (USC,
Biometry, completed, 1984)
Wendy Mack: Use of an iterative procedure to estimate confidence limits for the relative
risk in the presence of confounding (USC, Biometry, completed,1987). Published
in J Natl Cancer Inst, 1985.
Kris Monroe: An evaluation of prenatal factors and risk of thyroid cancer (USC, Applied
Biometry, completed, 1987). Published Cancer Cause Control, 1995.
Lisa Trent: Nested case-control study of accidental death and suicide in the Leisure World
Cohort - (USC, Biometry, completed, 1987). Published in Prev Med, 1990.
Carla Rother: The study of normal and hypoplastic discs in children - (USC, Applied
Biometry, completed, 1987).
Kathy Danley: Prostate cancer in Los Angeles County: Trends in incidence and mortality
of prostate cancer (USC, Applied Biometry, completed, 1991). Published in
Cancer Causes Control, 1995.
Tom Gilman, Pharm.D: Models for predicting gentamicin pharmokinetics in pediatric
patients with appendicitis (USC, Biometry, completed, 1996).
Rebecca Nelson: A case-control study of high and intermediate grade non-Hodgkin's
lymphoma (USC, Epidemiology, completed, 1997). Published in Br J Cancer,
1997.
Presley Hayes: Pathology characteristics and survival of women diagnosed with
endometrial cancer following treatment for breast cancer (USC, Epidemiology,
completed, 2001)
Doojduen Villaluna: Screening practices among California teachers (USC, Epidemiology,
completed 2002)
La Creachia Glass: Lymphedema: Impact on breast cancer survivors (USC,
Epidemiology, completed, 2003)
Cher Dallal: Physical activity and breast cancer risk: the California Teachers Study
(USC, Epidemiology, completed, 2005). Published in Arch Int Med 2007.
6
Leslie Bernstein, PhD
Hossein Jadvar, MD, PhD: Decision Tree Sensitivity Analysis of FDG PET in Axillary
Staging of Breast Cancer (Co-chair committee for MPH at Harvard, July, 2005).
Published as a monograph.
Lei Duan, MD: Non-steroidal anti-inflammatory drugs and risk of esophageal and gastric
adenocarcinomas in Los Angeles County (USC, Biometry, completed 2007).
Published in Cancer Epidemiol Biomarkers Prev, 2007.
Carmen West: The impact of physical activity on breast cancer survival and mortality: the
California Teachers Study. (USC, Epidemiology, completed 2008). Published in
Cancer Epidemiol Biomarkers Prev, 2009.
Yani Lu, MD: Women’s risk of NHL and oral contraceptive use. (USC, Applied Biometry,
completed 2008). Published in Am J Epidemiol 2009.
Xinxin Xu: Personal hair dye use and risk of B-cell non-Hodgkin’s lymphomas among adult
women in Los Angeles County. (USC, Epidemiology, completed 2010).
Jialuo Liu: Physical activity and risk of B-cell non-Hodgkin’s lymphoma among adult women
in Los Angeles County (USC, Epidemiology, completed 2012).
PhD Dissertation Committee Member
Afsahneh Rahimian: Migration and mobility of the urban homeless (USC, Urban Planning,
completed, 1990
Sandra Carter: Effects of a school/community based health promotion program on
changes in physical activity, max VO2, weight, and percent body fat in parents of
middle school aged children (USC, Preventive Medicine: Health Behavior;
completed 1991)
Kathleen Dwyer: The relationship between physical fitness, blood pressure and cholesterol
levels in German youth (USC, Preventive Medicine: Health Behavior; completed
1991)
Deborah Gruen-Goodman, MD: Predictors of onset of menarche (UCLA School of Public
Health, Epidemiology; completed 1993)
Lihua Lu: Socioeconomic status and cancer risk among diverse populations in Los
Angeles County (USC, Sociology: Demography, completed 1996; ACS preDoctoral fellowship, 1996). Published in Cancer Causes and Control, 1998.
Jennifer Unger: Effects of social support, physical activity and widowhood on functional
status, incidence of cancer and myocardial infarction, and death in the Longitudinal
Study on Aging (USC, Preventive Medicine: Health Behavior, completed 1996).
Published in Ann Behavior Med, 1997.
Esteban Castellao, MD: Risk factors for testicular cancer (UCLA School of Public
Health, Epidemiology; completed 1998 – all research done under Dr. Bernstein’s
Direction at USC.
Terry Huang: Understanding visceral fat, subcutaneous abdominal fat and total body fat in
children: longitudinal changes and relations to metabolic risks of type 2 diabetes
(USC, Preventive Medicine: Health Behavior Research, completed 2001).
Published in Obesity Res, 2001 and 2002, Diabetes Care, 2002
Betsy Osth Lillie: AR-CAG repeat length and breast cancer (USC, Preventive Medicine:
Epidemiology – completed 2003). Published in Breast Cancer Res, 2003, Cancer
Research, 2004.
7
Leslie Bernstein, PhD
Jasmeet Gill: Oral contraceptive use, alcohol intake, smoking and risk of in situ breast
cancer (UCLA School of Public Health: Epidemiology – completed 2005 – all
research done at USC under Dr. Bernstein’s direction). Published in Cancer
Causes and Control, 2006.
Huiyan Ma: Risk factors for breast cancer by estrogen and progesterone receptor status
(USC, Preventive Medicine, Epidemiology, completed 2006). Two publications
in Breast Cancer Res, 2006, third in Breast Cancer Res Treat, 2007.
Stephanie Whisnant: Exploring the role of physical activity in DNA repair, thyroid
cancer prevention, and weight-related quality of life. (University of Washington,
Epidemiology, completed 2012). Two publications in Cancer Epidemiology, 2012;
Journal of Physical Activity and Health, 2014;
Amie Hwang: Early childhood health experience & adult phenotype in twins (USC, Preventive
Medicine: Epidemiology, completed 2012) Published in American Journal of
Epidemiology, 2013.
Jody Schnabl: Achieving faculty diversity at University of California medical schools
While maintaining compliance with proposition 209 (USC, Rossier School of
Education: EDD, completed 2012)
Anne Dee: Factors that Influence Mammographic Density - Role of estrogen metabolism
genes, biomarkers of inflammation, and lifestyle (USC, Preventive Medicine:
Epidemiology, completed 2013) Published in BMC Cancer, 2012.
John Charles Arizala Lacson: Putative functional exonic variants and breast cancer risk and
survival in the California Teachers Study (USC, Preventive Medicine: Molecular
Epidemiology, qualified 2014, will graduate 2015)
MS Thesis Committee Member
Sandra Jacoby Klein: Hospice effectiveness for significant others: meeting their needs
during a patient's final stages (California State University, Northridge, Psychology,
completed 1982). Published in Medical Care, 1985.
Donna Boone: Motion of peripheral joints of hemophiliac subjects: a ten year study (USC,
Biometry, completed 1983)
Colleen Azen: Paired comparisons between early treated PKU children and their matched
sibling controls on intelligence and school achievement results at eight years of age
(USC, Biometry, completed 1983). Published in Pediatrics, 1984.
Melody Kawamoto, MD: Respiratory effects of cotton dust exposure in the cotton.
garnetting industry (USC, Occupational Medicine, completed 1985). Published in
Am J Indus Med, 1987
Ann Tien Tze Chao: Recent trends in the incidence of adenocarcinoma of the uterine
cervix in Los Angeles County (USC, Biometry, completed 1986). Published in J
Natl Cancer Inst, 1986.
Ruth Lowengart, M.D.: Childhood leukemia and parents' exposures (USC, Occupational
Medicine, completed 1986). Published in J Natl Cancer Inst, 1987
John Barone, D.O.: Smoking as a risk factor for noise induced hearing loss (USC,
Occupational Medicine, completed 1986). Published in J Occ Med, 1987.
Robert Goldberg, M.D.: Occupational fatalities in California, 1972-1983. (USC,
Occupational Medicine, completed 1987). Published in Am J Ind Med, 1989.
8
Leslie Bernstein, PhD
David Shelton - Compliance with cancer chemotherapy: implications for improvements in
survival for patients with hematologic malignancy. (USC, Applied Biometry,
completed 1988). Published in J Clin Oncol, 1990.
Griselda Jasso - Long-term effects of rape (California State University, Los Angeles,
Psychology, completed 1989)
James R. Hackett - Analytic methods for studies with multiple repeated measurement
factors and small sample sizes (USC, Biometry, completed 1989).
Aili Gong - The comparison of the Mini-Mental State examination with the modified
Mini-Mental State Test (USC, Applied Biometry, completed 1989)
Rachel Louie - Occupation and lung cancer among females in Northern China (USC,
Applied Biometry, completed 1990). Published in Am J Ind Med, 1993.
Jerzy Lysikowski - Health related factors and risk of non-Hodgkin's lymphoma: A
case-control study of 619 pairs (USC, Biometry, completed 1990)
Yunbao Liu - A comparison of findings from City of Hope's mobile screening unit program
with data from the Los Angeles County Cancer Surveillance Program (USC,
Biometry, completed 1991)
Richard J. Paulson, MD - Cumulative pregnancy success rate after oocyte donation (USC,
Biometry, completed 1996). Published in Human Reprod, 1996.
Tmirah Haselkorn – Descriptive epidemiology of thyroid cancer in Los Angeles County,
1972-1995 (USC, Epidemiology, completed 1998). Published in Cancer Cause
Control, 2000.
Madé Wenten – Weight and weight change in breast cancer risk in Hispanic and nonHispanic whites (USC, Epidemiology, completed 2000). Published in Annals
Epidemiol, 2002.
Yaping Wang – Do reproductive factors have the same effect on breast cancer risk in
African-American and white women? (USC, Epidemiology, completed 2001).
Published in Cancer, 2004.
Dongyun Yang – Physical activity and breast cancer risk of Asian-American women
(USC, Epidemiology, completed 2002). Published in Cancer, 2003.
Yaling Teng - β3 adrenergic receptor gene TRP64ARG polymorphism and obesityrelated characteristics among African American women with breast cancer: An
analysis of the USC HEAL Study (USC – Applied Biometry, completed 2006)
Conchitina Chato Siozon – The association between recreational physical activity and
mammographic density (USC –Epidemiology, completed 2003) Published in Int
J Cancer 2006
Donald S. Minckler, MD – Aqueous shunts for glaucoma: A Cochran Review (USC –
Clinical Sciences, completed 2005). Published in Expert Rev Med Devices 2010.
Farzana Choudhury – Physical activity and sex steroid hormones (USC- Applied
Epidemiology, completed 2009). Published in Menopause, 2011.
Tao Feng – Genetic correlates of the timing of natural menopause: the Breast and Prostate
Cancer Cohort Consortium (USC – Applied Epidemiology, completed 2010)
Mary DeHaven – Survival in de novo metastatic breast cancer: Association with
clinicopathologic and treatment-related factors (USC –Applied Epidemiology,
completed 2011)
9
Leslie Bernstein, PhD
Post-Doctoral Fellows
Chisato Nagata, M.D. - studies of risk factors for immunoblastic B-cell lymphoma;
development of a study of familial risk of prostate cancer (Professor – Gifu
University, Japan).
David Olayeye, M.D. - Fogarty fellow - studies of the prevalence of HIV-1, HIV-2,
HTLV-1 and HTLV-2 in Nigeria. (Faculty position at the University of Ibadan,
Nigeria)
Lisa Shames, Ph.D. - studies of the effects of exercise on hormonal patterns of college
students. (Research position at Amgen)
Shelley M. Enger, M.P.H., Ph.D. - Alcohol and risk of estrogen-receptor positive breast
cancer (California Breast Cancer Research Program post-doctoral fellowship,
1995-1997); Hormone receptor status, body mass index and breast cancer survival
(California Breast Cancer Research Program post-doctoral fellowship, 1997
-1999).(Epidemiologist at Kaiser Permanente Southern California)
Catherine L. Carpenter, M.P.H., Ph.D. - Physical activity: impact on early hormonal
patterns and breast cancer risk among young and older women (California Breast
Cancer Research Program post-doctoral fellowship, 1995-1998). Long-term
survival among young breast cancer patients (NIH Post-doctoral fellowship, 1998
-2000) (Faculty position – University of California, Irvine; UCLA)
Hyacinth Mason, Ph.D. - Factors affecting African American and white women's
participation in breast cancer clinical trials (ACS Pilot Funds, 1996-1998; NIH
Training Grant, 1997-1999). (Faculty position – Vanderbilt University)
Carol Koprowski, M.S., PhD - Exercise, diet, energy balance and onset of menarche,
(California Breast Cancer Research Program post-doctoral fellowship, 19971999). (Faculty position – California State University, Northridge; now Asst Prof,
University of Southern California)
Deirdre Hill, M.P.H., PhD - Breast cancer and medical radiation (grant support: 19971998; California Breast Cancer Research Program postdoctoral fellowship, 19982000). (Epidemiologist at the National Cancer Institute; now Asst Prof, University
of New Mexico)
Warren Wen, M.D., PhD – Does tamoxifen preferentially induce endometrial cancers with
p53 mutations? (California Cancer Research Program grant, 1999-2001)
(Completing residency in family medicine)
Maya Mahue-Giangreco, PhD –Abortion and breast cancer; smoking and breast cancer
risk. (2001-2004)
Kathy Meeske, PhD, MSN – Predictors of fatigue in breast cancer patients; long-term
impact of treatment on childhood cancer survivors (NIH post-doctoral fellowship,
2004-2006) (Asst Prof, Pediatrics and Preventive Medicine, University of
Southern California)
Phuong Mai, MD – Colon cancer –descriptive epidemiology among Asians; physical
activity and colon cancer risk; NSAIDs and colon cancer risk (NCI training grant
to City of Hope (medical genetics), 2004 – 2006)(Staff Scientist, NCI, DCEG,
Clinical Genetics Branch)
Katherine Delellis Henderson, PhD – Environmental and genetic predictors of menopause;
hormonal therapy and risk of ovarian, colon and breast cancer (NIH post-doctoral
fellowship (gerontology), 2005-2007) (Assistant Research Professor, City of Hope).
Jennifer Prescott, PhD – Reproductive and hormonal factors and risk of NHL in women
10
Leslie Bernstein, PhD
(NIH post-doctoral fellowship (gerontology), 2007)(Instructor, Harvard University
School of Medicine).
Christina Diele-Conwright, PhD – Impact of physical activity interventions on symptoms
associated with aomatase inhibitor treatment for breast cancer (2009-2011)./Assistant
Professor, Division of Physical Therapy, University of Southern California
Yani Lu, MD, PhD – Do risk factors for breast cancer predict survival? (California Breast
Cancer Research Program Postdoctoral Fellowship, 2009-2011)/Assistant Research
Professor, Beckman Research Institute, City of Hope..
Aina Emaus, MD, PhD – Analyses of a cohort of Norwegian women (Fulbright fellowship
and funding from the government of Norway, 2009-2010)
Preceptor/Mentor for Trainees
Preceptor, Year III and Year IV research rotation in Preventive Medicine, 1986-2007.
Preceptor/mentor, City of Hope National Medical Center Fellowship in Surgical Oncology
- research/elective year and Post-doctoral Fellowship Training Program - 1987 to
2007.
Preceptor, CHLA Professional Oncology Fellowship Program, 1986, 1988.
Mentor, University of Southern California School of Gerontology Pre/Post-doctoral Fellowship
Training Program, 2005-present.
Mentor, Institute for Prevention Research Pre/Post-doctoral Fellowship Training Program,
1993-2007.
Preceptor/mentor, Health Promotion and Disease Prevention undergraduate major, 1998
-2007.
Preceptor/Mentor, Biomedical Engineering undergraduate major, 2006- 2007.
D. SERVICE
State, National and International Committees
Current
Member, Editorial Board, JAMA Oncology, 2014-present
Member, Cohort Consortium Steering Committee, 2014-present
Member, External Advisory Committee, Seattle Cancer Consortium Breast SPORE, Fred
Hutchinson Cancer Research Center and University of Washington, 2011-present
Deputy Editor, Breast Cancer Research, 2011-present
Member, External Advisory Committee, UT MD Anderson Comprehensive Cancer Center,
2009-present.
Member, Breast Cancer Care & Research Fund Advisory Committee, 2009-present.
Member, USC Environmental Health Center, Career Development Committee, 2010-present.
Member, Scientific Advisory Committee, Three Generation Breast Cancer Cohort, 2009
-present.
Member, Scientific Advisory Board of the Susan G. Komen for the Cure Tissue Bank at the
IU Simon Cancer Center, 2008-present
Member, Editorial Board, Obesity, 2007-present
Member, Scientific Advisory Committee for ACS Cohorts, American Cancer Society,
2006-present.
Member, Scientific Advisory Committee, Breast Cancer Action, 2006-present.
Member, Breakthrough Generations Study Scientific Advisory Committee, London,
11
Leslie Bernstein, PhD
England, 2004-present.
Member, Advisory Board, Genetic Epidemiology Research Institute, University of
California, Irvine, 2004-present.
Member, Young Survivors Coalition’s Medical Advisory Board, 2003-present.
Chair, External Advisory Committee, Nurses Health Studies, Harvard University, 1995present
Member, Permanent Scientific Committee, International Organization for Statistical
Studies on Diseases of the Esophagus (O.E.S.O.), 1994-present
Past
Chair, Scientific Advisory Committee, Texas Mexican-American Cohort Study,
University of Texas-MD Anderson Comprehensive Cancer Center, 2002-2014.
Member, Women in Cancer Research (WICR) Council, American Association for Cancer
Research, 2011-2014.
Member, Center for Environmental Health and Susceptibility External Advisory
Committee, University of North Carolina School of Public Health, 2004-2014.
Chair, The Sisters Study Scientific Advisory Board, National Institute of Environmental
Health Sciences, 2003-2012.
Member, Board of Directors, Da Costa International Program for Breast Cancer
Prevention, 2003-2011.
Member, External Advisory Committee, University of Hawaii Cancer Research Center, 1997
-2007, 2010-2012.
National Cancer Institute
Member, Division of Cancer Control and Populations Sciences Cohort Working
Group, 2007-2008
Member, Board of Scientific Counselors, 2001-2006
Epidemiology Working Group, Committee on Best Practices Ensuring Confidentiality
in the Conduct of Clinical Research, 1999-2000.
Department of Defense Breast Cancer Research Program
Member, Abstract Review Committee, Era of Hope 2011 meeting
Member, Technical Program Committee, Era of Hope Meeting, scientific chair Day 2
-Prevention; 2001-2002
Member, Technical Program Committee, Era of Hope Meeting, scientific chair Day 1;
2004-2005.
Member, Integration Panel 2000-2003.Member,
Member, Technical Program Committee, Era of Hope Meeting, 1999-2000.
American Association for Cancer Research
Member, AACR, Selection Committee for the 2014 AACR-Women in Cancer
Research Charlotte Friend Memorial Lectureship, 2013
Chair, AACR Cancer Epidemiology and Prevention Award Selection Committee, 2010
-2011.
Member, Scientific Review Committee, Frontiers in Cancer Research, 2010 meeting
Chair, Nominating Committee, for position of MEG Chair, 2009
Member, Scientific Review Committee, Frontiers in Cancer Research, 2009 meeting
Co-Chair, Women in Cancer Research Mentoring Forum 2010 meeting
Organizer, Educational Session, Annual Meeting 2008
Co-Chair, Scientific Program Committee for Frontiers in Cancer Prevention Meeting,
12
Leslie Bernstein, PhD
2007-2008
Reviewer AACR-NCI International Investigator Opportunity Grants, 2008
Member, 2004-2005 Local Liaison Committee for Annual Meeting
Member, Awards Committee 2004-2005
Member, Scientific Committee, 2nd AACR Frontiers in Cancer Prevention Research
Conference, 2002-2003
American Cancer Society
Member, Search Committee, Vice President of Epidemiology for ACS, 2008.
Member, Department of Epidemiology and Surveillance Research Advisory
Committee, 1999.
Member At Large, Board of Directors, California Division, 1998-2001.
Member, Breast Health Initiative Team, California Division, 1998-2000.
Member, Data Committee/Data Work Team, California Division, 1994-1997.
Member, Breast Health Committee, California Division, 1994-1997.
Co-Chair, 2011 North American Epidemiology Congress, Montreal, June 2011
Member, Society for Epidemiologic Research, Board of Directors/Executive Committee,
2007-2010 and local meeting chair, for 2009 meeting in Anaheim
Member, Marin County, CA, Breast Cancer Scientific Advisory Group, 2002-2010.
Member, External Advisory Committee, Program Project Grant, Barrett's Esophagus:
Predictors and Progression, Brian J. Reid, PI, University of Washington, 2002
-2010.
Member, Scientific Advisory Committee for WINCART: Weaving an Islander Network
For Cancer Awareness, Research and Training, NCI-funded Community Network
Program, Cal State Fullerton, 2005-2009.Co-chair, American Cancer Society Breast
Member, National Advisory Environmental Health Sciences Council (NAEHSC) Working
Group on Breast Cancer and the Environment, 2003-2006.
Cancer Prevention Forum, 1998-2000
Member, SEER Patterns of Care Data Use Committee, 2002-2007
Member, Scientific Advisory Committee, Registry for Research on Transplacental
Carcinogenesis (DES Registry), University of Chicago, 1997-2006.
Co-chair, External Advisory Board for University of South Carolina Center for Cancer
Research Excellence, 2006-2008.
Member, Strategy Team, California Breast Cancer Research Program’s Special Research
Initiatives, 2006-2008.
Member, City of Hope Comprehensive Cancer Center Scientific Advisory Committee,
2004-2007.
Member, Scientific Advisory Panel for conference on Research Needs in Environmental
Exposures and Breast Cancer Risk, UC Berkeley, 2001
Member, National Breast Cancer Coalition Fund’s Environmental Advisory Committee,
2000-2002.
Vice Chair, External Advisory Committee, National Network for Research on Causes of
Cancer in Children, 1999-2001.
13
Leslie Bernstein, PhD
Chair, External Advisory Committee, Long Island Breast Cancer Study, Columbia
University, 1994-2000
Expert Reviewer, State Master Plan on Breast and Cervical Cancer, California Elected
Women’s Association for Education and Research, 1999.
Reviewer, Breast Health Compendium, Harvard Center for Cancer Prevention, 1999
Member, External Advisory Board, UC San Francisco School of Medicine Breast
Cancer SPORE Grant, 1998-2002.
Member, External Advisory Board, Netherlands Cancer Center, 1998-1999.
Member, External Scientific Advisory Committee, New York City Cancer Project, 19981999.
Participant, Breast Cancer Prevention Trial Workshop, Construction of Risk/Benefit
Analysis and Risk Perception/Communication, 1998.
Member, External Advisory Committee, Northern California Cancer Center, 1997-2000
Past president/President/President-elect - Society for Epidemiologic Research, 1995-1998.
Member, Editorial Board, SEER Monograph on Childhood Cancer, 1996-1999.
Member, Board of Reviewers, Harvard Report on Cancer Prevention, 1995-1996.
Member, Working Group on Methodological Problems in Measuring Cancer in Hispanics.
North American Association of Central Cancer Registries, 1995-1997.
Member, Editorial Board, SEER Monograph on Special Populations, 1995.
Member, Program Committee, North American Association of Central Cancer Registries,
1994-1995, 1995-1996.
Member, Publications Committee, North American Association of Central Cancer
Registries, 1993-1995.
Voluntary Faculty, National Breast Cancer Coalition’s Project Lead, 1993-2001.
Member, Technical Advisory Committee, American Association of Central Cancer
Registries Cancer Surveillance and Control Program, 1991-1993.
Member, Program Committee, California Cancer Registries Conference, California Tumor
Registry, 1990, 1993-2003.
Member, Governor's Scientific Advisory Panel, Proposition 65: Safe Drinking Water and
Toxic Enforcement Act, California Health and Welfare Agency, 1989-1992.
Grant and Contract Review
National Institutes of Health,
Reviewer, Cancer Therapy Evaluation Program, Division of Cancer Treatment and
Diagnosis, NCI, External Evaluators of Phase Three Concepts, Role of Weight
Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast
Cancer, 2015
Member, Review Committee, Lasker Clinical Research Scholars Awards, 2013
Member, Editorial Board, NIH Director’s Early Independence Award (EIA), 2012
Reviewer, NCI Breast Cancer Steering Committee project review, 2012
Review, NIH Gulf Oil cohort study, 2011
Reviewer, NCI Biomarker, Imaging and Quality of Life Supplemental Funding
Program, 2008
Reviewer, NIH Director's New Innovator Award Program, NIH, 2007
Member, Subcommittee E, Study Section, National Cancer Institute, 2007-2009
14
Leslie Bernstein, PhD
Co-chair, External Review Committee and Board of Scientific Counselors
Member, Occupational Epidemiology Branch, National Cancer Institute,
May 2003
Chair, External Review Committee and Board of Scientific Counselors Member,
Biostatistics Branch, National Cancer Institute 2002 and 2006
Chair, External Review Committee and Board of Scientific Counselors Member,
Environmental Epidemiology Branch, National Cancer Institute, 2002.
National Cancer Institute, Center for Cancer Research, Intramural Research
Award, 2002
National Cancer Institute, DCEG, Intramural Research Awards, 2002, 2004, 2006
National Institute for Child Health and Development, Intramural Research Award,
2002.
National Cancer Institute, Environmental Epidemiology Branch, Program Review,
External Reviewer, 1998
National Institute for Environmental Health Sciences, Epidemiology Branch,
External Reviewer, 1996, 2007
Grant reviewer, World Cancer Research Fund International, 2015
Member, Scientific Review Panel, MD Anderson R Lee Clark Fellows Awards, 2014-present
Susan Komen Foundation for the Cure, Chair, Epidemiology Study Section, 2007,
member, 2008-2009.
American Cancer Society review - scientific programs, 1999; CPS-3 2006, 2009-present
National Cancer Institute of Canada,
Panel C, Epidemiology, 1999
Chair, Program Project Grant Review, 2005-2006
Alberta (Canada) Cancer Board, 1994, 1998, 2000-2002, 2008.
American Institute for Biological Sciences, 1997.
Department of Defense, US Army Funds for Breast Cancer Research,
Chair, Epidemiology, 1B Study Section, 1994.
Member, Integration Panel, 2000-2003.
Ad hoc member, Integration Panel, 2004.
State of California, Department of Health Services Alzheimer's Disease Program,
Technical Review Panel (No. 3, Neuroimaging, Neuropsychology,
Epidemiology), 1992.
Kaiser-Permanente Research Committee, 1984
Haynes Foundation, 1985
National Science Foundation, 1987
USC Comprehensive Cancer Center Scientific Review, 1987-1990
USC Faculty Research Innovation Fund (FRIF), 1988-1990
USC Medical Faculty Women's Research Fund, 1989-1991
USC BSRG Grant Review, 1992
USC Research Committee/IRB 1993
City of Hope Service
Member, Search Committee, Director of the Beckman Research Institute, 2014
Interim Chair, Department of Population Sciences, 2014-present
Member Search Committee, Chair Department of Population Sciences, 2014-present
Member Various Search Committees for faculty in the Department of Population Sciences, as
15
Leslie Bernstein, PhD
needed
Dean for Faculty Affairs, 2007-2015
Member, Data Warehouse Advisory Board, 2008-present
Member, Cancer Center Senior Leadership Group, 2008-2009.
Ex-Officio Member, Faculty Senate Executive Committee, 2008-2014
Member, CRIME Committee (bioinformatics and clinical information systems), 2007-present
Member, Postdoctoral Training Office Advisory Committee, 2009-2013
Member, Steering Committee, Women’s Cancers Program, 2010-present.
Chair, Strategic Planning Committee – Education, 2011-2012.
Member, Scientific Professional Development Committee Meeting, 2012-present.
University Service (USC)
Member, School of Gerontology Dean Search Committee, 2005-2006.
Member, Templeton Foundation Interdisciplinary Committee, 2004-2006.
Member, University Strategic Planning Committee, 2003-2007.
Member, University Academic Review Committee (3 member internal review committee),
School of Gerontology, 2003.
Member, Data Safety Monitoring Committee. Grant CA084424: Biomarkers of Barrett’s
esophagus and adenocarcinoma, 2002-2004.
Member, University/Los Angeles County Hospital Performance Workgroup, 2001-2004
President, Advisory Committee, Friends of the Norris Medical Library, 2000-2004.
Member, Provost’s Committee for the Review of Academic Leaders and Faculty,
Subcommittee on Faculty Review, 1998.
Member, University Employee Benefits Committee, 1997-1999.
Member, Academic Senate White Paper Committee: Faculty Accountability, 1997.
Member, Provost's Emergency Committee for the Future of the Medical School, 1995-1996.
Member, Joint University/Senate Research Committee, 1994-1996.
Member, Provost's Advisory Search Committee for the Vice-Provost for Research and
Dean of the Graduate School, 1994.
Faculty Representative, Academic Affairs Committee of the University Board of Trustees,
1993-1995.
Member, Provost's Advisory Committee, 1993-1994.
Member-at-large, Executive Committee, Academic Senate, 1993-94, 1994-95.
Member, Commission on the Future of the University, USC Faculty Senate, 1992.
Member, Research Committee, USC Faculty Senate, 1986-1988.
Keck School of Medicine Service (USC)
Member, Search Committee, Chair, Department of Pediatric Surgery, Childrens Hospital
of Los Angeles, 2003-2004.
Member, Search Committee, Chair of Neurosurgery, 2003-2004.
Member, Collegium of Medical Educators Foundation Committee, 2002-2004
Member, USC Care Medical Group Fellows Taskforce, 2000-2001.
Member, Institutional Biosafety Committee, 2000-2001.
Member, Search Committee, Chair of Pediatrics, 1999-2000.
16
Leslie Bernstein, PhD
Member, School of Medicine “Report Card” Task Force to assess accomplishments of
the School’s strategic plan, September, 1998-2000.
Chair, Governance Task Force, December,1997-May, 1998.
Member, Task Force on Future Tenure at CHLA, December, 1997-2000.
Member, Finance Committee, 1996-2000.
Member, Economic Security Task Force, 1996.
Member, Productivity Committee, 1996.
Chair, Medical School Admissions Committee, 1993-1996.
Member, Budget Advisory Committee, 1995.
Chair/Member, Advisory Committee, Admissions, 1993-1998.
Member, MD-PhD Admissions Committee, 1992-1993.
Member, Medical Student Research Committee, 1991-1996.
Interviewer, MD-PhD Admissions Committee, 1991-1993.
Member, Year 3 Curriculum Committee, 1988-1992.
Interviewer, Admissions Committee, 1985-1988.
Member, USC/Norris Comprehensive Cancer Center Breast Cancer Research Advisory
Committee, 1994-2000.
Member, USC Comprehensive Cancer Center, 1984-2007.
Biostatistician, Cancer Center, 1982-1989.
Member, USC Medical Faculty Women's Association, 1983-2004.
Senior Member-at-Large, Executive Committee, 1988-1989.
Member-at-Large, Executive Committee, 1987-1988.
Membership Committee, 1987-1990 (co-chair, 1988-1989, 1993-1994)
Professional Development Committee, 1987-1995.
Publications Subcommittee, 1987-1991.
Biostatistical consultant, various clinical departments, USC School of Medicine,
1984-2001.
Department of Preventive Medicine Service (USC/Keck School of Medicine)
Interim Vice Chair, Department of Preventive Medicine and Chair, Faculty Appointments
and Promotions Committee, 2006-2007
Southern California Environmental Health Science Center Internal Advisory Committee,
2005-present
Search Committee, Statistician for CHLA, 2001-2003
Epidemiology Graduate Program Oversight Committee, 1994-2002.
Director, Medical Record Validation Core Resource, 1987-1997
Curriculum Committee, 1986-1988.
Biometry Graduate Program Oversight Committee, 1984-1997.
Computer Needs Committee, 1984-1987.
Liaison Committee on Applied Epidemiologic Research, Behavioral Health Institute
(Pharmacy) and Department of Preventive Medicine, 1984-1986.
Search Committees, 1984-1985; 1987-1990.
Reviewer, Scientific Manuscripts and Other Journal Service
American Journal of Epidemiology
Member, Board of Overseers, 1996-1998
American Journal of Obstetrics and Gynecology
17
Leslie Bernstein, PhD
American Journal of Public Health
Annals of Epidemiology
Archives of Internal Medicine
Arteriosclerosis, Thrombosis and Vascular Biology
Biometrics
BMC Public Health
BMC Medical Research Methodology
Breast Cancer Research
Deputy Editor, 2011-present
Breast Cancer Research and Treatment
British Journal of Cancer
British Journal of Sports Medicine
Cancer
Cancer Causes and Control
Cancer Detection and Prevention
Cancer Epidemiology, Biomarkers and Prevention
Member Editorial Advisory Committee, 1995-1998;
Associate Editor, 1998-2002
Cancer Prevention Research
Cancer Research
Clinical Breast Cancer
Clinical Cancer Research
Contraception
Environmental Science and Technology
Epidemiology
Member, Editorial Board, 5-yr term, 2003-2008
Expert Opinion in Pharmacotherapy
Ethnicity and Disease
European Journal of Cancer and Clinical Oncology
International Journal of Cancer
International Journal of Epidemiology
JAMA
JAMA Oncology
Member Editorial Board, 2014-present
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Journal of Clinical Oncology
Journal of Neurosurgery
Journal of the American Medical Association
Journal of the National Cancer Institute
Journal of Sports Science and Medicine
Journal of Women’s Cancer (formerly Women and Cancer)
Member, Editorial Board, 1998-2005
Medical and Pediatric Oncology
Medicine and Science in Sports and Exercise
Nature Reviews Cancer
Nature Reviews Drug Discovery
New England Journal of Medicine
18
Leslie Bernstein, PhD
Nutrition and Cancer
PLoS Medicine
Obesity
Member, Editorial Board, 2007-present
Obstetrics and Gynecology
Radiation Research
Seminars in Oncology
Sports Medicine
The Cancer Journal
Women & Health
Consultantships
Wake Forest Comprehensive Cancer Center, consulting on Cancer Prevention and Control,
2010.
Duke Comprehensive Cancer Center, consulting on Cancer Prevention, Detection and
Control Research Program, 2005
Cepheid Corporation, Sunnyvale, CA: Statistical consultant, 2004-2006
UMDNJ and Cancer Institute of New Jersey, consulting on Cancer Control and
Population Sciences program, 2003.
Julie Britton, K07 Award, Mt. Sinai Medical School, mentor, 2002-2007.
Member, Consultant Committee, University of Utah Health Sciences Center Epidemiology
Initiative, 2002.
Vysis Corporation, Chicago, IL: Statistical consultant, 1999-2003.
Member, Permanent Epidemiology Advisory Board, Strategic Consultants International,
1998-2000
California Family Health Council: Phase II/III contraceptive efficacy trial: comparing the
male latex condom and male non-latex condom. NICHD/CD-95-02. Consulting
epidemiologist, 1997-2003.
Ann Chao, PhD, Preventive Oncology Award, University of New Mexico/American
Cancer Society, mentor, 1998-2003
Mary Croughan-Minihane, PhD, Department of Epidemiology and Biostatistics,
University of California, San Francisco: NCI Grant, “Fertility Drugs and Ovarian
Cancer,” 1996-2001.
Oncor, Inc., Gaithersburg, MD: Statistical consultant for assays demonstrating utility and
efficacy of HER-2/neu DNA probe, 1995-1998.
Office of Disease Prevention and Health Promotion, Assistant Secretary for Health, US
Department of Health and Human Services, National Action Plan for Breast
Cancer, Breast Cancer Core Questionnaire Development Project, 1995-1996.
Jacquelin Perry, MD, Pathokinesiology Laboratory, Rancho Los Amigos Medical Center:
NINDS Grant, "Recovery and Rehabilitation of Gait in Stroke Patients," serve as
biostatistical consultant, 1995-1998.
Esther M John, PhD: Case-control study of breast cancer among Hispanic women (NCIfunded), Northern California Cancer Center, 1995-2000.
Los Angeles Oncology/St. Vincent’s Hospital: Implementation of a Prostate Cancer
Screening Program among African American Men in Los Angeles. 1995-2002.
19
Leslie Bernstein, PhD
Los Angeles Regional Family Planning Association: Improving intrauterine contraception:
antibiotic prophylaxis at the time of IUD insertion. NICHD/N01-HD-1-3112.
Consulting biostatistician. 1993-1997
International Association of Cancer Registries and National Cancer Institute: developing
epidemiologic research capabilities of Latin American cancer registries October,
1991, Quito, Ecuador.
National Cancer Institute FIRST award to Sally Glaser, Ph.D.: "Reproductive Factors in
Hodgkin's Disease": 1989-1994.
National Institute of Justice: Drug Testing Technologies Study, 1988-1991.
National Institute of Child Health and Human Development, Workshop on Oral
Contraceptives and Breast Cancer, Consultant, 1986.
Research Triangle Institute and Environmental Protection Agency: Development of
software for analysis of genetic toxicology data 1985-1986.
Division of Geriatric Medicine, Department of Medicine, University of California, Los
Angeles, Consulting biostatistician, Hospice Evaluation Project, 1981-1984.
Department of Biochemistry and Lawrence Berkeley Laboratories, University of
California, Berkeley, Consulting biostatistician, Carcinogenic Potency Project,
1980-1995.
Lawrence Berkeley Laboratories, University of California, Berkeley, Consulting
biostatistician, Salmonella test project, 1980-1982.
Department of Hematology, Oncology, Children's Hospital, Los Angeles, Consulting
biostatistician, 1980.
City of Los Angeles Area Agency on Aging, Consulting biostatistician, 1977-1978.
Health Systems Agency of Los Angeles County, Development of Health Systems Plan for
Long-Term Health Care in Los Angeles County, 1977.
E. OTHER PROFESSIONAL ACTIVITIES
Membership in Professional Societies
American Association for Cancer Research, 1995-present
Member, Molecular Epidemiology Working Group, 1998-present
Member, Women in Cancer Research, 2000-present
American Epidemiology Society, 1997-present
Member, Membership Committee, 1997-2003 (Chair, 2003)
Member, Nominating Committee, 2002-2003
American College of Epidemiology, 1987-present
Elected to Fellow, 1994
Member, Nominating Committee, 2001
American Public Health Association, 1980-1982
American Statistical Association, 1980-1993
Biometrics Society, 1980-2000
Caucus for Women in Statistics, 1989-present
20
Leslie Bernstein, PhD
Gerontological Society of America, 1976-1984.
Chairperson, Student Section, 1977-1979.
Member, Finance Committee, 1978-1980.
International Epidemiological Association, 1990-present
International Society for Environmental Epidemiology, 2000-present.
Society for Epidemiologic Research, 1984-present
Selection committee, Student Prize Paper, 1994.
President-elect, 1995-1996.
President, 1996-1997.
Past president, 1997-1998.
Faculty, Student Workshop, 2000
Year 2002 and 2009 Meeting Host
Elected member, Board of Directors/Executive Committee 2007-2010
Western Gerontological Society, 1976-1983
Other Activities
Center Fellow, UCLA/USC Long Term Care Gerontology Center, 1981-1987
F. RESEARCH ACTIVITIES
Major Areas of Research Interest
Epidemiology of Breast Cancer and Other Hormone Dependent Tumors
Cancer Risk and Exposure to Exogenous and Endogenous Hormones
Effects of Exercise and Diet on Onset of Puberty and on Hormonal Patterns
Factors Affecting Breast Cancer Prognosis and Quality of Life
Long-term Health Risks and Benefits of Cancer Therapies
Descriptive Epidemiology of Cancer in Los Angeles County
Epidemiology of Non-Hodgkin's Lymphoma and Other Hematologic Malignancies
Epidemiology of Adenocarcinoma of the Esophagus and Stomach
Methods for Epidemiologic Research: Cohort Studies and Case-control Studies
Current Research Activities:
Principal Investigator
NCI/R01 CA77398/Breast and Other Cancers in the California Teachers’ Cohort/Current
year’s support, $2,643,925/9-25-98 to 8-31-16 (PI, 2006 onward).
NCI/ U01 CA199277 Innovative Infrastructure to Enhance the California Teachers Study/PIs: Lacey
and Bernstein, L,$2,500,000/09-01-2015 to 08-31-2020
Co-investigator
NCI/R01 CA129639-02/Genome-Wide Association Study of Radiation Exposure and Bilateral
Breast Cancer/J Bernstein, Memorial Sloan Kettering, PI; L Bernstein PI of
subcontract/4-1-09 to 2-29-16
NCI/R03 CA162140/ Parental age at birth and risk of adult-onset cancer in female offspring/Y
Lu/$50,000/4-1-12 to 3-31-14
NCI/R01 CA166210/Molecular epidemiology of non-Hodgkin lymphoma prognosis and
21
Leslie Bernstein, PhD
prevention/S Wang/$380,400/4-17-12 to 3-31-17
NCI/UM1 CA169417/New biospecimens to enhance research in the California Teachers Study
Cohort/J Lacey/9-15-12 to 9-14-16.
NCI/R01 CA170394 /Where were you then? New insights into breast cancer and the environment
(PQ2)/Peggy Reynolds, Cancer Prev Institute of CA, PI; Leslie Bernstein PI of
subcontract/$10,000/9-1-12 to 8-31-15
CBCRP/16-NB-8501-COH/Persistent organic pollutants and breast cancer risk/Peggy Reynolds,
Cancer Prevention Institute of CA, PI; Leslie Bernstein PI of subcontract/$45,000/12-1
-10 to 11-30-15
NCI/R03 CA179558/Autoimmune conditions, genetic variations and lymphoma etiology/Sophia
Wang/$50,000/4-2-14 to 3-31-16
NCI/R03 CA188549/ A pooled analysis for risk factors of triple negative breast cancer/Huiyan
Ma/$50,000/9-18-14 to 8-31-16
Previous Research Activities
Principal Investigator
American Cancer Society Institutional Research Grant/Feasibility of Retrieving Physician
Prescribing Records to Establish Reliability of Recall of Oral Contraceptive Use
Histories/L Bernstein/$7500/5-1-86 to 4-30-87
NCI/CP41077/Leukemia and Preleukemia following Chemotherapy for Breast Cancer/L
Bernstein/$69,981/9-30-86 to 12-31-87
NCI/CP71123/Record Linkage Study of Leukemia Following Radiotherapy for Uterine
Corpus Cancer/$76,226/9-30-87 to 3-31-89
USC/Faculty Innovation Research Fund/A Case-Control Study of Testis Cancer in Young
Men/$13,333/7-1-88 to 6-30-89
USC/BRSG Award/Evaluation of Effects of Prenatal Estrogen and Testosterone
Administration of Incidence of Teratomas in Susceptible Male Mice/$6,869/9-1-88
to 3-31-89
Wright Foundation/Tamoxifen Therapy for Breast Cancer and Risk of Endometrial
Cancer: A Case-Control Study/$39,712/7-1-89 to 6-30-90
NCI/CA22849/Second Cancer in Patients with Hodgkin's Disease/G Hutchison-R Monson
(Harvard University)/$1,073,314/2-1-86 to 1-31-91/Collaborative Study/
Co-investigator: Subcontract/L Bernstein/$203,927/2-1-86 to 1-31-91
American Cancer Society/CCG258/Collaborative Pediatric Cancer Clinical Trials:
Protocol vs. Non-Protocol Patients - A Population Study/$36,496/3-1-90
NCI/CA44546/Case-Control Study of Breast Cancer in Young Women/L Bernstein,
PI/$584,378/4-1-87 to 3-31-92
NCI/CA17054/USC Cancer Center Epidemiology & Biostatistics Unit: Iatrogenic Causes
of Cancer (Program Project Grant)/RK Ross, PI; L Bernstein,
Co-inv/$7,546,634/4-1-87 to 3-31-92/ Projects: Case-control study of breast
cancer in young women - validation component/L Bernstein, PI
American Cancer Society/CCG-271/Cancer Control Grant/Incidence, Survival and
Mortality of Pediatric Cancer Patients: The Wider Effects of Cooperative Group
Trials/ 5-1-91 to 4-30-92/$39,899
22
Leslie Bernstein, PhD
NIH/NCI-N01-CN-15364/Study of Effects of Tamoxifen Therapy for Breast Cancer on
The Subsequent Risk of Endometrial Cancer - SEER supplement/$750,000/4-15
-94 to12-31-96
NIH/NCI-N01-CN-15364/Extension of Study of Effects of Tamoxifen Therapy for Breast
Cancer on the Subsequent Risk of Endometrial Cancer - SEER
supplement/$197,162/9-30-95 to 12-31-96
NIH/NCI-N01-CN-15364/Expansion of Study of Effects of Tamoxifen Therapy for Breast
Cancer on the Subsequent Risk of Endometrial Cancer - SEER
supplement/$203,500/9-1-94 to 12-31-96
NIH/NCI-N01-CN-15364/Epidemiology and Molecular Biology of Breast Carcinoma in
Situ - SEER supplement/$151,829/9-29-95 to 12-31-96
NIEHS/ES07084/Relationship of Pesticide Residues to Breast Cancer Risk of Black
Women/$675,782/9-30-94 to 9-29-99
NIH/NO1-CN-67010/Hormone Receptors and Breast Cancer Prognostic Factors
/$59,457/10-1-97 to 9-28-99
NIH/CA59636/H2-Receptor Antagonists and Adenocarcinoma of the Gastric Cardia/
Lower Esophagus/$1,415,973/6-1-93 to 3-31-00
NIH/NCI/PC-85063-20/Surviving Breast Cancer/$185,000/7-1-98 to 12-31-00.
NIH/NCI/N01-PC-95018-20/Childhood Cancer Clinical Trials: Who Has Access?/
$120,380/9-29-99 to 9-29-01
NIH/NO1-CN-75014/Interdisciplinary Case-Control Study of Non-Hodgkin’s Lymphoma/
$719,817/10-1-97 to 9-30-01
State of California/Assessment of p53 Mutations in Tamoxifen-Associated and
Spontaneous Endometrial Cancer/$264,700/1-1-99 to 6-30-01.
California Breast Cancer Research Program/51B-0098/Postmenopausal Breast Cancer :
Obesity, Leptin & OB-R Pilot/$75,000/7-1-99 to 6-30-02
CDC/Patterns of Ovarian Cancer Incidence/$50,000/10-1-00 to 9-29-02
NIH/NCI/N01-PC-95019-20/Assessing Quality of Life Among Cancer Survivors/
$382,331/7-1-99 to 7-30-03
NIH/NCI/N01-PC-67010-22/Prenatal Factors and Breast Cancer Risk, Data Collection and
and Linkage Analysis – A Feasibility/Validation Study/$56,482/10-1-01 to 10-31-03
NIH/NICHD-CRE-91-13/Breast Cancer and the Birth Control Pill: Case-Control
Study of Perimenopausal and Past Oral Contraceptive Use/$7,264,598/11-30-92
to 6-30-04
NIH/CA58531/Tamoxifen: Risk of MI, Stroke, and Venous Thromboembolism
/$2,645,027/9-1-97 to 6-30-04
NIH/NCI/N01-PC-67010-2-18/Defining Issues of Survivorship for Long Term Survivors
of Breast Cancer/$139,204/7-1-02 to 7-30-04
NIH/NCI/ CA83178/Interaction of ATM and Radiation in Breast Cancer (subcontract)/
$1,903,444/11-1-99 to 8-31-04
NIH/NCI/CA74847/BRCA1, oral contraceptives and hormonal risk factors/5-9-1999 to 229-2005
NIH/NCI/CA17054/USC Program Project Grant: Iatrogenic Causes of Cancer
/$8,246,634/4-1-92 to 3-30-99 /renewed through 3-30-2004 ($7,049,339 direct
costs); became PI of Project C: Oral Contraceptives, hormonal risk factors and
BRCA1
NIH/NCI/CA096400/Physical Activity, Ovarian and Endometrial Cancer Risk/$162,500/
23
Leslie Bernstein, PhD
10-1-02 to 8-31-05
Susan G. Komen Foundation/Compilation of database on studies of obesity, physical
activity and breast cancer/$75,000/8-20-04 to 8-20-05
CDC/U Penn 54150/Study of the efficacy of screening mammography using cases and
Controls from the Women’s CARE Study (subcontract)/$35,939/9/30/02-9/29/06
Cancer Surveillance Program Scientific Director and Co- Principal Investigator,
California State Contract 050G-8709/Cancer Surveillance Program/$1,315,219
(annually renewed) 7-1-87 to 9-15-2007
NIH/NCI-N01-CN-15364/Operation of a Population-Based Surveillance,
Epidemiology, and End Results (SEER) Registry in Los Angeles County
/$29,000,000/8-1-96 to 7-31-10
NIH/NCI/CA97395/Interaction of radiation, BRCA1/2, and Breast Cancer (subcontract)/
/$318,007/8-1-02 to 7-31-07
NCI/Market Requisition/GST, physical activity and breast cancer risk in the Breast
Cancer Family Registries/$48,000/9-15-06 to 9-14-07
NCI/CA091019/ Genes and the Estrogen Effect on Endometrial Cancer/$676,736/
03/01/02-12/31/08 (PI, 2006-2008)
NIH/NCI/R01 CA108634/Exogenous hormones, IL-6 and NHL risk in women/ $3,724,936/
7/15/04 to 12/31/09 (transferred into CA17054 – Program Project Grant as a
Project – 9/1/05)
California Breast Cancer Research Program/Survival Pilot for the Los Angeles component
of the Women’s CARE Study/$20,000/12-1-08 to 2-29-10.
NCI/R01 CA77398/ Supplement to the California Teachers Study, $160,000/9-29-07 to 831-10
NIH/NCI/PC-67010/Weight, Physical Activity, Diet and Breast Cancer – Prognosis Study
(HEAL)/$1,981,529 total direct cost support/7-1-98 to 9-30-12
Avon Foundation/The Love/Avon Army of Women Hope Cohort (now renamed the Health
of Women Study)/$450,000 -3 yr total/10-1-09 to 9-30-13.
CBCRP/16ZB-8003/Physical activity and survival after breast cancer//$76,064 year 1 direct/
1-01-11 to 12-31-13/
NCI/ K05 CA136967/ Research and Mentoring on Energetic Factors and Cancer:
Established Investigator Award/$696,686-5 year direct/9-1-09 to 8-31-14.
Independent Support for Graduate Students and Postdoctoral Students
American Cancer Society (California Division)/Predoctoral fellowship for Carol
Koprowski to study diet and growth patterns as a predictor of age at
menarche and hormonal patterns after menarche/$10,000/3-1-95 to 3-1-97
American Cancer Society (California Division)/Predoctoral fellowship for Lihua Liu to
study socioeconomic status as a predictor of cancer risk among various racial
ethnic groups in Los Angeles County/$10,000/3-1-96 to 3-1-97
California Breast Cancer Research Program/Postdoctoral fellowship for Shelley M. Enger,
Ph.D./Alcohol and Risk of Estrogen Receptor Positive Breast Cancer/$74,312/71-96 to 6-30-97
24
Leslie Bernstein, PhD
California Breast Cancer Research Program/Postdoctoral fellowship for Shelley M. Enger,
Ph.D./Hormone receptor status, body mass index and breast cancer survival/
$75,081/7-1-97 to 10-1-97.
California Breast Cancer Research Program/Postdoctoral fellowship for Cathy
Carpenter, PhD/Physical Activity: Impact on Early Hormonal Patterns and Breast Cancer
Risk Among Young and Older Women/$60,069/9-1-95 to 6-30-98.
California Breast Cancer Research Program/Postdoctoral fellowship for Carol Koprowski,
Ph.D./ Exercise, diet, energy balance and onset of menarche/$75,000/7-1-97 to
6-30-99.
California Breast Cancer Research Program/Postdoctoral fellowship for Deirdre Hill,
Ph.D./Diagnostic radiation, incomplete pregnancy and other risk factors for breast
cancer/ $75,000/7-1-98 to 6-30-2000.
California Breast Cancer Research Program/Postdoctoral fellowship for Yani Lu, Ph.D./
Predictors of survival in African American and Caucasian breast cancer patients: Followup of the cases in the Women’s CARE Study/$80,000/7-1-2009 to 6-30-2011.
Fullbright Fellowship/Postdoctoral Fellow from Norway, Aina Emaus, MD, Ph.D./The
influence of physical activity on metabolic markers/with supplement from the
Norwegian government/8-1-2009 to 7-31-2010.
Co-Principal Investigator/Co-Investigator
NCI/CA28215/Epidemiology of Tumors of the Parotid Gland/S. Preston-Martin/$85,427
(final year)/7-1-81 to 6-30-85
NCI/CA33512/Hormones in the Etiology of Breast and Prostate Cancer/RK Ross
/$217,530 (final year)/8-1-83 to 7-31-85
NCI/CP11042/Epidemiologic Study of Mesothelioma Risk Factors Utilizing
Population-based Tumor Registries/BE Henderson/$40,210(final year)/3-1-84 to
2-28-85
NCI/CP41-62/Follow-up Study of Patients Treated for Hyperthyroidism/S. Preston-‘
Martin/ $45,357(yr 3)/9-13-84 to 9-27-87
NCI/CA14089/Cancer Center Core Support Grant/BE Henderson/$1,809,381 (yr 1)/
4-1-84 to 11-30-87/ Biostatistical Core: Biostatistician
NCI/CA17054/USC Cancer Center Epidemiology and Biostatistics Unit/B. E. Henderson
/$1,370,281 (final year) to 3-31-87
PI: Second phase of case-control study of breast cancer in young women
Co-investigator: Case-control study of thyroid tumors in women
Co-investigator: Case-control study of adenocarcinoma of the cervix
NCI/CA36929/Biochemistry and Pathology of 5-fluorouracil Effects/ C. P. Spears
/$101,925(yr 3)/4-1-85 to 3-31-88
NCI/CA44401/Case-Control Study of Adenocarcinoma of the Cervix in Young Women/R
Peters/$610,487/4-1-87 to 3-31-92
NCI/CA51621/Pathogenesis of Kaposi's Sarcoma/P Gill, PI/$1,089,335/9-30-89 to
7-31-94
NIAID/89-AI-20/AIDS Institutional Training Grant/S Rasheed, PI/$616,000/8-1-90 to
7-31-95
NCI/CA14089/Cancer Center Core Support Grant/P Jones, PI/$1,809,381 12-1-90 to
11-30-95, Staff Scientist
25
Leslie Bernstein, PhD
NIH/CA50850/An Epidemiologic Study of HIV Related Lymphoma/A Levine, PI/
$1,772,985/6-1-89 to 5-31-96
State of California/Smoking as a Risk Factor for Gastric Cancer/A Wu-Williams, PI/
$781,462/7-1-92 to 6-30-96
NIH/NCI-N01-CN-15364/Operation of a Population-Based Surveillance, Epidemiology
and End Results (SEER) Registry in Los Angeles County/R Ross, PI/
$4,923,900/10-1-92 to 7-31-96
NIH/NCI-N01-CN-15364/Prostate Cancer Practice Patterns and Health-Related Quality
of Life - SEER Supplement/D Deapen, PI/$617,000/9-1-94 to 12-31-97
State of California/Exercise and the Prevention of Breast Cancer/$369,931/L Shames, PI –
new investigator award/7-1-95 to 6-30-98/serve as advisor.
DOD/The Effects of a Moderate Aerobic Training Program on Ovarian Function/
$447,645/L Shames-first award/9-1-96 to 8-31-99/serve as advisor
NIH/NCI/N01-PC-95019-20/Mammographic Breast Density, Weight, Physical Activity,
Diet and Breast Cancer Prognosis Study-5 yr follow-up/$409,090/F Gilliland, PI/
7-1-01 to 6-30-04
NIH/NCI/N01-PC-95019-20/The Interaction of Genetic Susceptibility and Hormonal
Exposures in Breast Cancer Prognosis/$264,298/F Gilliland, PI/7-1-99 to 6-30-04
State of California/Do Breast Cancer Risk Factors Vary by Dual Receptor Status/A
Geiger (Kaiser)- new investigator award/$217,104/7-1-96 to 6-30-99/serve as
advisor
State of California/Mammographic Densities and Breast Cancer Risk/MC Pike,
PI/$569,620/7-1-96 to 6-30-99
State of California Breast Cancer Research Program /4PB-0092/G Ursin, PI/$1,041,683/
BRCA1, Oral Contraceptives, and Hormonal Risk Factors (The LIFE Study)
7/1/98-6/30/01
DOD/Molecular Epidemiology of Breast Carcinoma in Situ/ $2,113,620/M Press, PI/9-196 to 8-30-02
Whittier Foundation/Research on Development of Innovative Strategies of Breast Cancer/
$883,132/R Ross, PI/1-1-98 to 12-31-02
State of California Breast Cancer Research Program/Can Molecular Markers Predict
Response to Adjuvant Therapy?/S Enger (Kaiser) with subcontract to M Press
(USC)/$783,409/7-1-99 to 6-30-03
NCI/CA76513/Risk of Cancer in A-T Families/RW Haile, PI/$1,699,515/7-1-99 to 6-30-03
California Breast Cancer Research Program/7PB-0051/HER-2/neu Polymorphism, Gene
Amplification and Breast Cancer/$1,147,535/M Press, PI/7-1-01 to 6-30-06
NCI/CA095983/ Socioeconomic trends in breast cancer incidence/N Krieger (Harvard),
PI/USC subcontract $74,720 (annual)/ 7-1-03 to 6-30-06
NCI/CA17054/USC Program Project Grant: Unresolved Public Health Issues
Related to Hormone Therapy and Cancer (co-PI of PPG)/$8,246,634/
4-1-92 to 9-15-07; and Co-PI of Project D: Hormone Therapy, Mammographic
Densities and Breast Cancer 8-1-05 to 9-15-07.
NCI/CA01815/DNA Methylation Markers in Esophageal Adenocarcinoma/P Laird,
PI/$225,000 (annual)/9-26-02 to 8-30-07
NCI/CA14089/Norris Cancer Center Core Grant/P Jones, PI/$2,839,589/12/01/009-15-07 (served as Co-director of Women’s Cancer Program)
NCI/CA115234/Risk factors for non-Hodgkin lymphoma in twins/W Cozen, PI/$100,000
26
Leslie Bernstein, PhD
/4-1-05 to 3-31-07
NCI/CA119755/Carotid artery disease in childhood cancer survivors who received
radiation to the neck/K Meeske, PI/$100,000 /9-30-05 to 9-29-07
NCI/CA121303/Is Stroke a Late Effect of Chemotherapy/A Geiger, PI/$34,000 (L
Bernstein PI subcontract with Wake Forest)/8-31-06 to 8-31-08
NCI/CA130108/ Risk and prognosis of uterine corpus cancer after tamoxifen treatment
for breast cancer: pooled analysis of three case-control studies/ FE van Leeuwen,
PI/$100,000/9-30-07 to 9-29-09.
California Breast Cancer Research Program 13IB0065/Circuit training and breast cancer
risk biomarkers in teens/Jaimie Davis, PI/$244,500/7-1-07 to 6-30-09.
NCI/CA17054/Unresolved Public Health Issues Related to HT and Cancer, Program
Project Grant/R Ross; B Henderson since 2006, PI/$7,691,719/Serve as co-PI of
PPG (until 9/15/07) and as co-PI of Project C-Hormone Therapy, Mammographic
Density and Breast Cancer (G Ursin PI).
NCI/CA 116848/Transdisciplinary Centers on Energetics and Cancer/M Goran, PI/$12.1
million/9-1-05 to 8-31-10; Co-PI and Co-Director of Center, Director of Mentoring
Core and co-Director of Administrative Core, 2005-2007, Senior Advisor on Project
B , 2005-2010.
California Breast Cancer Research Program/Survival Pilot for the California Teachers
Study /K Henderson/$20,000/12-1-08 to 7-31-10
Scientific Director – then Scientific Advisor: Los Angeles County Cancer Surveillance
Program NIH/NCI-N01-CN-15364/Operation of a Population-Based Surveillance,
Epidemiology, and End Results (SEER) Registry in Los Angeles County
/$29,000,000/8-1-96 to 7-31-10
DOD/BC075007/Genome-wide Breast Cancer Scan in African Americans/Chris Haiman,
PI/5-1-08 to 4/20/11
NIDDK/K01DK078858/Circuit Training and Motivational Interviewing to Reduce Type
2 Diabetes in Youth/Jaimie Davis, PI (L Bernstein, Mentor)/$466,978/7-1-07 to
6-30-11
NCI/R25T CA085771-07 / The Cancer Genetics Career Development Program/J Weitzel/
09-19-06 to 08-31-11.
NCI/R01 CA136725/Barrett’s and Esophageal Adenocarcinoma Genetic Susceptibility Study
(BEAGESS)/T Vaughan/9-1-09 to 8-31-12
ACS RSGT-00-263-02/Hereditary Breast Cancer and Novel Hispanic BRCA Mutations/J
Weitzel/1-1-10 to 12-31-12.
NINDS/R21 NS075608/ Modifiable risk factors in stroke incidence and mortality among
women/S Wang/07-01-2011 to 06-30-13
27
Leslie Bernstein, PhD
BIBLIOGRAPHY
(students/trainees marked with *)
Peer-reviewed Publications
1. Bernstein L, Anderson J, Pike MC. Estimation of the proportional hazard in two treatment group
clinical trials. Biometrics, 37, 513-519, 1981.
2. Anderson J, Bernstein L, Pike MC. Confidence intervals for the probabilities of survival and
quantiles in life-table analysis. Biometrics, 38, 407-416, 1982.
3. Bernstein L, Kaldor J, McCann J, Pike MC. An empirical approach to the statistical analysis of
mutagenesis data from the Salmonella test. Mutation Res, 97, 267-281, 1982.
4. Musk AW, Peters JM, Bernstein L, Rubin C Monroe CB. Pulmonary function in firefighters: a six
year follow-up in the Boston Fire Department. Am J of Indust Med, 3, 3-9, 1982.
5. Wales J, Kane R, Robbins S, Bernstein L, Krasnow R. The UCLA/VA hospice evaluation study:
methodology and instrumentation. Medical Care, 21, 734-744, 1983.
6. Peters RK, Cady LD, Bischoff DP, Bernstein L, Pike MC. Physical fitness and subsequent
myocardial infarction in healthy workers. JAMA, 249, 3052-3056, 1983.
7. Wright WE, Sherwin RP, Plyler EA, Bernstein L, Fromm JB, Henderson BE. Malignant
mesothelioma: incidence, asbestos exposure and reclassification of histopathology. Br J Indust Med,
41, 39-45, 1984. PMC1009234.
8. Peters JM, Smith TJ, Bernstein L, Wright WE, Hammond SK. Pulmonary effects of exposures in
silicon carbide manufacturing. Br J Indust Med, 41, 109-115, 1984. PMC1009244.
9. Peters RK, Mack TM, Bernstein L. Parallels in the epidemiology of selected anogenital
carcinomas. J Natl Cancer Inst, 72, 609-615, 1984.
10. Kane RL, Wales J, Bernstein L, Liebowitz A, Kaplan S. A randomized controlled trial of hospice
care. Lancet, i, 890-894, 1984.
11. Sawyer C, Peto R, Bernstein L, Pike MC. Calculation of carcinogenic potency from long-term
animal carcinogenesis experiments. Biometrics, 40, 27-40, 1984.
12. Peto R, Pike MC, Bernstein L, Gold LS, Ames BN. The TD50: a proposed general convention for
the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal
experiments. Environ Health Perspect, 58, 1-8, 1984. PMC1569426.
13. Gold LS, Sawyer CB, Magaw R, Backman G, deVeciana M, Levinson R, Hooper NK, Havender
WR, Bernstein L, Peto R, Pike MC, Ames BN. A carcinogenic potency database of the standardized
results of animal bioassays. Environ Health Perspect, 58, 9-319, 1984. PMC1569423.
14. Garabrant DH, Peters JM, Mack TM, Bernstein L. Job activity reduces colon cancer risk in Los
Angeles men. Am J Epidemiol, 119, 1005-1014, 1984.
15. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Berne M, Bernstein L, Danenberg PV.
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous
5-fluorouracil. Cancer Res, 44, 4144-4150, 1984.
16. Garabrant DH, Bernstein L, Peters JM, Smith TJ. Respiratory and eye irritation from boron oxide
and boric acid dusts. J Occ Med, 26, 584-586, 1984.
17. Akmal J, Tuma S, Goldstein DA, Pattabhiraman R, Bernstein L, Massry SG. Intact and
carboxyterminal PTH do not cross the blood-cerebrospinal barrier. Proc Soc Exp Biol Med,
176,434-437, 1985.
18. Pike MC, Bernstein L. Statistical errors invalidate conclusions in "Caffeine and unsaturated fat diet
significantly promotes DMBA-induced breast cancer in rats. Cancer, 55, 1855-1857, 1985.
28
Leslie Bernstein, PhD
19. Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Some tautologous aspects of the comparison
of carcinogenic potency in rats and mice. Fund Appl Toxicol, 5, 79-86, 1985.
20. Preston-Martin S, Bernstein L, Maldonado AA, Henderson BE, White SC. A dental x-ray validation
study: comparison of information from patient interviews and dental charts. Am J Epidemiol, 121,
430-439, 1985.
21. Kane RL, Bernstein L, Wales J, Rothenberg R. Hospice effectiveness in controlling pain. JAMA,
253, 2683-2686, 1985.
22. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone
binding globulin levels in nulliparous and parous women. J Natl Cancer Inst, 74, 741-745, 1985.
23. Kane RL, Klein SJ*, Bernstein L, Rothenberg R, Wales J. Hospice role in alleviating the emotional
stress of terminal patients and their families. Medical Care, 23, 189-197, 1985.
24. Anderson JR, Bernstein L. Asymptotically efficient two-step estimators of the hazard ratio for
follow-up studies and survival data. Biometrics, 41 733- 740, 1985.
25. Musk AW, Peters JM, Bernstein L. Absence of respiratory effects in subjects exposed to low
concentrations of TDI and MDI: a revaluation. J Occ Med, 27, 917-920, 1985.
26. Garabrant DH, Bernstein L, Peters JM, Smith TJ, Wright WE. Respiratory effects of borax dust. Br
J Ind Med, 42, 831-837, 1985. PMC1007587.
27. Peters JM, Garabrant DH, Wright WE, Bernstein L, Mack TM. Uses of a cancer registry to assess
occupational cancer risks. J Natl Cancer Inst Monograph, 69, 157-161, 1985.
28. Preston-Martin S, Henderson BE, Bernstein L. Medical and dental x-rays as risk factors for recently
diagnosed tumors of the head. J Natl Cancer Inst Monograph, 69, 175-179, 1985.
29. Mack TM, Berkl J, Bernstein L, Mack W*. Religion and cancer in Los Angeles County. J Natl
Cancer Inst Monograph, 69, 235-245, 1985.
30. Mack TM, Walker A*, Mack W*, Bernstein L. Cancer in Hispanics in Los Angeles County. J Natl
Cancer Inst Monograph, 69, 99-104, 1985.
31. Berkel J, Mack TM, Bernstein L. Religie en kanker. T Soc Gez Zorg, 63, 872-875, 1985.
32. Ross RK, Bernstein L, Judd HL, Hanisch R, Pike MC, Henderson BE. Serum testosterone levels in
healthy young black and white men. J Natl Cancer Inst, 76, 45-48, 1986.
33. Peters RK, Chao A*, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of
adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst, 76,
423-428, 1986.
34. Gold LS, Bernstein L, Kaldor J, Backman G, Hoel DG. An empirical comparison of methods used
to estimate carcinogenic potency in long-term animal bioassays: lifetable vs. summary incidence data.
Fund Appl Toxicol, 6, 263- 269, 1986.
35. Osorio AM*, Bernstein L, Garabrant DH, Peters JM. Investigation of lung cancer among female
cosmetologists. J Occ Med, 28, 291-295, 1986.
36. Gold LS, Ward JM, Bernstein L, Stern B. Association between carcinogenic potency and tumor
pathology in rodent carcinogenesis bioassays. Fund Appl Toxicol, 6, 677-690, 1986.
37. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher maternal levels of
free estradiol in first compared to second pregnancy: a study of early gestational differences. J Natl
Cancer Inst, 76, 1035-1039, 1986.
38. Bernstein L, Chilvers C, Murrells T, Pike MC. Month of birth of men with malignant germ cell
tumours of the testis. J Epidemiol Community Health, 40, 214-217, 1986. PMC1052525.
29
Leslie Bernstein, PhD
39. Gold LS, deVeciana M, Backman G, Magaw R, Lopipero P, Smith M, Blumenthal M, Levinson R,
Bernstein L, Ames BN. Chronological supplement to the carcinogenic potency database:
standardized results of animal bioassays published through December 1982. Environ Health Perspect,
67, 161-200, 1986. PMC1474421.
40. Kane RL, Klein SJ*, Bernstein L, Rothenberg R. The role of hospice in reducing the impact of
bereavement. J Chronic Dis, 39, 735-742, 1986.
41. Preston-Martin S, Bernstein L, Pike MC, Maldonado AA, Henderson BE. Thyroid cancer among
young women related to prior thyroid disease and pregnancy history. Br J Cancer, 55, 191-195, 1987.
42. Kawamoto MM*, Garabrant DH, Held J, Balmes JR, Patzman J, Dimick JR, Sunonowitz JA,
Bernstein L. Respiratory effects of cotton dust exposure in the cotton garnetting industry. Am J
Indus Med, 11, 505-515, 1987.
43. Grunberg SM, Daniels AM, Muensch H, Daniels JR, Bernstein L, Kortes V, Weiss MH. Correlation
of meningioma hormone receptor status with hormone sensitivity in a tumor stem cell assay. J
Neurosurgery, 66,405-408, 1987.
44. Garabrant DH, Fine LJ, Oliver C, Bernstein L, Peters JM. Abnormalities of pulmonary function and
pleural disease among titanium metal production workers. Scand J Work, Environ and Health, 13,
47-51, 1987.
45. Gold L, Wright C, Bernstein L, deVeciana M. Reproducibility of results in "near-replicate"
carcinogenesis bioassays. J Natl Cancer Inst, 78, 1149-1158, 1987.
46. Depue RH, Bernstein L, Ross RK, Judd HL, Pike MC, Henderson BE. Hyperemesis gravidarum in
relation to estradiol levels, pregnancy outcome, and other maternal factors: a sero-epidemiologic
study. Am J Obstet Gynecol, 156, 1137-1141, 1987.
47. Bernstein L, Ross RK, Lobo R, Hanisch R, Krailo MD, Henderson BE. The effects of moderate
physical activity on menstrual cycle patterns in adolescence: implications for breast cancer
prevention. Br J Cancer, 55, 681- 685, 1987.
48. Lowengart R*, Peters JM, Cicioni C, Buckley J, Bernstein L, Preston-Martin S, Rappaport E.
Childhood leukemia and parents' exposures. J Natl Cancer Inst, 79, 39-46, 1987.
49. Barone JA*, Peters JM, Garabrant DH, Bernstein L, Krebsbach R. Smoking as a risk factor for
noise induced hearing loss. J Occ Med, 29, 741-745, 1987.
50. Grunberg SM, McDermed JE, Bernstein L, Cohen JL. Examination of the correlation of serum
metoclopramide levels with antiemetic efficacy in patients receiving cisplatin. Cancer Chemo
Pharmacol, 20, 332-336, 1987.
51. Henderson BE, Ross RK, Bernstein L. Estrogens as a cause of human cancer: The Richard and
Hinda Rosenthal Foundation Award Lecture. Cancer Res, 48, 246- 253, 1988.
52. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in-utero estrogen and
testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer, 57,
216-218, 1988.
53. Honda GD*, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette
smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br
J Cancer, 57, 326-331, 1988.
54. Garabrant DH, Held J, Langholz B, Bernstein L. Mortality of aircraft manufacturing workers in
Southern California. Am J Ind Med, 13, 683-693, 1988.
55. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L,
Schoenberg JB, Stemhagen A, Fraumeni JF. Smoking and drinking in relation to oral and pharyngeal
cancer. Cancer Res, 48, 3282-3287, 1988.
30
Leslie Bernstein, PhD
56. Ahlering TE*, Kanellos A, Boyd SD, Lieskowsky G, Skinner DG, Bernstein L. A comparative
study of peri-operative complications with Kock pouch urinary diversion in highly irradiated versus
non-irradiated patients. J Urol, 139, 1202-1204, 1988.
57. Wright W, Bernstein L, Peters JM, Garabrant DH, Mack TM. Adenocarcinoma of the stomach and
exposure to occupational particulates. Am J Epidemiol, 128, 64-73, 1988.
58. Ross RK, Bernstein L, Garabrant D, Henderson BE. Avoidable non-dietary lifestyle risk factors for
cancer: implications for prevention. Am Family Phys, 38, 153-160, 1988.
59. Spears CP, Gustavsson BG, Berne M, Frosing R, Bernstein L, Hayes AA. Mechanisms of innate
resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res, 48, 5894-5900, 1988.
60. Bernstein L, Pike MC, Depue RH, Ross RK, Moore JW, Henderson BE. Maternal hormone levels
in early gestation of cryptorchid males: A case-control study. Br J Cancer, 58, 379-381, 1988.
61. Preston DS*, Bernstein L, Sadun AA. Office techniques for detecting optic neuropathies:
Brightness sense compared to traditional screening tests. Neuro Ophthalmol, 8, 245-250, 1988.
62. Bernstein L, Levin D*, Menck H, Ross RK. AIDS-related secular trends in cancer in Los Angeles
County men: A comparison by marital status. Cancer Res, 49, 466-470, 1989.
63. Goldberg RL*, Bernstein L, Peters JM, Garabrant D. Fatal occupational injuries in California,
1972-1983. Am J Indus Med, 15, 177-185, 1989.
64. Bernstein L, Pike MC, Lobo R, Ross R, Depue R, Henderson BE. Cigarette smoking in pregnancy
results in marked decrease in maternal hCG and estradiol levels. Br J Obstet Gynaecol, 96, 92-96,
1989.
65. Pike MC, Bernstein L, Peters R. "Total energy intake: implications for epidemiologic analyses."
Am J Epidemiol, 129, 1312-1313, 1989.
66. Gold LS, Slone T, Bernstein L. Summary of carcinogenic potency and positivity for 492 rodent
carcinogens in the Carcinogenic Potency Database. Environ Hlth Perspect, 79, 259-272, 1989.
PMC1567574.
67. Gold LS, Bernstein L, Magaw R, Slone TH. Interspecies extrapolation in carcinogenesis: Results
on 955 chemicals in the Carcinogenic Potency Database. Environ Hlth Perspect, 81, 211-219, 1989.
PMC 1567549.
68. Hull CJ*, Doyle E*, Peters JM, Garabrant DH, Bernstein L, Preston-Martin, S. Case-control study
of lung cancer in Los Angeles County welders. Am J Ind Med, 16, 103-112, 1989.
69. Bernstein L, Ross RK, Pike MC, Casagrande JT, Henderson BE. Urinary estrogens and the
female-to-male breast cancer ratio. Int J Cancer, 44, 954-956, 1989.
70. Bernstein L, Ross RK, Pike MC, Brown JB, Henderson BE. Hormone levels in older women: A
study of postmenopausal breast cancer patients and healthy population controls. Br J Cancer, 61,
298-302, 1990.
71. Grimes DA, Bernstein L, Lacarra M, Shoupe D, Mishell DR. Predictors of failed attempted abortion
with the antiprogestin mifepristone (RU 486). Am J Obstet Gynecol, 162, 910-917, 1990.
72. Bernstein L, Newton P*, Ross RK. Epidemiology of hairy cell leukemia in Los Angeles County.
Cancer Research, 50, 3605-3609, 1990.
73. Ross RK, Bernstein L, Trent L*, Henderson BE, Paganini-Hill A. A prospective study of risk
factors for traumatic deaths in a retirement community. Prev Med, 19, 323-334, 1990.
74. Bernstein L, Yuan JM*, Ross RK, Pike MC, Hanisch R, Lobo R, Gao YT, Henderson BE. Serum
hormone levels in premenopausal Chinese women and white women in Los Angeles: results from
two breast cancer case-control studies. Cancer Cause Control, 1, 51-58, 1990.
31
Leslie Bernstein, PhD
75. Shimizu H, Ross RK, Bernstein L, Pike MC, Henderson BE. Serum estrogen levels in
postmenopausal women: comparison of US whites and Japanese in Japan. Br J Cancer, 62, 451-454,
1990.
76. Walker A*, Bernstein L, Warren D, Warner N, Zheng X, Henderson BE. The effect of prenatally
administered ethinyl estradiol on the incidence of cryptorchid testis and testicular teratomas in the 129
Sv-S1 C P strain of mice. Br J Cancer, 62, 599-602, 1990.
77. Gold LS, Bernstein L, Ames BN. The importance of ranking possible carcinogenic hazards using
HERP. Risk Analysis, 10, 625-628, 1990.
78. Ross RK, Hartnett NM*, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the
small intestine: is bile a small bowel carcinogen? Br J Cancer, 63, 143-145, 1991.
79. Shimizu H, Ross RK, Bernstein L. Possible underestimation of the incidence rate of prostate cancer
in Japan. Japanese J Cancer Res, 82, 483-485, 1991.
80. Henderson BE, Bernstein L. The international variation in breast cancer rates: An epidemiological
assessment. Breast Cancer Res Treat,18, S11-S17, 1991.
81. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and
breast among Japanese and white immigrants in Los Angeles County. Br J Cancer, 63, 963-966,
1991.
82. Ross RK, Bernstein L, Hartnett NM*, Boone J. Cancer patterns among Vietnamese immigrants in
Los Angeles County. Br J Cancer, 64, 185-186, 1991.
83. Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of
adult women. Cancer Cause Control, 2, 221-225, 1991.
84. Cicioni C*, London SJ, Garabrant DH, Bernstein L, Phillips K*, Peters JM. Occupational asbestos
exposure and mesothelioma risk in Los Angeles County. Application of an occupational hazard
survey job-exposure matrix. Am J Industr Med, 20, 371-379, 1991.
85. Ross RK, Bernstein L. Primary prevention of hormone-related cancers. Contemp Int Med,3, 77-91,
1991.
86. Gold LS, Slone TH, Manley NB, Bernstein L. Target organs in chronic bioassays of 533 chemical
carcinogens. Environ Health Perspect, 93, 233-246, 1991. PMC2568038.
87. Bernstein L, Ross RK, Henderson BE. Prospects for the primary prevention of breast cancer. Am J
Epidemiol, 135, 142-152, 1992.
88. Ross RK, Bernstein L, Shimizu H, Lobo R, Stanczyk F, Pike MC, Henderson BE. Evidence for
reduced 5-alpha-reductase activity in Japanese compared to US White and Black males: Implications
for prostate cancer risk. Lancet, 339, 887-889, 1992.
89. Bernstein L, Ross RK, Henderson BE. The relationship of hormone use to cancer. J Natl Cancer
Inst Monograph, 12, 137-147, 1992.
90. Lobo RA, Notelovitz M, Bernstein L, Kahn FY, Ross RK, Paul WL. Lipoprotein(a) [Lp(a)] in
women: relationship to cardiovascular disease risk factors, exercise and estrogen. Am J Obstet
Gynecol, 166, 1182-1190, 1992.
91. Curtis RE, Boice JD, Stoval M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P,
Moloney WC, Hoover RN. Dose-dependent leukemia risk after drug and radiation treatment for
breast cancer. N Engl J Med,326, 1745-1751, 1992.
92. Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K*, Ross RK. Stage and delay in
breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer, 65, 922-926, 1992.
32
Leslie Bernstein, PhD
93. Takemoto KA*, Bernstein L, Lopez JF, Marshak D, Rahimtoola SH, Chandraratna PA.
Abnormalities of diastolic filling of the left ventricle associated with aging are less pronounced in
exercise-trained individuals. Am Heart J, 124, 143-148, 1992.
94. Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's
lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res, 52,
5510s-5515s, 1992.
95. Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak M, Bauch S, Riley CL,
Weiss L, Levine P, Rasheed S, Bernstein L. Epidemiologic and biologic study of AIDS-related
lymphoma. Cancer Res, 52, 5482s-5484s, 1992.
96. Lindheim SR*, Legro RS, Bernstein L, Stanczyk FZ, Vijod MA, Lobo RA. Behavioral stress
responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet
Gynecol, 167, 1831-1836, 1992.
97. Bernstein SM, McKeever P, Bernstein L. Percutaneous reduction of displaced radial neck fractures
in children. J Ped Orthoped, 13, 85-88, 1993.
98. Gold LS, Slone TH, Stern B, Bernstein L. Comparison of target organs of carcinogenicity for
mutagenic and non-mutagenic chemicals. Mutation Research, 286, 75-100, 1993.
99. Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, Schoenberg JB, Winn
DM, McLaughlin JK, Fraumeni JF. Racial differences in risk of oral and pharyngeal cancer: alcohol,
tobacco and other determinants. J Natl Cancer Inst, 85, 465-473, 1993.
100. Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM. Epstein Barr
virus associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency
virus. Blood, 81, 2102-2109, 1993.
101. Olayeye OD*, Bernstein L, Ekweozor CC, Sheng Z, Omilabu SA, Li XY, Sullivan-Halley J,
Rasheed S. Prevalence of human immunodeficiency virus types 1 and 2 infections in Nigeria. J
Infect Dis, 167, 710-4, 1993.
102. Bernstein L, Halley J, Krailo M, Hammond GD. Trends in patterns of treatment of childhood
cancer in Los Angeles County. Cancer, 71, 3222-3228, 1993.
103. Krailo MD, Bernstein L, Sullivan-Halley J, Hammond GD. Patterns of enrollment on cooperative
group studies: An analysis of trends from the Los Angeles County Cancer Surveillance Program.
Cancer, 71, 3325-3330, 1993.
104. Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of cystosarcoma phyllodes tumors
of the breast. Cancer, 71, 3020-3024, 1993.
105. Pike MC, Peters R, Bernstein L. Re: Total energy intake: implications for epidemiologic analyses.
Am J Epidemiol, 137, 811-812, 1993.
106. Bernstein L, Hamilton AS. The epidemiology of AIDS-related malignancies. Curr Opin Oncol, 5,
822-830, 1993.
107. Bernstein L, Ross RK. Endogenous hormones and the risk of breast cancer. Epi Rev, 15, 48-65,
1993.
108. Slovak ML, Weiss LM, Nathwani BN, Bernstein L, Levine AM. Cytogenetic studies of
monocytoid B-cell lymphoma. Hum Path, 24, 1086-1094, 1993.
109. Aghajanian A*, Bernstein L, Grimes D. Bartholin's gland abscess: a case-control study. Southern J
Med, 87, 26-29, 1994.
110. Hamilton A, Radka S, Bernstein L, Gill P, Gonsalves M, Naemura JR, Ross RK. Serum levels of
Oncostatin M in AIDS-related and classic Kaposi's sarcoma cases and controls. J Acquired Immune
Def Syndr, 7, 410-414, 1994.
33
Leslie Bernstein, PhD
111. Olayeye D*, Bernstein L, Sheng Z, Ekweozor CC, Li XY, Sullivan-Halley J, Rasheed S.
Type-specific response to human T-cell lymphotropic virus (HTLV) type 1 and type 2 infections in
Nigeria. Am J Trop Med Hyg, 50, 479-486, 1994.
112. London SJ, Bowman JD, Sobel E, Thomas DC, Garabrant DH, Pearce N, Bernstein L, Peters JM.
Exposure to magnetic fields among electrical workers in relation to leukemia risk in Los Angeles
County. Am J Indust Med, 26, 47-60, 1994.
113. Ghalambor N*, Matta JM, Bernstein L. Heterotopic ossification following operative treatment of
acetabular fracture: an analysis of risk factors. Clin Orthop, 305, 96-105, 1994.
114. Curtis RE, Boice JD, Stovall M, Bernstein L, Holowaty E, Karjalainen S, Langmark F, Nasca PC,
Schwartz AG, Schymura M, Storm HH, Weyer P, Moloney WC. Relation of leukemia risk to
radiation dose after cancer of the uterine corpus. J Natl Cancer Inst, 86, 1315-1324, 1994.
115. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. Physical exercise activity
reduces the risk of breast cancer in young women. J Natl Cancer Inst, 86, 1403-1408, 1994.
116. Walsh TL, Bernstein GS, Grimes DA, Frezieres R, Bernstein L, Coulson AH and IUD Study
Group. Effect of prophylactic antibiotics on morbidity associated with IUD insertion. Contraception,
50, 319-327, 1994.
117. Goldstein AM, Blot WJ, Greenberg RS, Schoenberg JB, Austin DF, Preston-Martin S, Winn DM,
Bernstein L, McLaughlin JK, Fraumeni JF. Familial risk in oral and pharyngeal cancer. Oral Oncol,
Eur J Cancer, 30B, 319-322, 1994.
118. Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J.
Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med, 51, 804-811,
1994. PMC1128120.
119. Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CTC.
Mauch P, Ultmann JE. Incidence of second cancers in patients treated for Hodgkin's disease. J Natl
Cancer Inst, 87, 732-741, 1995.
120. Preston-Martin S, Monroe K*, Lee P, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson
B. Spinal meningiomas in women in Los Angeles County: Investigation of an etiologic hypothesis.
Cancer Epidemiol Biomarkers Prev, 4, 333-339, 1995.
121. Bernstein L, Hanisch R, Sullivan-Halley J, Ross RK. Treatment with human chorionic
gonadotropin (hCG) and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 4, 437-440, 1995.
122. Bernstein L, Lipworth L, Ross RK, Trichopoulos D. Correlation of estrogen levels between
successive pregnancies. Am J Epidemiol, 142, 625-628, 1995.
123. Bernstein L, Miu A*, Monroe K, Henderson BE, Ross RK. Cancer incidence among Filipinos in
Los Angeles County, 1972-1991. Int J Cancer, 63 345-348, 1995.
124. Danley KL*, Richardson JL, Bernstein L, Langholz B, Ross RK. Prostate cancer: trends in
mortality and stage-specific incidence rates in Los Angeles County. Cancer Causes Control, 6, 492498, 1995.
125. Stanczyk FZ, Rosen GF, Ditkoff E, Vijod AG, Bernstein L, Lobo RA. Influence of estrogen on
prostacyclin and thromboxane balance in postmenopausal women. Menopause, 2, 137-143, 1995.
126. Levine A, Bernstein L, Sullivan-Halley J, Shibata D, Mahterian SB, Nathwani BN. Role of
zidovudine and other anti-retroviral therapy in the pathogenesis of AIDS-related lymphoma. Blood,
86, 4612-4616, 1995.
127. Kelsey J, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health, 17,
47-67, 1996.
34
Leslie Bernstein, PhD
128. Heineman EF, Bernstein L, Stark A, Spirtas R. Mesothelioma, asbestos and reported history of
cancer in first-degree relatives. Cancer, 77, 549-554, 1996.
129. Mishra SI, Luce-Aoelua P, Wilkins L, Bernstein L. Cancer among American Samoans: Sitespecific incidence in California and Hawaii. Int J Epidemiol, 25, 713-721, 1996.
130. Longnecker MP, Bernstein L, Bird CL, Yancey AK, Peterson JC. Measurement of organochlorine
levels in postprandial serum or in blood collected in serum-separator tubes. Cancer Epidemiol
Biomarkers Prev, 5, 753-755, 1996.
131. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM*, Ross RK. Risk factors for in situ
breast cancer. Cancer Epidemiol Biomarkers Prev, 5, 961-965, 1996.
132. Deapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14-year follow-up
of the Los Angeles study. Plast Reconstr Surg, 99, 1346-1353, 1997.
133. Henderson BE, Ross RK, Yu MC, Bernstein L. An explanation for the increasing incidence of
testis cancer: Decreasing age at first full term pregnancy. J Natl Cancer Inst, 89, 818-820, 1997.
134. Enger SM*, Ross RK, Henderson BE, Bernstein L. Breastfeeding history, pregnancy experience
and risk of breast cancer. Br J Cancer, 76, 118-123, 1997.
135. Ursin G, Henderson B, Haile RW, Zhou N, Diep A, Bernstein L. Oral contraceptive use is more
common in women with BRCA1/BRCA2 mutations than in other women with breast cancer. Cancer
Res, 57, 3678-3681, 1997.
136. Press MP, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris
C, El-Naggar A, Slamon DJ, Peyrot M, Phillips R, Wolman SR, Flom KJ. HER-2/neu amplification
by fluorescence in situ hybridization: Evaluation of archival specimens and utility as a marker of poor
prognosis in node-negative invasive breast carcinomas. J Clin Oncol, 15, 2894-2904, 1997.
137. Nelson RA*, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and
the risk of non-Hodgkin’s lymphoma unrelated to HIV infection: a case-control study. Br J Cancer,
76, 1532-1537, 1997.
138. Bernstein L, Press MF. Does estrogen receptor expression in normal breast tissue predict breast
cancer risk? (Editorial). J Natl Cancer Inst, 90, 5-7, 1998.
139. Walsh T, Grimes D, Frezieres R, Nelson A, Bernstein L, Colson A, Bernstein G, IUD Study Group.
Prophylactic antibiotics before intrauterine device insertion: a randomized controlled trial. Lancet,
351, 1005-1008, 1998.
140. Enger SM*, Ross RK, Paganini-Hill A, Bernstein L. Breastfeeding experience and breast cancer
risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev, 7, 365-369, 1998.
141. Liu L*, Deapen D, Bernstein L. Socioeconomic impact on cancers of female reproductive organs:
A comparison across racial/ethnic populations. Cancer Causes Control, 9, 369-380, 1998.
142. Nelson RA*, Levine AM, Bernstein L. Blood transfusions and the risk of intermediate or high
grade non-Hodgkin’s lymphoma. J Natl Cancer Inst, 90, 1742-1743, 1998.
143. Ursin G, Ross RK, Sullivan-Halley J, Hanisch R, Henderson B, Bernstein L. Use of oral
contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat, 50, 175-184,
1998.
144. Bernstein L, Wu AHT. Colon and rectal cancer among Asian Americans and Pacific Islanders.
Asian Am Pac Island J Hlth, 6, 184-200, 1998.
145. Wu AHT, Bernstein L. Breast cancer among Asian Americans and Pacific Islanders. Asian Am
Pac Island J Hlth, 6, 327-343, 1998.
35
Leslie Bernstein, PhD
146. Enger SM*, Ross RK, Paganini-Hill A, Longnecker M, Bernstein L. Alcohol consumption and
breast cancer hormone receptors: results from two population-based case-control studies. Br J
Cancer, 79, 1308-1314, 1999.
147. Wen WH*, Reles A, Sullivan Halley J, Bernstein L, Jones LA, El-Naggar A, Felix JC, Runnebaum
I, Press MF. P53 mutations and expression in ovarian cancer: Correlation with overall survival.
Intern J Gynecol Pathol, 18, 29-41, 1999.
148. Levine AM, Nelson R*, Zuckerman E, Zuckerman T, Fong TL, Bernstein L. Lack of association
between hepatitis C infection and development of AIDS-related lymphoma. J AIDS Human
Retrovirol, 20, 255-258, 1999.
149. Koprowski C*, Ross RK, Mack WJ, Henderson B, Bernstein L. Diet, body size and menarche in
a multiethnic cohort. Br J Cancer, 79, 1907-1911, 1999.
150. Carpenter C*, Ross RK, Paganini-Hill A, Bernstein L. Lifetime exercise activity and breast
cancer risk among post-menopausal women. Br J Cancer, 80, 1852-1858, 1999.
151. Cozen W, Bernstein L, Wang F, Press M, Mack T. The risk of angiosarcoma following primary
breast cancer. Br J Cancer, 81,.532-536, 1999.
152. Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman J, Ford
L. Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst, 91, 16541662, 1999.
153. Mack WJ, Preston-Martin S, Bernstein L, Qian D, Xiang M. Reproductive and hormonal risk
factors for thyroid cancers in Los Angeles County females. Cancer Epidemiol Biomarkers Prev, 8,
991-997, 1999.
154. Deapen D, Hamilton A, Bernstein L, Brody G. Breast cancer stage at diagnosis and survival
among patients with prior breast implants. J Plastic Reconstruct Surgery, 105, 535-539, 2000.
155. Haselkorn T*, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of
thyroid cancer in Los Angeles County, 1972-1995. Cancer Cause Control, 11, 163-170, 2000.
156. Wen WH*, Bernstein L, Lescallett J, Beazer-Barclay Y, Sullivan-Halley J, White M, Press MF.
Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA
sequence analysis. Cancer Res, 60, 2716-2722, 2000.
157. Enger SM*, Ross RK, Paganini-Hill A, Carpenter CL*, Bernstein L. Body size, physical activity
and hormone receptor status of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev,
9, 681-687, 2000.
158. Gale RP, Cozen W, Goodman M, Wang FF, Bernstein L. Decreased chronic lymphocytic
leukemia in Asians in Los Angeles County. Leukemia Res, 24, 665-669, 2000.
159. Nelson RA*, Levine AM, Bernstein L. Reproductive factors and risk of intermediate- or highgrade non-Hodgkin’s lymphoma in women. J Clin Oncol, 19, 1381-1387, 2001.
160. Liu L, Cozen W, Bernstein L, Ross R, Deapen D. The changing relationship between
socioeconomic status and prostate cancer incidence. J Natl Cancer Inst, 93, 705-709, 2001.
161. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH,
DeMeester SR, DeMeester TR, Skinner KA, Laird PW. Distinct classes of epigenetic behavior in
the progression of esophageal carcinoma. Cancer Res, 61, 3410-3418, 2001.
162. Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol, and
body size and risk of adenocarcinomas of the stomach and esophagus. Cancer Causes Control, 12,
721-732, 2001.
163. Koprowski C*, Coates R, Bernstein L. Ability of young women to recall past body size and age
at menarche. Obesity Res, 9, 478-485, 2001.
36
Leslie Bernstein, PhD
164. Bernstein L. The roles of physical activity and electric blankets in breast cancer occurrence.
Epidemiol, 12, 598-600, 2001.
165. Haiman CA*, Pike MC, Bernstein L, Jaque SV, Stanczyk FZ, Afghani A, Peters RK, Wan P,
Shames L. Ethnic differences in ovulatory function in nulliparous women. Br J Cancer, 86, 367371, 2002.
166. Marchbanks PA, McDonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, Malone KE,
Strom BL, Norman SA, Weiss LK, Liff JM, Wingo PA, Burkman RT, Folger SG, Berlin JA,
Deapen DM, Ursin G, Coates RJ, Simon MS, Press MF, Spirtas R. The NICHD Women’s
Contraceptive and Reproductive Experiences Study: methods and operational results. Annals
Epidemiol, 12, 213-221, 2002.
167. Bernstein L. Epidemiology of endocrine risk factors for breast cancer. J Mammary Gland Biol
Neoplasia, 7, 3-15, 2002.
168. Haiman CA*, Bernstein L, Van Den Berg D, Ingles SA, Salane M, Ursin G. Genetic
determinants of mammographic density. Breast Cancer Res, 4, R5, 2002. Available online
http://breast-cancer-research.com/content/4/3/R5. PMC111030.
169. Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L, Stanczyk FZ, Gentzschein E.
Urinary 2-hydroxyestrone/16-hydroxyestrone ratio and family history of breast cancer in
premenopausal women. Breast Cancer Res Treat, 72, 139-143, 2002.
170. Deapen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates
among Asian-American women. Int J Cancer, 99, 747-750, 2002.
171. Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L,
Malone KE, Ursin G, Strom BL, Norman SA, Weiss LK, Wingo PA, Burkman RT, Berlin JA,
Simon MS, Spirtas R. Oral contraceptives and breast cancer risk: Findings from the NICHD
Women’s Contraceptive and Reproductive Experiences Study. New Engl J Med, 346, 2025-2032,
2002. Winner of the Charles C. Shepard Science Award (CDC/ATSDR).
172. Bu X*, Bernstein L, Brynes RK. Reduced risk of synovial sarcoma in females: evidence for Xchromosome inactivation. Br J Cancer, 87, 28-30, 2002.
173. Horn-Ross PL, Hoggatt KJ, West DW, Krone M, Stewart SL, Anton-Culver H, Bernstein L,
Deapen D, Pinder R, Peel D, Reynolds P, Ross RK, Wright W. Recent diet and breast cancer risk:
the California Teachers Study. Cancer Causes Control, 13, 407-415, 2002.
174. Press MF, Slamon DJ, Flom K, Park J, Zhou JY, Bernstein L. Evaluation of HER-2/neu gene
amplification and overexpression: comparison of frequently used assay methods in a molecularly
characterized cohort of breast cancer specimens. J Clin Oncol, 20, 3095-3105, 2002.
175. Mack WJ, Preston-Martin S, Bernstein L, Qian D. Dietary, anthropometric, and medical risk
factors for thyroid cancer in Los Angeles County females. Ann Epidemiol, 12, 395-401, 2002.
176. Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross P, Pinder R, Peel D, Reynolds P,
Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK. High breast cancer rates among
California teachers: results from the California Teachers Study cohort. Cancer Causes Control, 13,
625-635, 2002.
177. Hoggatt KJ, Bernstein L, Reynolds P, Anton-Culver H, Deapen D, Peel D, Pinder R, Ross RK,
West DW, Wright W, Ziogas A, Horn-Ross PL. Correlates of vitamin supplement use in the
United States: Data from the California Teachers Study cohort. Cancer Causes Control, 13, 735740, 2002.
37
Leslie Bernstein, PhD
178. Hill DA*, Preston-Martin, Ross R, Bernstein L. Medical radiation, family history of cancer, and
benign breast disease in relation to risk of breast cancer in young women, USA. Cancer Causes
Control, 13, 711-718, 2002.
179. Weiss L, Burkman R, Cushing-Haugen K, Voigt L, Simon M, Daling J, Norman S, Bernstein L,
Ursin G, Marchbanks P, Strom B, Berlin J, Liff J, Spirtas R. Post-menopausal hormone
replacement therapy regimens and breast cancer risk: Results of a multi-center case-control study.
Obstet Gynecol, 100, 1148-1158, 2002.
180. Simon MS, Tang MTC, Bernstein L, Norman SA, Weiss L, Burkman RT, Daling JR, Deapen D,
Folger SG, Malone K, Marchbanks PA, McDonald JA, Strom BL, Wilson HG, Spirtas R. Do
thyroid disorders increase the risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 11, 15741578, 2002.
181. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman
SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Folger SG, McDonald JA, Simon MS, Strom BL,
Wingo PA, Spirtas R. Relation of regimens of combined hormone replacement therapy to lobular,
ductal, and other histologic types of breast carcinoma. Cancer, 95, 2455-2464, 2002.
182. Bernstein L, Teal CR*, Joslyn S, Wilson J. Ethnicity-related variation in breast cancer risk
factors. Cancer, 97 (suppl), 222-229, 2003.
183. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Sosnoswska D, Forman D. Role of
Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J
Cancer,103, 815-821, 2003.
184. Liu L, Krailo M, Reaman G, Bernstein L. Childhood cancer patients’ access to cooperative
group cancer programs: a population-based study. Cancer, 97,1339-1345, 2003.
185. Walsh TL, Frezieres RG, Peacock K, Nelson AL, Clark VA, Bernstein L, Wraxall BGD. Use of
prostatic-specific antigen (PSA) to measure semen exposure resulting from male condom failures:
implications for contraceptive efficacy and the prevention of sexually transmitted disease.
Contraception, 67, 139-150, 2003.
186. Mahue-Giangreco M*, Ursin G, Sullivan Halley J, Bernstein L. Induced abortion, miscarriage
and breast cancer risk of young women. Cancer Epidemiol Biomarkers Prev, 12, 209-214, 2003.
187. Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland F, Ballard-Barbash
R, Kriska A. Physical activity levels before and after a diagnosis of breast cancer: The Health,
Eating, Activity and Lifestyle (HEAL) Study. Cancer, 97, 1746-1757, 2003. PMC3034406.
188. Bernstein JL, Teraoka S, Haile RW, Borresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT,
Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, the WECARE
Study Collaborative Group, Concannon PJ. Designing and implementing quality control for multicenter screening of mutations in the ATM gene among women with breast cancer. Human
Mutation, 21, 542-550, 2003. PMID: 12673797.
189. Lillie EO*, Bernstein L, Ursin G. The role of androgens and polymorphisms in the androgen
receptor in the epidemiology of breast cancer. Breast Cancer Research, 5, 164-173, 2003.
PMC165007.
190. Ursin G, Ma H, Wu A, Bernstein L, Salane M, Pariski Y, Astrahan M, Siozon T, Pike MC.
Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers
Prev, 12, 332-338, 2003.
191. Yang D*, Bernstein L, Wu AH. Physical activity and breast cancer risk among Asian-American
women in Los Angeles: A case-control study. Cancer, 97, 2565-2575, 2003.
38
Leslie Bernstein, PhD
192. McTiernan A, Rajan B, Tworoger S, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk
F, Yasui Y, Ballard-Barbash, R. Adiposity and sex hormones in breast cancer patients. J Clin
Oncol, 21, 1961-1966, 2003. PMC2996263.
193. Burkman RT, Tang MTC. Malone KE,. Marchbanks PA, McDonald JA, Folger SG, Norman SA,
Strom BL, Bernstein L, Ursin G, Weiss LK, Daling JR, Simon MS, Spirtas R. Infertility drugs and
the risk of breast cancer: Findings from the National Institute of Child Health and Human
Development Women’s Contraceptive and Reproductive Experiences Study. Fertil Steril, 79, 844851, 2003.
194. Walsh T, Frezieres R, Peacock K, Nelson A, Clark V, Bernstein L. Evaluation of the efficacy of
a non-latex condom: Results from a randomized controlled clinical trial. Perspect Sexual Reprod
Health, 35, 79-86, 2003.
195. Carpenter C*, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and
exercise on breast cancer risk among postmenopausal women. Int J Cancer, 106, 96-102, 2003.
196. Norman SA, Localio AR, Zhou L, Bernstein L, Coates RJ, Flagg EW, Marchbanks PA, Malone
KE, Weiss LK Lee NC, Nadel MR. Validation of self-reported screening mammography histories
among women with and without breast cancer. Am J Epidemiol, 158, 264-271.
197. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size and risk of
adenocarcinoma of the esophagus and stomach. Cancer, 98, 940-948, 2003.
198. Patel AV*, Calle EE, Bernstein L, Wu A, Thun M. Recreational physical activity and risk of
postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control, 14, 519529, 2003.
199. Bernstein J, Bernstein L, Thompson WD Teitelbaum SL, Lynch CF, Boice JD, Rosenstein BS,
Borresen-Dale AL, Gatti RA, Concannon PJ, Haile RW and the WECARE Study Collaborative
Group. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral
breast cancer. Br J Cancer, 89, 1513-1516, 2003.
200. Marshall SF, Deapen D, Allen M, Anton-Culver H, Bernstein L, Horn-Ross PL, Peel D, Pinder
R, Reynolds P, Ross RK, West D, Ziogas A. Validating California Teachers Study self-reports of
recent hospitalization: Comparison with California hospital discharge data. Am J Epidemiol, 158,
1012-1020, 2003.
201. Patel AV*, Press MF, Meeske K*, Calle EE, Bernstein L. Lifetime recreational physical activity
and risk of breast carcinoma in situ. Cancer, 98, 2161-2169, 2003.
202. Daling JR, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss
LK, Ursin G, Burkman RT, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.
Association of regimens of hormone replacement therapy to prognostic factors among women
diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev, 12, 1175-1181,
2003.
203. Norman SA, Berlin JA, Weber A, Strom B, Daling J, Weiss L, Marchbanks P, Bernstein L, Voigt
L, McDonald J, Ursin G, Burkman R, Simon M, Folger S, Spirtas R. Combined effect of oral
contraceptive use and hormone replacement therapy on breast cancer risk in post menopausal
women: Results from the NICHD Women’s Contraceptive and Reproductive Experiences Study.
Cancer Causes Control, 14, 933-943, 2003.
204. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL,
Peel D, Pinder R, Ross RK, Wright WE, Ziogas A. Active smoking, household passive smoking,
and breast cancer: Evidence from the California Teachers Study. J Natl Cancer Inst, 96, 29-37,
2004.
39
Leslie Bernstein, PhD
205. Chen Z*, Wu AH, Gauderman J, Bernstein L, Ma H, Pike MC, Ursin G. Does mammographic
density reflect ethnic differences in breast cancer incidence? Am J Epidemiol, 159, 140-147, 2004.
206. Lillie EO*, Bernstein L, Ingles SA, Gauderman WJ, Rivas G, Gagalang V, Krontiris T, Ursin G.
Polymorphism in the androgen receptor and mammographic density in women taking and not
taking estrogen and progestin therapy. Cancer Res, 64, 1237-1241, 2004.
207. Horn-Ross PL, Canchola AJ, West DW, Stewart SL, Bernstein L, Deapen D, Pinder R, Ross RK,
Anton-Culver H, Peel D, Ziogas A, Reynolds P, Wright W. Patterns of alcohol consumption and
breast cancer risk in the California Teachers Study. Cancer Epidemiol Biomarkers Prev, 13, 405411, 2004.
208. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch
CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD, Berkowitz GS, Gatti RA, Teitelbaum SL,
Rosenstein BS, Børrensen-Dale AL, Concannon P, Thompson WD. Study design: Evaluating geneenvironment interactions in the etiology of breast cancer: the WECARE Study. Breast Cancer
Research, 6, R199-R214, 2004. Online: http://breast-cancer-research.com/content/6/3/R191.
PMC400669.
209. Meeske KA*, Press MF, Patel AV*, Bernstein L. Impact of reproductive factors and lactation
history on breast carcinoma in situ risk. Int J Cancer, 110, 102-109, 2004.
210. Cozen W, Gill PS, Ingles SA, Masood R, Martines-Maza O, Cockburn MG, Gauderman WJ, Pike
MC, Bernstein L, Nathwani BN, Salam MT, Danley KL, Wang W, Gage J, Gundell-Miller S,
Mack TM. IL-6 phenotype and genotype are associated with decreased risk of young adult
Hodgkin’s disease. Blood, 103, 3216-3221, 2004.
211. Enger SM, Bernstein L. Exercise activity, body size and premenopausal breast cancer survival.
Br J Cancer, 90, 2138-2141, 2004.
212. Reynolds P, Goldberg DE, Hurley S, Wright W, Allen M, Anton-Culver H, Bernstein L, Deapen
D, Horn-Ross PL, Peel D, Pinder R, Ross, RK, West D, Ziogas A. Prevalence and patterns of
environmental tobacco smoke exposure among California teachers. Am J Health Promotion, 18,
358-365, 2004.
213. Ursin G, Bernstein L, Wang Y*, Lord SJ*, Deapen D, Liff J, Norman SA, Weiss LK, Daling JR,
Marchbanks PA, Malone KE, Folger SG, McDonald JA, Burkman RT, Simon MS, Strom BL,
Spirtas R. Reproductive factors and breast cancer risk in a study of white and African American
women. Cancer, 101, 352-363, 2004.
214. Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D,
Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R. Absence of an
effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast
cancer. Contraception, 69, 353-360, 2004.
215. Furberg A-S, Veierød MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein
cholesterol, metabolic syndrome, and breast cancer risk. J Natl Cancer Inst, 96, 1152-1160, 2004.
216. Prentice RL, Willett WC, Greenwald P, Alberts D, Bernstein L, Boyd NF, Byers T, Fraser G,
Freedman L, Hunter D, Kipnis V, Kolonel L, Kristal BS, Kristal A, Lampe J, McTiernan A, Milner
J, Patterson R, Potter J, Riboli E, Schatzkin A. Nutrition, physical activity and chronic disease
prevention: Research strategies and recommendations. J Natl Cancer Inst, 96, 1276-1287, 2004.
217. Irwin M, McTiernan A, Bernstein L, Gilliland F, Baumgartner R, Baumgartner K, BallardBarbash R. Physical activity levels among breast cancer survivors. Med Sci Sports Exerc, 36, 13831391, 2004. PMC3000611.
40
Leslie Bernstein, PhD
218. Reynolds P, Hurley S, Goldberg DE, Yerabati S, Gunier R, Herta Z, Anton-Culver H, Bernstein
L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A.
Residential proximity to agricultural pesticide use and incidence of breast cancer in the California
Teachers Study Cohort. Environ Res, 96, 206-218, 2004.
219. Reynolds P, Hurley S, Hoggatt KJ, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R,
Ross RK, West D, Wright W, Ziogas Z, Horn-Ross HL. Correlates of active and passive smoking
in the California Teachers Study cohort. J Women’s Health, 13, 778-790, 2004.
220. Geiger AM, Fischberg GM, Chen W, Bernstein L. Stroke risk and tamoxifen therapy for breast
cancer. J Natl Cancer Inst, 96, 1528-1536, 2004.
221. Walsh TL, Frezieres RG, Peacock K, Nelson AL, Clark VA, Bernstein L, Wraxall BGD.
Effectiveness of the male latex condom: Combined results for three popular condom brands used
as controls in randomized clinical trials. Contraception, 70, 407-413, 2004.
222. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL,
Peel D, Pinder R,. Ross RK, West D, Wright WE, Ziogas A. Regional variations in breast cancer
incidence in the California Teachers Study cohort. Epidemiol, 15, 746-754, 2004.
223. Baumgartner KB, Baumgartner R, Hunt C, Crumley D, Gilliland F, McTiernan A, Bernstein L,
Ballard-Barbash R. Association of body composition and weight history with breast cancer
prognostic markers in Hispanic and Non-Hispanic White women. Am J Epidemiol, 160, 10871097, 2004.
224. McDonald JA, Mandel MG, Marchbanks PA, Folger SG, Daling JR, Ursin G, Simon MS,
Bernstein L, Malone KE, Strom BL, Norman SA, Weiss LK, Burkman RT, Weber AL, Spirtas R.
Alcohol exposure and breast cancer: Results of the Women’s Contraceptive and Reproductive
Experiences Study. Cancer Epidemiol Biomarkers Prev, 31, 2106-2116, 2004.
225. Lubin JH, Colt JS, Camann D, Davis S, Cerhan J, Severson RK, Bernstein L, Hartge P.
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health
Perspect, 112, 1691-1696, 2004. PMC1253661.
226. Hurley SE, Reynolds P, Goldberg DE, Hertz A, Horn-Ross PL, Anton-Culver H, Bernstein L,
Deapen D, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Residential mobility in the
California Teachers Study: Implications for geographic differences in disease rates. Soc Sci Med,
60, 1547-1555, 2005.
227. Irwin ML, McTiernan A, Baumgartner R, Baumgartner K, Bernstein L, Gilliland FD, BallardBarbash R. Changes in body fat and weight after a breast cancer diagnosis: Influence of
demographic, prognostic and lifestyle factors. J Clin Oncol, 23, 774-782, 2005. PMC3000612.
228. Patel AV, Rodriguez C, Bernstein L, Chao A, Thune MJ, Calle EE. Obesity, recreational
physical activity, and risk of pancreatic cancer in a large US cohort. Cancer Epidemiol Biomarkers
Prev, 14, 459-466, 2005.
229. Simon MS, Korczak JF, Yee CL, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Folger
SG, McDonald JA, Norman SA, Strom BL, Deapen D, Ursin G,. Burkman RT, Press MF, Schwartz
AG, Spirtas R. Racial differences in the familial aggregation of breast cancer and other female
cancers in the Women’s Contraceptive and Reproductive Experiences (CARE) Study. Breast
Cancer Res Treat, 89, 227-235, 2005.
230. Bu X*, Bernstein L. A proposed explanation for female predominance in alveolar soft part
sarcoma: noninactivation of X;autosome translocation fusion gene. Cancer, 103, 1235-1253, 2005.
41
Leslie Bernstein, PhD
231. Kendall AR*, Mahue-Giangreco M*, Carpenter CL*, Ganz PA, Bernstein L. Influence of
physical activity on quality of life in long-term breast cancer survivors. Qual Life Res, 14, 361-371,
2005.
232. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BCH, Vineis P, Stagnaro E, Willett EV,
Francheschi S, LaVecchia C, Hughes AM, Cozen W, Davis S, Severson RK, Bernstein L, Mayne
ST, Dee FR, Cerhan JR, Zheng T. Cigarette smoking and risk of non-Hodgkin lymphoma: a
pooled analysis from the InterLymph consortium. Cancer Epidemiol Biomarkers Prev, 14, 925-933,
2005.
233. Geiger AM, Chen W, Bernstein L. Myocardial infarction and tamoxifen therapy for breast
cancer. Br J Cancer, 92, 1614-1620, 2005.
234. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D,
Pinder R, Purdie D, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Non-steroid
anti-inflammatory medicine and breast cancer risk by stage and hormone-receptor status. J Natl
Cancer Inst, 97, 805-812, 2005.
235. Morton LM, Zheng T, Holford TR, Holly EA, Chiu BCH, Constantini AS, Stagnaro E, Willett
EV, Dal Maso L, Serraino D, Chang ET, Cozen W, Davis S, Severson RK, Bernstein L, Mayne
ST, Dee FR, Cerhan JR, Hartge P. Alcohol consumption and risk of non-Hodgkin lymphoma: a
pooled analysis from the InterLymph consortium. Lancet Oncol, 6, 469-476, 2005.
236. Ursin G, Bernstein L, Lord SJ*, Karim R*, Deapen D, Press MF, Daling JR, Norman SA,. Liff
JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R.
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J
Cancer, 93, 364-371, 2005.
237. Meeske K*, Siegel S, Globe DR, Mack W, Bernstein L. Prevalence and correlates of fatigue in
long-term survivors of childhood leukemia. J Clin Oncol, 23, 5501-5510, 2005.
238. Press MF, Sauter G, Bernstein L, Villalobos I, Mirlacher M, Zhou JY, Wardeh R, Li B, Guzman
R, Ma Y, Sullivan-Halley J, Riva A, Slamon DJ. Diagnostic evaluation of HER-2/neu as a
molecular target: Centralized FISH testing compared to local testing for clinical trials. Clin Cancer
Research, 11, 6598-6607, 2005.
239. Saffari B*, Bernstein L, Hong DC, Runnebaum IB, Grill HJ, Jones LA, El Naggar A, Press MF.
Association of P53 mutations and codon 72 single nucleotide polymorphism with lower overall
survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinoma. Int J
Gynecol Cancer, 15, 952-963, 2005.
240. Cockburn M, Wu A, Bernstein L. Histology-specific trends in esophageal and lung cancers and
the role of changing constituents of tobacco smoke. Cancer Cause Control, 16, 1065-1074, 2005.
241. Cerhan J, Bernstein L, Severson R, Davis S, Colt J, Blair A, Hartge P. Anthropometrics, obesityrelated medical conditions, physical activity and the risk of non-Hodgkin’s lymphoma. Cancer
Causes Control, 16, 1203-1214, 2005.
242. Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, Daling JR,
McDonald JA, Norman SA, Malone KE, Strom BL, Liff J, Folger SG, Simon MS, Burkman RT,
Marchbanks PA,Weiss LK, Spirtas R. Lifetime recreational exercise activity and breast cancer risk
among black and white women. J Natl Cancer Inst, 97, 1671-1679, 2005.
243. Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, BallardBarbash R. Relationship of obesity and physical activity with c-peptide, leptin, and insulin-like
growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev, 14, 2881-2888,
2005. PMC3000615.
42
Leslie Bernstein, PhD
244. Vigen C*, Bernstein L, Wu AH. Occupational physical activity and risk of adenocarcinomas of
the esophagus and stomach. Int J Cancer, 118, 1004-1009, 2006.
245. Bernstein L. The risk of breast, endometrial and ovarian cancer in users of hormonal
preparations. Basic Clin Pharmacol Toxicol, 98, 288-298, 2006.
246. Wayne SJ, Baumgartner K, Baumgartner R, Bernstein L, Bowen DJ, Ballard-Barbash R. Diet
quality is directly associated with quality of life in breast cancer survivors. Breast Cancer Res
Treat, 96, 227-232, 2006.
247. Bernstein L. Control recruitment in population-based case-control studies. Epidemiology, 17,
255-257, 2006.
248. Li CL, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS,
Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R. Relationship between
established breast cancer risk factors and risk of seven different histologic types of invasive breast
cancer. Cancer Epidemiol Biomarkers Prev, 15, 946-954, 2006.
249. Smith-Warner SA, Spiegelman D, Ritz J, Adami HO, Albanes D, Beeson WL, Bernstein L,
Berrino F, van den Brandt PA, Buring JE, Cho E, Colditz GA, Folsom AR, Freudenheim JL,
Giovannucci E, Goldbohm RA, Graham S, Harnack L, Horn-Ross PL, Korgh V, Leitzmann MF,
McCullough M, Miller AB, Rimm EB, Rodriguez C, Rohan TE, Schatzkin A, Shore R, Virtanen
M, Willett WW, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Hunter DJ. Methods for pooling
results of epidemiologic studies: The Pooling Project of Prospective Studies of Diet and Cancer.
Am J Epidemiol, 163, 1053-1064, 2006.
250. Simon MS, Korczak MJ, Yee CL, Malone KE, Ursin G, Bernstein L, McDonald JA, Deapen D,
Strom BL, Press MF, Marchbanks PA, Burkman RT, Weiss LK, Schwartz AG, Breast cancer risk
estimates for relatives of white and African American women with breast cancer in the Women’s
Contraceptive and Reproductive Experiences (CARE) Study. J Clin Oncol, 24, 2498-2504, 2006.
251. Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Smith AW, Baumgartner KB,
Bernstein L, Ballard-Barbash R, Malone K, Ganz P, McTiernan A,. Psychometric evaluation of
the Brief Cancer Impact Assessment among breast cancer survivors. Oncology, 70, 190-202, 2006.
PMC2996238.
252. Norman SA, Localio AR, Zhou L, Weber AL, Coates RJ, Malone KE, Bernstein L, Marchbanks
PA, Liff JM, Lee NC, Nadel MR. Benefit of screening mammography in reducing the rate of late
stage breast cancer diagnoses (United States). Cancer Cause Control, 17, 921-929, 2006.
253. Ma H*, Bernstein L, Ross RK, Ursin G. Hormone-related risk factors for breast cancer in
women under age 50 years by estrogen and progesterone receptors status – results from a casecontrol and a case-case comparison. Breast Cancer Res, 8:R39 (1-10), 2006. PMC1779482.
254. Gebregziabher M*, Bernstein L, Wang Y, Cozen W. Risk patterns of multiple myeloma in Los
Angeles County, 1972-1999 (United States). Cancer Cause Control, 17, 931-938, 2006.
255. Irwin MI, Aiello EJ, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland
FD, Ballard-Barbash R. Pre-diagnosis physical activity and mammographic density in breast
cancer survivors. Breast Cancer Res Treat, 95, 171-178, 2006. PMC3034407.
256. Malone KE, Daling JR, Doody, DR, Hsu L, Bernstein L, Coates R, Marchbanks PA, Simon M,
McDonald JA, Norman SA, Strom BL, Burkman RT, Ursin G, Deapen D, Weiss LK, Folger S,
Madeoy JJ, Friedrichsen DM, Suter NM, Humphrey MC, Spirtas R, Ostrander EA. Prevalence and
predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white
and black women ages 35-64 years. Cancer Res, 66, 8297-8308, 2006.
43
Leslie Bernstein, PhD
257. Ma H*, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according
to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
Breast Cancer Res, 8:R43, 1-11, 2006. PMC1779465.
258. Siozon CC*, Ma H*, Hilsen M*, Bernstein L, Ursin G. The association between recreational
physical activity and mammographic density. Int J Cancer, 119, 1695-1701, 2006.
259. Bu X*, Ma Y, Der R, DeMeester TR, Bernstein L, Chandrasoma P. Body mass index is
associated with Barrett esophagus and cardiac mucosal metaplasia. Digestive Dis Sci, 51, 15811594, 2006.
260. Fan J*, McKean-Cowdin R, Bernstein L, Stanczyk FZ, Li AX, Ballard-Barbash R, McTiernan A,
Baumgartner R, Gilliland F. An association between a common variant (G972R) in the IRS-1 gene
and sex hormone and growth factor levels in post-menopausal breast cancer survivors. Breast
Cancer Res Treat, 49, 323-331, 2006. PMC3063148.
261. Gill J*, Press M, Patel AV*, Bernstein L. Oral contraceptive use and risk of breast carcinoma insitu. Cancer Cause Control, 17, 1155-1162, 2006.
262. Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Baumgartner KB, Bernstein L,
Ballard-Barbash R, Malone K, Ganz PA, McTiernan A. Psychometric properties of a tool for
measuring hormone-related symptoms in breast cancer survivors. Psychooncology, 15, 985-1000,
2006. PMC2996243.
263. Cozen W, Gebregziabher M*, Van Den Berg DJ, Conti D, Coetzee GA, Wang S, Rothman N,
Bernstein L, Hartge P, Morbacher A, Coetzee SG, Salam MT*, Wang W, Zadnick J, Ingles SA.
Interleukin-6 related genotypes, body mass index and risk of multiple myeloma. Cancer Epidemiol
Biomarkers Prev, 15, 2285-2291, 2006.
264. Gatto NM*, Longnecker MP, Press MF, Sullivan-Halley J, McKean-Cowdin R, Bernstein L.
Serum organochlorines and breast cancer: A case-control study among African-American women.
Cancer Cause Control, 18, 29-39, 2007. PMC1839921.
265. Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, Bernstein L, Stram DO,
Anton-Culver H, Deapen D, Mohrenweiser H, Peel D, Pinder R, Ross RK, West DW, Wright W,
Ziogas A, Horn-Ross PL. Wine and other alcohol consumption and risk of ovarian cancer in the
California Teachers Study cohort. Cancer Cause Control, 18, 91-103, 2007. PMC1764867.
266. Clegg L, Reichman M, Hankey BF, Miller BA, Lin YD, Johnson NJ, Schwartz SM, Bernstein L,
Chen VW, Goodman MT, Gomez SL, Graff JJ, Lynch CF, Lin CC, Edwards BK. Comparison of
demographic information in SEER (Surveillance, Epidemiology, and End Results) data with selfreport. Cancer Cause Control, 18, 177-187, 2007.
267. Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin J, Daling JR, Norman
SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Deapen D, Spirtas R. Risk of breast cancer
associated with short-term use of oral contraceptives. Cancer Cause Control, 18, 189-198, 2007.
268. Stoddard JL*, Dent CW, Shames L*, Bernstein L. Exercise training effects on premenstrual
distress and ovarian steroid hormones. Eur J Appl Physiol, 99, 27-37, 2007.
269. Dallal CM*, Sullivan-Halley J, Ross RK, Wang Y*, Deapen D, Horn-Ross PL, Reynolds P, Stram
D, Pinder R, Anton-Culver H, Ziogas A, Peel D, West DW, Clarke-Dur C, Wright W, Bernstein L.
Long-term recreational physical activity and risk of invasive and in situ breast cancer. Arch Int
Med, 167, 408-415, 2007.
270. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H,
Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A,
Horn-Ross PL. Diet and risk of ovarian cancer in the California Teachers Study. Am J Epidemiol,
165, 802-813, 2007. PMC2093945.
44
Leslie Bernstein, PhD
271. Irwin ML, Aiello EJ, McTiernan A, Bernstein L, Gilliland FD, Baumgartner RN, Baumgartner
KB, Ballard-Barbash R. Physical activity, body mass index and mammographic density in
postmenopausal breast cancer survivors. J Clin Oncol, 25, 1061-1066, 2007.
272. Prescott J*, Ma H*, Bernstein L, Ursin G. Cigarette smoking is not associated with breast cancer
risk in young women. Cancer Epidemiol Biomarkers Prev, 16, 620-623, 2007.
273. Mai P*, Sullivan-Halley J, Ursin G, Stram DO, Deapen D, Villaluna D*, Horn-Ross PL, Clark C,
Reynolds P, Ross RK, West DW, Anton-Culver H, Ziogas A, Bernstein L. Physical activity and
colon cancer risk among women in the California Teachers Study. Cancer Epidemiol Biomarkers
Prev, 16, 517-525, 2007.
274. Wang SS, Slager SL Brennan P, Holly EA, De Sanjose S, Bernstein L, Bofetta P, Cerhan JR,
Maynadie M, Spinelli J, Chiu BCH, Cocco P, Mensah F, Zhang Y, Nieters A, Dal Maso L, Bracci
PM, Costantini AS, Severson RK, Roman E, Cozen W, Weisenberger D, Davis S, Franceschi S,
LaVecchia C, Foretova L, Becker N, Staines A, Vornanen M, Zheng T, Hartge P. Family history
of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of
10,214 cases and 11,906 controls from the InterLymph Consortium. Blood, 209, 3479-3488, 2007.
PMC1852242.
275. Haiman CA, Setiawan VW, Xia L, LeMarchand L, Ingles SA, Ursin G, Press M, Bernstein L,
John E, Henderson BE. A variant in the cytochrome P450 oxidoreductase (POR) gene is associated
with breast cancer risk in African Americans. Cancer Res, 67, 3565-3568, 2007.
276. Lee JE, Hunter DJ, Spiegelman D, Adami HO,Albanes D, Bernstein L, van den Brandt PA,
Buring JE, Adami HO, Cho E, Folsom AR, Freudenheim JL, Giovannucci E, Graham S, Horn-Ross
PL, Leitzmann MF, McCullough ML, Miller AB, Parker AS, Rodriguez C, Rohan TE, Schatzkin
A, Schouten LJ, Virtanen M, Willett WC, Wolk A, Zhang SM, Smith-Warner SA. Alcohol intake
and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst, 99, 801-810,
2007.
277. Largent JA, Capanu M, Bernstein L, Langholz B, Mellemkjaer L, Malone KE, Begg C, Haile
RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL. Reproductive history and risk of
second primary breast cancer: the WECARE Study. Cancer Epidemiol Biomarkers Prev, 16, 906911, 2007.
278. McKean-Cowdin R, Li AX, Bernstein L, McTiernan A, Ballard-Barbash R, Gauderman WJ,
Gilliland F. The ADRB3 Trp64Arg variant and obesity in African American breast cancer cases.
Int J Obesity, 31, 1110-1118, 2007. PMC3063149.
279. Wu AH, Tseng C, Hankin J, Bernstein L. Fiber intake and risk of adenocarcinomas of the
esophagus and stomach. Cancer Cause Control, 18, 713-722, 2007.
280. Brody JG, Rudel RA, Michels KB, Moysich KP, Bernstein L, Attfield KR, Gray S.
Environmental pollutants, diet, physical activity, body size and breast cancer: Where do we stand
in research to identify opportunities for prevention. Cancer, 109 (12 suppl), 2627-2634, 2007.
281. Meeske K*, Smith A, McGregor BA, McTiernan A, Baumgartner KB, Malone KE, Alfano A,
Reeve BB, Ballard-Barbash R, Bernstein L. Correlates of fatigue in breast cancer survivors. Qual
Life Res, 16, 947-960, 2007.
282. Cozen W, Cerhan JR, Martinez-Maza O, Ward MH, Linet M, Colt JS, Davis S, Severson RK,
Hartge P, Bernstein L. The effect of atopy, childhood crowding and other immune-related risk
factors on non-Hodgkin lymphoma risk. Cancer Cause Control, 18, 821-831, 2007.
283. Meeske K*, Nelson M, Lavey R, Gee S, Nelson M, Bernstein L, Weaver F, Siegel S. Premature
carotid artery disease in long-term survivors of childhood cancer treated with neck irradiation: Five
case reports. J Ped Hematol Oncol, 29, 480-494, 2007.
45
Leslie Bernstein, PhD
284. Norman SA, Localio AR, Weber AL, Coates RJ, Zhou L, Bernstein L, Malone KE, Liff JM,
Marchbanks PA, Lee NC, Nadel MR. Mammography screening protects against death from breast
cancer in women 40-64 years. Cancer Causes Control, 18, 909-918, 2007.
285. Abrahamson PE, Tworoger SS, Aiello EJ, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R,
Bernstein L, Sorensen B, Ballard-Barbash R, McTiernan A. Associations between the CYP17,
CYP1B1, COMT, and SHBG polymorphisms and serum sex hormones in postmenopausal breast
cancer survivors. Breast Cancer Res Treat, 105, 45-54, 2007. PMC2997631.
286. Nunez NP, Carpenter CL, Berrigan D, Jaque SV, Ingles SA, Perkins SN, Bernstein L, Forman
RM, Barrett JC, Hursting SD. Extreme obesity reduces bone density in the absence of ovarian
hormones: complementary evidence from mice and women. Obesity Res, 15, 1980-1987, 2007.
287. Morton LM, Bernstein L, Wang SS, Hein DW, Rothman N, Colt JS, Davis S, Cerhan JR,
Severson RK, Welch R, Hartge P, Zahm SH. Hair dye use, genetic variation in N-acetyltransferase
1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis, 28, 1759-1764,
2007. PMC2085367.
288. Lee JE, Spiegelman D, Hunter DJ, Adami HO, Albanes D, Bernstein L, van den Brant PA,
Buring JE, Colditz GA, Folsom AR, Freudenheim JL, Giovannucci E, Horn-Ross PL, Leitzmann
M, McCullough ML, Miller AB, Parker AS, Rodriguez C, Rohan TE, Schatzkin A, Schouten LJ,
Virtanen M, Willett WC, Wolk A, Zhang SM, Smith-Warner SA. Intakes of coffee, tea, milk soda,
and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer, 121,
2236-2253, 2007.
289. Bowen DJ, Alfano CM, McGregor BA, Kuniyuki A, Bernstein L, Meeske K, Baumgartner KB,
Fetherolf J, Reeve BB,Smith AW, Malone K, Ganz P, McTiernan A, Ballard-Barbash R. Possible
socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast
Cancer Res Treat, 106, 85-95, 2007. PMC2999962.
290. Setiawan VW*, Ursin G, Horn-Ross PL, Van Den Berg D, Le Marchand L, Henderson BE,
Bernstein L, Haiman CA. Germline variation at 8q24 and endometrial cancer risk. Cancer
Epidemiol Biomarkers Prev, 16, 2166-2168, 2007.
291. Gail MH, Costantino JP, Pee D, Bondy M, Newman, Selvan M, Anderson GL, Malone KE,
Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Bernstein L.
Projecting individualized absolute invasive breast cancer risk in African American women. J Natl
Cancer Inst, 99, 1782-1792, 2007.
292. Bertelsen L*, Bernstein L, Olsen JH, Mellemkjær L, Haile R, Lynch CF, Malone KM, AntonCulver H, Christensen J, Langholz B, Thomas DC, Begg C, Capanu M, Thompson D, Ejlertsen B,
Stovall M, Boice JD, Shore RE, The WECARE Study Collaborative Group, Bernstein JL. The
effect of systemic adjuvant treatment on risk of contralateral breast cancer in the WECARE Study.
J Natl Cancer Inst, 100, 32-40, 2008.
293. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L,
Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Humer AJ, Sima C, Bernstein JL.
Penetrance and heterogeneity of breast cancer risk among BRCA1/2 carriers: An investigation by
the WECARE Study Group. JAMA, 299, 194-201, 2008. PMC2714486.
294. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS,
Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA, Spirtas R. Timing of
menarche and first full-term pregnancy in relation to breast cancer risk. Am J Epidemiol, 167, 230239, 2008.
46
Leslie Bernstein, PhD
295. Duan L* Wu AH, Sullivan-Halley J, Bernstein L. Non-steroidal anti-inflammatory drugs and
risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol
Biomarkers Prev, 17, 126-134, 2008.
296. Lee E* Haiman CA, Ma H, Vandenberg D, Bernstein L, Ursin G. The role of established breast
cancer susceptibility loci in mammographic density in young women. Cancer Epidemiol
Biomarkers Prev, 17, 258-260, 2008.
297. Shen M, Cozen W, Huang L, Colt J, De Roos AJ, Severson RK, Cerhan JR, Bernstein L, Morton
LM, Pickle L, Ward MH. Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma. Am J Epidemiol, 167, 350-361,
2008.
298. Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, Press MF, Ursin G, Haiman
CA, Neuhausen SL. Mitochondrial DNA G10398A variant is not associated with breast cancer in
African American women. Cancer Genetics and Cytogenetics, 181, 16-19, 2008 (PMID:18262047).
299. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, Marchbanks PA, Strom BL,
Humphrey MC, Ostrander EA. Vitamin D receptor polymorphisms and breast cancer risk in a large
population-based case control study. Breast Cancer Res, 2007 Dec7;9(6):R84 (PMID: 18067661).
PMC2246187.
300. Berstad P, Ma H*, Bernstein L, Ursin G. Breast cancer risk and alcohol intake among young
women. Br Cancer Res Treat, 108, 113-120, 2008 (PMID: 17468952).
301. Mellemkjær L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL,
Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile R, Andersson M, Thomas DC,
Concannon P, Capanu M, Boyce JD, the WECARE Study Collaborative Group, Bernstein JL. Risk
for contralateral breast cancer among carriers of CHEK2*1100delC: a population-based multicenter case-control study. Br J Cancer, 98:728-733, 2008. PMC2259175..
302. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, Cerhan J, Chiu BCH,
Cocco P, Dal Maso L, Davis S, De Sanjose S, Smedby KE, Foretova L, Holly E, La Vecchia C,
Matsuo K, Maynadie M, Melbye M, Severson R, Spinelli JJ, Staines A, Vornanen M, Roman E for
the InterLymph Consortium. Non-Hodgkin lymphoma and obesity: a pooled analysis from the
InterLymph Consortium. Int J Cancer, 122, 2062-2070, 2008. PMC3928289.
303. Figueiredo JC*, Bernstein L, Capanu M, Malone KE, Haile RW, Bernstein JL, WECARE Study
Collaborative Group. Oral contraceptives and hormone replacement therapy and risk of
asynchronous bilateral breast cancer. The WECARE Study Group. (corresponding author) J
Clinical Oncol, 26, 1411-1418, 2008 (PMID: 18250348).
304. Stuedal A, Ma H* Bernstein L, Pike MC, Ursin G. Does breast size modify the association
between mammographic density and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 17,
621-627, 2008 (PMID: 18349279).
305. Alfano, C. M., Smith, A. W., Irwin, M., Bowen, D.J., Sorensen, B., Reeve, B., Meeske KA,
Bernstein, L., Baumgartner, K.B., Ballard-Barbash, R., Malone, K., McTiernan, A. Physical
activity, long-term symptoms, and health-related quality of life among breast cancer survivors: A
prospective analysis. J Cancer Surviv, 1, 116-128, 2007 (avail 2008). PMC2996230.
306. Ma H*, Hill CK, Bernstein L, Ross RK, Ursin G. Low-dose medical radiation and breast cancer
risk in women under age 50 years overall and by estrogen and progesterone receptor status. Breast
Cancer Res Treat, 109, 77-90, 2008 (PMID: 17616809).
47
Leslie Bernstein, PhD
307. Knight JA, Lesosky M, Blackmore K, Voigt LF, Holt VL, Bernstein L, Marchbanks PA,
Burkman RT, Daling JR, Whittemore AS. Ovarian cysts and breast cancer: Results from the
Women’s Contraceptive and Reproductive Experiences Study. Breast Cancer Res Treat, 109, 157164, 2008 (PMID: 17616808).
308. Chang ET, Lee VS, Canchola AJ, Dalvi T, Clarke CA, Reynolds P, Purdie DM, Stram DO, West
DW, Bernstein L, Horn-Ross PL. Dietary patterns and risk of ovarian cancer in the California
Teachers Study cohort. Nutr Cancer, 60, 285-291, 2008. PMC2365491.
309. Lee E* McKean-Cowdin R, Ma H, Chen Z, Vandenberg D, Henderson BE, Bernstein L, Ursin G.
Evaluation of unclassified variants (UVs) in the breast cancer susceptibility genes BRCA1 and
BRCA2 using five methods: Results from a population-based study of young breast cancer
patients. Breast Cancer Res 10:R19, 2008. PMC 2384975.
310. Henderson KD,* Sullivan-Halley J, Reynolds P, Horn-Ross PL, Clarke CA, Chang ET,
Neuhausen S, Ursin G, Bernstein L. Incomplete pregnancy is not associated with breast cancer
risk: the California Teachers Study. Contraception, 77, 391-396, 2008. PMC2473863
311. Henderson KD,* Bernstein L, Henderson BE, Kolonel L, Pike MC. Predictors of the timing of
natural menopause in the Multiethnic Cohort Study. Am J Epidemiol, 167, 1287-1294, 2008
(PMID: 18359953).
312. Zhang Y, de Sanjose S, Bracci PM, Morton LM, Wang R, Brennan P, Hartge P, Boffetta P,
Becker N, Maynadie M, Foretova L, Cocco P, Staines A, Holford T, Holly EA, Nieters A,
Benavente Y, Bernstein L, Zahm SH, Zheng T. Personal hair dye use increases the risk of nonHodgkin lymphoma: Results from the International Lymphoma Epidemiology Consortium
(InterLymph). Am J Epidemiol, 167, 1321-1331, 2008. PMC4025953.
313. Horn-Ross PL, Lee VS, Collins C, Stewart SL, Canchola AJ, Lee MM, Reynolds P, Clarke CA,
Bernstein L, Stram DO. Dietary assessment in the California Teachers Study: Reproducibility and
validity. Cancer Cause Control, 19, 595-603, 2008. PMC2751594.
314. Neuhouser ML, Sorensen B, Hollis BW, Ambs A, Ulrich CM, McTiernan A, Bernstein L, Wayne
S, Gilliland F, Baumgartner K, Baumgartner R, Ballard-Barbash R. Vitamin D insufficiency in a
multiethnic cohort of breast cancer survivors. Am J Clin Nutr, 88, 133-139, 2008. PMC2997620.
315. Lord SJ* Bernstein L, Johnson K, Malone KE, MacDonald JA, Marchbanks PA, Simon MS,
Strom BL, Press MS, Folger SG, Burkman RT, Deapen D, Spirtas R, Ursin G. Breast cancer risk
and hormone receptor status in older women by parity, age of first birth, and breastfeeding - a casecontrol study. Cancer Epidemiol Biomarkers Prev, 17, 1723-1730, 2008. PMC2754711.
316. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, Deapen D, Ziogas A,
Reynolds P, Cress R, Anton-Culver H, West D, Ross RK, Bernstein L. Adenomyosis and
endometriosis in the California Teachers Study: Reproductive and lifestyle correlates. Fertil Steril,
90, 415-424, 2008. PMC2813675.
317. Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teroaka SN, Diep AT,
Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L,
Olsen JH, Malone KE, Lynch CF, Anton-Culver H, the WECARE Study Collaborative Group,
Bernstein JL. Variants in the ATM gene associated with a reduced risk of contralateral breast
cancer. Cancer Res, 68, 6486-6491, 2008. PMC2562548.
318. Irwin ML, Smith A, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD, Baumgartner RN,
Baumgartner KB, Bernstein L. Influence of pre- and postdiagnosis physical activity on mortality in
breast cancer survivors: the Health, Eating, Activity, and Lifestyle Study. J Clin Oncol, 26, 39583964, 2008. PMC2654316.
319. Wayne SJ, Neuhouser ML, Ulrich CM, Koprowski C, Baumgartner KB, Baumgartner RN,
48
Leslie Bernstein, PhD
McTiernan A, Bernstein L, Ballard-Barbash R. Dietary fiber is associated with serum sex
hormones and insulin-related peptides in postmenopausal breast cancer survivors. Breast Cancer
Res Treat, 112, 149-158, 2008. PMID: 18058020.
320. Wayne S, Neuhauser ML, Ulrich CM, Koprowski C, Wiggins C, Baumgartner KB, Bernstein L,
Baumgartner RM, Gilliland F, McTiernan A, Ballard-Barbash R. The association between alcohol
intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.
Cancer Epidemiol Biomarkers Prev, 17,3224-3232, 2008. PMC2673729.
321. Lee E*, Ma H, McKean-Cowdin R, Vandenberg D, Bernstein L, Henderson BE, Ursin G. The
effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 carriers and
non-carriers, results from a population-based study. Cancer Epidemiol Biomarkers Prev, 17, 31703178, 2008. PMID: 18990759.
322. Lee JE, Spiegelman D, Hunter DJ, Albanes D, Bernstein L, van den Brandt PA, Buring JE, Cho
E, English D, Freudenheim JL, Giles GG, Graham S, Horn-Ross PL, Håkansson N, Jacobs EJ,
Leitzmann M, Männistö S, McCullough ML, Miller AB, Parker AS, Rohan TE, Schatzkin A,
Schouten LJ, Sweeny C, Willett WC, Wolk A, Zhang SM, Smith-Warner SA. Fat, protein and
meat consumption and risk of renal cell cancer in a pooled analysis of 13 prospective studies. J Natl
Cancer Inst, 100, 1695-1706, 2008. PMC2727138.
323. Stovall M, Smith SA, Langholz BM, Boice Jr, JD, Shore RE, Andersson M, Buchholz TA,
Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Reiner A, Thomas
DC, WECARE Study Collaborative Group, Bernstein JL. Dose to the contralateral breast from
radiation therapy and risk of second primary breast cancer in the WECARE Study. Int J Radiation
Oncol, Biol Phys, 72, 1021-30, 2008. PMID: 18556141.
324. Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef
MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels EA, Hein DW, Hill DA,
Kelemen LE, Lim U, Lynch CF, Schenk M, Wacholder S, Ward M, Zahm SH, Chanock SJ, Cerhan
JR, Hartge P. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood, 112, 515060, 2008. PMC2597610.
325. Meeske K*, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, Bernstein
L. Risk factors for arm lymphedema following breast cancer diagnosis in black women and white
women. Br Cancer Res Treat, 113, 383-391, 2009. PMID: 18297429
326. Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R,
Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, Ulrich CM. Correlates of circulating Creactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res
Treat, 114, 155-167, 2009. PMC3523176.
327. Smith AW, Alfano C, Reeve BB, Irwin M, Bernstein L, Baumgartner K, Bowen D, McTiernan
A, Ballard-Barbash R. Race/ethnicity, physical activity and quality of life in breast cancer
survivors. Cancer Epidemiol Biomarkers Prev, 18, 656-663, 2009. PMC3031117.
328. Duan L*, Wu AH, Sullivan-Halley J, Bernstein L. Antacid drug use and risk of esophageal and
gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev, 18, 526-533,
2009.
329. Lu Y*, Sullivan-Halley J, Cozen W, Chang E, Henderson K, Ma H, Deapen D, Clarke C,
Reynolds P, Neuhausen SL, Anton-Culver H, Ursin G, West D, Bernstein L. Family history of
hematopoietic malignancies and non-Hodgkin lymphoma risk in the California Teachers Study. Br
J Cancer, 100, 524-526, 2009. PMC2658543
49
Leslie Bernstein, PhD
330. Ma H, Luo J, Press MF, Bernstein L, Ursin G. Is there a difference in the association between
mammographic density and subtypes of breast cancer? - Luminal A and basal-like breast cancer.
Cancer Epidemiol Biomarkers Prev, 18, 479-485, 2009.
331. Pullarkat S,* Danley K, Bernstein L, Brynes R, Cozen W. High lifetime incidence of acute
lymphoblastic leukemia among adult Hispanics in California. Cancer Epidemiol Biomarkers Prev,
18, 611-614, 2009.
332. Knight JA, Bernstein L, Largent J, Capanu M, Begg C, Mellemkjær L, Lynch CF, Malone KE,
Reiner AS, Liang X, Haile RW, Boice JR, WECARE Study Collaborative Group, Bernstein JL.
Alcohol intake and cigarette smoking and risk of a contralateral breast cancer in the Women’s
Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol, 169, 962-968, 2009.
PMC2727227.
333. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, Goodman MT, Lynch CF,
Schwartz SM, Chen VW, Bernstein L, Gomez SL, Graff, Lin CC, Johnson NJ, Edwards BK.
Impact of socioeconomic status on cancer incidence and stage at diagnosis: Selected findings from
the Surveillance Epidemiology, and End Results -- National Longitudinal Mortality Study. Cancer
Cause Control, 20, 417-435, 2009. PMC2711979.
334. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, Doody DR, MacArthur S,
Tyrer J, Pharoah PD, Luben R, SEARCH Collaborators, Bernstein L, Kolonel LK,. Henderson BE,
Le Marchand L, Ursin G, Press MF, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY,
Wu PE, Wang JC,, Kang D, Yoo KY, Noh DY, Ahn SH, Ponder BAJ, Haiman CA, Malone KE,
Dunning AM, Ostrander EA, Easton DF. FGFR2 variants and breast cancer: Fine scale mapping
using African American studies and analysis of chromatic conformation. Hum Molec Genetics, 18,
1692-1703, 2009. PMC2733817
335. Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA,
English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Hankinson SE, Horn-Ross PL,
Leizmann M, Marshall JR, Männistö S, McCullough ML, Miller AB, Reding DJ, Robien K, Rohan
TE, Schatzkin A, Stevens VL, Verhage BAJ, Wolk A, Ziegler R, Smith-Warner SA. Alcohol intake
and pancreatic cancer risk: A pooled analysis of fourteen cohort studies. Cancer Epidemiol
Biomarkers Prev, 18, 765-776, 2009. PMC2715951
336. Cheng CY, Kao WHL, Patterson N, Tandon A, Haiman CA, Ziv E, Harris TB, Xing C,
Ambrosone CB, John EM, Brancati FL, Coresh J, Parekh RS, Klag MJ, Meoni LA, Hsueh WC,
Fejerman L, Pawlikowska L, Freedman ML, Nalls MA, Akylbekova EL, Orwoll ES, Leak TS, Li
R, Miljkovic-Gacic I, Ursin G, Bernstein L, Ardlie K, Cummings SR, Taylor HA, Boerwinckle E,
Zmuda JM, Henderson BE, Wilson JG, Reich D. Admixture mapping of 15,280 African
Americans identifies obesity susceptibility loci on chromosome 5 and X. PloS Genet, 5, e1000499,
doi:10.1371/journal.pgen.1000490, 2009. PMC2679192.
337. Duan L*, Wu AH, Sullivan-Halley J, Bernstein L. Passive smoking and risk of oesophageal and
gastric adenocarcinomas. Br J Cancer, 100, 1483-1485, 2009. PMC2694436.
338. Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very longterm breast cancer survivors. Br Cancer Res Treat, 116, 387-396, 2009. PMID: 18712472.
339. Lee JE, Männistö S, Spiegelman D, Hunter DJ, Bernstein L, van den Brandt PA, Buring JE, Cho
E, English D, Flood A, Freudenheim JL, Giles GG, Giovannucci E, Håkansson N, Horn-Ross PL,
Jacobs E, Leitzmann M, Marshall JR, McCullough ML, Miller AB, Rohan TE, Ross J, Schatzkin
A, Schouten LJ, Virtamo J, Wolk A, Zhang SM, Smith-Warner SA. Intakes of fruits, vegetables,
and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer
Epidemiol Biomarkers Prev, 18, 1730-1739, 2009. PMC2883186.
50
Leslie Bernstein, PhD
340. Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K,
Baumgartner KB, Ballard-Barbash R. Comorbidities, therapy, and newly diagnosed conditions for
women with early stage breast cancer. J Cancer Survivor, 3, 89-98, 2009. PMC2998176.
341. Langholz B, Thomas DC, Stovall M, Smith SA, Boice JD, Shore RE, Bernstein L, Lynch CF,
Zhang X, the WECARE Study Group, Bernstein JL. Statistical methods for analysis of radiation
effects with tumor and dose location-specific information with application to the WECARE Study
of asynchronous contralateral breast cancer. Biometrics, 65, 599-608, 2009. PMC2728135.
342. Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, Strom BL, Simon MS,
Press MF, Deapen D, Burkman RT, Folger SG, McDonald JA, Spirtas R. Relationship between
migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer
Epidemiol Biomarkers Prev, 18, 2030-2034, 2009. PMC2756173
343. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML,. Wener MH,.
Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM. Elevated biomarkers of
inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol , 27,
3437-3444, 2009. PMC2717751.
344. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL,
Ursin G, Marchbanks PA, Mc Donald JA, Spirtas R, Press MF, Bernstein L. Breast cancer
receptor status: Do results from a centralized pathology laboratory agree with SEER registry
reports? Cancer Epidemiol Biomarkers Prev, 18, 2214-2220, 2009. PMC19661080.
345. Meeske KA*, Siegel SE, Gilsanz V, Bernstein L, Nelson MB, Sposto R, Lavey RS, Weaver FA,
Mack WJ, Nelson MD. Premature carotid artery disease in pediatric cancer survivors treated with
neck irradiation. Pediatr Blood Cancer 53, 615-621, 2009. PMID: 19533651.
346. Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB,
Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R. Breast cancer survivors who use
estrogenic botanical supplements have lower serum estrogen levels than non users. Breast Cancer
Res Treat, 117, 111-119, 2009. PMID: 18931907.
347. Von Behren J, Lipsett M, Horn-Ross PL, Delfino RJ, Gilliland F, McConnell R, Bernstein L,
Clarke CA, Reynolds P. Obesity, waist size, and risk of current asthma in the California Teachers
Study cohort. Thorax, 64, 889-893, 2009. PMC2813683.
348. Templeman C, Marshall SF, Clarke CA, Henderson KD, Largent J, Neuhausen S, Reynolds P,
Ursin G, Bernstein L. Risk factors for surgically-removed fibroids in a large cohort of teachers.
Fertil Steril, 92, 1436-1446, 2009. PMC2765807.
349. Bernstein L. Combined hormone therapy at menopause and breast cancer: A warning – shortterm use increases risk. J Clin Oncol, 27, 5116-5119, 2009. PMID:19752330. PMC pending.
350. Lu Y*, Prescott J*, Sullivan-Halley J, Henderson KD, Ma H, Chang ET, Clarke CA, Horn-Ross
PL, Ursin G, Bernstein L. Body size, recreational physical activity and B-cell non-Hodgkin
lymphoma risk among women in the California Teachers Study. Am J Epidemiol, 170, 1231-1240,
2009. PMC2781760.
351. Zell JA*, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent J, Neuhausen SL, Stram DO,
Ursin G, Anton-Culver H. Non-steroidal anti-inflammatory drugs: effects on mortality after
colorectal cancer diagnosis. Cancer, 115, 5662-5671, 2009 PMC3008399.
352. Bernstein L. Exercise and breast cancer prevention. Curr Oncol Reports, 11, 490-496, 2009.
PMID:19840527.
51
Leslie Bernstein, PhD
353. West-Wright CN*, Henderson KD, Sullivan-Halley J, Ursin G, Deapen D, Neuhausen S,
Reynolds P, Chang E, Ma H, Bernstein L. Long-term and recent recreational physical activity and
survival after breast cancer: the California Teachers Study. Cancer Epidemiol Biomarkers Prev, 18,
2851-2959, 2009. PMC2783945.
354. Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, Ambrosone C, Whittemore A,
Bernstein L, Henderson BE, Press M, Ursin G, Huntsman S, Ziv E, Freedman M. An admixture
scan in 1,484 African American women with breast cancer. Cancer Epidemiol Biomarkers Prev, 18,
3110-3117, 2009. PMC2783219
355. Bernstein L. Identifying population-based approaches to lower breast cancer risk. Oncogene, 27,
s3-s8, 2008.
356. Prescott J*, Lu Y, Chang ET, Sullivan-Halley J, Henderson K D, Clarke C A, Ma H, Templeman
C, Deapen D, Bernstein L. Reproductive factors and non-Hodgkin lymphoma risk in the California
Teachers Study. PloS ONE, 4(12): e8135. doi:10.1371/journal.pone.0008135, 2009.
PMC2780313
357. Reynolds P, Goldberg D, Hurley S, Nelson DO, Henderson KD, Bernstein L. Passive smoking
and breast cancer in the California Teachers Study. Cancer Epidemiol Biomarkers Prev, 18, 33893398, 2009. PMC290853.
358. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Burkman RT, Simon MS, Malone KE, Strom BL,
Ursin G, Marchbanks PA, Mc Donald JA, Spirtas R, Press MF, Bernstein L. Use of four
biomarkers to evaluate the risk of breast cancer subtypes in the Women’s Contraceptive and
Reproductive Experiences Study. Cancer Res, 70, 575-587, 2010. PMC2807992.
359. Delellis-Henderson K*, Duan L*, Sullivan-Halley J, Ma H, Clarke CA, Neuhausen SL,
Templeman C, Bernstein L. Menopausal hormone therapy use and risk of invasive colon cancer:
the California Teachers Study. Am J Epidemiol, 171, 415-25, 2010. PMC2842195.
360. Ostro B, Lipsett M, Reynolds P, Goldberg D, Hertz A, Garcia C, Henderson KD, Bernstein L.
Long-term exposure to constituents of fine particulate air pollution and mortality: Results from the
California Teachers Study. Environ Health Perspect, 118, 363-369, 2010. PMC2854764.
361. Marshall SF*, Clarke CA, Henderson KD, Largent J, Neuhausen S, Reynolds P, Ursin G, HornRoss PL, Stram DO, Bernstein L. Recent breast cancer incidence trends according to hormone
therapy use: the California Teachers Study. Breast Cancer Res, 2010, 12:R4. PMC2880422.
362. Neuhouser ML, Nojomi M, Sorensen B, Baumgartner RN, Baumgartner KB, Gilliland F,
Bernstein L, Stanczyk F, Ballard-Barbash R, McTiernan A. Dietary fat, tamoxifen use and
circulating sex hormones in postmenopausal breast cancer survivors Nutr Cancer.62, 164-174,
2010. PMID 20099190.
363. Figueiredo JC*, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF,
Bertelsen L, Capanu M, Concannon P, Borg A, Borresen-Dale AL, WECARE Study Collaborative
Group, Bernstein JL. Oral Contraceptives and Post-menopausal Hormones and Risk of
Contralateral Breast Cancer among BRCA1 and BRCA2 mutation carriers and non-carriers: The
WECARE Study. Br Cancer Res Treat, 120, 175-183, 2010. PMC2835545.
364. Neuhouser ML, Bernstein L, Hollis B, Xiao L, Ambs A, Baumgartner K, Baumgartner R,
McTiernan A, Ballard-Barbash R. Serum vitamin D and breast density in breast cancer survivors.
Cancer Epidemiol Biomarkers Prev, 19, 412–417, 2010. PMC2819627.
365. Razavi P*, Pike MC, Horn-Ross PL, Templeman C, Bernstein L, Ursin G. Long-term
postmenopausal hormone therapy and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev,
19, 475–483, 2010. PMC2821215.
52
Leslie Bernstein, PhD
366. Lu Y*, Sullivan-Halley J, Henderson KD, Ma H, Horn-Ross PL, Reynolds P, Cress R, Bernstein
L. Anthropometric characteristics and multiple myeloma risk. Epidemiol, 21, 272-273, 2010.
PMID 20160567.
367.
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas
DC, Concannon P, Mellemkjaer L, Bernstein L, Tellhed L, Xue S, Olson ER, Liang X, Dolle J,
Børresen-Dale AL, The WECARE Study Collaborative Group, .Bernstein JL. Characterization of
BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in
unilateral and bilateral breast cancer: The WECARE Study. Hum Mutation, 31, E1200-E1240,
2010. PMC2928257.
368. Udler MS, Healey CS, Meyer K, Ahmed S, Struewing J, Maranian M, Kwon EM, Zhang J, Tyrer
J, Karlins E, Platte R, Kalmerzyaev B, Dicks E, Field H, Maia AT, Prathalingam R, Teschendorff
A, McArthur S, Doody DR, Luben R, Caldas C, Bernstein L, Kolonel LK, Henderson BE, Wu A,
LeMarchand L, Ursin G, Press MF, Lindblom A, Shen CY, Wu PE, Wang HC, Kang D, Yoo KY,
Noh DY, Ahn SH, Malone KE, Haiman CA, Pharoah PD, Ponder BAJ, Ostrander E, Easton DF,
Dunning AM. Towards identifying the function of the breast cancer 16q12 locus. Hum Molec
Genet, 19, 2507-2515, 2010. PMC2876886.
369. Bernstein J, Haile R, Stovall M, Boice J, Shore R, Langholz B, Thomas D, Olsen J, Bernstein L,
Lynch C, Malone K, Mellemkjaer L, Borresen-Dale AL, Rosenstein B, Teraoka S, Diep A, Smith
S, Capanu M, Reiner A, Liang X, Gatti RA, The WECARE Collaborative Study Group, Concannon
P. Radiation exposure, the ATM gene, and risk of asynchronous contralateral breast cancer in the
WECARE Study. J Natl Cancer Inst, 102, 475-483, 2010. PMC2902825.
370. Emaus A*, Veierød MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Thune I.
Metabolic profile, physical activity and mortality in breast cancer patients. Breast Cancer Res
Treat, 121, 651-660, 2010. PMID: 19882245.
371. Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A,
Concannon P, Teraoka SN, Xue S, Diep AT, Törngren T, Begg CB, Capanu M, Haile RW, the
WECARE Study Collaborative Group, Bernstein JL. Reproductive factors and risk of contralateral
breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer
Cause Control, 21, 839–846, 2010. PMC2873079.
372. Norman SA, Weber AL, Localio R, Newcomb PA, Ursin G, Strom BL, Weiss LK, Burkman RT,
Bernstein L, Deapen D, Folger SG, Simon MS, Nadel MR. Hormone therapy and risk of fatal
breast cancer. Pharmacoepidemiol Drug Safety, 19, 440-447, 2010. PMC3098621.
373. Malone KE, Begg CB, Haile RW, Borg A, Concannon PJ Xue S, Bernstein L, Langholz B,
Capanu M, Reiner A, Thomas DC, Mellemkjaer L, Lynch CF, Anton-Culver H, The WECARE
Collaborative Study Group, Bernstein JL. A population-based study of the relative and absolute
risks of contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2:
Results from the WECARE Study. J Clin Oncol, 28, 2404-2410, 2010. PMC2881721.
374. Bellizzi KM, Smith, AW, Reeve BB, Alfano CM, Bernstein L, Meeske K, Baumgartner KB,
Ballard-Barbash R. Posttraumatic growth and health-related quality of life in an ethnically diverse
cohort of breast cancer survivors. J Health Psychol, 15, 615-626, 2010. PMID: 20460418.
375. Lu Y*, Ma H, Sullivan-Halley J, Henderson KD, Chang ET, Clarke CA, Neuhausen S, Bernstein
L, Wang SS. Parents’ ages at birth and risk of adult-onset hematological malignancies among
California female teachers. Am J Epidemiol, 171, 1262-1269, 2010. PMC2915497
53
Leslie Bernstein, PhD
376. Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent
J, Deapen DM, Lacey JV Jr, Bernstein L. Pregnancy-related factors and the risk of breast
carcinoma in situ and invasive breast cancer among postmenopausal women in the California
Teachers Study cohort. Breast Cancer Res, 12, R35, 2010. PMC2917030.
377. Berstad P, Coates RJ, Bernstein L, Folger SG, Malone KE, Marchbanks PA, Weiss LK, Liff JM,
McDonald JA, Strom BL, Simon MS, Deapen D, Press MF, Burkman RT, Spirtas R, Ursin G. A
case-control study of body mass index and breast cancer risk in white and African American
women. Cancer Epidemiol Biomarkers Prev, 19, 1532-1544, 2010. PMC2891096.
378. Zell JA*, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO,
Ursin G, Anton-Culver H. Meat consumption, non-steroidal anti-inflammatory drugs, and
colorectal cancer mortality in the California Teachers Study. Cancer Prev Res, 3, 865-875, 2010.
PMC2931369.
379. Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, Gao X, Cozen W, Rothman N, Davis
S, Severson RK, Bernstein L, Hartge P, Carrington M. Human leukocyte antigen class I and II
alleles in non-Hodgkin lymphoma etiology. Blood, 115, 4820-4823, 2010. PMC2890176.
380. Lee E*, Hsu C, Haiman CA, Razavi P, Horn-Ross PL, Vandenberg D, Bernstein L, LeMarchand
L, Henderson BE, Setiawan VW, Ursin G. Genetic variation in the progesterone receptor gene and
risk of endometrial cancer: a haplotype-based approach. Carcinogenesis, 31, 1392-1399, 2010.
PMC2915632.
381. Patel AV, Calle EE, Deka A, Bernstein L, Feigelson HS, Campbell P, Rodriguez C, Thun MJ.
Leisure time spent sitting in relation to total mortality in a prospective cohort of U.S. adults. Am J
Epidemiol, 172, 419-429, 2010. PMID 20650954.
382. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM,
Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, Ward MH, Giffen C, Casson AG,
Abnet CC, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow WH. Cigarette smoking and
adenocarcinomas of the esophagus and esophagogastric junction: A pooled analysis from the
International BEACON Consortium. J Natl Cancer Inst, 102, 1344-1353, 2010. PMC2935475.
383. Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, Ursin G, Horn-Ross
PL. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal
women in the California Teachers Study cohort. Cancer Cause Control. 21, 1407-1416, 2010.
PMC2925506.
384. Largent JA*, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell
JA, Ziogas A, Anton-Culver H. Hypertension, antihypertensive medication use and breast cancer
risk in the California Teachers Study cohort. Cancer Cause Control, 21, 1616-1624, 2010.
PMC2941047.
385. George SM, Neuhouser ML, Mayne ST, Irwin ML, Albanes D, Gail MH, Alfano CM, Bernstein
L, McTiernan A, Reedy J, Smith AW, Ulrich CM, Ballard-Barbash R. Postdiagnosis diet quality is
inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol
Biomarkers Prev, 19, 2220-2228, 2010. PMC3077799.
386. Saxena T*, Lee E, Henderson KD, Clarke CA, West D, Marshall SF, Deapen D, Bernstein L,
Ursin G. Menopausal hormone therapy and subsequent risk of specific invasive breast cancer
subtypes in the California Teachers Study. Cancer Epidemiol Biomarkers Prev, 19, 2366-2378,
2010 PMC2936672.
54
Leslie Bernstein, PhD
387. Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF,
Concannon P, Borg A, Teraoka SN, Törngren T, Diep A, Xue S, Bertelsen L, Liang X, Reiner AS,
Capanu M, Malone KE; WECARE Collaborative Study Group. Adjuvant systemic therapy for
breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of
contralateral breast cancer. Breast Cancer Res Treat, 123, 491-498, 2010. PMC2903659.
388. Chen GK, Millikan RC, John EM, Ambrosone CB, Bernstein L, Zheng W, Hu JJ, Chanock S,
Ziegler RG, Bandera E, Henderson BE, Haiman CA, Stram DO. The potential for enhancing the
power of genetic association studies in African Americans through the reuse of existing genotype
data. PLoS Genet. 2010 Sep 2;6(9). pii: e1001096. PMC2932740.
389. Emaus A*, Degerstrøm J, Wilsgaard T, Hansen BH, Dieli-Conwright CM, Furberg AS, Pettersen
SA, Andersen LB, Eggen AE, Bernstein L, Thune I. Does a variation in self-reported physical
activity reflect variation in objectively measured physical activity, resting heart rate and physical
fitness? Results from the Tromso Study. Scand J Public Health, 38(5 Suppl), 105-118, 2010.
PMID: 21062845.
390. Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, Ursin G, Horn-Ross
PL. Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers
Study. Cancer Cause Control, 21, 2241-2248, 2010. PMC3120052.
391. Chang ET, Clarke CA, Canchola AJ, Lu Y, Wang SS, Ursin G, West DW, Bernstein L, HornRoss PL. Alcohol consumption over time and risk of lymphoid malignancies in the California
Teachers Study cohort. Am J Epidemiol, 172, 1373-1383, 2010. PMC3105275.
392. Lu Y*, Wang SS, Sullivan-Halley J, Chang ET, Clarke CA, Henderson KD, Ma H, Duan L, Lacey
JV, Deapen D, Bernstein L. Oral contraceptives, menopausal hormone therapy use and risk of Bcell non-Hodgkin lymphoma in the California Teachers Study. Int J Cancer, 129, 974-982, 2011.
PMC3258672.
393. Press DJ*, Sullivan-Halley J, Ursin G, Deapen D, McDonald JA, Strom BL, Norman SA, Simon
MS, Marchbanks PA, Folger SG, Liff JM, Burkman RT, Malone KE, Weiss LK, Spirtas R,
Bernstein L. Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the
Women’s Contraceptive and Reproductive Experiences Study. Am J Epidemiol, 173, 38–47, 2011.
PMC3025644.
394. Wang SS, Menashe I, Cerhan J, Cozen W, Severson R, Davis S, Hutchison A, Rothman N,
Chanock S, Bernstein L, Hartge P, Morton L. Variations in chromosomes 9 and 6p21.3 with risk
of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev, 20, 42-49, 2011. PMC3817834.
395. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB,
Bernstein L, Ballard-Barbash R, McTiernan A. Associations of insulin resistance and adiponectin
with mortality in women with breast cancer. J Clin Oncol, 29, 32-39, 2011. PMC3055857.
396. Chang ET, Canchola AJ, Clarke CA, Lu Y, West DW, Bernstein L, Wang SS, Horn-Ross PL.
Dietary phytocompounds and risk of lymphoid malignancies in the California Teachers Study
cohort. Cancer Causes Control, 22, 237-249, 2011. PMC3074494.
397. Irwin ML, Duggan C, Smith AW, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein
L, Ballard-Barbash R. Fasting C-peptide levels and death resulting from all causes and breast
cancer: The Health Eating Activity and Lifestyle Study. J Clin Oncol, 29, 47-53, 2011
PMC305585.
55
Leslie Bernstein, PhD
398. Stram DO, Liu Y, Henderson K, Sullivan-Halley J, Luo J, Saxena T, Reynolds P, Chang E,
Neuhausen S, Horn-Ross P, Bernstein L, Ursin G. Age-specific effects of hormone therapy use on
overall mortality and ischemic heart disease mortality among women in the California Teachers
Study. Menopause, 18, 253-261, 2011. PMC3253313.
399. Purdue MP, Bakke B, Stewart P, De Roos AJ, Schenk M, Lynch CF, Bernstein L, Morton LM,
Cerhan JR, Severson RK, Cozen W, Davis S, Rothman N, Hartge P, Colt JS. A case-control study
of occupational exposure to trichloroethylene and non-Hodgkin lymphoma. Environ Health
Perspect, 119, 232-238, 2011. PMC3040611.
400. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, English
DR, Folsom AR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Horn-Ross PL, Larsson
SC, Leitzman M, Männistö S, Marshall JR, Miller AB, Patel AV, Rohan TE, Schatzkin A, Verhage
BAJ, Virtamo J, Wilcox BJ, Wolk A, Ziegler RG, Smith-Warner SA. A pooled analysis of 14
cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer, 129, 1708-1717,
2011. PMC3073156.
401. Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee
WD, Duggan DJ, Siniard A, Concannon P, Capanu M, Lynch CF, Olsen JH, Haile RW, Bernstein
JL. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2:
Potential modifying effect of BRCA1/BRCA2 mutation carrier status. Breast Cancer Res Treat,
127, 819-829, 2011. PMC3234998.
402. Dieli-Conwright CM*, Sullivan-Halley J, Patel A, Press M, Malone K, Ursin G, Burkman R,
Strom B, Simon M, Weiss L, Marchbanks P, Folger S, Spirtas R, Deapen D, Bernstein L. Does
hormone therapy counter the beneficial effects of physical activity on breast cancer risk in
postmenopausal women? Cancer Cause Control, 22, 237-249, 2011. PMC3229264.
403. Bessonova L*, Marshall SF, Ziogas A, Largent J, Stram D, Bernstein L, Henderson KD, Ma H,
West DW, Anton-Culver H. The association of body mass index with mortality in the California
Teachers Study cohort. Intl J Cancer, 129, 2492-2501, 2011. PMC3246901.
404. Press MF, Sauter G, Buyse M, Bernstein L, Guzman R, Santiago A, Villalobos I, Eiermann W,
Pienkowski T, Martin M, Robert N, Crown J, Bee V, Taupin H, Flom K, Tabah-Fisch I, Pauletti G,
Lindsay MA, Riva A, Slamon DJ. Alteration of topoisomerase II-alpha gene in human breast
cancer: Association with responsiveness to anthracycline-based chemotherapy. J Clin Oncol, 29,
859-867, 2011. PMC3068060.
405. Kruper L*, Holt A, Xu XX, Duan L, Henderson K, Bernstein L, Ellenhorn J. Disparities in
reconstruction rates after mastectomy: Patterns of care and factors associated with the use of breast
reconstruction in Southern California. Ann Surg Oncol, 18, 2168-2165, 2011, PMID: 21308486.
406. Clague J*, Reynolds P, Sullivan-Halley J, Ma H, Lacey Jr JV, Henderson KD, Ursin G, West D,
Bernstein L. Menopausal hormone therapy does not influence lung cancer risk: Results from the
California Teachers Study. Cancer Epidemiol Biomarkers Prev, 20,560-564, 2011. PMC3065239.
407. Bernstein L, Lacey JV. (Invited editorial) Receptors, associations, and risk-factor differences by
breast cancer subtypes: Positive or Negative? J Natl Cancer Inst, 103, 451-453, 2011.
408. Shahabi A*, Bernstein L, Azen SP, McClain AD, Belcher B, Hsu YW, Nguyen-Rodriguez ST,
Spruijt-Metz D. Recruitment and retention of African-American and Latina pre-adolescent females
into a longitudinal bio-behavioral study. Ethnicity & Health, 21, 91-98, 2011. PMID: 21462737.
56
Leslie Bernstein, PhD
409. Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyren O, Ye W, Wu A,
Bernstein L, Brown LM, Ward MH, Pandeya N, Green A, Casson AG, Giffen C, Risch HA,
Gammon MD, Chow WH, Vaughan TL, Corley DA, Whiteman DC. Alcohol intake and risk of
esophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut, 60. 10291037, 2011. PMC3439838.
410. George, SM, Irwin, ML, Smith, AW, Neuhouser, ML, McTiernan, A, Alfano, CM, Bernstein, L,
Ulrich, CM, Baumgartner, KB, Albanes, D, Reedy, J, Mayne, ST, Gail, M, Ballard-Barbash, R.
Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and
prognosis after early-stage breast cancer. Cancer Cause Control, 22, 589-598, 2011. PMC
3091887.
411. Lee E*, Schumacher F, Lewinger JP, Neuhausen SL, Anton-Culver H, Horn-Ross PL, Henderson
KD, Van Den Berg D, Bernstein L, Ursin G. The association of polymorphisms in hormone
metabolism pathway genes, menopausal hormone therapy, and breast cancer risk in the California
Teachers Study. Breast Cancer Res, 13, R37, 2011. PMC3219200
412. Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A,
Ballard-Barbash R, Neuhouser ML. Dietary fiber, carbohydrates, glycemic index and glycemic
load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomarkers Prev,
20, 890-899, 2011. PMC 3104475.
413. Davis-Dao CA*, Henderson KD, Sullivan-Halley J, Ma H, West D, Xiang YB, Gago-Dominguez
M, Stern MC, Castelao E, Conti D, Pike MC, Bernstein L, Cortessis VK. Lower risk in parous
women suggests hormonal factors important in bladder cancer etiology. Cancer Epidemiol
Biomarkers Prev, 20, 1156-1170, 2011. PMC3312020.
414. Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN,
Diep AT, Thomas DC, Bernstein JL, The WECARE Study Collaborative Group, Begg CB.
Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical
modeling. Genet Epidemiol, 35, 389-397, 2011. PMC 3111904.
415. Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, Bernstein L,
Baumgartner KB, Ballard-Barbash R. Sleep duration change across breast cancer survivorship:
associations with symptoms and health-related quality of life. Breast Cancer Res Treat, 130, 243254, 2011. PMID:21567239.
416. Lu Y*, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Simon MS, Marchbanks
PA, McDonald JA, West DW, Henderson KD, Deapen D, Ursin G, Bernstein L. Oral
contraceptive use and survival in women with invasive breast cancer. Cancer Epidemiol
Biomarkers Prev, 20, 1391-1397, 2011. PMC3132273.
417. Pasaniuc B, Pollack S, Zaitlen N, Lettre G, Chen G, Tandon A, Kao L, Ruczinski I, Fornage NM,
Siscovick D, Zhu X, Larkin E, Lange L, Cupples A, Yang Q, Akylbekova M, Musani S, Divers J,
Mychalecky J, Li M, Papanicolaou G, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng
W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Chanock SJ, Deming SL,
Rodriguez-Gil JL, Henderson BE, Myers S, Haiman C, Reich D, Patterson N, Wilson J, Price AL.
Enhanced statistical tests for GWAS in admixed populations: Assessment using African Americans
from CARe. PLoS Genetics, 2011 Apr;7(4):e1001371. Epub 2011 Apr 21. PMC3080860.
418. Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L, Clarke CA, Horn-Ross PL.
Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D and risk of lymphoid
malignancies in the California Teachers Study. Blood, 118, 1591-1599, 2011 PMC3156047.
57
Leslie Bernstein, PhD
419. Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L. The roles of complementary and alternative
medicine in survivorship and quality of life among long-term breast cancer survivors – results of a
prospective study. BMC Cancer.11:222, 2011. PMC3126792.
420. Choudhury F*, Bernstein L, Hodis HN, Stanczyk F, Mack WJ. Physical activity and sex
hormone levels in estradiol and placebo-treated postmenopausal women. Menopause, 18, 10791086, 2011. PMC3183237.
421. Lipsett MJ, Ostro BD, Reynolds P, Goldberg D, Hertz A, Hurley S, Jerrett M, Smith DF, Garcia
C, Chang ET, Bernstein L. Long-term exposure to air pollution and cardiorespiratory disease in
the California Teachers Study cohort. Am J Respiratory Crit Care Med, 184, 828-835, 2011.
PMC3208653.
422. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of
papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers
Prev, 20, 1751-1759, 2011. PMC3288117.
423. Lu Y*, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Marchbanks PA, Spirtas R,
Burkman RT, Deapen D, Folger SG, Simon MS, Press MF, McDonald JA, Bernstein L. Obesity
and survival among Black women and White women with invasive breast cancer. J Clin Oncol, 29,
3358-3365, 2011. PMC3164241.
424. Lu Y*, Wang SS, Reynold P, Ma H, Chang ET, Sullivan-Halley E, Clarke CA, Bernstein L.
Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: Evidence from the
California Teachers Study. Am J Epidemiol, 174, 563-573, 2011. PMC3202153.
425. Hinch AG, Tandon A, Patterson N, Chen GK, Palmer CD, Akylbekova M,. Ambrosone CB,
Bandera EV, Berndt SI, Bernstein L, Blot WJ, Boerwinkle E, Buxbaum SG, Casey G,. Chanock
SJ, Cupples A, Deming SL, Diver WR, Divers J, Fornage M, Hu JJ, Ingles SA, Isaacs W, John EM,
Kao L, Keating B, Kittles RA, Kolonel LN, Larkin E, Liu K, Le Marchand L, Millikan RC, Murphy
A, Musani S, Neslund-Dudas C, Nyante S, Papanicolaou G, Press MF, Psaty B, Reiner A, Rich S,
Rodriguez-Gil JL, Rotter J, Rybicki BA, Signorello LB, Strom SS, Thun MJ, Witte JS, Yamamura
Y, Zheng W, Ziegler RG, Zhu X, Hirschhorn JN, Henderson BE, Taylor, Jr. HA, Price AL, Haiman
CA, Wilson JG, Reich D, Myers SR. The landscape of recombination in African Americans.
Nature, 476, 170-175, 2011 doi: 10.1038/nature10336. PMC3154982.
426. Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, Bernstein L, Zheng W, Hu JJ,
Ziegler RG, Deming SL, Bandera EV, Nyante S, Ingles SA, Press MF, Rodriguez-Gil JL, Chanock
SJ, LeMarchand L, Kolonel LN, Henderson BE, Stram DO, Haiman CA. Fine-mapping of breast
cancer susceptibility loci characterizes genetic risk in African-Americans. Hum Mol Genet, 15,
4491-4503, 2011. PMC3196889
427. Kruper L*, Xu X, Henderson K, Bernstein L. Disparities in reconstruction rates after mastectomy
for ductal carcinoma in situ (DCIS): Patterns of care and factors associated with the use of breast
reconstruction for DCIS as compared with invasive cancer. Ann Surg Oncol, 18, 3210-3219, 2011.
PMID:21863363.
428. Wang X, Kang GH, Campan M, Weisenberger D, Long T, Cozen W, Bernstein L, Wu A,
Siegmund K, Shibata D, Laird P. Epigenetic subgroups of esophageal and gastric adenocarcinoma
associated with clinical and lifestyle factors. PloS One, 6,: e25985. PMC3212525.
58
Leslie Bernstein, PhD
429. Bao Y, Michaud DS, Spiegelman D, Albanes D, Anderson KR, Bernstein L, van den Brandt P,
English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Goldbohm S, Hakansson N,
Jacobs EJ, Kitahara C, Marshall JR, Miller AB, Robien K, Rohan TE, Schatzkin A, Stevens VL,
Stolzenberg-Solomon R, Virtamo J, Wolk A, Ziegler R, Smith-Warner SA. Folate intake and
pancreatic cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst, 103, 1840-1850,
2011. PMC3243674.
430. Ma H, Sullivan-Halley J, Smith AW, Neuhouser ML, Alfano CM, Meeske K, George SM,
McTiernan A, McKean-Cowdin R, Baumgartner KB, Ballard-Barbash R, Bernstein L. Estrogenic
botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in
breast cancer survivors: A HEAL Study report. BMC Complement Alternat Med, 11, 109 (8
November), 2011. doi 10.1186/1472-6882-11-109. PMC3234199.
431. Haiman CA, Chen GK, Vashon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa
F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann WM, Berg CD,
Bernstein L, Blomqvist C, Blot W, Brauch H, Buring J, Carpenter JE, Chang-Claude J, Chanock
SJ, Chasman D, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, Dimopoulos AM, Driver
WR, Dunnebier T, Durcan L, Eccles D, Edlund CK, Ekici AB, Fasching PA, Feigelson H, FleschJanys D, Fletcher O, Fostira F, Forsti A, Fountzilas G, Gerty SM, The GENICA Consortium, Giles
GG, Godwin AK, Goodfellow P, Graham N, Greco D, Hamann U, Hankinson S, Hartmann A, Hein
R, Heinz J, Hoover RN, Hu JJ, Hunter D, Ingles SA, Irwanto A, Janssen H, John EM, JukkolaVuorinen A, Kaaks R, Ko YD, Kolonel LN, Konstantopoulou I, Kulkarni S, Lambrechts D, Lee
AM, LeMarchand L, Lesnick T, VanLimbergen E, Liu J, Lindstrom S Mannnermaa A, Margolin S,
Martin NG, Miron P, Montgomery GW, Nevanlinna H, Nickels S, Nyante S, Olopade OI, Huo D,
Olswold C, Palmer J, Pathak H, Pectasides D, Peto J, Pharoah PDP, Pooler L, Press MF, Pylkas K,
Rebbeck TR, Rodriguez-Gil JL, Rosenberg L, Ross E, Rudiger T, dos Santos Silva I, Sawyer E,
Schmidt MK, Schulz-Wendtland R, Schumacher F, Severi G, Sheng X, Signorello L, Sinn HP,
Stevens KN, Southey MC, Tapper WJ, Tomlinson I, Verhoef S, Weaver JE, Winqvist R, Van Den
Berg D, Wan P, Yannoukako D, Zheng W, Ziegler RG, Siddiq A, Slager SL, Stram DO, Easton D,
Kraft P, Henderson BE, Couch FJ. A susceptibility locus for estrogen receptor-negative breast
cancer at 5p15 (TERT). Nature Gen, 43, 1210-1214, 2011. doi: 10.1038/ng.985. [Epub ahead of
print]. PMC3279120.
432. Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall
M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD, Duggan D,
Siniard A, Thomas DC, the WECARE Study Collaborative Group, Concannon P. Breast cancer
associated GWAS SNPs and risk for contralateral breast cancer in the Women’s Environment,
Cancer and Radiation Epidemiology (WECARE) study. Breast Cancer Res. 13:R114, 2011.
PMC3326556.
433. Wang SS, Lu Y, Rothman N, Abdou AM, Cerhan JR, De Roos A, Davis S, Severson RK, Cozen
W, Chanock SJ, Bernstein L, Morton LM, Hartge P. Variation in effects of non-Hodgkin
lymphoma (NHL) risk factors according to human leukocyte antigen (HLA)-DRB1*0101 allele and
ancestral haplotye (AH) 8.1. PLoS ONE 2011;6(11):e26949. PMC3212525.
434. Lee E*, McKean-Cowdin R, Ma H, Spicer DV, Van Den Berg D, Bernstein L, Ursin G.
Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation, results from a
population-based study of young women. J Clin Oncol, 29, 4373-4380, 2011. PMC3221522.
435. N’Diaye A, Chen GK, Palmer CD, Ge B, Tayo B, Mathias RA, Ding J, Nalls MA, Adeyemo A,
Adoue V, Ambrosone CB, Atwood L, Bandera EV, Becker LC, Berndt SI, Bernstein L, Blot WJ,
Boerwinkle E, Britton A, Casey G, Chanock SJ, Demerath E, Deming SL, Diver WR, Fox C,
59
Leslie Bernstein, PhD
Harris TB, Hernandez DG, Hu JJ, Ingles SA, John EM, Johnson C, Keating B, Kittles RA, Kolonel
LN, Kritschevsky SB, Le Marchand L, Lohman K, Liu J, Millikan RC, Murphy A, Musani S,
Neslund-dudas C, North K, Nyante S, Ogunniyi A, Ostrander EA, Papanicolaou G, Patel S,
Pettaway CA, Press MF, Redline S, Rodriguez-Gil JL, Rotimi C, Rybicki BA, Salako B, Schreiner
PJ, Signorello L, Stanford JL, Stram A, Strom SS, Suktitipat B, Thun MJ, Witte JS, Yanek LR,
Ziegler RG, Zheng W, Zhu X, Zmuda J, Zonderman AB, Evans MK, Liu Y, Becker DM, Cooper
RD, Pastinen T, Henderson BE, Hirschhorn JN, Lettre G, Haiman CA. Identification, replication,
and fine-mapping of loci associated with adult height in individuals of African ancestry. PLoS
Genet. 2011 October; 7(10): e1002298. Published online 2011 October 6. doi:
10.1371/journal.pgen.1002298. Correction: PLoS Genet 2011 Nov;7(11). doi:10.1371/annotation/
58c67154-3f10-4155-9085-dcd6e3689008. PMC3188544.
436. Lu Y*, Abdou AM, Cerhan JR, Morton LM, Severson RK, Davis S, Cozen W, Rothman N,
Bernstein L, Chanock S, Hartge P, Carrington M, Wang SS. Human leukocyte antigen class I and
II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Scientific
World Journal, 11, 2062-2070, 2011. PMC3217596.
437. Jiang X, Bernstein L, Wu AH. Diabetes and risk of esophageal and gastric adenocarcinomas. Int
J Cancer. 131, 1417-1422, 2012. doi: 10.1002/ijc.27390. PMC3340473.
438. Genkinger JM, Li R, Spiegelman D, Anderson KE, Albanes D, Bergkvist L, Bernstein L, van den
Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Goldbohm RA,
Horn-Ross PL, Jacobs EJ, Koushik A, Mannisto S, Marshall JR, Miller AB, Patel AV, Robien K,
Rohan TE, Schairer C, Stolzenberg-Solomon R, Wolk A, Smith-Warner SA. Coffee, tea, and sugarsweetened carbonated soft drink intake and pancreatic cancer risk: A pooled analysis of 14 cohort
studies. Cancer Epidemiol Biomarkers Prev, 21, 305-318 2012. PMC3275675.
439. Marchbanks PA, Curtis KM, Mandel MG, Wilson HG, Jeng G, Folger SG, McDonald JA, Daling
JR, Bernstein L, Malone KE, Wingo PA, Simon MS, Norman SA, Strom BL, Ursin G, Weiss LK,
Burkman RT, Spirtas R. Oral contraceptive formulation and risk of breast cancer. Contraception,
85, 342-350, 2012. PMC3790909.
440. Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA,
Giffen C, Freedman ND, Chow WH, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein
L, Gammon MD, Wu AH. Non-steroidal anti-inflammatory drug use reduces risk of
adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
Gastroenterol, 142, 442-452.e5; quiz e22-23, 2012. PMC3488768.
441. Keegan THM, Hurley S, Goldberg G, Nelson DO, Reynolds P, Bernstein L, Horn-Ross PL,
Gomez SL. The association between neighborhood characteristics and body size and physical
activity in the California Teachers Study cohort. Am J Public Health, 102, 689-697, 2012
PMC3410673.
442. Razavi P*, Lee E, Bernstein L, Van Den Berg D, Horn-Ross PL, Ursin G. Variations in sex
hormone metabolism genes, postmenopausal hormone therapy and risk of endometrial cancer. Int J
Cancer, 130, 1629-1638, 2012. PMC3267886.
443. Duan L*, Xu X, Koebnick C*, Lacey JV, Sullivan-Halley J, Templeman C, Marshall SF,
Neuhausen SL, Ursin G, Bernstein L, Henderson KD. Bilateral oophorectomy is not associated
with increased mortality risk: The California Teachers Study. Fertil Steril, 97, 111-117, 2012.
PMC3245786.
60
Leslie Bernstein, PhD
444. Brooks JD*, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M,
Stovall M, Smith SA, Wei S, Shore RE, Boice, Jr. JD, Lynch CF, Mellemkjær L, Malone KE,
Liang X, the WECARE Study Collaborative Group, Haile RW, Concannon P, Bernstein JL.
Variants in activators and downstream targets of ATM, radiation exposure and contralateral breast
cancer risk in the WECARE Study. Hum Mutat, 33, 158-164, 2012. PMC3240722.
445. Brooks JD*, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile
RW, Shore RE, The WECARE Study Collaborative Group, Bernstein JL, Bernstein L. Body mass
index and risk of second primary breast cancer: The WECARE Study. Breast Cancer Res Treat,
131, 571-580, 2012. PMC3251700.
446. Zhang X, Spiegelman D, Baglietto L, Bernstein L, van den Brandt PA, Buring JE, Gapstur S,
Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M,
Jung S, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y,
Robien K, Rohan TE, Rosenberg L, Ross JA, Schatzkin A, Schouten LJ, Shikany JM, Tsugane S,
Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG, Smith-Warner SA.
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor
status: A pooled analysis of 18 prospective cohort studies. Am J Clin Nutr, 95, 713-725, 2012.
PMC3278246.
447. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q,
Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N,
Orr N, Dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F;
Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Hall P,
Czene K, Irwanto A, Liu J, Nevanlinna H, Aittomäki K, Blomqvist C, Meindl A, Schmutzler RK,
Müller-Myhsok B, Lichtner P, Chang-Claude J, Hein R, Nickels S, Flesch-Janys D, Tsimiklis H,
Makalic E, Schmidt D, Bui M, Hopper JL, Apicella C, Park DJ, Southey M, Hunter DJ, Chanock
SJ, Broeks A, Verhoef S, Hogervorst FB, Fasching PA, Lux MP, Beckmann MW, Ekici AB,
Sawyer E, Tomlinson I, Kerin M, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P,
Truong T, Cordina-Duverger E, Menegaux F, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H,
Milne RL, Alonso MR, González-Neira A, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Dur
CC, Brenner H, Müller H, Arndt V, Stegmaier C; Familial Breast Cancer Study (FBCS),
Justenhoven C, Brauch H, Brüning T; The Gene Environment Interaction of Breast Cancer in
Germany (GENICA) Network, Wang-Gohrke S, Eilber U, Dörk T, Schürmann P, Bremer M,
Hillemanns P, Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Bermisheva M,
Prokofieva D, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM,
Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Manoukian S, Bonanni B,
Fortuzzi S, Peterlongo P, Couch FJ, Wang X, Stevens K, Lee A, Giles GG, Baglietto L, Severi G,
McLean C, Alnæs GG, Kristensen V, Børrensen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs
K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Glendon G, Mulligan AM, Devilee P, van
Asperen CJ, Tollenaar RA, Seynaeve C, Figueroa JD, Garcia-Closas M, Brinton L, Lissowska J,
Hooning MJ, Hollestelle A, Oldenburg RA, van den Ouweland AM, Cox A, Reed MW, Shah M,
Jakubowska A, Lubinski J, Jaworska K, Durda K, Jones M, Schoemaker M, Ashworth A,
Swerdlow A, Beesley J, Chen X; kConFab Investigators; Australian Ovarian Cancer Study Group,
Muir KR, Lophatananon A, Rattanamongkongul S, Chaiwerawattana A, Kang D, Yoo KY, Noh
DY, Shen CY, Yu JC, Wu PE, Hsiung CN, Perkins A, Swann R, Velentzis L, Eccles DM, Tapper
WJ, Gerty SM, Graham NJ, Ponder BA, Chenevix-Trench G, Pharoah PD, Lathrop M, Dunning
AM, Rahman N, Peto J, Easton DF. Genome-wide association analysis identifies three new breast
cancer susceptibility loci. Nat Genet, 44, 312-318, 2012. PMC3653403.
61
Leslie Bernstein, PhD
448. Canchola AJ, Anton-Culver H, Bernstein L, Clarke CA, Henderson K, Ma H, Ursin G, HornRoss PL. Body size and the risk of postmenopausal breast cancer subtypes in the California
Teachers Study cohort. Cancer Causes Control, 23(3), 473-485, 2012. PMC3366039.
449. Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H,
Greco D, Aittomaki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, WangGohrke S, Nickels S, Brauch H, Ko YD, Fischer HP, The GENICA Network, Schmutzler RK,
Meindl A, Bartram CR, Schott S, Engel C, Godwin AK, Weaver JE, Pathak H, Sharma P, Brenner
H, Muller H, Arndt V, Stegmaier C, Miron P, Yannoukakos D, Stavropoulou A, Fountzilas G,
Gogas H, Swann R, Dwek M, Perkins A, Milne RL, Benitez J, Zamora MP, Arias Perez JI, Bojesen
S, Nielsen SF, Nordestgaard BG, Flyger H, Guenel P, Truong T, Menegaux F, Duverger-Cordina
E, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Sawyer E, Tomlinson I, Kerin MJ, Peto J,
Johnson N, Fletcher O, Dos Santos Silva I, Fasching P, Beckmann MW, Hartmann A, Ekici AB,
Lophatananon A, Muir K, Puttawibul P, Wiangnon S, Schmidt MK, Broeks A, Braaf LM,
Rosenberg EH, Hopper JL, Dite GS, Apicella C, Southey MC, Swerdlow AJ, Ashworth A, Orr N,
Schoemaker M, Anton-Culver H, Ziogas A, Bernstein L, Clarke Dur C, Shen CY, Yu JC, Hsu
HM, Hsiung CN, Hamann U, Dunnebier T, Rudiger T, Ulmer HU, Pharoah PP, Dunning AM,
Humphreys MK, Wang J, Cox A, Cross S, Reed MWR, Hall P, Czene K, Ambrosone CB,
Ademuyiwa F, Hwang H, Eccles D, Garcia-Closas M, Figueroa JD, Sherman ME, Lissowska J,
Devilee P, Seynaeve CM, Tollenaar RAEM, Hooning MJ, Andrulis I, Knight JA, Glendon G,
Mulligan AM, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Grip M, John EM, Miron A, Alnaes
GG, Kristensen V, Borresen-Dale AL, Giles GG, Baglietto L, McLean CA, Severi G, Kosel M,
Pankratz VS, Slager S, Olson JE, Radice P, Peterlongo P, Manoukian S, Barile M, Lambrechts D,
Hatse S, Dieudonne AS, Christiaens MR, Chenevix-Trench G, kConFab Investigators, AOCS
Group, Beesley J, Chen X, Mannermaa A, Kosma VM, Hartikainen J, Soini Y, Easton DF, Couch
FJ. 19p13.1 is a triple negative-specific breast cancer susceptibility locus. Cancer Res, 72, 17951803, 2012. PMC3319792.
450. Cialdella-Kam L, Sabado P, Bispeck MK, Silverman S, Bernstein L, Krawiec V, Hawk E,
O’Donnell JF. Implementing cancer prevention into clinical practice. J Cancer Educ, 27 Suppl 2,
136-143, 2012. PMID: 22367592.
451. Reding KW, Chen C, Lowe K, Doody DR, Carlson CS, Chen CT, Houck J, Weiss LK,
Marchbanks PA, Bernstein L, Spirtas R, McDonald JA, Strom B, Burkman R, Simon M, Liff JM,
Daling JR, Malone KE. Estrogen-related genes and their contribution to racial differences in breast
cancer risk. Cancer Causes Control, 23, 671-681, 2012. PMC3356164.
452. Alfano CM, Imayama I, Neuhouser ML, Kiecolt-Glaser JK, Smith AW, Meeske K, McTiernan A,
Bernstein L, Baumgartner KB, Ulrich CM, Ballard-Barbash R. Fatigue, inflammation, and Ω-3
and Ω-6 fatty acid intake among breast cancer survivors. J Clin Oncol, 30, 1280-1287, 2012.
PMC3341143.
453. Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallée MP, Tavtigian S, Concannon P,
Foulkes WD, Bernstein L, The WECARE Study Collaborative Group, Bernstein J, Begg CB. Rare
germline mutations in PALB2 and breast cancer risk: A population-based study. Hum Mutation, 33,
674-680, 2012. doi: 10.1002/humu.22022. PMC3767757.
454. Brooks JD*, Boice JD, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjaer L,
Knight JA, Thomas DC, Haile RW, Smith SA, Capanu M, The WECARE Collaborative Group,
Bernstein JL, Shore RE. Reproductive status at first diagnosis influences risk of radiation-induced
second primary contralateral breast cancer in The WECARE Study. Int J Rad Onc Biol Physics, 84,
917-924,
1
2012. PMC3394928.
62
Leslie Bernstein, PhD
455. Bernstein L. Breast cancer: Risk and mortality after oestrogen-alone therapy—is it safe? Nat Rev
Clinical Oncol, 9:255-7, 2012 PMID: 22473098.
456. Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ,
Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyrén O,.Gammon MD, Corley
DA, Wu AH, Brown LM, Chow WH, Ward MH, Freedman ND, Whiteman DC. The importance of
exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal
adenocarcinoma and squamous cell carcinoma in the Barrett’s Esophagus and Esophageal
Adenocarcinoma Consortium. Cancer Epidemiol, 36, 306-316, 2012. PMC3489030.
457. Reding KW, Carlson CS, Kahsai O, Chen CC, McDavid A, Doody DR, Chen C, Ornelas I, Lowe
K, Bernstein L, Weiss L, McDonald JA, Simon MS, Strom B, Marchbanks P, Burkman R, Spirtas
R, Liff JM, Malone KE. Examination of ancestral informative markers and self-reported race with
tumor characteristics of breast cancer among black and white women. Breast Cancer Res Treat,
134, 801-809, 2012. PMC3697473.
458. Jones ME, van Leeuwen FE, Hoogendoorn WE, Mourits MJE, Hollema H, van Boven H, Press
MF, Bernstein L, Swerdlow AJ.Endometrial cancer survival after breast cancer in relation to
tamoxifen treatment: pooled results from three countries. Breast Cancer Res, 14(3), R91, 2012.
PMC3446354.
459. Setiawan VS, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H,
Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey
JV, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson
SH, Rastog R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu X, Spurdle AB, Strom BL,
Thompson PJ, Ursin G, Webb PM, Weiss N, Wentzensen N, Xiang YB, Yang HP, Yu H, HornRoss PL and De Vivo I, The Australian National Endometrial Cancer Study Group. Age at last
birth in relation to risk of endometrial cancer: Pooled analysis in the Epidemiology of Endometrial
Cancer Consortium. Am J Epidemiol,176, 269-278, 2012. PMC3491967.
460. Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC,
Mahmoodi M, Schmidt MK, Broeks A, Cornelissen S, Braaf LM, Muir KR, Lophatananon A,
Chaiwerawattana A, Wiangnon S, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R,
Sawyer EJ, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Guenel P,
Truong T, Laurent-Puig P, Mulot C, Bojesen SE, Nielsen SF, Flyger H, Nordestgaard BG, Milne
RL, Benitez J, Arias-Perez JI, Zamora MP, Anton-Culver H, Ziogas A, Bernstein L, Clarke Dur C,
Brenner H, Muller H, Arndt V, Langheinz A, Meindl A, Golatta M, Bartram CR, Schmutzler RK
Brauch H, Justenhoven C, Bruning T, The GENICA Network, Chang-Claude J, Wang-Gohrke S,
Eilber U, Dork T, Schurmann P, Bremer M, Hillemanns P, Nevanlinna H, Muranen TA, Aittomaki
K, Blomavist C, Bogdanova N, Antonenkova N, Rogov Y, Bermisheva M, Prokofyeva D,
Zinnatullina G, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kosma VM,
Hartikainen JM, Kataja V, Chenevix-Trench G, Beesley J, kConFab Investigators-Australian
Ovarian Cancer Study Group, Chen X, Lambrechts D, Smeets A, Paridaensa R, Weltens C, Flesch
Janys D, Buck K, Behrens S, Peterlongo P, Bernard L, Manoukian S, Radice P, Couch FJ, Vachon
C, Wang X, Olson J, Giles G, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R,
Pylkas K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Mulligan AM, Weerasooriya N,
Devilee P, Tollenaar RAEM, Martens JWM, Seynaeve CM, Hooning MJ, Hollestelle A, Jager A,
Tilanus-Linthorst MMA, Hall P, Czene K, Jianjun L, Jingmei L, Cox A, Cross SS, Brock IW, Reed
MWR, Pharoah P, Blows FM, Dunning AM, Ghoussaini M, Ashworth A, Swerdlow A, Jones M,
Schoemaker M, Easton DF, Humphreys M, Wang Q, Peto J, dos-Santos-Silva I. 9q31.2-rs865686
as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast
63
Leslie Bernstein, PhD
Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev, 21, 1783-1791, 2012.
PMC3772723.
461. Dee A*, McKean-Cowdin R, Neuhouser ML, Ulrich CM, Baumgartner RN, McTiernan A,
Baumgartner K, Alfano C, Ballard-Barbash R, Bernstein L. DEXA measures of body fat
percentage and acute phase proteins among breast cancer survivors: A cross-sectional analysis.
BMC Cancer, Aug 8, 12(1), 343, 2012. Doi: 10.1186/1371-2407-12-343. PMC3500231.
462. Horn-Ross PL, Canchola AJ, Bernstein L, Clarke CA, Lacey JV, Neuhausen SL, Reynolds P,
Ursin G. Alcohol consumption and breast cancer risk among postmenopausal women following the
cessation of hormone therapy use: the California Teachers Study. Cancer Epidemiol Biomarkers
Prev, 21, 2006-2013, 2012. PMC3721729.
463. Koushik A, Spiegelman D, Albanes D, Anderson KE, Bernstein L, van den Brandt PA, Bergkvist
L,. English DR, Freudenheim JL, Fuchs CS, Genkinger JM, Giles GG, Goldbohm RA, Horn-Ross
PL, Männistö S, McCullough ML, Millen A, Miller AB, Robien K, Rohan TE, Schatzkin A,
Shikany JM, Stolzenberg-Solomon RZ, Willett WC, Wolk A, Ziegler RG, Smith-Warner SA.
Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort
studies. Am J Epidemiol, 176, 373-386, 2012. PMC3499118.
464. Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks
A, Hogervorst FBL, Bueno-de-Mesquita B, Muir KR, Lophatananon A, Rattanamongkongul S,
Puttawibul P, Fasching P, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos
Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C,
Burwinkel B, Guénel P, Cordina E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger
H, Milne RL, Arias Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L,
Clarke Dur C, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C,
Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, The
GENICA Network, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P,
Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV,
Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A,
Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, kConFab
Investigators, AOCS Group, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys
D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z,
Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Grenaker
Alnæs G, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, JukkolaVuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, GarcíaClosas M, Lissowska J, Sherman ME, Hooning M, Martens JWM, Seynaeve C, Collée M, Hall P,
Humpreys K, Czene K, Liu J, Cox A, Brock IW, Cross SS, Reed MWR, Ahmed S, Ghoussaini M,
Pharoah PDP, Kang D, Yoo KY, Noh DY, Jakubowska A, Jaworska K, Durda K, Zł
owocka E,
Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Yu JC, Hsu HM, Hou MF, Orr N,
Schoemaker M, Ashworth A, Swerdlow A, Trentham-Dietz A, Newcomb PA, Titus L, Egan KM,
Chenevix-Trench G, Antoniou AC, Humphreys MK, Morrison J, Chang-Claude J, Easton DF,
Dunning AM. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide
Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS ONE, 7(8):
e42380, 2012. PMC3413660.
465. Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W,
Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF,
Rosenberg L, Deming SL, Rodriguez-Gil JL, DeMichele A, Chanock SJ, Blot W, Signorello L, Cai
Q, Li G, Long J, Huo D, Zheng Y, Cox NJ, Olopade OI, Ogundiran TO, Adebamowo C, Nathanson
64
Leslie Bernstein, PhD
KL, Domchek SM, Simon MS, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Hutter C,
Young A, Kooperberg C, Peters U, Wan P, Sheng X, Pooler LC, Van Den Berg DJ, LeMarchand L,
Kolonel LN, Henderson BE, Haiman CA. A genome-wide association study of breast cancer in
women of African ancestry. Hum Genet, 132, 39-48, 2013. PMC3749077.
466. Reeve BB, Stover AM, Alfano CM, Smith AW, Ballard-Barbash R, Bernstein L, McTiernan A,
Baumgartner KB, Piper BF. The Piper Fatigue Scale-12 (PFS-12): Psychometric findings and item
reduction in a cohort of breast cancer survivors. Breast Cancer Res Treat, 136, 9-20, 2012.
PMC3739964.
467. Su Z, Gay LJ, Strange A, Palles C, Band G, Whiteman DC, Lescai F, Langford C, Nanji M,
Edkins S, van der Winkel A, Levine D, Sasieni P, Bellenguez C, Howarth K, Freeman C, Trudgill
N, Tucker AT, Pirinen M, Peppelenbosch MP, van der Laan LJ, Kuipers EJ, Drenth JP, Peters WH,
Reynolds JV, Kelleher DP, McManus R, Grabsch H, Prenen H, Bisschops R, Krishnadath K,
Siersema PD, van Baal JW, Middleton M, Petty R, Gillies R, Burch N, Bhandari P, Paterson S,
Edwards C, Penman I, Vaidya K, Ang Y, Murray I, Patel P, Ye W, Mullins P, Wu AH, Bird NC,
Dallal H, Shaheen NJ, Murray LJ, Koss K, Bernstein L, Romero Y, Hardie LJ, Zhang R, Winter
H, Corley DA, Panter S, Risch HA, Reid BJ, Sargeant I, Gammon MD, Smart H, Dhar A,
McMurtry H, Ali H, Liu G, Casson AG, Chow WH, Rutter M, Tawil A, Morris D, Nwokolo C,
Isaacs P, Rodgers C, Ragunath K, Macdonald C, Haigh C, Monk D, Davies G, Wajed S, Johnston
D, Gibbons M, Cullen S, Church N, Langley R, Griffin M, Alderson D, Deloukas P, Hunt SE, Gray
E, Dronov S, Potter SC, Tashakkori-Ghanbaria A, Anderson M, f C, Blackwell JM, Bramon E,
Brown MA, Casas JP, Corvin A, Duncanson A, Markus HS, Mathew CG, Palmer CN, Plomin R,
Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood N, Trynka G, Wijmenga C, Cazier
JB, Atherfold P, Nicholson AM, Gellatly NL, Glancy D, Cooper SC, Cunningham D, Lind T,
Hapeshi J, Ferry D, Rathbone B, Brown J, Love S, Attwood S, Macgregor S, Watson P, Sanders S,
Ek W, Harrison RF, Moayyedi P, de Caestecker J, Barr H, Stupka E, Vaughan TL, Peltonen L,
Spencer CC, Tomlinson I, Donnelly P, Jankowski JA, Esophageal Adenocarcinoma Genetics
Consortium, Welcome Trust Case Control Consortium 2. Common variants at the MHC locus and
at chromosome 16q24.1 predispose to Barrett’s esophagus. Nature Gen, 44, 1131-1136, 2012. doi:
10.1038/ng.2408. PMC3459818.
468. Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, Bernstein L, Enger SM, Press MF.
Impact of breast cancer subtypes and treatment on survival: An analysis spanning two decades.
Cancer Epidemiol Biomarkers Prev, 21, 1848-1855, 2012. PMC3467337.
469. Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, GarciaClosas M, Stram DO, Beckmann L, Ambrosone CB, Aittomäki K, Amiano P, Apicella C, Baglietto
L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Brauch H,
Brinton L, Buring JE, Buys SS, Campa D, Carpenter JE, Chasman DI, Chang-Claude J, Chen C,
Clarke CL, Clavel-Chapelon F, Cox A, Cross SS, Czene K, Deming SL, Diasio RB, Diver WR,
Dunning AM, Durcan L, Ekici AB, Fasching PA, Familial Breast Cancer Study, Feigelson HS,
Fejerman L, Figueroa JD, Fletcher O, Flesch-Janys D, Gaudet M, The BENICA Consortium, Gerty
SM, Rodriguez-Gil JL, Giles GG, van Gils CH, Godwin AK, Graham N, Greco D, Hall P,
Hankinson SE, Hartmann A, Hein R, Heinz J, Hoover RN, Hopper JL, Hu JJ, Huntsman S, Ingles
SA, Irwanto A, Isaacs C, Jacobs KB, John EM, Kaaks R, Ko YD, Kolonel LN, Lathrop M, Le
Marchand L, Lee AM, Lee IM, Lesnick T, Lichtner P, Liu J, Lund E, Martin NG, Meijers-Heijboer
H, Meindl A, Miron P, Monroe KR, Montgomery GW, Müller-Myhsok B, Nickels S, Nyante S,
Olswold C, Overvad K, Palli D, Park DJ, Pathak H, Peto J, Pharoah P, Rahman N, Rivadeneira F,
Schmutzler RK, Slager S, Southey M, Stevens KN, Sinn HP, Press MF, Ross E, Riboli E, Ridker
65
Leslie Bernstein, PhD
PM, Schumacher FR, Severi G, dos Santos Silva I, Sund M, Tapper WJ, Thun MJ, Travis RC,
Turnbull C, Uitterlinden AG, Waisfisz Q, Wang X, Wang Z, Weaver JE, Schulz-Wendtland R,
Wilkens LR, Van Den Berg D, Zheng W, Ziegler RG, Ziv E, Nevanlinna H, Easton DF, Hunter DJ,
Henderson BE, Chanock SJ, Kraft P, Haiman CA, Vachon CM. A meta-analysis of genome-wide
association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum
Molec Genet, 21,5373-5384, 2012. PMC3510753.
470. Lacson JCA*, Carroll JD, Tuazon E, Castelao EJ, Bernstein L, Cortessis VK. Population-based
case-control study of recreational drug use and testis cancer risk confirms an association between
marijuana use and non-seminoma risk. Cancer, 118, 5374-5383, 2012. PMC3775603.
471. Brooks JD*, Bernstein L, Teraoka SN, Knight JA, Mellemkjær L, John EM, Malone KE, Reiner
AS, Lynch CF, Concannon P, Haile RW, The WECARE Study Group, Bernstein JL. Variation in
genes related to obesity, weight and weight change and risk of contralateral breast cancer in the
WECARE Study population. Cancer Epidemiol Biomarkers Prev, 21, 2261-2267, 2012.
PMC3518741.
472. Clague J*, Bernstein L. Physical activity and cancer. Curr Oncol Rep, 14, 550-558, 2012. doi:
10.1007/s11912-012-0265-5. PMC3490043.
473. Villasenor A*, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, McTiernan A,
Neuhouser ML. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: The
HEAL Study. J Cancer Surviv, 6, 398-406, 2012. PMC3747827.
474. Cash SW*, Ma H, Horn-Ross PL, Reynolds P, Canchola AJ, Sullivan-Halley J, Beresford SAA,
Neuhouser ML, Vaughan TL, Heagerty PJ, Bernstein L. Recreational physical activity and risk of
papillary thyroid cancer among women in the California Teachers Study. Cancer Epidemiol, 37, 4653, 2012. PMC3543486.
475. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch
HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyrén O, Pandeya
N, Webb PM, Vaughan TL, Chow WH, Gammon MD. Body mass index in relation to oesophageal
and oesophagogastric junction adenocarcinomas: a pooled analysis from the International
BEACON Consortium. Int J Epidemiol, 41, 1706-1718, 2012. PMC3535758.
476. Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA,
Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC,
Haile RW, Thomas DC, Begg CB, the WECARE Collaborative, Bernstein JL. Risk of
asynchronous contralateral breast cancer in non-carriers of BRCA1 and BRCA2 mutations with a
family history of breast cancer: A report from the Women’s Environmental Cancer and Radiation
Epidemiology Study. J Clin Oncol, 31, 433-439, 2012. PMC3731919.
477. Banks K, Tuazon E, Berhane K, Koh C, DeFilippo R, Chang A, Kim S, Daneshmand S, DavisDao C, Lewinger JP, Bernstein L, Cortessis V. Cryptorchidism and testicular germ cell tumors:
Comprehensive meta-analysis reveals that association between these conditions has diminished
over time and is modified by features of cryptorchidism. Front Endocrin, 3,182, 2012. doi:
10.3389/fendo.2012.00182. PMC3574983.
478. Kane EV, Roman E, Becker N, Bernstein L, Boffetta P, Bracci P, Cerhan JR, Chiu B, Cocco P,
Costas L, Foretova L, LaVecchia C, Matsuo K, Maynadie M, Sanjose S, Spinelli SJ, Staines A,
Talamini R, Wang S, Zhang Y, Zheng T, Kricker A for the InterLymph Consortium. Menstrual
and reproductive factors, and hormonal contraception use: associations with non-Hodgkin
lymphoma in a pooled analysis of InterLymph case-control studies. Ann Oncol, 23,. 2362-2374,
2012. PMC3425371
66
Leslie Bernstein, PhD
479. David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasbergers JL, Brown WM, Petruzella
S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV,
Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N,
Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M,
Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA,
John EM, Kittle R, Kolb S, Kolonel LN, LeMarchand L, Liu Y, Lohman KK, McKnight B,
Millikan RC, Murphy A, Neslund-Duda C, Nyante S, Press M, Psaty BM, Rao DC, Redline S,
Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B,
Stanford J, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF, Witte JS, Yamamura Y, Yanek
LR, Yu K,Zheng W, Ziegler RG, Zonderman, Jorgenson E, Haiman CA, Furberg H. Genome-wide
meta-analyses of smoking behaviors in African Americans. Translational Psychiatry. 2012 May
22;2:e119. doi: 10.1038/tp.2012.41. PMC3365260.
480. Emaus A*, Dieli-Conwright C*, Xu X, Lacey JV, Ingles SA, Reynolds P, Bernstein L,
Henderson KD*. Increased long-term recreational physical activity is associated with older age at
natural menopause among heavy smokers: the California Teachers Study. Menopause, 20, 282-290,
2013. PMC3580010.
481. Duggan C, Wang CY, Neuhouser ML, Xiao L, Smith AW, Reding KW, Baumgartner RN,
Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A. Associations of insulin-like
growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast
cancer. Int J Cancer, 132, 1191-1200, 2013. PMC3764990.
482. George SM, Alfano CM, Smith AW, Irwin ML, McTiernan A, Bernstein L, Baumgartner KB,
Ballard-Barbash R. Sedentary behavior, health-related quality of life and fatigue among breast
cancer survivors. J Physical Activ Health, 10, 350-358, 2013. PMC3794705.
483. Forsythe LP, Alfano CM, George SM, McTiernan A, Baumgartner KB, Bernstein L, BallardBarbash R. Pain in long-term breast cancer survivors: The role of body mass index, physical
activity, and sedentary behavior. Breast Cancer Res Treat, 137, 617-630, 2013. PMID: 23242613.
484. Wang J, Cozen W, Thorne PS, Berhane K, Cerhan JR, Hartge P, Ward M, DeRoos AJ, Severson
R, Morton LM, Bernstein L, Linet M, Colt JS. Household endotoxin levels and the risk of nonHodgkin lymphoma. Cancer Cause Control, 24, 357-364, 2013. PMC3800025.
485. Gyllenhammer L*, Vanni A, Byrd-William C, Kalan M, Bernstein L, Davis JN. Objective
habitual physical activity and estradiol levels in obese Latina adolescent females. J Phys Act
Health, 10, 727-733, 2013. PMC3779056.
486. Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE,
Cerhan JR, Gaudet M, Giles GG, Goodman G, Håkansson N, Hankinson SE, Helzlsouer KJ, HornRoss PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park
Y, Robien K, Rohan TE, Scarmo ST, Schairer C, Schouten LJ, Shikany JM, Sieri S, Tsugane S,
Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Zhang X,
Ziegler R, Smith-Warner SA. Fruit and vegetable intake and risk of breast cancer by hormone
receptor status. J Natl Cancer Inst, 105, 219-236, 2013. PMC:3593764.
487. Villasenor A*, Ballard-Barbash R, Ambs A, Bernstein L, Baumgartner K, Baumgartner R, Ulrich
CM, Hollis BW, McTiernan A, Neuhouser ML. Associations of serum 25-hydroxyvitamin D with
overall and breast cancer-specific mortality in a multi-ethnic cohort of breast cancer survivors.
Cancer Cause Control, 24, 759-767, 2013. PMC3731052.
488. George SM, Smith AW, Alfano CM, Bowles HR, Irwin ML, McTiernan A, Bernstein L,
Baumgartner KB, Ballard-Barbash R. The association between television watching time and allcause mortality after breast cancer. J Cancer Surviv, 7, 247-252, 2013. PMC3777275.
67
Leslie Bernstein, PhD
489. Kruper L*, Xu XX, Henderson K, Bernstein L, Chen SL. Utilization of mastectomy and
reconstruction in the outpatient setting. Ann Surg Oncol, 20, 828-835, 2013. PMC3819218.
490. Press DJ*, Bernstein L. Invited Commentary: Reproductive organ surgeries and breast cancer
risk—apples, oranges, or fruit cocktail? Am J Epidemiol, 177, 500-503, 2013. PMC3657528.
491. Stover AM, Reeve BB, Piper B, Alfano C, Wilder Smith A, Mitchell S, Bernstein L,
Baumgartner KB, McTiernan A, Ballard-Barbash R. Deriving clinically meaningful cut-scores for
fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL)
Study. Qual Life Res, 22(9):2279-2292, 2013, Feb 19. [Epub ahead of print] DOI: 10.1007/s11136013-0360-6. PMC3823669.
492. Song C, Chen GK, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ,
Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL, Rodriguez-Gil JL, Chanock
SJ, Wan P, Sheng X, Pooler LC, Van Den Berg DJ, Le Marchand L, Kolonel LN, Henderson BE,
Haiman CA, Stram DO. A genome-wide scan for breast cancer risk haplotypes among African
American women. PLoS One. 8(2):e57298, 2013. doi: 10.1371/journal.pone.0057298.
PMC3585353
493. Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal
carcinoma in the United States. J Clin Oncol, 31, 1569-1575, 2013. PMC3753461.
494. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook M, Orr N, Rhie
SK, Riboli E, Feigelson HS, LeMarchand L, Buring JE, Eccles D, Miron P, Fasching PA, Brauch
H, Chang-Claude J, Carpenter J, Godwin A, Nevanlinna H, Giles GG, Cox A, Hopper J,
Humphreys MK, Wang Q, Dennis J, Dicks E, Howat WJ, Schoof N, Bojesen SE, Lambrecht D,
Broek A, Andrulis IL, Cuenel P, Burwinkel B, Sawyer EJ, Hollestelle A, Fletcher O, Winqvist R,
Brenner H, Mannermaa A, Hamann U, Meindl A, Lindblom A, Wheng W, Deville P, Goldberg
MS, Lubinski J, Kristensen V, Swerdlow A, Anton-Culver H, Dork T, Muir K, Matsuo K, Wu AH,
Radice P, Teo SH, Shu XO, Blot W, Kang D, Hartman M, Sangrajrang S, Shen CY, Southey MC,
Park DJ, Hammet F, Stone J, Van’t Veer LJ, Rutgers EJ, Lophatananon A, Stewart-Brown S,
Siriwanarangsan P, Peto J, Schrauder MG, Ekici AB, Beckmann MW, dos Santos Silva I, Johnson
N, Warren H, Tomlinson I, Kerin MJ Miller N, Marme F, Schneeweiss A, Sohn C, Truong T,
Laurent-Puig P, Kerbrat P, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Perez JIA,
Menendez P, Muller H, Arndt V, Stegmaier C, Lichtner P, Lochmann M, Justenhoven C, Ko YD,
The GENICA Network, Muranen TA, Aittormaki K, Blomqvist C, Greco D, Heikkinen T, Ito H,
Iwata H, Yatabe Y, Antonenkova NN, Margolin S, Kataja V, Kosma VM, Hartikainen JM, Balleine
R, kConFab Investigators, Tseng CC, Van Den Berg D, Stram DO, Neven P, Dieudonne AS,
Leunen K, Rudolph A, Nickels S, Flesch-Janys D, Peterloong P, Peissel B, Bernard L, Olson JE,
Wang X, Steven K, Severi G, Baglietto L, McLean C, Coetzee GA, Henderson BE, Schumacher F,
Bogdanova NV, Labreche F, Dumont M, Yip CH, Taib NAM, Cheng CY, Shrubsole M, Long J,
Pylkas K, Jukkola-Vuorinen A, Kauppila S, Knight JA, Glendon G, Mulligan AM, Tollenaar
RAEM, Seynaeve CM, Kriege M, Hooning MJ, van den Ouweland AMW, van Deurzen CHM, Lu
W, Gao YT, Cai H, Balasubramanian SP, Cross SS, Reed MWR, Signorello L, Cai Q, Shah M, Mia
H,Chan CW, Chia KS, Jakubowska A, Jaworska K, Durda K, Hsiung CN, Wu PE, Yu JC,
Ashworth A, Jones M, Tessier DC, Glnzalez-Neira A, Pita G, Alonso MR, Vincent D, Bacot F,
Ambrosone CB, Bandera EV, John EM, Chen GK, Hu JJ, Rodriquez-Gil JL, Bernstein L, Press
MF, Ziegler RG, Milikan RM, Deming-Halverson SL, Nyante S, Ingles SA, Waisfisz Q, Tsimiklis
H, Makalic E, Schmidt D, Bui M, Gibson L, Muller-Myhsok B, Hein R, Dahmen N, Beckmann L,
Aaltonen K, Czene K, Irwanto A, Liu J, Turnbull C, FBCS, RahmanN, Meijers-Heijboer H,
Uitterlinden AG, Rivadeneira F, ABCTB Investigators, Oswold C, Slager S, Pilarski R,
68
Leslie Bernstein, PhD
Ademuyiwa F, Konstantopoulou I, Martin NG, Montgomery GW, Slamon SJ, Rauh C, Lux MP,
Jud SM, Bruning T, Weaver JE, Sharma P, Pathak H, Tapper W, Gerty S, Durcan L, Trichopoulos
D, Tumino R, Peeters PH, Weiderpass E, Johansson M, Khaw K, Travis R, Clavel-Chapelon F,
Kolonel LN, Chen C, Hankinson SE, Berg C, Hoover RN, Lissowska J, Figueroa J, Chasman DI,
Gaudet MM, Diver WR, Willett WC, Hunter DJ, Simard J, Benitez J, Dunning AM, Sherman ME,
Chenevix-Trench G, Chanock SJ, Hall P, Pharoah P, Vachon C, Easton DF, Haiman CA, Kraft P.
Genome-wide association studies identify four ER-negative specific breast cancer risk loci. Nature
Gen, 45, 392-398, 2013. PMC3771695.
495. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Haberle L,
Vrieling A, Gaudet M, Gifueroa J, Schoof N, Spurdle A, Rudolph A, Fashing PA, Hopper JL,
Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, dos Santos
Silva I, Peto J, Humphreys MK, Wang J, Cordina E, Menegaux F, Nordestgaard BG, Bojesen SE,
Lanng C, Anton-Culver H, Ziogas A, Bernstein L, Clarke Dur C, Brenner H, Muller H, Arndt V,
Stegmaier C, Brauch H, Bruning T, Harth V, The GENICA Network, Mannermaa A, Kataja V,
Kosma VM, Hartikainen JM, Lambrechts D, Smeets D, Neven P, Paridaens R, Flesch-Janys D, Obi
N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K,
John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J,
Liu J, Cox A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz
A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody MM, AOCS
Management Group, Guenel P, Pharoah P, Schmidt M, Hall P, Easton DF, Garcia-Closas M, Milne
RL, Chang-Claude J. Evidence of gene-environment interactions between common breast cancer
susceptibility loci and established environmental risk factors. PLoS Genetics. 2013
Mar;9(3):e1003284. doi: 10.1371/journal.pgen.1003284. Epub 2013 Mar 27. PMC3609648.
496. Brooks JD*, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjaer L,
Duggan DJ, Reiner AS, Concannon P, Schiermeyer K, Lewinger JP, The WECARE Study
Collaborative Group, Bernstein JL, Figueiredo JC. Variants in tamoxifen metabolizing genes: A
case-control study of contralateral breast cancer risk in the WECARE Study. Int J Mol Epidemiol
Genet, 4, 35-48. 2013. PMC3612453.
497. Wang SS, Voutsinas J, Chang ET, Clarke CA, Lu Y, Ma H, Sullivan-Halley J, West D, Bernstein
L. Anthropometric, behavioral and female reproductive factors and risk of multiple myeloma: A
pooled analysis. Cancer Cause Control, 24, 1279-1289, 2013. PMC 3684420.
498. Hurley S, Goldberg D, Nelson DO, Lu Y, Henderson K, Bernstein L, Reynolds P. Risk of
colorectal cancer associated with active smoking among female teachers. Cancer Cause Control,
24, 1291-1304, 2013. PMC3733091.
499. Mason C, Alfano CM, Smith AW, Wang CY, Neuhouser ML, Duggan C, Bernstein L,
Baumgartner K, Ballard-Barbash R, McTiernan A. Long-term physical activity trends in breast
cancer survivors. Cancer Epidemiol Biomarkers Prev, 22, 1153-1161, 2013. PMC 3688258.
500. Demerath EW, Liu CT, Franceschini N, Chen G, Palmer JR, Smith EN, Chen CTL, Ambrosone
CB, Arnold AM, Bandera EV, Berenson GS, Bernstein L, Britton A, Cappola AR, Carlson C,
Chanock SJ, Chen W, Deming SL, Elks C, Evans MK, Gajdos Z, Henderson BE, Hu JJ, John EM,
Kerr KF, Kolonel LN, LeMarchand L, Lu X, Millikan RC, Musani SK, Nock N, Nyante S, Press
MF, Rodriquez-Gil JL, Ruiz-Narvaez EA, Schork MJ, Srinivasan SR, Zheng W, Ziegler RG,
Zonderman A, Heiss G, Windham RG, Wellons M, Murray SS, Nalls M, Rajkovic A, Hirschhorn J,
Cupples LA, Kooperberg C, Murabito JM, Haiman CA. Genome-wide association study of age at
menarche in African-American women. Hum Mol Genet, 22 (16), 3329-3346, 2013. PMC3723312.
69
Leslie Bernstein, PhD
501. Hwang AE, Mack TM, Hamilton AS, Gauderman J, Bernstein L, Cockburn MG, Rand K,
Zadnick J, Hopper J, Cozen W. Childhood infections and adult height in monozygotic twin pairs.
Am J Epidemiol, 178 (4), 551-558, 2013. PMC3736755.
502. Monda KL, Chen GK, Taylor KC, Palmer C, Lange L, Edwards TL, Ng MCY, Adeyemo AA,.
Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, Liu Y, Lu YC, Nalls MA, Sun
YV, Wojczynski MK, Yanek LR, Aldrich MC, Amos C, Bandera EV, Bock CH, Britton A,
Broeckel U, Cai Q, Caporaso N, Carlson C, Carpten J, Casey G, Chen YDI, Chiang CWK, Coetzee
GA, Demerath E, Deming SL, Driver RW, Dubbert P, Feitosa M, Freedman BI, Gillanders EM,
Gottesman O, Guo X, Haritunians T, Harris T, Harris CC, Hennis AJM, Hernandez DG, McNeill
LH, Howard TD, Howard B, Johnson KC,. Kang SJ, Keating BJ, Kolb S, Kuller L, Kutlar A,
Langefeld CD, Lettre G, Lohman K, Lotay V, Lyon H, Manson JE, Maixner W, Meng Y, Monroe
K, Murphy AB, Nadukuru R, N’Diaye A, Nemesure B, Neslund-Dudas C, Neuhouser M, Nyante S,
Ochs-Balcom H, Oguinniyi A, Palmer J, Palmer ND, Press MF, Rampersaud E, Rasmussen-Torvik
LJ, Rodriguez-Gil JL, Ruiz-Narvaez EA, Salako B, Schadt EE, Schwartz AG, Shriner DA,
Siscovick C, Smith S, Smoller S, Speliotes E, Spitz M, Sucheston L, Taylor H,. Tayo BO, Tucker
MA, Van Den Berg DJ, Velez Edwards DR, Wang Z, Wiencke JK, Witte JS, Wrensch M, Wu X,
Young TR, Zakai N, Zanetti K, Zhao JH, Zhao W, Zhou J, Ziegler RG, Zmuda J, Ambrosone CB,
Arnett DK, Atwood L, Becker DM, Berndt SI, Bernstein L, Blot WJ, Borecki IB, Bottinger EP,
Bowden DW, Burke G, Chanock SJ, Cooper RS, Ding J, Evans MK, Fox C, Grant S, Hsing A, Hu
JJ, Ingle SA, John EM, Jordan JM, Kabagambe EK, Kardia SL, Ketkar S, Kittles RA, Kolonel LN,
LeMarchand L, Liu S, McKnight B, Millikan RC, Mosley TH, Patel SR, Pettaway CA, Peyser PA,
Psaty BM, Redline S, Rotimi CN, Rybicki BA, Schreiner P, Signorello LB, Singleton AB, Stanford
JL, Strom SS, Thun MJ, Vitolins M, Zheng W, Zhu X, Zonderman AB, NABEC Consortium,
UKBEC Consortium, BioBank Japan Project, AGEN Consortium, Kooperberg C, Papanicolaou G,
Henderson BE, Reiner AP, Hirschhorn JN, Loos RJF, North KE, Haiman CA. A meta-analysis
identifies new loci associated with body mass index in individuals of African ancestry. Nature Gen,
45, 690-696, 2013. PMC 3694490.
503. Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, Burkman RT, Strom BL,
McDonald JA, Folger SG, Simon MS, Sullivan-Halley J, Press MF, Bernstein L. Mortality risk of
black women and white women with invasive breast cancer by hormone receptors, HER2, and p53
status. BMC Cancer. 2013, 13:225 (4 May 2013). Doi:10.1186/1471-2407-13-225. PMC3648503.
504. Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N,
Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, The Australian National
Endometrial Cancer Study Group, Strom BL, Spurdle AB, Soslow RA, Shu X, Schairer C,
Sacerdote C, Rohan TE, Robien K, Risch H, Ricceri F, Rebbeck TR, Rastogi R, Prescott J,
Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco
AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV, Kolonel LN, Henderson BE, Hankinson SE,
Hakansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL,
Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein
L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. Type I and type II endometrial
cancers: have they different risk factors? J Clin Oncol, 31, 2607-2618, 2013. PMC3699726.
505. Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein
L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Xue S, Teraoka SN, Begg
CB, Olsen JH, Mellemkjaer L, Liang X, Olson E, Diep AT, The WECARE Study Collaborative
Group, Borg A, Concannon P, Haile RW. Contralateral breast cancer after radiotherapy among
BRCA1 and BRCA2 mutation carriers: A WECARE Study Report. Eur J Cancer, 49(14), 2979-
70
Leslie Bernstein, PhD
2985, 2013. doi:pii S0959-8049(13) 00362-6n 10.1016 j.ejca.2013.04.028. [Epub ahead of print].
PMC3755053.
506. Brooks JD*, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW,
Concannon P, Reiner AS, Duggan DJ, Schiermeyer K, The WECARE Study Collaborative Group,
Bernstein JL, Figueiredo JC. Common variants in genes coding for chemotherapy metabolizing
enzymes, transporters and targets: A case-control study of contralateral breast cancer risk in the
WECARE Study. Cancer Causes Control, 24 (8), 1605-1614, 2013. PMC3709075.
507. Imayama I, Alfano CM, Neuhouser ML, George SM, Smith AW, Baurmgartner RN, Baumgartner
KB, Bernstein L, Ballard-Barbash R, McTiernan A. Weight, inflammation, cancer-related
symptoms and health-related quality of life among breast cancer survivors. Breast Cancer Res
Treat, 140 (1), 159-176, 2013. PMC3772666.
508. Kane EV, Bernstein L, Bracci P, Cerhan JR, Costas L, Dal Maso L, Holly EA, LaVecchia C,
Matsuo K, Sanjose S, Spinelli J, Wang SS, Zhang Y, Zheng T, Roman E, Kricker A for the
Interlymph Consortium. Menopausal hormone therapy and non-Hodgkin lymphoma: a pooled
analysis of InterLymph case-control studies. Ann Oncol, 24, 433-441, 2013. doi:
10.1093/annonc/mds3. PMC3551484.
509. Kent EE, Alfano C, Smith AW, Bernstein L, McTiernan A, Baumgartner KB, Ballard-Barbash R.
The roles of support seeking and race/ethnicity in posttraumatic growth among breast cancer
survivors. J Psychosocial Oncol, 31, 393-412, 2013. PMC3812815.
510. Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson K,
Bernstein L, De Vivo I, Friedenreich C, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross P,
Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller A, Olson S,
Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg LA, Schairer C, Shu XO,
van den Brandt PA, Virkus RA, Wentzensen N, Xiang YB, Xu WH, Yang HP, Brinton LA. The
etiology of uterine sarcomas: a pooled analysis of the Epidemiology of Endometrial Cancer
Consortium (E2C2). Br J Cancer, 108 (3), 727-734, 2013. doi: 10.1038/bjc.2013.2. Epub 2013 Jan
24. PMC3593566.
511. Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE. A conceptual and
methodological framework for investigating etiologic heterogeneity. Stat Med, 32(29), 5039-5052,
2013. doi: 10.1002/sim.5902. PMC4104361.
512. Wu AH, Gomez SL, Vigen C, Kwan ML, Keegan THM, Lu Y, Shariff-Marco S, Monroe KR,
Kurian AW, Cheng I, Caan BJ, Lee FS, Roh JM, Sullivan-Halley J, Bernstein L, John EM, Sposto
R. The California Breast Cancer Survivorship Consortium (CBCSC): Prognostic factors associated
with racial/ethnic differences in breast cancer survival. Cancer Cause Control, 24 (10), 1821-1836,
2013. PMC40426898.
513. Lee E*, Horn-Ross PL, Rull RP, Neuhausen S, Anton-Culver H,Ursin G, Henderson KD,
Bernstein L. Reproductive factors, exogenous hormones and pancreatic cancer risk: the California
Teachers Study. Am J Epidemiol, 178(9), 1403-1413, 2013. PMC3813312.
514. Ma H, Lu Y, Marchbanks PA, Folger SG, Strom BL, McDonald JA, Simon MS, Weiss LK,
Malone KE, Burkman RT, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L. Quantitative
measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among
white women and black women. Breast Cancer Res, 15(5):R90, 2013. PMC3978823.
71
Leslie Bernstein, PhD
515. Duggan C, Ballard-Barbash R, Baumgartner RN, Baumgaratner KB, Bernstein L, McTiernan A.
Associations between null mutations in GSTT1 and GSTM1, the GSTP1 Ile105Val polymorphism
and mortality in breast cancer survivors. Springerplus, 2013 Sep 11; 2:450, doi: 10.1186/21931801-2-450. PMC:3786079.
516. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley
DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow WH, Risch HA, Nyrén O, Ye W,
Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock S, Harrington P, Caldas I, DebiramBeecham I, Caldas C, Haywward NK, Pharoah P, Fitzgerald R, macGregor S, Whiteman DC,
Vaughan TL. A genome-wide association study identifies new susceptibility loci for esophageal
adenocarcinoma and Barrett’s esophagus. Nature Genet, 45, 1487-1493, 2013. PMC3840115.
517. Link LB, Canchola AJ, Bernstein L, Clarke CA, Stram DO, Ursin G, Horn-Ross PL. Dietary
patterns and breast cancer risk in the California Teachers Study cohort. Am J Clin Nutr, 98(6),
1524-1532, 2013. PMC3831538.
518. George SM, McTiernan A, Villasenor A, Alfano CM, Irwin ML, Neuhouser ML, Baumgartner
RN, Baumgartner KB, Bernstein L, Smith AW, Ballard-Barbash R. Disentangling the body
weight-bone mineral density association among breast cancer survivors: An examination of the
independent roles of lean mass and fat mass. BMC Cancer, Oct 25, 13, 497, 2013. doi:
10.1186/10.1186/1471-2407-13-497. PMC:3924343.
519. Ek WE, Levine D, D’Amato MD, Pedersen NL, Magnusson PKE, Bresso F, Onstad LE, Schmidt
PT, Rornblom H, Nordenstedt H, Romero Y, (on behalf of the Mayo Clinic Esophageal
Adenocarcinoma and Barrett’s Esophagus Registry Consortium), Chow WH, Murray LJ, Gammon
MD, Liu G, Bernstein L, Casson AG, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA,
Hardie LJ, Ye W, Wu AH, Zucchelli M, Spector TD, Hysi P, Vaughan TL, Whiteman D,
MacGregor S; on behalf of the BEACON Study investigators. Germline genetic contributions to
risk for esophageal adenocarcinoma, Barrett’s esophagus and gastroesophageal reflux. J Natl
Cancer Inst, 105, 1711-1718, 2013. PMC3833931.
520. Dieli-Conwright CM*, Ma H, Lacey JV, Henderson KD, Neuhausen S, Horn-Ross PL, Deapen D,
Sullivan-Halley J, Bernstein L. Long-term and recent recreational physical activity and risk of
endometrial cancer: The California Teachers Study. Br J Cancer, 109(3), 761-768, 2013.
PMC3738142.
521. Rosner BA, Colditz GA, Hankinson SE, Sullivan-Halley J, Lacey JV Jr, Bernstein L. Validation
of Rosner-Colditz breast cancer incidence model using an independent data set, the California
Teachers Study. Breast Cancer Res Treat, 142(1),187-202, 2013. doi: 10.1007/s10549-013-2719-3.
PMC3825503.
522. Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, ChangClaude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper
WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P,
Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G,
Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP,
Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C,
Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl
S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek V, Sicotte H, Prodduturi N,
Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma
VM, Fischer HP, Network TG, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q,
Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rüdiger T, Wölfing H, Ulmer
HU, Försti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkilä P, Aittomäki K,
72
Leslie Bernstein, PhD
Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P,
Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H,
Vachon CM, Couch FJ. Genome-wide association study identifies 25 known breast cancer
susceptibility loci as risk factors for triple negative breast cancer. Carcinogenesis. 2013 Dec 9.
[Epub ahead of print]. PMC:4004200.
523. Kwan ML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I, Gomez SL, Henderson BE,
Keegan TH, Kurian AW, Lu Y, Monroe KR, Roh JM, Shariff-Marco S, Sposto R, Vigen C, Wu
AH. Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer
Survivorship Consortium. Am J Epidemiol, 179(1), 95-111, 2014. PMC3864715.
524. Park Y, Wang S, Kitahara CM, Morre SM, Berrington de Gonzalez A, Bernstein L, Chang ET,
Flint AJ, Freedman DM, Gaziano JM, Hoover RN, Linet MS, Purdue M, Robien K, Schairer C,
Sesso HD, White E, Willcox BJ, Thun MJ, Hartge P, Willett WC. Body mass index and risk of
death in Asian Americans. Am J Public Health, 104(3), 520-525, 2014. doi:
10.2105/AJPH.2013.301573. PMC3953786.
525. Jiang X, Tseng CC, Bernstein L, Wu AH. Family history of cancer and gastroesophageal
disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. BMC Cancer.
2014 Feb 4, 14(1), 60. doi: 10.1186/1471-2407-14-60. PMC3915076
526. Thrift AP, Risch HA, Onstad L, Shaheen NJ, Casson AG, Bernstein L, Corley DA, Levine DM,
Chow WH, Reid BJ, Romero Y, Hardie LJ, Liu G, Wu AH, Bird NC, Gammon MD, Ye W,
Whiteman DC, Vaughan TL. Risk of esophageal adenocarcinoma decreases with height, based on
consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol,
12(10), 1667-1676. e1. doi: 10.1016/j.cgh.2014.01.039. PMC4130803.
527. Chen CT, Liu CT, Chen GK, Andrews JS, Arnold AM, Dreyfus J, Franceschini N, Garcia ME,
Kerr KF, Li G, Lohman KK, Musani SK, Nalls MA, Raffel LJ, Smith J, Ambrosone CB, Bandera
EV, Bernstein L, Britton A, Brzyski RG, Cappola A, Carlson CS, Couper D, Deming SL,
Goodarzi MO, Heiss G, John EM, Lu X, Le Marchand L, Marciante K, McKnight B, Millikan R,
Nock NL, Olshan AF, Press MF, Vaiyda D, Woods NF, Taylor HA, Zhao W, Zheng W, Evans
MK, Harris TB, Henderson BE, Kardia SL, Kooperberg C, Liu Y, Mosley TH, Psaty B, Wellons
M, Windham BG, Zonderman AB, Cupples LA, Demerath EW, Haiman C, Murabito JM, Rajkovic
A. Meta-analysis of loci associated with age at natural menopause in African-American women.
Hum Molec Genet , 23(12), 3327-3342, 2014. doi: 10.1093/hmg/ddu041. Epub 2014 Feb 2.
PMC:4030781.
528. Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami HO, Ebbert JO, English
DR, Gapstur SM, Giles GG, Horn-Ross PL, Park Y, Patel AV, Robein K, Weiderpass E, Willett,
WC, Wolk A, Zeleniuch-Jacquotte A, Hartge P, Bernstein L, Berrington de Gonzalez A. A pooled
analysis of waist circumference and mortality in 650,000 adults. Mayo Clinic Proc, 89(3), 335-345,
2014. doi: 10.1016/j.mayocp. PMC4104704.
529. Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Baumgartner K, Baumgartner R,
Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A. Changes in peripheral blood
leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst. 2014
106(4):dju035. doi: 10.1093/jnci/dju035. PMC3982887.
73
Leslie Bernstein, PhD
530. Dieli-Conwright CM, Mortimer JE, Schroeder ET, Courneya K, Demark-Wahnefried W,
Buchanan TA, Tripathy D, Bernstein L. Randomized controlled trial to evaluate the effects of
combined progressive exercise on metabolic syndrome in breast cancer survivors: Rationale,
design and methods. BMC Cancer 2014; Apr 3, 14(1), 238. Doi: 10.1186/1471-2407-14-238.
PMC3985576.
531. Genkinger JM, Wang M, LI R, Albanes D, Anderson KE, Bernstein L, van den Brandt PA,
English DR, Freudenheim JL, Fuchs CS, Giles GG, Goldbohm RA, Håkansson N, Horn-Ross PL,
Jacobs EJ, Koushik A, Marshall JR, Miller AB, Patel AV, Robien K, Rohen TE, Schairer C,
Stolzenberg-Solomon R, Virtamo J, Willett WC, Wolk A, Ziegler RG, Smith-Warner SA. Dairy
products and pancreatic cancer risk: A pooled analysis of 14 cohort studies. Ann Oncol, 25(6),
1106-111, 2014. Epub 2014 Mar 14. Doi: 10.1093/annonc/mdu019. PMC:4037857.
532. Setiawan VW, Schumacher F, Prescott J, Haessler J, Malinowski J, Wentzensen N, Yang H,
Chanock S, Brinton L, Hartge P, Lissowska J, Park L, Cheng I, Bush WS, Crawford DC, Ursin G,
Horn-Ross P, Bernstein L, Lu L, Risch H, Yu H, Sakoda LC, Doherty J, Chen C, Jackson R,
Yasmeen S, Cote M, Kocarnik JM, Peters U, Kraft P, De Vivo I, Haiman CA, Kooperberg C,
LeMarchand L. Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2
Consortia. Carcinogenesis, 35(9),2068-2073, 2014. doi: 10.1093/carcin/bgu107. PMC4146418.
533. Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang
Q, Bolla MK, Meyer KB, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A,
Lindblom A, Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, Ito H, Iwata H,
Kondo N; kConFab Investigators; Australian Ovarian Cancer Study Group, Hartman M, Hui M,
Lim WY, Iau PT, Sawyer E, Tomlinson I, Kerin M, Miller N, Kang D, Choi J-, Park SK, Noh D-,
Hopper JL, Schmidt DF, Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay W-,
Brauch H, Brüning T, Hamann U; GENICA Network, Dunning AM, Shah M, Andrulis IL, Knight
JA, Glendon G, Tchatchou S, Schmidt MK, Broeks A, Rosenberg EH, van't Veer LJ, Fasching PA,
Renner SP, Ekici AB, Beckmann MW, Shen C-, Hsiung C-, Yu J-, Hou M-, Blot W, Cai Q, Wu
AH, Tseng C-, Van Den Berg D, Stram DO, Cox A, Brock IW, Reed MW, Muir K, Lophatananon
A, Stewart-Brown S, Siriwanarangsan P, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J,
Shu X-, Lu W, Gao Y-, Zhang B, Radice P, Peterlongo P, Manoukian S, Mariette F, Sangrajrang S,
McKay J, Couch FJ, Toland AE; TNBCC, Yannoukakos D, Fletcher O, Johnson N, dos Santos
Silva I, Peto J, Marme F, Burwinkel B, Guénel P, Truong T, Sanchez M, Mulot C, Bojesen SE,
Nordestgaard BG, Flyer H, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Mannermaa A,
Kataja V, Kosma V-, Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, ChangClaude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K,
Giles GG, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Marchand LL,
Simard J, Dumont M, Goldberg MS, Labréche F, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip
M, Devilee P, Tollenaar RA, Seynaeve C, García-Closas M, Chanock SJ, Lissowska J, Figueroa
JD, Czene K, Eriksson M, Humphreys K, Darabi H, Hooning MJ, Kriege M, Collée JM, TilanusLinthorst M, Li J, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Nevanlinna H,
Muranen TA, Aittomäki K, Blomqvist C, Bogdanova N, Dörk T, Hall P, Chenevix-Trench G,
Easton DF, Pharroah PD, Arias-Perez JI, Zamora P, Benítez J, Milne RL. +160 Collaborators (160)
Berchuck A, Eeles RA, Amin Al Olama A, Kote-Jarai Z, Benlloch S, Antoniou A, McGuffog L,
Offit K, Lee A, Dicks E, Luccarini C, Tessier DC, Bacot F, Vincent D, LaBoissière S, Robidoux F,
Nielsen SF, Cunningham JM, Windebank SA, Hilker CA, Meyer J, Angelakos M, Maskiell J,
Cornelissen S, van der Schoot E, Rutgers E, Verhoef S, Hogervorst F, Boonyawongviroj P,
74
Leslie Bernstein, PhD
Siriwanarungsan P, Hein A, Schrauder M, Rübner M, Oeser S, Landrith S, Williams E, Ryder-Mills
E, Sargus K, McInerney N, Colleran G, Rowan A, Jones A, of Sohn C, Schneeweiss A, Bugert P,
Osorio A, Barroso A, Fernández V, González-Niera M, Malats N, Real F, Herráez B, Álvarez N,
Díaz E, Miguel-Martin M, Bernstein L, Lacey J, Wang S, Ma H, Lu Y, Clague DeHart J, Deapen
D, Pinder R, Lee E, Schumacher F, Horn-Ross P, Reynolds P, Nelson D, Park H, Ziegler H, Wolf
S, Hermann V, Fischer-Bosch M, Lo WY, Justenhoven C, Yon-Dschun K, Baisch C, Fischer HP,
Pesch B, Rabstein S, Lotz A, Harth V, Heikkinen T, Erkkilä I, Aaltonene K, von Smitten K,
Antonenkova N, Hillemanns P, Christiansen H, Myöhänen E, Kemiläinen H, Thorne H,
Niedermayr E, Botwell D, Chenevix-Trench G, deFazio A, Gertig D, Green A, Webb P, Parsons P,
Hayward N, Webb P, Whiteman D, Fung A, Yashiki J, Peuteman G, Smeets D, Van Brussel T,
Corthouts K, Obi N, Heinz J, Behrens S, Eilber U, Celik M, Olchers T, Peissel B, Scuvera G,
Zaffaroni D, Bonanni B, Barile M, Feroce I, Tranchant M, Valois MF, Turgeon A, Heguy L, Yee
PS, Kang P, Nee KI, Mariapun S, Sook-Ye Y, Lee D, Ching TY, Mohd Taib NA, Otsukka M,
Mononen K, Selander T, Weerasooriya N, Krol-Warmerdam E, Molenaar J, Blom J, Brinton L,
Szeszenia-Dabrowska N, Peplonska B, Zatonski W, Chao P, Stagner M, Bos P, Blom J, Crepin E,
Nieuwlaat A, Heemskerk A, Higham S, Cross S, Cramp H, Conley D, Luccarini C, Conroy D,
Baynes C, Chua K, Pilarski R. FGF receptor genes and breast cancer susceptibility: results from
the Breast Cancer Association Consortium. Br J Cancer. 2014 Feb 18;110(4):1088-100. doi:
10.1038/bjc.2013.769. PMCID: PMC3929867.
534. Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, Folkerd EJ, Haynes BP,
Hopper JL, Southey MC, Dite GS, Apicella C, Schmidt MK, Broeks A, Van T Veer LJ, Atsma F,
Muir K, Lophatananon A, Fasching PA, Beckmann MW, Ekici AB, Renner SP, Sawyer E,
Tomlinson I, Kerin M, Miller N, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Guénel P,
Truong T, Cordina E, Menegaux F, Bojesen SE, Nordestgaard BG, Flyger H, Milne R, Zamora
MP, Arias Perez JI, Benitez J, Bernstein L, Anton-Culver H, Ziogas A, Clarke Dur C, Brenner H,
Müller H, Arndt V, Dieffenbach AK, Meindl A, Heil J, Bartram CR, Schmutzler RK, Brauch H,
Justenhoven C, Ko YD, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Matsuo K, Dörk
T, Bogdanova NV, Antonenkova NN, Lindblom A, Mannermaa A, Kataja V, Kosma VM,
Hartikainen JM, Chenevix-Trench G, Beesley J, Wu AH, Van den Berg D, Tseng CC, Lambrechts
D, Smeets D, Neven P, Wildiers H, Chang-Claude J, Rudolph A, Nickels S, Flesch-Janys D,
Radice P, Peterlongo P, Bonanni B, Pensotti V, Couch FJ, Olson JE, Wang X, Fredericksen Z,
Pankratz VS, Giles GG, Severi G, Baglietto L, Haiman C, Simard J, Goldberg MS, Labrèche F,
Dumont M, Soucy P, Teo S, Yip CH, Phuah SY, Cornes BK, Kristensen VN, Grenaker Alnæs G,
Børresen-Dale AL, Zheng W, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL,
Knight JA, Glendon G, Mulligan AM, Devillee P, Figueroa J, Chanock SJ, Lissowska J, Sherman
ME, Hall P, Schoof N, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Liu J, Cox
A, Brock IW, Reed MW, Cross SS, Blot W, Signorello LB, Pharoah PD, Dunning AM, Shah M,
Kang D, Noh DY, Park SK, Choi JY, Hartman M, Miao H, Lim WY, Tang A, Hamann U, Försti A,
Rüdiger T, Ulmer HU, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Sangrajrang S,
Gaborieau V, Brennan P, McKay J, Slager S, Toland AE, Vachon C, Yannoukakos D, Shen CY,
Yu JC, Huang CS, Hou MF, González-Neira A, Tessier DC, Vincent D, Bacot F, Luccarini C,
Dennis J, Michailidou K, Bolla MK, Wang J, Easton DF, García-Closas M, Dowsett M, Ashworth
A, Swerdlow AJ, Peto J, Dos Santos Silva I, Fletcher O. Genetic variation at CYP3A is associated
with age at menarche and breast cancer risk: a case-control study. Breast Cancer Res. 2014 May
26;16(3):R51. [Epub ahead of print] PMID: 24887515.
75
Leslie Bernstein, PhD
535. Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, Patel AV, Adami HO,
Weiderpass E, Giles GG, Singh PN, Alavanja M, Beane Freeman LE, Bernstein L, Buring JE,
Colditz GA, Fraser GE, Gapstur SM, Michael Gaziano J, Giovannucci E, Hofmann JN, Linet MS,
Neta G, Park Y, Purdue MP. Body size and multiple myeloma mortality: a pooled analysis of 20
prospective studies. Br J Haematol, 166(5), 667-676, 2014. doi: 10.1111/bjh.12935. PMC4134758.
536. Cash SW*, Beresford SAA, Vaughan TL, Heagerty L, Bernstein L, White E, Neuhouser ML.
Recent physical activity in relation to DNA damage and repair using the comet assay. J Phys Activ
Health, 11(4), 770-776, May, 2014. PMC3844056.
537. Feng Y, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W,
Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL,
Rodriguez-Gil JL, Palmer JR, Olopade OI, Huo D, Stram A, Park K, Rand K, Chanock SJ,
LeMarchand L, Kolonel LN, Conti D, Easton D, Henderson BE, Haiman CA. A comprehensive
examination of breast cancer risk loci in African American women. Hum Molec Genetics, 23(20),
5518-5526, 2014. doi: 10.1093/hmg/ddu252. PMC4168823.
538. Nuyujukian D, Voutsinas J, Bernstein L, Wang SS. Medication use and multiple myeloma risk in
Los Angeles County. Cancer Cause Control, 25(9), 1233-1237, 2014. Doi:10.1007/s10552-0140424-0. PMC: 4156901.
539. George SM, Alfano CM, Neuhouser ML, Smith AW, Baumgartner RN, Baumgartner KB,
Bernstein L, Ballard-Barbash R. Better postdiagnosis diet quality is associated with less cancerrelated fatigue in breast cancer survivors. J Cancer Surviv, 8(4), 680-687, 2014. PMID:25001403.
540. Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ,
Moore SC, Robien K, Rosenberg PS, Singh PN, Weiderpass E, Adami HO, Anton-Culver H,
Ballard-Barbash R, Buring JE, Freedman DM, Fraser GE, Freeman LB, Gapstur SM, Gaziano JM,
Giles GG, Håkansson N, Hoppin JA, Hu FB, Koenig K, Linet MS, Park Y, Patel AV, Purdue MP,
Schairer C, Sesso HD, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Hartge P. Class
III obesity (BMI of 40-59) and mortality in a pooled analysis of 20 prospective studies. PLoS Med
2014 July 8; 11(7): e1001673. doi: 10.1371/journal.pmed.1001673. eCollection 2014. PMCID:
PMC4087039.
541. Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch HA,
Casson AG, Freedman ND, Chow WH, Wu AH, Bernstein L, Nyren O, Pandeya N, Whiteman
DC, Vaughan TL. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: A
pooled analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON).
PLoS One. 2014 Jul 30;9(7):e103508. doi: 10.1371/journal.pone.0103508. eCollection 2014.
PMCID: PMD4116205.
542. Clague J Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos
GL, Du XL, Forman MR, Bernstein L. Menopausal hormone therapy and lung cancer-specific
mortality following diagnosis: The California Teachers Study. PLoS One, 2014 July 31; 9(7),
e103735. doi: 10.1371/journal.pone.0103735. eCollection 2014. PMCID: PMC4117568..
543. Hurley S, Goldberg D, Nelson D, Hertz A, Horn-Ross P, Bernstein L, Reynolds P. Light-at-night
and breast cancer risk among California Teachers. Epidemiology. 2014 Sep;25(5):697-706. doi:
10.1097/EDE.0000000000000137. PMCID: PMC4130422.
544. George SM, Bernstein L, Smith AW, Neuhouser ML, Baumgartner KB, Baumgartner RN,
Ballard-Barbash R. Central adiposity after breast cancer diagnosis is related to mortality in the
Health, Eating, Activity, and Lifestyle study. Breast Cancer Res Treat, 146(3):647-55, 2014. doi:
10.1007/s10549-014-3048-x. PMID:25056184.
76
Leslie Bernstein, PhD
545. Togawa K, Ma H, Sullivan-Halley J, Neuhouser M, Imayama I, Baumgartner KB, Smith AW,
Alfano C, McTiernan A, Ballard-Barbash R, Bernstein L. Risk factors for self-reported arm
lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res
2014 Aug 22;16(4):414. doi: 10.1186/213058-014-0414-x. PMCID: PMC4189147.
546. Linet MS, Vajdic CM, Morton LM, de Roos AJ, Skibola CV, Boffetta P, Cerhan JR, Flowers CR,
de Sanjose S, Monnereau A, Cocco P, Kelly JL, Smith AG, Weisenburger DD, Clarke CA, Blair A,
Bernstein L, Zheng T, Miligi L, Clavel J, Benavente Y, Chiu BCH. Medical history, family
history, lifestyle, and occupational risk factors for follicular lymphoma: The InterLymph
NHL Subtypes Project. J Natl Cancer Inst Monogr, 215 (48), 26–40, 2014. PMCID:
PMC4155461.
547. Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjose S,
Smedby KE, Chiu BCH, Zhang Y, Mbulaiteye S, Monnereau A, Turner JJ, Clavel J, Adami HO,
Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, Miligi L, Nanni O, Ramazzotti V,
Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y,
Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W,
Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL,
Habermann TM, Liebow M, Blair A, Cantor K, Zahm SH, Kane EV, Lightfoot T, Roman E, Smith
A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A,
Holford TR, Lan Q, ZhengT, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino
D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA,
Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN.
Etiologic heterogeneity among NHL subtypes: The InterLymph NHL Subtypes Project. J Natl
Cancer Inst, 2014 (48):16-40. PMCID: PMC4155467.
548. Cerhan JR, Kricker A, Paltiel O, Flowers C, Wang SS, Monnereau A, Blair A, Dal Maso L, Kane
EV, Nieters A, Foran J, Miligi L, Clavel J, Bernstein L, Rothman N, Slager SL, Sampson JN,
Morton LM, Skibola CF. History, lifestyle, family history, and occupational risk factors for diffuse
large B-cell lymphoma (DLBCL): The InterLymph NHL Subtypes Project. J Natl Cancer Inst.
2014 Aug 2014(48):15-25. PMCID: PMC4155465.
549. Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, Galipeau PC, Shaheen NJ, Hardie
LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley
DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL. Integrative post
genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal
adenocarcinoma. Carcinogenesis, 35(12), 2740-2747, 2014. pii:bgu207. [Epub ahead of print].
PMID: 25280564. PMCID:PMC4247522.
550. Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird
NC, Wu AH, Corley DA, Romero Y, Chanock S, Chow WH, Casson AG, Levine D, Zhang R, Ek
WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC. Obesity and risk of esophageal
adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst.
2014 Sept 30;106 (11). pii:dju252. doi: 10.1093/mnci/dju252. Print 2014 Nov. PMCID:PMC
4200028.
551. Bhatia G, Tandon A, Ambrosone CB, Bandera EV, Berndt SI, Bernstein L, Casey G, Deming
DL, Diver WR, Ingles SA, Isaacs W, John EM, Kittles RA, Larkin E, Millikan RC, Murphy A,
Neslund-Dudas C, Nyante S, Press MF, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Strom SS,
Witte JS, Yamamura Y, Zheng W, Ziegler RG, Henderson BE, Chanock SJ, Haiman CA, Reich D,
Price AL. Genome-wide scan of 29,141 African Americans finds no evidence of selection since
admixture. Am J Human Genet. 2014 Oct 2;95(4):437-444. doi: 10.1016/ajhg.2014.08.011.
[Epub ahead of print]. PMCID: PMC4185117.
77
Leslie Bernstein, PhD
552. Wu AH, Kurian AW, Kwan ML John EM, Lu Y, Keegan THM, Gomez SL, Cheng I, ShariffMarco S, Monroe KR, Caan BJ, Lee VS, Roh JM, Sullivan-Halley J, Tseng CC, Bernstein L,
Sposto R, Vigen C. Diabetes and other comorbidities in breast cancer survival by race/ethnicity:
The California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers
Prev, 24(2); 361–368, 2015. PMID: 25425578.
553. Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Giner FC, Peppelenbosch MP, Kovac M,
Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S,
Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Zietek B, Maroo N, Gay L,
Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I,
Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers
EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A,
Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley
DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH,
Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van
den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K,
Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA,
Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J. Polymorphisms near
TBX5 and GDF7 are associated with increased risk for Barrett's Esophagus. Gastroenterol, 148(2),
367-378, 2014. pii: S0016-5085(14)01334-1. doi: 10.1053/j.gastro. 2014.10.041. PMCID:
PMC4315134..
554. Kim JY, Winters JK, Kim J, Bernstein L, Raz D, Gomez SL. Birthplace and esophageal cancer
and incidence patterns among Asian-Americans. Dis of the Esophagus 2014. doi:
10.1111/dote.1230. PMID:25487184.
555. Lee E, Luo J, Su YC, Lewinger JP, Schumacher F, Van Den Berg D, Wu AH, Bernstein L, Ursin
G. Hormone metabolism pathway genes and mammographic density change after quitting estrogen
and progestin combined hormone therapy in the California Teachers Study. Breast Cancer Res.
16(6):477, 2014 doi:10.1186/s13058-014-0477-8. PMCID: PMC4318222.
556. Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin
S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, Nicholson WK, Park AB,
Petruzella S, Rebbeck TR, Setiawan VW, Signorello LB, Simon MS, Weiss NS, Wentzensen N,
Yang HP, Olson SH. Risk factors for endometrial cancer in black and white women: A pooled
analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes
Control, 26(2), 287-296, 2015. 2015 Doi: 10.1007/210552-014-0510-3. Epub 2014 Dec 23. PMID:
25534916.
557. Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E, Adami HO, Beresford
S, Bernstein L, Chen C, Cook LS, De Vivo I, Friedenreich C, Gapstur SM, Hill D, Horn-Ross PL,
Lacey JV, Levi F, Liang X, Lu L, Magliocco A, McCann SE, Hegri E, Olson SH, Palmer JR, Patel
AV, Petruzella S, Prescott J, Risch HA, Rosenberg L, Sherman ME, Spurdle AB, Webb PM, Wise
LA, Xiang Y-B,, Xu W, Yang HP, Yu H, Zeleniuch-Jacquotte A, Brinton LA. Intrauterine devices
and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer
Consortium. Int J Cancer, 136(5);E410-422, 2015. doi:10.1002/ijc.29229 [Epub ahead of print].
.PMCID:PMC4267918.
558. Truong L, Park HL, Chang SS, Ziogas A, Neuhausen SL, Wang SS, Bernstein L, Anton-Culver
H. Human nail clippings as a source of DNA for genetic studies. Open J Epidemiol. 5, 41-50,
2015. doi: 10.4236/ojepi.2015.51006. PMCID: PMC4499506.
78
Leslie Bernstein, PhD
559. Ostro B, Hu J, Goldberg D, Reynolds P, Hertz A, Bernstein L, Kleeman MJ. Associations of
mortality with long-term exposures to fine and ultrafine particles, species and sources: Results from
the California Teachers Study cohort. Environ Health Perspect, 123, 549-556, 2015.
http://dx.doi.org/10.1289/ehp.1408565. PMCID: PMC4455590.
560. Canchola AJ, Lacey JV Jr., Bernstein L, Horn-Ross PL. Dietary patterns and endometrial cancer
risk in the California Teachers Study cohort. Cancer Cause Control, 26(4), 627-634, 2015. PMCID:
PMC4396622.
561. Mavaddat N, Pharoah P, Michailidou K, Tyrer J, Brook M, Bolla M, Wang Q, Dennis J, Dunning
A, Shah M, Luben R, Brown J, Bojesen S, Nordestgaard B, Nielsen S, Flyger H, Czene K, Darabi
H, Eriksson M, Peto J, dos Santos Silva I, Dudbridge F, Johnson N, Schmidt M, Broeks A, Verhoef
S, Rutgers E, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Figueroa J, Chanock S, Brinton L,
Lissowska J, Couch F, Olson J, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, van Ongeval
C, van Limbergen E, Kristensen V, Alnæs G, Nord S, Børresen-Dale AL, Nevanlinna H, Muranen
T, Aittomä K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching P,
Haeberle L, Ekici A, Beckmann M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, TrenthamDietz A, Newcomb P, Titus-Ernstoff L, Egan K, Hunter D, Lindstrom S, Tamimi R, Kraft P,
Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Zamora MP,
Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova
N, Antonenkova N, Dö T, Anton-Culver H, Neuhausen S, Ziogas A, Bernstein L, Devilee P,
Tollenaar R, Seynaeve C, Van Asperen C, Cox A, Cross S, Reed M, Khusnutdinova E, Bermisheva
M, Prokofieva D, Takhirova Z, Meindl A, Schmutzler R, Sutter C, Yang R, Schürmann P, Bremer
M, Christiansen H, Park-Simon TW, Hillemanns P, Gué P, Truong T, Menegaux F, Sanchez M,
Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper J, Tsimiklis H, Apicella C, Southey M,
Brauch H, The GENICA Network, Brü T, Ko YD, Sigurdson A, Doody M, Hamann U, Torres D,
Ulmer HU, Fö A, Sawyer E, Tomlinson IP, Kerin M, Miller N, Andrulis I, Knight J, Glendon G,
Mulligan AM, Chenevix-Trench G, kConFab Investigators, Australian Ovarian Cancer Study
Group, Balleine R, Giles G, Milne R, McLean C, Lindblom A, Margolin S, Haiman C, Henderson
B, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning M, Hollestelle A, van den
Ouweland A, Koppert L, Carpenter J, ABCTB Investigators, Clarke C, Scott R, Mannermaa A,
Kataja V, Kosma VM, Hartikainen J, Brenner H, Arndt V, Stegmaier C, Dieffenbach A, Winqvist
R, Pylkä K, Jukkola-Vuorinen A, Grip M, Offitt K, Vijai J, Robson M, Rau-Murthy R, Dwek M,
Swann R, Perkins K, Goldberg M, Labrèche F, Dumont M, Eccles D, Tapper W, Rafiq S, John E,
Whittemore A, Slager S, Yannoukakos D, Toland A, Yao S, Zheng W, Halverson S, Gonzá A, Pita
G, Alonso MR, Álvarez N, Herrero D, Tessier D, Vincent D, Bacot F, Luccarini C, Baynes C,
Ahmed S, Maranian M, Healey C, Simard J, Hall P, Easton D, Garcia-Closas M. Prediction of
breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst, 107(5),
2015. pii: djv036. doi: 10.1093/jnci/djv036. Epub Print 2015 May. PMID:25855707
562. Lu Y, John EM, Sullivan-Halley J, Vigen C, Gomez SL, Kwan ML, Caan BJ, Lee VS, Roh JM,
Shariff-Marco S, Keegan THM, Kurian AW, Monroe KR, Cheng I, Sposto R, Wu AH, Bernstein
L. History of recreational physical activity and survival after breast cancer: The California Breast
Cancer Survivorship Consortium. Am J Epidemiol, 181(12), 944-955, 2015. pii: kwu466. PMCID
PMC4462332.
563. Hurley S, Goldberg D, Bernstein L, Reynolds P. Sleep duration and cancer risk in women.
Cancer Cause Control, 26(7), 1037-1045, 2015, PMCID: PMC4466005.
79
Leslie Bernstein, PhD
564. Ma H, Xu X, Ursin G, Simon M, Marchbanks PA, Malone K, Lu Y, McDonald J, Folger SG,
Weiss LK, Sullivan-Halley J, Deapen DM, Press M, Bernstein L. Reduced risk of breast cancer
associated with recreational physical activity varies by HER2 status. Cancer Med. 2015 Apr 27.
doi: 10.1002/cam4.465. [Epub ahead of print] PMID:25924995.
565. Gaudet MM, Kitahara CM, Newton CC, Bernstein L, Reynolds P, Weiderpass E, Kreimer AR,
Yang G, Adami HO, Alavanja MC, Beane Freeman LE, Boeing H, Buring J, Chaturvedi A, Chen
Y, D'Aloisio AA, Freedman M, Gao YT, Gaziano JM, Giles GG, Håkansson N, Huang WY, Lee
IM, Linet MS, MacInnis RJ, Park Y, Prizment A, Purdue MP, Riboli E, Robien K, Sandler DP,
Schairer C, Sesso HD, Ou Shu X, White E, Wolk A, Xiang YB, Zelenuich-Jacquotte A, Zheng W,
Patel AV, Hartge P, Berrington de González A, Gapstur SM. Anthropometry and head and neck
cancer: A pooled analysis of cohort data. Int J Epidemiol, 44(2), 673-681,.2015. doi:
10.1093/ije/dyv059. PMCID: PMC4481608..
566. Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, Fitzgerald RC, Bernstein L, Ye
W, Bird NC, Romero Y, Casson AG, Murray LJ, Corley DA, Shaheen NJ, Wu AH, Gammon MD,
Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-related SNPs and risk of
esophageal adenocarcinoma and Barrett’s esophagus: Post genome-wide association analysis in the
BEACON consortium. PLoS One. 2015 Jun 3;10(6):e0128617. doi: 0.1371/journal.pone.0128617.
eCollection 2015. PMCID: PMC4454432.
567. Clarke CA, Reynolds P, Oakley-Girvan I, Lee E, Lu Y, Yang J, Moy LM, Bernstein L, HornRoss PL. Indicators of microbial-rich environments and the development of papillary thyroid
cancer in the California Teachers Study. Cancer Epidemiol,. 2015 May 22. pii: S18777821(15)00096-X. doi: 10.1016/j.canep.2015.04.014. [Epub ahead of print PMID:26007306.
568. Shariff-Marco S, Yang J, John EM, Kurian AW, Cheng I, Leung R, Koo J, Monroe KR,
Henderson BE, Bernstein L, Lu Y, Kwan ML, Sposto R, Vigen C, Wu AH, Keegan THM, Gomez
SL. , Intersection of race/ethnicity and socioeconomic status in mortality after breast cancer. J
Community Health. 2015 June 16. doi:10.1007/s10900-015-0052-y. PMID:26072260.
569. Cheng I, Shariff-Marco S, Koo J, Monroe KR, Yang J, John EM, Kurian AW, Kwan ML,
Henderson BE, Bernstein L, Lu Y, Sposto R, Vigen C, Wu AH, Gomez SL, Keegan HM.
Conribution of the neighborhood environment and obesity to breast cancer survival: The California
Breast Cancer Survivorship Consortium. Cancer Epidemiol Biomarkers Prev. 2015 Jun 10. pii:
cebp.0055.2015. [Epub ahead of print] PMID: 26063477.
570. Chen F, He J, Zhang J, Chen GK, Thomas V, Ambrosone CB, Bandera EV; Berndt SI, Bernstein
L, Blot W, Cai Q, Carpten J, Casey G, Chanock SJ, Cheng I, Chu L, Deming SL, Driver RW,
Goodman P,. Hayes RB, Hennis AJ, Hsing AW, Hu JJ, Ingles SA, John EM, Kittles RA, Kolb S,
Leske CM, Millikan RC, Monroe KR, Murphy A, Nemesure B, Neslund-Dudas C, Nyante S,
Ostrander EA, Press MF, Rodriguez-Gil JL, Rybicki BA, Schumacher F, Stanford JL; Signorello
LB, Strom SS, Stevens V, Van Den Berg D, Wang Z, Witte JS, Wu SY, Yamamura Y, Zhang W,
Ziegler RG, Stram AH, Kolonel LN, Le Marchand L,Henderson BE, Haiman CA, Stram DO.
Methodological considerations in estimation of phenotype heritability using genome-wide SNP
data, Illustrated by an analysis of the heritability of height in a large sample of African ancestry
adults. PLoS One. 2015 Jun 30;10(6):e0131106. doi: 10.1371/journal.pone.0131106. eCollection
2015. PMCID: PMC4488332.
80
Leslie Bernstein, PhD
571. Drahos J, Xiao Q, Risch HA, Freedman ND, Abnet CC, Anderson LA, Bernstein L, Brown L,
Chow WH, Gammon MD, Kamangar F, Liao LM, Murray LJ, Ward MH, Ye W, Wu AH, Vaughan
TL, Whiteman DC, Cook MB. Age-specific risk factor profiles of adenocarcinomas of the
esophagus: A pooled analysis from the international BEACON consortium. Int J Cancer, 2015 Jul
14. doi: 10.1002/ijc.29688. [Epub ahead of print]. PMID: 26175109
572. Wang J, Mack TM, Hamilton AS, Hwang AE, Nathwani BN, Masood K, Buchanan LH,
Bernstein L, Deapen DM, Martinez-Maza O, Cozen W. Common immune-related
exposures/conditions and risk of Non-Hodgkin lymphoma: A case-control study of diseasediscordant twin pairs. Am J Epidemiol. 2015 Aug 12. pii: kwv053. [Epub ahead of print]
PMID:26271116.
573. Lee E, Stram D, Ek WE, Onstad LE, MacGregor S, Gharahkhani P, Ye W, Lagergren J, Shaheen
NJ, Murray LJ, Hardie LJ, Gammon MD, Chow WH, Risch HA, Corley DA, Levine D, Whiteman
DC, Bernstein L, Vaughan TL, Wu AH. Pleiotropic analysis of cancer risk loci on esophageal
adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 2015 Sep 12. pii: cebp.0596.2015.
[Epub ahead of print] PMID:26364162.
574. Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA,
Brinton L, Buring JE, Heather Eliassen A, Falk R, Gapstur SM, Giles GG, Goodman G, HoffmanBolton J, Horn-Ross PL, Inoue M, Kolonel LN, Krogh V, Lof M, Maas P, Miller AB, Neuhouser
ML, Park Y, Robien K, Rohan TE, Scarmo S, Schouten LJ, Sieri S, Stevens VL, Tsugane S,
Visvanathan K, Wilkens LR, Wolk A, Weiderpass E, Willett WC, Zeleniuch-Jacquotte A, Zhang
SM, Zhang X, Ziegler RG, Smith-Warner SA. Alcohol consumption and breast cancer risk by
estrogen receptor status: in a pooled analysis of 20 studies. Int J Epidemiol 2015 Aug 28. pii:
dyv156. [Epub ahead of print] PMID: 26320033.
Papers in press
1. Dowty JG, Lee E, Tavtigian S, McKean-Cowdin R, Henderson BE, Bernstein L, Ursin G, Hopper
2.
3.
4.
5.
JL. Estimating risks for variants of unknown significance according to their predicted
pathogenicity classes: application to BRCA1. Breast Cancer Res Treat.
Dai JY, de Dieu Tapsoba J, Buas MF, Onstad L, Levine JM, Risch HA, Chow WH, Liu G,
Bernstein L, Ye W, Lagergren J, Bird NC, Romero Y, Murray LJ, Corley DA, Shaheen NJ, Wu
AH, Gammon MD, Reid BJ, Hardie LJ, Whiteman DC, Vaughan TL. A newly identified
susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett’s
esophagus. Cancer Epidemiol Biomarkers Prev.
Wang SS, Deapen D, Voutsinas J, Lacey JV, Jr., Lu Y, Ma H, Clarke CA, Weisenburger D,
Forman S, Bernstein L. Breast implants and anaplastic large cell lymphomas among females in the
California Teachers Study cohort. Br J Haematol.
Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena J, Giles
G, Hartge P, Singh PN, Stolzenberg-Solomon RZ, Weiderpass Vainio E, Adami HO, Anderson KE,
Beane-Freeman LE, Buring JE, Fraser GE, Fuchs CS, Gapstur SM, Gaziano JM, Lacey JV Jr.,
Linet MS, Liu JJ, Park Y, Peters U, Purdue M, Robien K, Schairer C, Sesso HD, Visvanathan K,
White E, Wolk A, Woolpin BM, Zeleniuch-Jacquotte A, Jacobs EJ. Central adiposity, obesity
during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies.
Annals Oncol.
Ek WE, Lagergern K, Cook M, Wu AH, Abned CC, Levine D, Chow WH, Bernstein L, Risch HA,
81
Leslie Bernstein, PhD
Shaheen NJ, Bird NC, Corley DA, Hardie LJ, Fitzgerald RC, Gammon M, Roero Y, Liu G, Ye W,
Vaughan TL, MacGregor S, Whiteman DC, Westberg L, Lagergren J.Polymorphisms in genes in
the androgen pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma. Int J
Cancer.
6. Lagergren K, Ek WE, Levine D, Chow WH, Bernstein L, Casson AG, Risch HA, Shaheen NJ,
Bird NC, Reid BJ, Corley DA, Hardie LJ, Wu AH, Vaughan TL, MacGregor S, Whiteman D,
Westberg L, Nyrén O, Lagergren J. Polymorphisms in genes of relevance for oestrogen and
oxytocin pathways and risk of Barrett’s oesophagus and oesophageal adenocarcinoma.PLoS One.
Papers Submitted
1. Day FR, Ruth KS, Thompson DJ Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK,
Sulem P, Bulik-sullivan B, Eskos T, Johnson AD, Elks CE, Franceschini N, He C, Altmaier ES,
Brody JA, Franke LL, Hufman JE, Keller MM, McArdle PF, Nutile T, Porcu E, Robino AA, Rose
LM, Schick UM, Smith JA, Teumer A, Traglia MM, Vuckovic DD, Yao J, Zhao W, Albrecht E,
Amin N, Corre T, Hottenga JJ, Mangino M, Smith AV, Tanaka T, Abeasis G, Andrulis IL, AntonCulver H, Antoniou AC, Arndt V, Arnold AM, Barbieri CC, Bec,mann MW, Beeghly-Fadiel A,
Benitez J, Bernstein L, Bielinski SJ, Blomqvist C, Boerwinkle E, Bogdanova NV, BojesenSE,
Bollas MK, Borresen-Dale AL, Boutin T, Brauch H, Brenner H, Bruning T, Burwinkel B,
Campbell A, Campbell H, Chanock SJ, Chapman R, Chen YDI, Chenevix-Trench G, Collee M,
Couch FJ, Coviello AD, Cox A, Czene K, Darabi H DeVivo I, Demerath EW, Dennis J, Devilee P,
Dork T, dos-Santos-Silva I, Dunning AM, Eichers JD, Fasching PA, Faul JD, Figueroa J, Gandin
II, Garcia ME, Garcia-Closas M, Giles GG, Girotto GG, Godlberg MS, Gonzales-Neira A,
Goodarzi MO, Grove-Gaona ML, Gudbjartsson DF, Guenel P, Guo X, Haiman CA, Hall P,
Hamann U, Henderson BE, Hocking LJ, Hofman A, Homuth G, Hooning MJ, Hopper JL Hu BF,
Huang J, Humphrey K, Hunter DJ, Jakubowska A, Jones SE, Karasik D, Knight JA, Kolcic I,
Kooperberg C, Kosma VM, Kriebel J, Kristensen V, Lanbrechts D, Langenberg C, Li X, Lindstrom
S, Liu Y, Luan J, Lubinski J, Magi R, Mannermaa A, Manz J, Margolin S, Marten J, Martin NG,
Masciullo CM, Meindl A, Michailidou K, Mihailov E, Milani L, Milne RL, Muller-Nurasyid M,
Nalls MA, Neale BM, Nevanlinna H, Neven P, Newman AB, Nordestgaard BG, Olson JE,
Padmanabhan S, Peterlongo P, Peters U, Petersmann A, Peto J, Pharoah PDP, Pirastu NN, Pirie A,
Pistis G, Polasek O, Porteous D, Psaty BM, Pylkas K, Radice P, Raffel LJ, Rivadeneira F, Rudan I,
Rudolph A, Ruggiero D, Sala CCF, Sanna S, Sawyer EJ, Schlessinger D, Schmidt MK, Schmidt F,
Schmutzler RK, Schoemaker MJ, Scott RA, Simard J, Sorice R, Southey MC, Stampfer MJ, Stockl
D, Strauch K, Swerdlow A, Taylor KD, Thorsteinsdottir U, Toland AE, Tomlinson I, Truong T,
Surner ST, Vozzi DD, Wang Q, Wellons M, Willemsen G, Wilson JF, Winqvist R, Wolffenbuttel
BBHR, Wright AF, Yannoukakos D, Zemunik T, Zhao W, Zheng W, Zygmunt M, Bergmann S,
Boomsma D, Buring JE, Ferrucci L, Grant MW, Gudnason V, S[ector TD, van Duijna CM,
Alizadeh BZ, Ciullo M, Crisponi L, Easton DF, Gasparini PP, Gieger C, Harris TB, Hayward C,
Kardia SLR, Kraft P, McKnight B, Metspalu A, Morrison AC, Reiner AP, Ridker PM, Rotter JI,
Toniolo DD, Uitterlinden AG, Ulivi SS, Volzke H, Wareham NJ, Weir DR, Yerges-Armstrong
LM, Kconfab/AOCS Investigators, Generation Scotland, InterAct Consortium, Lifelines Cohort
Study, Price AL, Stefansson K, Visser JA, Ong KK, Chang-Claude J, Murabitos JM, Perry JRB,
Murray A. Large-scale genomic analyses link reproductive ageing to hypothalamic signaling,
breast cancer 1 susceptibility and BRCA1-mediated DNA double strand break repair.
82
Leslie Bernstein, PhD
2. Davis JN*, Kalan MJ, Lane CJ, Bernstein L, Guerra-Vargas L, Weigensberg MJ, Goran MI.
Gender differences in pubertal changes in sex hormones, adiposity and insulin secretion in
overweight Latino youth.
3. Smith AW, Irwin M, Dunn M, Alfano C, Neuhouser ML, George S, McTiernan A, Duggan L,
Bernstein L, McKean-Cowdin R, Baumgartner K, Baumgartner R, Ballard-Barbash R. Body
weight and survival in the HEAL breast cancer cohort.
4. Lacey JV, Chung NT, Clarke CA, Anton-Culver H, Ursin G, Chang ET, Ma H, Voutsinas J,
Deapen D, Neuhausen SL, Henderson KD, Dieli-Conwright C, Nelson D, Horn-Ross P, Reynolds
P, Ziogas A, Wang SS, Bernstein L. Declines in incidence of multiple chronic diseases associated
with menopausal hormone therapy among women in California, 1997-2007.
5. Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Palmer JR, Zheng W,
Hu JJ, Rebbeck TR, Ziegler R, Chen F, Nyante S, Bandera EV, Ingles SA, Press MF, Rosenberg L,
Deming S, Rodriguez-Gil JL, DeMichele A, Chanock S, Olopade OI, Huo D, Edlund CK, Wan P,
Sheng X, Pooler LC, Van Den Berg DJ, Le Marchand L, Kolonel LN, Henderson BE, Haiman CA.
Towards understanding genetic susceptibility for breast cancer in African American women: a
novel risk locus at 5q31
6. Rand KA, Conti DV, Haiman CA, Van Den Berg DJ, Birmann BM, De Roos AJ, Severson RK,
Edlund CK, Gebregziabher M, Mohrbacher A, Ailawadhi SK, Lieber M, Wang SS, Bernstein L,
Henderson BE, Rothman N, Chanock SJ, Morton LM, Kolonel LN, Colditz GA, Munshi N,
Anderson KC, Cozen W. Risk Loci in the 8q24 region and the risk of multiple myeloma.
7. Grigsby TJ, Marshall SF, Ziogas A, Bernstein L, Ma H, Anton-Culver H. Characteristics of
women hospitalized with a mental health problem. Findings from the California Teachers Study.
8. Dee A, McTiernan A, Bernstein L, Aiello E, Baumgartner RN, Baumgartner K, Ballard-Barbash
R, McKean-Cowdin R. Mammographic density and CYP17, CYP1B1, COMT, and MTHFR
polymorphisms in postmenopausal breast cancer patients.
9. Villasenor A, Hutter C, Carlson C, Ballard-Barbash R, Makar KW, Duggan C, Baumgartner K,
Baumgartner R, Bernstein L, Hollis B, McTiernan A, Neuhouser ML. Associations of five
candidate genes with serum concentrations of 25-hydroxyvitamin D and prognostic outcomes in
breast cancer survivors.
10. Stevens KN, Slager S, Eccles DM, Yannoukakos D, Fasching PA, Miron P, Carpenter J, ChangClaude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper
WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P,
Konstanta I, Kotoula V, Lakis S,. Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G,
Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP,
Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C,
Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE,. Ingle JN, Cafourek V, Olswold
C,, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Sicotte H, Prodduturi N,
Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma
VM, Fischer HP, The GENICA Network, Reed MWR, Cross SS, Deming-Halverson S, Shrubsole
M, Cai Q, Shu XO, Daly M, Weaver JE, Ross EA, Sharma P, Klemp J, Torres D, Rüdiger T,
Wölfing H, Ulmer HU, Försti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D. Heikkilä P,
Aittomäki K, Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A,
Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland
AE, Nevanlinna H, Vachon CM, Couch FJ. Genetic variation in 25 known breast cancer
susceptibility loci is associated with risk of triple negative breast cancer.
11. Prescott J, Setiawan VW, Wentzensen N, Schumacher F, Yu H, Delahanty R, Bernstein L,
83
Leslie Bernstein, PhD
Chanock S, Chen C, Cook LS, Friedenreich C, Garcia-Closas M, Haiman CA, Hartge P, Horn-Ross
P, Le Marchand L, Liang X, Lissowska J, Lu L, Magliocco AM, Olson SH, Risch HA, Shu XO,
Ursin G, Weiss NS, Yang HP, Kraft P, De Vivo I. Body mass index genetic risk score and
endometrial cancer risk.
12. Goodman D, Ziogas A, Chang J, Marshall S, Lacey JV, Reynolds P, Bernstein L, Anton-Culver H.
Total and red meat consumption and risk of postmenopausal breast cancer: the California Teachers
Study.
13. Dee A, Koprowski C, Bernstein L, McTiernan A, Neuhouser ML, Wu A, Baumgartner RN,
Baumgartner K, Ballard-Barbash R, McKean-Cowdin R. No association between alcohol, tobacco
and mammographic density among breast cancer survivors.
14. Park HL, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS,
Ma H, Clague J, Reynolds P, Lacey JV, Bernstein L, Anton-Culver H. Novel polymorphisms in
caspase-8 are associated with breast cancer risk in the California Teachers Study.
15. Lacey JV, Jr., Benbow JL, Park HL, Duffy C, Chung NT, Brankin AE, Angell-Mendez K, Ziogas
A, Deapen D, Anton-Culver H, Neuhausen SL, Bernstein L, Wang SS, Clarke CA. Novel
implementation of cloud computing and mobile technology for biobanking and data management in
the California Teachers Study cohort.
16. Rand KA, Song C, Dean E, Serie D, Curtin K, Hazelett D, Sheng X, Hu D, Huff CA, BernalMizrachi L, Tomasson MH Ailawadhi S, Singhal S, Pawlish K, Peters E, Bock CH, Stram A, Van
Den Berg DJ, Edlund CK, Conti CV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A,
Pregja S, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber M,
Goodman P, Hennis AJM, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy
AB, Nemesure B, Neslund-Dudas C, Pettaway C, Vij R, Rodriguez-Gil JL, Rybicki BA, Stanford
JL, Signorello LB, Nooka A, Strom SS, Witte JS, Xu J, Zheng SL, Wu SY, Yamamura Y,
Gebregziabher M, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ,
Ziegler RG, Nyante S, Bandera EV, Birmann BM, Ingles SA, Press MF, Zangari M, Martin T,
Tricot G, Kumar S, Wolf J, Deming SL, Severson RK, Rothman N, Brooks-Wilson AR, Rajkumar
V, Kolonel LN, Chanock SJ, Slager S, Janakiraman N, Tolebero H, Brown EE, DeRoos AJ,
Mohrbacher A, Colditz GA, Henderson BE, Giles GG, Spinelli JJ, Chiu B, Munshi N, Anderson
KC, Zonder J, Orlowski RZ, Lonial S, Camp N, Vachon C, Ziv E, Stram DO, Haiman CA, Cozen
W. Multiple myeloma susceptibility loci examined in African and European ancestry populations.
17. Kitahara, C, McCullough ML Franceschi S, Rinaldi S, Wolk A, Neta G, Adami HO, Anderson K,
Andreotti G, Beane Freeman LE, Bernstein L, Buring JE, Clavel-Chapelon F, De Roo LA, Gao
YT, Gaziano JM, Giles GG, Håkansson N, Horn-Ross PL, Kirsh VA, Linet MS, MacInnis RJ,
Orsini N, Park Y, Patel AV, Purdue MP, Riboli E, Robien K, Rohan T, Sandler DP, Schairer C,
Schneider A, Sesso HD, Shu XO, Singh PN, van den Brandt PA, Ward E, Weiderpass E, White E,
Xiang YB, Zeleniuch-Jacquotte A, Zheng W, Hartge P, Berringto de González. Anthropometric
factors and thyroid cancer risk by histological subtypes: pooled analysis of 22 prospective studies.
18. Zhong C, Cozen W, Voutsinas J, Lacey JV Jr., Luo J, Sullivan-Halley J, Bernstein L, Wang SS.
Evaluating the use of friend or family controls in epidemiologic case-control studies.
19. Brooks JD, John EM, Mellemkjær L, Lynch CF, Knight J, Malone KE, Reiner AS, Bernstein L,
Liang X, Shore RE, Stovall M, WECARE Study Collaborative Group, Bernstein JL. Body mass
index, weight change and risk of second primary breast cancer in the WECARE Study: Influence of
estrogen receptor status of the first breast cancer
84
Leslie Bernstein, PhD
20. Ma H, Clague J, Xu X, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park HL, Sullivan-Halley J,
Neuhausen S, Bernstein L.Recreational physical activity and its changes in adulthood with risk of
triple negative and luminal A-like invasive breast cancer in the California Teachers Study.
21. Vigen C, Kwan ML, John EM, Gomez SL, Keegan THM, Lu Y, Shariff-Marco S, Monroe KR,
Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Henderson BE, Bernstein L, Sposto R, Wu AH.
Validation of self-reported comorbidity status of breast cancer patients with medical records: The
California Breasst Cancer Survivorship consortium (CBCSC).
22. Hurley S, Hertz A, Layefsky M, Von Behren J, Deapen D, Bernstein L, Nelson DO, Reynolds P.
Tracing a path to the past: exploring the use of commercial credit reporting data to construct
residential histories for epidemiologic studies of environmental exposures
23. Wentzensen NA, Poole EM, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K,
Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, Chamosa S,
Clendenen TV, Dossus L, Fortner R, Gapstur SM, Gaudet MM, Gram IT, Hartge P, HoffmanBolton J, Idahl A, Jones M, Kaaks R, Kirsh V, Koh WP, Lacey JV, Lee IM, Lundin E, Merritt M,
Onland-Moret C, Peters U, Poynter JN, Rinaldi S, Robien K, Rohan T, Sandler DP, Schairer C,
Schouten LJ, Sjöholm LK, Sieri S, Swerdlow A, Tjonneland A, Trabert B, Trichopoulou A, van
den Brandt PA, Wilkens L, Wolk A, Yang HP, Zeleniuch-Jacquotte A, Tworoger SS. Ovarian
cancer risk factors by histologic subtype: An analysis from the Ovarian Cancer Cohort Consortium.
24. Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J,
Andersson M, Reiner A, Liang X, Woods M, Concannon P, Bernstein JL. Risk reduction in
contralateral breast cancer after systemic therapy: a report from the updated WECARE Study.
25. O’Reilly EJ, Wang M, Adami HO, Alonso A, Bernstein L, van den Brandt P, Buring J, Daugherty
S, Deapen D, Freedman DM, English D, Giles G, Hakansson N, Kurth T, Schairer C, English D,
Giles G, Hakansson N, Kurth T, Schairer C, Weiderpass E, Wolk A, Smith-Warner SA.
Prediagnostic anthropometry and risk of amyotrophic lateral sclerosis death
Collaborative Study Publications (Corporate Authorship)
1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal
contraceptives. Lancet, 347, 1713-1727, 1996.
2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal
contraceptives: further results. Contraception, 54, 1S-106S, 1996.
3. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement
therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with
breast cancer and 108411 women without breast cancer. Lancet, 350, 1047-1059, 1997.
4. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative
reanalysis of individual data from 52 epidemiological studies including 58209 women with breast
cancer and 101986 women without the disease. Lancet, 358, 1389-1399, 2001.
5. Marrett L, Theis B, Ashbury FD, and an Expert Panel. Workshop Report: Physical Activity and
Cancer Prevention. Chronic Diseases in Canada, 21, 143-149, 2001.
6. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer –
collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women
with breast cancer and 95067 women without the disease. Br J Cancer, 87,1234-1245, 2002.
7. Collaborative Group on Hormonal Factors in Breast Cancer. Breastfeeding and breast cancer.
Lancet, 360, 187-195, 2002.
85
Leslie Bernstein, PhD
8. Parikh-Patel A, Allen MA, Wright WE, and the California Teachers Study Steering Committee.
Validation of self-reported cancers in the California Teachers Study. Am J Epidemiol, 157, 539545, 2003.
9. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abortion:
collaborative reanalysis of data from 53 epidemiological studies, including 83000 women with
breast cancer from 16 countries. Lancet, 363,1007-1016, 2004.
10. Reynolds P, Hurley S, Goldberg D, and the California Teachers Study Steering Committee.
Accumulating evidence on passive and active smoking and breast cancer risk (letter). Int J Cancer,
119, 239, 2005.
11. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM,
Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, Olson SH,
Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le Marchand L, Kolonel LN,
Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton LA, Akbari MR;
Australian National Endometrial Cancer Study Group; Epidemiology of Endometrial Cancer
Consortium (E2C2), Goodman MT. The obesity-associated polymorphisms FTO rs9939609 and
MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One, 6(2),
e16756, 2011. doi: 10.1371/journal.pone.0016756. PMC 3035652.
12. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause and breast
cancer risk: individual participant meta-analysis, including 118,964 women with breast cancer from
117 epidemiological studies. Lancet Oncol, 13, 1141-51, 2012. doi: 10.1016/S14702045(12)70425-4. PMC3488186.
13. Lu Y, Ek WE, Whiteman D, Vaughan TL, Spurdle AB, Easton DF, Pharoah PD, Thompson DJ,
Dunning AM, Hayward NK, Chenevix-Trench G, Q-MEGA and AMFS Investigators, ANECSSEARCH, UKOPS-SEARCH, BEACON Consortium, MacGregor S. Most common ‘sporadic’
cancers have a significant germline genetic component. Hum Mol Genet, 23(22), 6112-6118, 2014.
doi: 10.1093/hmg/ddu312. Epub 2014 Jun 18. PMCID: PMC4271103.
Non-Peer-Reviewed Publications
1. Birren JE, Bernstein L. Health and aging in our society: perspectives on mortality. Transactions of
the Association of Life Insurance Medical Directors of America, 62, 135-152, 1978.
2. Azen S, Niland J, Bernstein L. Trends in the teaching of biostatistics in schools of medicine.
Proceedings of the Sisquentennial Meeting of the American Statistical Association, Washington DC,
1990.
3. Hammond GD, Nixon DW, Nachman JB, Murphy SB, Ho RCS, Smith MA, Reaman G, Bernstein
L, Krailo MD, Young JL. American Cancer Society Workshop on Adolescents and Young Adults
with Cancer: Clinical research implications. Cancer, 71, 2423, 1993.
4. Hammond GD, Haase GM, Krawiec V, Bleyer WA, Severson RK, Bernstein L, Krischer JP, Smith
MA, Brady AM, Menck H. American Cancer Society Workshop on Cancer in Children: Patterns of
care. Cancer, 71, 3202-3205, 1993.
5. Roy S, Wilkins J, Bernstein L, Solera NC, Ressler R, Neal J, Murillo MC. Cefotaxime revisited: I.
A cost-effective treatment for female upper genital tract infections. Proceedings of the 18th
International Congress of Chemotherapy. American Society for Microbiology, Washington DC, pp.
83-84, 1993.
86
Leslie Bernstein, PhD
6. Roy S, Wilkins J, Bernstein L, Solera NC, Ressler R, Neal J, Murillo MC. Cefotaxime revisited: II.
Susceptibility of pretreatment pathogens to various combination antibiotic therapies for treating
female upper genital tract infections. Proceedings of the 18th International Congress of
Chemotherapy. American Society for Microbiology, Washington DC, pp. 124-125, 1993.
7. Cozen W*, Bernstein L. Commentary on C S Palackdharry: "The epidemiology of non-Hodgkin's
lymphoma: why the increased incidence?" Oncology, 8, 77-78, 1994.
8. Bernstein L. La epidemiología del cán]cer de mama. Medico Interamericano, 16, 597-599, 1997.
9. Bernstein L. The epidemiology of breast cancer. Women and Cancer, 1 (1S), 7-13, 1998.
10. Brinton LA, Bernstein L, Colditz GA. Summary of the workshop: Workshop on Physical Activity
and Breast Cancer, November 13-14, 1997. Cancer, 83 (3 suppl), 595-599, 1998.
11. Mahue-Giangreco M*, Bernstein L. Epidemiology of Barrett’s esophagus. Problems in General
Surgery, 18, 4-11, 2001.
12. Bernstein L. Reducing cancer risk: The obesity and physical activity connection. Columbia-Weill
Cornell Cancer Centers Cancer Prevention Newsletter, October 2003, Issue #2. (consumer and
professional editions).
13. Canchola AJ, Stewart SL, Bernstein L, West DW, Ross RK, Deapen D, Pinder R, Reynolds P,
Wright W, Anton-Culver H, Peel D, Ziogas A, Horn-Ross PL. Cox regression using different time
scales. Proceedings of the Western Users of SAS Software Annual Meeting 2003 (on CD).
14. Bernstein L. Commentary “Incidence and Prognosis of Synchronous and Metachronous Bilateral
Breast Cancer.” [Hartman M, Czene K, Reilly M, et al. J Clin Oncol 25:4210-4216, 2007] Breast
Diseases: A Year Book Quarterly, 19, 273-274, 2008.
15. Bernstein L. Commentary: “Low-dose aspirin and breast cancer risk: results by tumour
characteristics from a randomised trial” [Zhang SM, Cook NR, Manson JE, et al. Br J Cancer
98:989-991, 2008] Breast Diseases: A Year Book Quarterly, 19, 319-320, 2008.
16. Bernstein L. Commentary: “Ethnic variations in mammographic density: A British multiethnic
longitudinal study.” [McCormack VA, Perry N, Vinnicombe SJ, et al. Am J Epidemiol 168:412421, 2008]. Breast Diseases: A Year Book Quarterly, 20, 46-48, 2009.
Letters to the Editor
1. Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Toxicity and carcinogenic potency. Risk
Analysis, 5, 263-264, 1985.
2. Bernstein L, Henderson BE. Sodium intake in groups at different risk of stomach cancer. J Cancer
Res Clin Oncol, 110, 184, 1985.
3. Depue R, Bernstein L, Ross RK, Henderson BE. Psychologic and behavioral factors in hyperemesis
gravidarum. Reply. Am J Obstet Gynecol, 159, 533, 1988.
4. Pike MC, Bernstein L. Oral contraceptives and breast cancer. Lancet, i, 615- 616, 1989.
5. Bernstein L, Deapen D, Ross RK. Mycosis fungoides. JAMA 261, 1882, 1989.
6. Pike MC, Bernstein L. Oral contraceptives and breast cancer. Lancet, ii, 158, 1989.
7. Pike MC, Bernstein L, Ross RK. Estrogen replacement therapy and breast cancer mortality.
Lancet, i, 297, 1990.
8. Pike MC, Bernstein L, Ross RK, Henderson BE. Estrogen replacement therapy and risk of breast
cancer. JAMA, 265, 1824, 1991.
9. Pike MC, Gerhardsson M, London S, Bernstein L. Combined analysis of breast cancer studies. J
Natl Cancer Inst, 83, 1505-7, 1991.
87
Leslie Bernstein, PhD
10. Pike MC, Bernstein L, Peters R. Re: "Dietary fat and postmenopausal breast cancer. J Natl Cancer
Inst, 84, 1666-1667, 1992.
11. Swift M, Daly MB, Bernstein L, Love SM. Breast cancer among radiologic technologists. JAMA,
276, 269, 1996.
12. Bernstein L, Ross RK. Re: Physical activity and breast cancer risk in a cohort of young women. J
Natl Cancer Inst, 90, 1907-1908, 1998.
13. Wickerham DL, Bryant J,. Runowicz CD, Costantino J, Bernstein L, Fisher B, Wolmark N.
Association of tamoxifen and uterine sarcoma. J Clin Oncol, 20, 2758-2760, 2002.
14. Press MF, Bernstein L, Flom K, Slamon D. Reply: Is fluorescence in situ hybridization really
superior to HercepTest? J Clin Oncol, 20, 4506-4509, 2002.
15. Geiger AM, Bernstein L. Re: Bradbury et al. Tamoxifen-Treated Breast Carcinoma Patients and
the Risk of Acute Myocardial Infarction and Newly-Diagnosed Angina. Cancer, 106, 480-481,
2005.
16. Langholz BM, Bernstein JL, Bernstein L, Olsen JH, Borresen-Dale AL, Rosenstein BS, Gatti RA,
the WECARE Study Collaborative Group, Concannon P. On the proposed association of the ATM
variants 5557G>A and IVS38-8T>C and bilateral breast cancer. Int J Cancer, 119, 724-725,
2006.
17. Zahm S, Morton L, Bernstein L, Wang S, Colt J, Severson R, Welch R, Hartge P. Re: Hair dye
use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin
lymphoma, Author Response. Carcinogenesis, 29, 1084-1085, 2008. PMC2741144.
18. Gail MH, Bernstein L, Costantino JP, Pee D, Ursin G. Re: Projecting individualized absolute
invasive breast cancer risk in African-American women. J Natl Cancer Inst, 100, 684, 2008.
19. DeLellis Henderson K, Bernstein L, Henderson B, Kolonel L, Pike M. Re: Determinants of age at
natural menopause: The Multiethnic Cohort. Am J Epidemiol, 68, 1091-1092, 2008.
20. Henderson KD, Bernstein L. Re: Incomplete pregnancy is not associated with breast cancer risk:
the California Teachers Study. Contraception, 79, 240-241, 2009. PMC2922012.
21. Press MF, Bernstein L, Sullivan-Halley J, Buyse M, Sauter G, Slamon DJ. Re: Simon R. Re: Does
topoisomerase II-alpha gene amplification provide useful information for treatment selection in
patients with breast carcinoma? J Clin Oncol, 29, 2941-2944, 2011. PMID: 21670460.
22. Lacson JCA, Bernstein L, Cortessis VK. Potential impact of age at first marijuana use on the
development of nonseminomatous testicular germ cell tumors. Cancer, 119, 1284-1285, 2013.
PMID: 23233189.
23. Hurley S, Nelson DO, Bernstein L, Reynolds P. Response to: Assessinng exposure to outdoor
lighting and health risks. Epidemiology 26(4), e51, 2015. doi: 10.1097/EDE.0000000000000306.
PMID:26039274.
Chapters
1. McCann J, Horn L, Litton G, Kaldor J, Magaw R, Bernstein L, Pike MC. Short-term tests for
carcinogens and mutagens: a data-base designed for comparative, quantitative analysis. In L
Goldberg (ed.), Structure Activity Correlation as a Predictive Tool in Toxicology. Fundamentals,
Methods and Applications. Hemisphere Press, Washington D. C., p 229-240, 1983.
88
Leslie Bernstein, PhD
2. Henderson BE, Ross RK, Bernstein L. Exogenous hormones and the risk of cancer. In M Kurihara,
K Aoki, R Miller, C Muir (eds.), Changing Cancer Patterns and Topics in Cancer Epidemiology - In
Memory of Professor Mitsuo Segi. fGann Monograph on Cancer Research 33, Tokyo, pp. 137-147,
1987.
3. Roy S, Bernstein L, Stanczyk FZ. Analysis of oral contraceptive risks. In B Runnebaum, T Rabe, L
Kiesel (eds.), Female Contraception. Springer Verlag, Berlin, pp. 21-55, 1988.
4. Bernstein L, Henderson BE. Hormone intake: Relationship to cancer risk. In V deVita, S Hellman,
and S Rosenberg (eds.), Cancer Prevention. J B Lippincott, Philadelphia, pp. 1-17, January 1990.
5. Bernstein SM, Bernstein L. Spinal deformity in the patient with cerebral palsy. In JD Hsu (ed.),
Spinal Disorders in the Child and Adolescent. Spine: State of the Art Reviews, Vol. 4, No. 1.
Hanley & Belfus, Philadelphia, pp 144-160, 1990.
6. Bernstein L, Pike MC, Krailo M, Henderson BE. Update of the Los Angeles Study of oral
contraceptives and breast cancer: 1981 and 1983. In R. Mann (ed.), Oral Contraceptives and Breast
Cancer, Parthenon Publishing Group, London, pp. 169-180, 1990.
7. Ross RK, Bernstein L, Henderson BE, Paganini-Hill A. Effects of cigarette smoking on
"hormone-related" diseases in a Southern California retirement community. In N Wald and J Baron
(eds.), Smoking and Hormone Related Disorders. Oxford University Press, London, pp. 32-54,
1990.
8. Ross RK, Bernstein L, Vessey MP, Henderson BE. Cigarette smoking and risk of uterine fibroids,
endometriosis and hyperemesis gravidarum. In N Wald and J Baron (eds.), Smoking and Hormone
Related Disorders. Oxford University Press, London, pp. 64-71, 1990.
9. Henderson BE, Bernstein L. Causes of breast cancer and high risk groups: The role of endogenous
and exogenous hormones in the etiology of breast cancer. In JR Harris, S Hellman, IC Henderson,
and DW Kinne (eds.), Breast Diseases. J B Lippincott, Philadelphia, pp. 126-136, 1990.
10. Ross RK, Bernstein L. Why can't we prove that ERT causes breast cancer? Methodologic and
biologic challenges. In R Mann (ed.), Hormone Replacement Therapy and Breast Cancer Risk,
Parthenon Publishing, London, pp. 241-251, 1992.
11. Pike MC, Bernstein L, Spicer DV. The relationship of exogenous hormones to breast cancer risk.
In JE Niederhuber (ed.), Current Therapy in Oncology. Mosby-Year Book, St Louis, pp. 292-303,
1993.
12. Henderson BE, Bernstein L, Ross RK. Hormones and the etiology of cancer. In JF Holland, E Frei,
RC Bast, DW Kinne, DL Morton, and RR Weichselbaum (eds.), Cancer Medicine, 3rd Edition,
Volume 1. Lei and Feibeger, Philadelphia, pp. 223-232, 1993.
13. Bernstein L, Reynolds P, Flannery TJ. Cancer in Italian migrants populations. The United States of
America. M Geddes, DM Parkin, M Khlat, D Balzi, E Buiatti (eds.), Cancer in Italian Migrant
Populations. IARC Scientific Publications, No. 123. Lyon, France, pp. 67-94, 1993.
14. Henderson BE, Bernstein L, Ross RK. Cancer prevention: hormones. In V.T. DeVita, S. Hellman,
SA Rosenberg (eds.), Cancer: Principles and Practice of Oncology, J B Lippincott, Philadelphia, pp.
474-480, 1993.
15. Ross RK, Bernstein L. Hormone replacement therapy, oral contraceptives and risk of breast cancer.
The Third World Congress of Gynecological Endocrinology Proceedings. Parthenon Publications,
London 1993.
16. Ross RK, Bernstein L. Influence of sex hormones on breast cancer risk and mortality. In R Lobo
(ed.), Treatment of the Post-menopausal Woman. Raven Press, New York, pp. 339-347, 1994.
17. Ursin G, Bernstein L, Pike MC. Breast cancer. In Cancer Surveys: Trends in Cancer Incidence and
Mortality, vol 19/20. Imperial Cancer Research Fund, London, pp. 241-264, 1994.
89
Leslie Bernstein, PhD
18. Bernstein L. The incidence of adenocarcinoma of the esophagus is currently increasing and
accounts for 50% of esophageal carcinomas in some series. In R. Guili, TNJ Tytgat, TR DeMeester,
JP Galmiche (eds.), The Esophageal Mucosa. Elsevier, Amsterdam, pp.1059-1065, 1994.
19. Bernstein L. What is the current status of investigations on the role of drugs and dietary changes in
the etiology of adenocarcinoma of the esophagus? In R. Guili, TNJ Tytgat, TR DeMeester, JP
Galmiche (eds.), The Esophageal Mucosa. Elsevier, Amsterdam, pp. 1065-1069. 1994.
20. Henderson BE, Bernstein L. Etiology and pathogenesis: endogenous and exogenous hormonal
factors. In JR Harris, ME Lippman, M Morrow, S Hellman (eds.), Diseases of the Breast. LippincottRaven, Philadelphia, pp. 185-200, 1995.
21. Bernstein L, Henderson BE. Exogenous hormones. In D Schottenfeld, J Fraumeni (eds.), Cancer
Epidemiology and Prevention. Second Edition. Oxford University Press, New York, pp. 462-488,
1996.
22. Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In D Schottenfeld, J Fraumeni
(eds.), Cancer Epidemiology and Prevention. Second Edition. Oxford University Press, New York,
pp. 1022-1039, 1996.
23. Henderson BE, Bernstein L, Ross RK. Hormones and the etiology of cancer. In JF Holland, E Frei,
RC Bast, DW Kufe, DL Morton, and RR Weichselbaum (eds.), Cancer Medicine, 4th Edition,
Volume 1. Lei and Feibeger, Philadelphia, pp. 277-292, 1996.
24. Bernstein L, Ross R, Henderson B. Cancer prevention: hormones. In V. DeVita, S Hellman, SA
Rosenberg (eds.), Cancer: Principles and Practices of Oncology. Fifth Edition. Lippincott-Raven,
Philadelphia, pp. 609-617, 1997.
25. Henderson B, Bernstein L, Ross R. Etiology of cancer: hormones. In V. DeVita, S Hellman, SA
Rosenberg (eds.), Cancer: Principles and Practices of Oncology. Fifth Edition. Lippincott-Raven,
Philadelphia, pp. 219-229, 1997.
26. Bernstein L, Wu A. Adenocarcinomas at the EGJ: What is the role of dietary intake in their
development? In R. Guili, Galmiche JP, Jamieson GG, Scarpignato C (eds.), The Esophagogastric
Junction. Elsevier, Amsterdam, pp. 1144-1151, 1998.
27. Bernstein L, Linet M, Smith MA, Olshan AF. Renal tumors. In LAG Ries, MA Smith, JG
Gurney, M Linet, T Tamra, JL Young, GR Bunin (eds). Cancer Incidence and Survival among
Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute,
SEER Program. NIH Publ No. 99-4649. Bethesda, MD, 1999.
28. Bernstein L, Smith MA, Liu L*, Deapen D, Friedman DL. Germ-cell, trophoblastic and other
gonadal tumors. In LAG Ries, MA Smith, JG Gurney, M Linet, T Tamra, JL Young, GR Bunin
(eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER
Program 1975-1995, National Cancer Institute, SEER Program. NIH Publ No. 99-4649. Bethesda,
MD, 1999.
29. Bernstein L, Gurney GJ. Carcinomas and other malignant epithelial neoplasms. In LAG Ries, MA
Smith, JG Gurney, M Linet, T Tamra, JL Young, GR Bunin (eds). Cancer Incidence and Survival
among Children and Adolescents: United States SEER Program 1975-1995, National Cancer
Institute, SEER Program. NIH Publ No.99-4649. Bethesda, MD, 1999.
30. Bernstein L. Barrett’s esophagus and adenocarcinoma: epidemiology. In MC Perry (ed),
American Society of Clinical Oncology Education Book. ASCO, Alexandria, VA, pp. 99-105, 1999.
90
Leslie Bernstein, PhD
31. Cozen W, Bernstein L, Deapen DM, Ross RK. Cancer incidence in Los Angeles County. In
Sommer H, Dear MJ (eds) Health Atlas of Southern California. Volume 3 of the Atlas of Southern
California. Southern California Studies Center, University of Southern California, Los Angeles, pp.
47-54, 1999.
32. Ross RK, Bernstein L. Influence of sex hormones on breast cancer risk and mortality. In R Lobo
(ed.), Treatment of the Post-menopausal Woman. Second Edition. Raven Press, New York, 1999,
pp. 487-495.
33. Ursin G, Spicer D, Bernstein L. Breast cancer epidemiology, treatment and prevention. In MB
Goldman, MC Hatch (eds.), Women and Health , Academic Press, San Diego, 2000, pp.871-883.
34. Henderson BE, Bernstein L, Ross RK. Hormones and the etiology of cancer. In RC Bast, DW
Kufe, RE Pollock, RR Weichselbaum, JF Holland, E Frei (eds.), Cancer Medicine, 5th Edition. B.
C. Decker Inc., Hamilton, Ontario, Canada, 2000, pp. 195-206.
35. Bernstein L, Cozen W. Non-Hodgkin’s lymphoma and multiple myeloma: epidemiology. In JR
Bertino (ed.), Encyclopedia of Cancer, 2nd Edition. Academic Press, San Diego, 2002, volume 3, pp
329-336.
36. Bernstein L. Epidemiology of breast carcinoma in situ. In M Silverstein (ed.), Ductal Carcinoma
In Situ of the Breast, 2nd edition, Lippincott, Williams and Wilkins, Philadelphia, 2002, pp 22-34.
37. Bernstein L. What are the epidemiologic similarities and differences between carcinomas arising in
Barrett’s mucosa and in the gastric cardia? In R. Guili, Siewert JR, Couturier D, Scarpignato C
(eds.), Barrett’s Esophagus:Columnar Lined Esophagus. Vol II. John Libbey Eurotext Ltd,
Montrouge, France, 2003, pp. 702-710.
38. Henderson BE, Bernstein L, Ross RK. Hormones and the etiology of cancer. In D Kufe, RE
Pollock, R Weichselbaum, R Bast, T Gansler, J Holland, E Frei (eds.), Cancer Medicine, 6th
Edition. B. C. Decker Inc., Hamilton, Ontario, Canada 2003.
39. Bernstein L. Endocrine risk factors. In M Morrow, VC Jordan (eds.), Managing Breast Cancer
Risk. B. C. Decker Inc., Hamilton, Ontario, Canada, 2003, pp. 43-56.
40. Bernstein L. Obesity, physical activity, and cancer risk. In MC Perry (ed), American Society of
Clinical Oncology Education Book. ASCO, Alexandria, VA, 2004, pp. 557-561.
41. Patel A, Bernstein L. Physical activity and cancer incidence: Breast cancer. In A McTiernan (ed.),
Cancer Prevention and Management Through Exercise and Weight Control. Taylor and Frances,
Boca Raton FL, 2006, pp. 49-74.
42. Carpenter C, Bernstein L. Obesity and cancer. In D Heber, VLW Go, GL Blackburn, J Milner
(eds.), Nutritional Oncology, Second Edition. Elsevier Press, San Diego, CA, 2006, pp. 184-197.
43. Bernstein L, Pearce CL, Ross RK, Henderson BE. Hormones and the etiology of cancer. In DW
Kufe, RC Bast, WN Hait, WK Hong, R Pollock, RR Weichselbaum, FJ Holland, E Frei (eds.),
Cancer Medicine, 7th Edition. B. C. Decker Inc., Hamilton, Ontario, Canada, 2006, pp. 259-269.
44. Bernstein L. Modifiable risk factors: Physical activity and cancer. In: American Association for
Cancer Research 99th Annual Meeting Education Book; 2008 Apr 12-16; San Diego, CA. AACR,
Philadelphia, 2008, pp. 225-232.
45. Henderson KD, Bernstein L. The etiology of cancer: physical activity and obesity. In V. DeVita,
Laurence TS, SA Rosenberg (eds.), Cancer: Principles and Practices of Oncology. Eighth Edition.
Lippincott-Raven, Philadelphia, 2008, pp. 239-245.
46. Henderson KD, Prescott J, Bernstein L. Physical Activity, anthropometric factors and breast
cancer risk. In Li C (ed.), Breast Cancer Epidemiology. Springer Science, Philadelphia, 2010, pp
137-152.
91
Leslie Bernstein, PhD
47. Bernstein L, Pearce CL, Cheng I, Henderson KD. Hormones and the etiology of cancer. In WK
Hong, RC Bast, WN Hait, DW Kufe, RE Pollock, RR Weichselbaum, JF Holland, E Frei (eds.),
Cancer Medicine, 8th Edition. People’s Medical Publishing House-USA, Shelton, CT, 2010, pp
237-247.
48. Bernstein L, Lu Y, Henderson KD. Physical activity and cancer. In N Berger (ed.), Energy
Balance and Cancer. Springer, Philadelphia, PA 2010, pp 201-218.
49. Henderson KD, Lu Y, Bernstein L. The etiology of cancer: obesity and physical activity. In V.
DeVita, TS Laurence, SA Rosenberg (eds.), Cancer: Principles and Practices of Oncology. Ninth
Edition. Lippincott-Williams & Wilkins, Philadelphia, PA 2011 pp 227-232.
50. Lacey JV Jr., Chung NT, Bernstein L. Breast cancer epidemiology. In M Goldman, R Troisi, K
M Rexrode (eds.), Women and Health. Second Edition. Elsevier, San Diego CA, 2013 pp 10991112.
51. Lu Y, Clague DeHart J, Bernstein L. The etiology of cancer: obesity and physical activity. In
V. DeVita, TS Laurence, SA Rosenberg (eds.), Cancer: Principles and Practices of Oncology.
Tenth Edition. Lippincott-Williams & Wilkins, Philadelphia, PA, 2015.
Book Reviews
1. Bernstein L. Book Review. Old People, New Lives: Community Creation in a Retirement
Residence. J Health and Human Resources Admin, 1, 168,270, 1977.
Books and Monographs
1. Henderson BE, Ross RK, Bernstein L. Exogenous hormones and cancer. University of Nagoya
Press, 1989.
2. Bernstein L, Ross RK. Cancer in Los Angeles County: A Portrait of Incidence and Mortality,
1972-1987. Los Angeles: University of Southern California, 1991.
3. Miller BA, Kolonel LN, Bernstein L, Young, Jr. JL, Swanson GM, West D, Key CR, Liff JM,
Glover CS, Alexander GA (eds). Racial/Ethnic Patterns of Cancer in the United States 1988-1992.
National Cancer Institute. NIH Pub. No. 96-4104. Bethesda, MD, 1996.
4. Liu L*, Deapen D, Bernstein L, Ross R. Cancer Incidence In Los Angeles County by
Race/Ethnicity, 1988-1993. Los Angeles County Cancer Surveillance Program, University of
Southern California, 1996.
5. Liu L*, Deapen D, Bernstein L, Ross R. Cancer Incidence In Los Angeles County by
Race/Ethnicity, 1988-1994. Los Angeles County Cancer Surveillance Program, University of
Southern California, 1997.
6. Deapen D, Berglund LC, Bernstein L, and Ross RK. Cancer in Los Angeles County: Cancer
Surveillance Program Bibliography Twenty-five Years 1972-1996. Los Angeles Cancer
Surveillance Program, University of Southern California, 1997.
7. Liu L*, Deapen D, Bernstein L, Ross R. Cancer Incidence and Mortality In Los Angeles County
by Race/Ethnicity, 1988-1995. Los Angeles County Cancer Surveillance Program, University of
Southern California, 1998.
92
Leslie Bernstein, PhD
8. Liu L, Deapen D, Bernstein L, Ross R. Cancer Incidence and Mortality In Los Angeles County
by Race/Ethnicity, 1988-1996. Los Angeles County Cancer Surveillance Program, University of
Southern California, 1999.
9. Liu L, Deapen D, Bernstein L, Ross R. Cancer In Los Angeles County: Incidence and Mortality
by Race/Ethnicity, 1988-1997. Los Angeles County Cancer Surveillance Program, University of
Southern California, 2000.
10. Liu L, Deapen D, Bernstein L, Ross R. Cancer In Los Angeles County: Incidence and Mortality
by Race/Ethnicity, 1988-1998. Los Angeles County Cancer Surveillance Program, University of
Southern California, 2001.
11. Liu L, Zhang J, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and
Mortality by Race/Ethnicity, 1988-1999. Los Angeles County Cancer Surveillance Program,
University of Southern California, 2002.
12. Liu L, Zhang J, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and
Mortality by Race/Ethnicity, 1988-2000. Los Angeles County Cancer Surveillance Program,
University of Southern California, 2003.
13. Liu L, Zhang J, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and
Mortality by Race/Ethnicity, 1988-2001. Los Angeles County Cancer Surveillance Program,
University of Southern California, 2004.
14. Liu L, Zhang J, Deapen D, Bernstein L, Ross RK. Cancer in Los Angeles County: Incidence and
Mortality by Race/Ethnicity, 1988-2002. Los Angeles County Cancer Surveillance Program,
University of Southern California, 2005.
15. Liu L, Zhang J, Deapen D, Bernstein L. Cancer in Los Angeles County: Incidence and Mortality
by Race/Ethnicity 1988-2003. Los Angeles County Cancer Surveillance Program, University of
Southern California, 2006.
Miscellany
1. Bernstein L. Implications of policy, legislation and regulation for long term care. A report of the
Task Force on Long Term Care. Health Systems Agency of Los Angeles County, 1977.
2. Cohen J, Fritz D, Coberly S, Fleischer D, Kobata F, Gozzi J, Bernstein L, Hudson E. Toward a
Designation Policy for Area Agencies on Aging. Andrus Gerontology Center Publication, University
of Southern California, 1978.
3. Bernstein L. Stroke rehabilitation, factors related to outcome. Masters Thesis. University of
Southern California, 1978.
4. Bernstein L. Carcinogenic and mutagenic potency: Statistical methods for analysis of Salmonella
test data and development of a potency index for animal bioassay results. PhD Dissertation.
University of Southern California, 1981.
5. Garabrant DH, Peters JM, Bernstein L, Smith T, Wright WE. U. S. Borax and Chemical
Corporation, Boron, California: Health Hazard Evaluation. Final Report. National Institute of
Occupational Safety and Health, 1983.
6. Kawamoto MM, Garabrant DH, Balmes JR, Fynboh R, Dimick JR, Sunonowitz JA, Held J,
Bernstein L. Respiratory effects of cotton dust exposure in the cotton garnetting industry. I.
Epidemiological study. Health Hazard Evaluation. California OSHA, 1987.
7. Bernstein L, Ross RK, Deapen D, Lynch C, Cerhan J, Schwartz S, Liff J. Tamoxifen therapy and
risk of endometrial cancer following breast cancer. Pharmacoepidemiol Drug Safety 6:S47, 1997.
93
Leslie Bernstein, PhD
8. Bernstein L, Cerhan J, Schwartz S, Liff J, Perlman J, Ford L. The combined effects of ERT, obesity
and tamoxifen therapy for breast cancer on endometrial cancer risk. Europ J Cancer 34:S46, 1998.
9. Bernstein JL, Concannon P, Langholz B, Thompson WD, Bernstein L, Stovall M, The WECARE
Study Collaborative Group, Thomas DC. Multi-center screening of mutations in the ATM gene
among women with breast cancer – The WECARE Study. Radiation Res 163, 698-699, 2005.
94
Leslie Bernstein, PhD
Invited Papers, Seminars, Lectures and Workshops
1. Bernstein L. Panel Chairman. "Appraisal of gerontological education, student issues."
Gerontological Society of America, Washington, D.C. 1979.
2. Bernstein L. "Cancer and Aging: Epidemiology." Andrus Gerontology Center Seminars in Aging.
University of Southern California 1979.
3. Bernstein L, Pike MC. "The analysis of Salmonella test dose-response data." Workshop on
Statistical Analysis of In Vitro Tests for Mutagenicity, National Institute of Environmental Health
and National Toxicology Program, 1981
4. Bernstein L. "Estimation of TD50, the dose to give 50% of animals tumors, from animal
carcinogenicity experiments." Western Regional Meeting of the Biometric Society. Session:
Quantitating mutagenesis and carcinogenesis assays as a basis for estimating risk to man. San Diego,
1982.
5. Peters JM, Garabrant DH, Wright WE, Bernstein L, Mack TM. "Uses of a cancer registry to assess
occupational cancer risks." Symposium on Epidemiology and Cancer Registries in the Pacific Basin.
Kona, Hawaii, 1984.
6. Preston-Martin S, Henderson BE, Bernstein L. "Medical and dental x-rays as risk factors for
recently diagnosed tumors of the head." Symposium on Epidemiology and Cancer Registries in the
Pacific Basin. Kona, Hawaii, 1984.
7. Mack TM, Berkl J, Bernstein L, Mack W. "Religion and cancer in Los Angeles County."
Symposium on Epidemiology and Cancer Registries in the Pacific Basin. Kona, Hawaii, 1984.
8. Mack TM, Walker A, Mack W, Bernstein L. "Cancer in Hispanics in Los Angeles County."
Symposium on Epidemiology and Cancer Registries in the Pacific Basin. Kona, Hawaii, 1984.
9. Peters R, Yu M, Bernstein L, Mack TM. "Job activity levels, diet and colon cancer in men under
age 45." Symposium on Epidemiology and Cancer Registries in the Pacific Basin. Kona, Hawaii,
1984.
10. Bernstein L, Ross RK, Henderson BE. "Hormone levels in women with breast cancer: Case-control
studies." Breast Cancer Workshop. Symposium on Epidemiology and Cancer Registries in the
Pacific Basin. Kauai, Hawaii, 1986.
11. Bernstein L. "An epidemiologic perspective: male sites and male/female dichotomy in cancer risk
related to obesity." Obesity and Cancer Workshop. Division of Cancer Etiology, National Cancer
Institute. Palo Alto, CA, April 1987.
12. Bernstein L. "Introduction to using computers for statistical analyses." Course for USC
Department of Nursing faculty conducted by the Educational Resource Division, Norris Medical
Library, USC School of Medicine. 1987.
13. Ross RK, Bernstein L, Henderson BE. "Cigarette smoking and risk of uterine fibroids,
endometriosis and hyperemesis gravidarum." Independent Scientific Committee on Smoking and
Health Symposium, "Smoking and Hormone-Related Disorders." London, 1988.
14. Ross RK, Bernstein L, Henderson BE, Paganini-Hill A. "Effects of cigarette smoking on
'hormone-related diseases in a Southern California retirement community." Independent Scientific
Committee on Smoking and Health Symposium, "Smoking and Hormone-Related Disorders."
London, 1988.
15. Bernstein L, Pike MC. "Update of the studies of oral contraceptives and breast cancer risk in young
women: 1981 and 1983." Meeting on Oral Contraceptives and Breast Cancer at the Royal Society of
Medicine. London, 1989.
95
Leslie Bernstein, PhD
16. Azen SA, Niland J, Bernstein L. Trends in the teaching of biostatistics in schools of medicine.
American Statistical Association. Washington DC, 1989.
17. Grimes DA, Bernstein L, Lacarra M, Shoupe D, Mishell DR. "Predictors of failed attempted
abortion with the antiprogestin RU 486". American Gynecological and Obstetrical Society, Hot
Springs, VA, 1989.
18. Bernstein L. "Serum hormone levels in premenopausal Chinese women in Shanghai and white
women in Los Angeles: Results from two breast cancer case-control studies." Symposium on
Epidemiology and Cancer Registries in the Pacific Basin, Kauai, HI, 1989.
19. Bernstein L. Rapporteur: Assessing the Risks. Chemical Risks in the 1990s: Effective action in
California. California State Health and Welfare Agency. Asilomar, CA, 1990.
20. Bernstein L. "Cancer risk of Italian migrants to Los Angeles County." Workshop on cancer in
Italian Migrant Populations. International Agency for Research on Cancer. Lyon, France, 1990.
21. Bernstein L. "Preventable cancers in minorities: a registry perspective." American Association of
Central Cancer Registries Annual Meeting. Atlanta GA, 1990.
22. Bernstein L. Oncology Grand Rounds. Interdisciplinary Conference. "Epithelial Ovarian Cancer:
Tumor Biology, Epidemiology and Treatment." USC/Norris Cancer Center, 1990.
23. Bernstein L. "Breast Cancer: Primary prevention - reducing adolescent ovulation." International
Union Against Cancer (UICC). International Cancer Congress. Hamburg, Germany, 1990.
24. Bernstein L. "Childhood cancer in Los Angeles County: A population-based assessment comparing
patients registered on cooperative group trials to non- registrants." Report to the American Cancer
Society Taskforce on Childhood Cancer. Atlanta, GA, 1990.
25. Bernstein L. Chairman. "Cancer clustering: investigation and community response." California
Cancer Registries' Conference: Community Cancer Concerns: The Registry Response. Sacramento,
CA, 1991.
26. Bernstein L. "Childhood cancer patterns in Los Angeles County: Opportunities for treatment."
American Cancer Society Workshop on Children and Cancer. Naples FL, 1991.
27. Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. "Stage and delay in
breast cancer diagnosis by race, socioeconomic status, age and year." North American Conference
on Cancer in Hispanics. Tuscon, 1991.
28. Bernstein L. "Ongoing and new epidemiologic studies of non-Hodgkin's lymphoma in Los
Angeles." National Cancer Institute Workshop on the Time Trends in Non-Hodgkin's Lymphoma:
Current Knowledge and Recommendations for Research. Bethesda, MD, 1991.
29. Bernstein L. "Methodologic issues of identifying race/ethnicity for Hispanics." American
Association of Central Cancer Registries Annual Meeting. Miama, FL, 1992.
30. Bernstein L. "Preventing breast cancer." Tumor Registrars Association of California Annual
Meeting. Sacramento, CA, 1992.
31. Bernstein L. "Current data on adolescents, young adults and cancer." Session Chair and presenter,
"Los Angeles County Cancer Surveillance Program." American Cancer Society Workshop on
Adolescents and Young Adults with Cancer. Atlanta, GA, 1992.
32. Bernstein L. "Alternative prevention strategies for breast cancer." Symposium: "A breast cancer
prevention trial: conduct, concerns and alternate strategies." American Society of Preventive
Oncology. Tucson, AZ, 1993.
33. Bernstein L. "The increasing incidence of adenocarcinoma of the esophagus." O.E.S.O. Fourth
World Congress on the Esophageal Mucosa. Paris, France, 1993.
96
Leslie Bernstein, PhD
34. Bernstein L. "Investigations on the role of drugs and dietary changes in the etiology of
adenocarcinoma of the esophagus." O.E.S.O. Fourth World Congress on the Esophageal Mucosa.
Paris, France, 1993.
35. Bernstein L. "Racial variations in 5-alpha-reductase activity." Epidemiology of Prostate Cancer:
An Endocrine Perspective. National Cancer Institute, Division of Cancer Etiology. Bethesda, MD,
1993.
36. Bernstein L. "Practical and novel approaches to breast cancer prevention." Prevention and Early
Detection of Cancer: Controversy & Progress. University of Wisconsin Comprehensive Cancer
Center 20th Anniversary Scientific Conference. Madison, WI, 1993.
37. Bernstein L. "Insights into the prevention of breast and prostate cancer." University of Nebraska
Medical Center. Omaha, NE, 1993.
38. Bernstein L. "Physical activity lowers breast cancer risk of young women." Gifu University
Medical School. Gifu, Japan, 1994.
39. Bernstein L. "Physical activity and primary prevention of breast cancer among young women."
Radiation Effects Research Foundation. Hiroshima, Japan, 1994.
40. Henderson BE, Ross RK, Bernstein L. "The prevention of hormone-induced cancers." Annual
Meeting of the American Association for Cancer Research. San Francisco, 1994.
41. Bernstein L. "Monitoring cancer epidemics: Do we sound the alarm?" Sixth Annual California
Cancer Registries Conference, Prospects for Cancer Prevention. San Diego, CA, 1994.
42. Bernstein L. "Exercise and breast cancer risk - possible mechanisms for the protective effect." USC
Cancer Center Grand Rounds. Los Angeles, 1994.
43. Bernstein L. "Reducing the risk of breast cancer with exercise." Seventh Annual Meeting of the
New England Association for Cancer Research. Providence, RI, 1995.
44. Bernstein L. "Tamoxifen treatment and endometrial cancer: A population-based approach to
assessing risk." 39th Group Meeting, National Surgical Adjuvant Breast and Bowel Project. San
Diego, CA, 1995.
45. Bernstein L. "Cancer among Asians in Southern California." North American Association of
Central Cancer Registries, Annual Conference. San Francisco, CA, 1995.
46. Bernstein L. "Utilizing birthplace to assess cancer risk among migrant populations." North
American Association of Central Cancer Registries, Annual Conference. San Francisco, CA, 1995.
47. Bernstein L. "Childhood cancer in Los Angeles." California Association of Regional Cancer
Registries, 7th Annual Conference. San Francisco, CA 1995.
48. Bernstein L. "Using biologically driven hypotheses to develop preventive strategies for breast
cancer." Society for Epidemiologic Research, 28th Annual Meeting, Snowbird, UT, 1995.
49. Bernstein L. "Prospects for breast cancer prevention." Legislative hearing: Breast Cancer: New
Treatments and Developments. State Capitol, Sacramento, CA, 1995.
50. Bernstein L. "Reducing the risk of breast cancer with exercise." California Association of Cancer
Registrars, Annual Meeting. Anaheim, CA 1995.
51. Bernstein L. "Breast cancer: why study exercise?" Department of Obstetrics and Gynecology
Grand Rounds. USC School of Medicine, 1995.
52. Bernstein L. "Epidemiology of Breast Cancer - Lifestyle and Reproduction: Can we modify risk?"
Breast Cancer and the Environment. American Cancer Society, San Francisco, CA 1995.
53. Bernstein L. "HER-2/neu amplification and risk of early recurrence, recurrence and death in women
with node-negative breast cancer." Genentech Seminar, South San Francisco, CA 1995.
54. Bernstein L. "The protective effect of physical activity on breast cancer." Symposium: New
Frontiers in Cancer Research, Los Angeles, 1996.
97
Leslie Bernstein, PhD
55. Bernstein L. "HCG and breast cancer." New Studies of Exogenous Hormones and Cancer. Sixth
Annual Cancer Surveillance Program Symposium, Los Angeles, 1996.
56. Bernstein L. "Exercise reduces breast cancer risk." Harvard School of Public Health, Public Health
Rounds, Boston, 1996.
57. Bernstein L. "Can exercise reduce breast cancer risk?" Fourth Annual Advocacy Training
Conference, National Breast Cancer Coalition, Arlington VA, 1996.
58. Bernstein L. "Breast cancer: where are we?." American Cancer Society, California Division, Annual
Directors Meeting. Los Angeles, CA 1996.
59. Bernstein L. "Adenocarcinomas at the EGJ: What is the role of dietary intake in their development?"
O.E.S.O. Fifth World Congress: The Esophagogastric Junction, Paris, France, 1996.
60. Bernstein L. "Methodologic challenges to understanding the epidemiology of Barrett's esophagus."
O.E.S.O. Fifth World Congress: The Esophagogastric Junction, Paris, France, 1996.
61. Bernstein L. “Risks and benefits of tamoxifen therapy.” USC Cancer Center Grand Rounds. Los
Angeles, 1996.
62. Bernstein L. “Physical activity and cancer.” 9th Annual California Association of Regional Cancer
Registries’ Conference. San Francisco, 1997.
63. Bernstein L. “Exercise and other non-traditional risk factors for breast cancer.” University of New
Mexico School of Medicine and Cancer Center. Albuquerque, 1997.
64. Bernstein L. “Tamoxifen and risk of endometrial cancer.” New Discoveries in Cancer Control.
Seventh Annual Cancer Surveillance Program Symposium, Los Angeles, 1997.
65. Bernstein L. “The combined effects of prior estrogen replacement therapy, obesity and tamoxifen
therapy for breast cancer on endometrial cancer risk” University of Tromsφ, School of Medicine,
Tromsφ, Norway, 1997.
66. Bernstein L. “Physical activity and cancer: state of the art.” University of Tromsφ, School of
Medicine, Tromsφ, Norway, 1997.
67. Bernstein L. “The status of peer review in epidemiology.” Presidential Address. 30th Annual
Meeting, Society for Epidemiologic Research. Edmonton, Alberta, Canada, 1997.
68. Bernstein L. “Tamoxifen therapy and risk of endometrial cancer following breast cancer.” National
Surgical Adjuvant Breast and Bowel Project, 41st Group Meeting. Los Angeles, CA, 1997.
69. Bernstein L. “Epidemiology of Barrett’s esophagus and adenocarcinoma.” Symposium: Barrett’s
Ablation Therapy. Brittany, France, 1997.
70. Bernstein L. “Breast cancer: Analyzing the evidence - data, trials and observational studies.”
Understanding Breast Cancer Science and Policy: A Workshop for the Media. New York, NY,
1997.
71. Bernstein L. “Hot issues in breast cancer for 1998: Physical activity and breast cancer.”
Understanding Breast Cancer Science and Policy: A Workshop for the Media. New York, NY,
1997.
72. Ursin G, London S, Stanczyk FZ, Gentzschein E, Bernstein L, Haile R, Pike MC. “Estrogen
metabolites in women with and without a family history of breast cancer.” Department of Defense,
Breast Cancer Research Program, Era of Hope Meeting, Washington DC, 1997.
73. Buckley J, VanTornout J, Bernstein L, Press M, Flom K. “Neural networks for breast cancer
prognosis.” Department of Defense, Breast Cancer Research Program, Era of Hope Meeting,
Washington DC, 1997.
74. Bernstein L. Member (presenting translational aspects of Etiology/Prevention research each day),
Translational Research Wrap-up Panel. Department of Defense, Breast Cancer Research Program,
Era of Hope Meeting, Washington DC, 1997.
98
Leslie Bernstein, PhD
75. Bernstein L. Chair, Workshop on Physical Activity and Breast Cancer. National Action Plan on
Breast Cancer. Albuquerque, 1997.
76. Bernstein L. “Endometrial cancer following treatment for breast cancer: the combined effects of
ERT, obesity and tamoxifen therapy.” Fox Chase Comprehensive Cancer Center. Philadelphia,
1997.
77. Bernstein L. “The risk of endometrial cancer following breast cancer: what are tamoxifen’s
effects?” Netherlands Cancer Center, Amsterdam, 1997.
78. Bernstein L. “The combined effects of ERT, obesity, and tamoxifen therapy for breast cancer on
endometrial cancer risk.” Tamoxifen and the Uterus: An international consensus meeting.
Brussels, 1997.
79. Bernstein L. “Breast Cancer: Understanding the evidence.” NBCCF Congressional Forum Series,
An Overview of Basic Breast Cancer Science and Policy. Capitol Hill, Washington DC, 1998.
80. Bernstein L. “The exercise connection: The role of physical activity in reducing the risk of breast
and other cancers.” Media Briefing: Nutrition, Exercise and Cancer Risk. American Cancer
Society, San Francisco Press Club, San Francisco, CA, 1998.
81. Bernstein L. “California Teachers Study.” 10th Annual Conference. California Association of
Regional Cancer Registries. San Diego, CA, 1998.
82. Bernstein L. “Non-Hodgkin’s lymphoma: Who’s at risk and why?” 8th Annual Cancer
Surveillance Program Educational Symposium, “25 Years of Research.” Los Angeles, CA 1998.
83. Bernstein L. “Does physical activity lower your risk of breast cancer?” 6th Annual Advocacy
Training Conference, “Vision, Reality, Challenge.” National Breast Cancer Coalition Fund.
Washington, D.C., 1998.
84. Bernstein L. “The Breast Cancer Prevention Trial: Risks and benefits of tamoxifen.” 6thAnnual
Advocacy Training Conference, “Vision, Reality, Challenge.” National Breast Cancer Coalition
Fund. Washington, D.C., 1998.
85. Bernstein L. “Exercise and breast cancer.” St. George Society, USC/Norris Comprehensive
Cancer Center. Los Angeles, CA 1998.
86. Bernstein L. “Non-traditional risk factors for breast cancer.” Epley Cancer Center Grand Rounds.
University of Nebraska School of Medicine, Omaha, NB 1998.
87. Bernstein L. “Colon and Rectal Cancer among Asian Americans and Pacific Islanders.” Cancer
Concerns for Asian Americans and Pacific Islanders. San Francisco, CA 1998.
88. Bernstein L. “Searching for Environmental Causes of Breast Cancer: Epidemiology of Breast
Cancer.” Tenth Conference of the International Society for Environmental Epidemiology. Boston,
MA 1998.
89. Bernstein L. “The Epidemiology of Breast Cancer: A Role for the Environment.” NBCCF
Congressional Forum. Capitol Hill, Washington DC, 1998.
90. Bernstein L. “Environmental Risk Factors for Breast Cancer.” California Breast Cancer Research
Program Symposium, New Frontiers in Breast Cancer, Los Angeles, CA, 1998.
91. Bernstein L. “Breast cancer: Analyzing the evidence - data, trials and observational studies.”
Understanding Breast Cancer: Science and Policy: A Workshop for the Media. Los Angeles, CA,
1998.
92. Bernstein L. “Breast cancer: Understanding risk analyses: relative vs. absolute risk.” Understanding
Breast Cancer: Science and Policy: A Workshop for the Media. Los Angeles, CA, 1998.
93. Bernstein L. “Hot issues in breast cancer for 1998: Physical activity and breast cancer.” Fundraising
Luncheon for the National Breast Cancer Coalition, Los Angeles, CA, 1998.
94. Bernstein L. “Breast cancer epidemiology: tradition vs. innovation.” Friends of the Norris Medical
Library. Los Angeles, CA, 1998.
99
Leslie Bernstein, PhD
95. Bernstein L. “Raloxifene vs. Tamoxifen: What do we really know?” 11th Annual California Cancer
Registries Conference. Costa Mesa, CA, 1999.
96. Bernstein L. “Global overview of environmental and lifestyle impacts on breast cancer.” Second
World Conference on Breast Cancer Advocacy – Influencing Change. Brussels, Belgium, 1999.
97. Bernstein L. “Discussant: Environmental chemicals and cancer.” Schilling Research Conference,
The Environment and Cancer. American Cancer Society. Santa Cruz, CA, 1999.
98. Bernstein L. “Exercise and Breast Cancer Risk – Understanding the evidence: Who benefits?” Bob
Rope Foundation Fifth Annual Breast Cancer Research Program Retreat, USC/Norris Comprehensive
Cancer Center. Newport Beach, CA, 1999.
99. Bernstein L. “ Tamoxifen vs. Raloxifene. What do we really know?” Bob Rope Foundation Fifth
Annual Breast Cancer Research Program Retreat, USC/Norris Comprehensive Cancer Center.
Newport Beach, CA, 1999.
100. Bernstein L. “Raloxifene and Tamoxifen.” New Perspectives on Old Problems. The Cancer
Surveillance Program 9th Annual CSP Educational Symposium, Los Angeles, CA, 1999.
101. Bernstein L. “Breast cancer epidemiology: can lifestyle modifications alter risk?” Karmanos
Cancer Institute Grand Rounds. Detroit, MI, 1999.
102. Bernstein L. “Barrett’s adenocarcinoma: Epidemiology.” 35th Annual Meeting, American Society
of Clinical Oncology (Educational Session). Atlanta, GA 1999.
103. Bernstein L. “Possible approaches to the prevention of breast cancer.” Setting Priorities:
Translating Women’s Health Research into Action. Los Angeles County Research Conference on
Women’s Health. Los Angeles, CA 1999.
104. Bernstein L. “Breast cancer epidemiology: tradition vs. innovation.” Roswell Park Comprehensive
Cancer Center Grand Rounds. Buffalo, NY, 1999.
105. Bernstein L. “Breast cancer epidemiology: tradition vs. innovation.” Plenary Speaker. Reasons
for Hope National Scientific Conference, Canadian Breast Cancer Research Initiative. Toronto,
Canada, 1999.
106. Bernstein L. “Exercise for the prevention of breast cancer.” USC/Norris Cancer Center Breast
Health Day. Los Angeles, CA 1999.
107. Bernstein L. “Breast cancer: Who is at risk?” Symposium 2000. National Council of Jewish
Women. Los Angeles, CA 2000.
108. Bernstein L. “Physical activity and the prevention of cancer.” Keynote address. American
Society for Preventive Oncology. Bethesda, MD 2000.
109. Bernstein L. “Physical activity and cancer.” Meet-the-Expert Sunrise Session. 91st Annual
Meeting of the American Association for Cancer Research, San Francisco, CA 2000.
110. Bernstein L. “Preventing breast cancer: What do we really know?” 8thAnnual Advocacy
Training Conference, “Breast Cancer Advocacy: The True Breakthrough.” National Breast
Cancer Coalition Fund. Washington, D.C., 2000.
111. Bernstein L. “Physical activity and the prevention of cancer.” Keynote address. 2000 San
Diego Epidemiology Research Exchange. San Diego, CA 2000.
112. Bernstein L “Exercise and cancer: a means to prevention.” Division of Nutrition and Physical
Activity and Division of Cancer Prevention and Control, Centers for Disease Control. Atlanta, GA
2000.
113. Bernstein L. “Eye-opener Controversy Session: Hormones in Breast Cancer.” Era of Hope,
Department of Defense Breast Cancer Research Program Meeting, Atlanta, GA 2000.
114. Bernstein L. Chair: Symposium – Hormones, Etiology, Prevention and Treatment of Breast
Cancer. Era of Hope, Department of Defense Breast Cancer Research Program Meeting, Atlanta,
GA 2000.
100
Leslie Bernstein, PhD
115. Press MF, Bernstein L. “Molecular epidemiology of breast carcinoma in situ.” Era of Hope,
Department of Defense Breast Cancer Research Program Meeting, Atlanta, GA 2000.
116. Bernstein L. “What Are the Epidemiologic Similarities and Differences between Carcinomas
Arising in Barrett’s Mucosa and in the Gastric Cardia?” O.E.S.O. Sixth World Congress: Barrett
2000: Transition to Telemedicine, Paris, France, 2000.
117. Bernstein L. Chair: Topic Forum – “What is Driving the Increasing Incidence of
Adenocarcinoma at the Gastric Cardia in Westernized Societies?” O.E.S.O. Sixth World Congress:
Barrett 2000: Transition to Telemedicine, Paris, France, 2000.
118. Bernstein L. Discussant: “Barrett’s Registries: What is the Advantage?” O.E.S.O. Sixth World
Congress: Barrett 2000: Transition to Telemedicine, Paris, France, 2000.
119. Bernstein L. “Ethnicity Related Variation in Breast Cancer Risk Factors.” Summit Meeting
Evaluating Research on Breast Cancer in African American Women. Washington DC, 2000.
120. Bernstein L. “Mid-life changes.” Joint meeting of Women in Management and the USC Faculty
Women’s Club. Los Angeles, CA, 2001.
121. Bernstein L. “Epidemiology of Barrett’s esophagus and its complications.” Medical and
Surgical Aspects of Esophagus and Foregut Disorders. Hawaii, 2001.
122. Bernstein L. “Exercise and Cancer.” Women and Cancer: Myths and Realities. Vancouver,
Canada, 2001.
123. Bernstein L. Chair, Symposium: The future of questionnaire-based research in physical activity:
Is the method up to the challenge? 25th Annual Meeting, American Society of Preventive
Oncology. New York, 2001.
124. Bernstein L. Panel member: Career Development for Junior Faculty/Researchers. 25th Annual
Meeting, American Society of Preventive Oncology, New York, 2001.
125. Bernstein L. “Cancer risks: A decade of progress. Lessons learned in the 1990s.” 13th Annual
California Cancer Registries Scientific Conference: Impacting the Natural History of Cancer:
From Etiology to Quality of Life. Berkeley, CA, 2001.
126. Bernstein L. “Nuts and bolts of epidemiology: Things they didn’t teach you in school.” .
Congress of Epidemiology. Toronto, Canada, 2001.
127. Bernstein L. “Adenocarcinoma of the esophagus: An epidemiologic perspective.” Second
International Chicago Symposium on Malignancies of the Chest and Head & Neck. Chicago, IL,
2001.
128. Bernstein L. “Physical activity and cancer survivorship: Issues and potential biases.” National
Cancer Institute Physical Activity and Cancer Survivorship Meeting. Washington DC, 2002.
129. Bernstein L. “The California Teachers Study.” 14th Annual California Cancer Registry
Conference. The Impact of Emerging Technology on Cancer Surveillance and Outcome. San
Diego, CA, 2002.
130. Bernstein L. “Why do teachers get so much breast cancer?” 12th Annual CSP Educational
Symposium: Cohort Studies in Cancer Registries: The CSP & Beyond. Los Angeles, CA 2002.
131. Bernstein L. “The epidemiology of breast cancer: a broad framework of study approaches.”
University of California, Riverside, 2002.
132. Bernstein L. “Epidemiology, molecular epidemiology and exposure assessment needs.” NIEHS
Brainstorming Session on Breast Cancer and the Environment. Charlotte, NC, 2002.
101
Leslie Bernstein, PhD
133. Bernstein L. “Are scientists asking the right questions about breast cancer?” National Breast
Cancer Coalition Annual Advocacy Training Conference. Washington DC, 2002.
134. Bernstein L. “Medical privacy: A dialogue with researchers.” National Breast Cancer Coalition
Annual Advocacy Training Conference. Washington DC, 2002.
135. Bernstein L. “How do lifestyle factors and ionizing radiation affect breast cancer risk?”
International Summit on Breast Cancer & the Environment: Research needs. Santa Cruz, CA,
2002.
136. Bernstein L. “Energy balance and intermediate biomarkers in breast cancer.” UICC
International Cancer Congress. Oslo, Norway, 2002.
137. Bernstein L. Discussant and panel member: “Methodologic aspects in studies on energy
balance and cancer risk.” University of Oslo School of Medicine. Oslo, Norway, 2002.
138. Bernstein L. “Cancer Prevention: Opportunities for Action.” Third Annual Advances in Cancer
Prevention Lecture. National Cancer Institute, Bethesda, MD, 2002.
139. Bernstein L. “Hormones, Lifestyle and Breast Cancer Risk: The Women’s CARE Study.” Bob
Rope Foundation Eighth Annual USC Breast Cancer Research Program Retreat. Lake Arrowhead,
CA, 2002.
140. Bernstein L. “Is Lifestyle a Viable Target for Breast Cancer Prevention?” Era of Hope.
Department of Defense Breast Cancer Research Program Meeting. Orlando, FL, 2002.
141. Bernstein L. “Recent Data Regarding Risk by Site.” First International Symposium on Cancer
Prevention. Lucie and Andre Chagnon Foundation. Montreal, Canada, 2002.
142. Bernstein L. “Implications of the California Teachers Study.” Glendora School Board
Community Forum. Glendora, CA 2003.
143. Bernstein L. “The California Teachers Study.” Marin County Breast Cancer Watch Community
Forum. San Rafael, CA, 2003.
144. Bernstein L. “Alcohol Intake, Lifestyle and Breast Cancer Risk.” Marin County Health
Department. San Rafael, CA, 2003.
145. Bernstein L. “Breast Cancer Risk in Relation to Pregnancy.” National Cancer Institute
Workshop on Early Reproductive Events and Breast Cancer Risk. Bethesda, MD, 2003.
146. Bernstein L. “Cancer Risk among California Teachers.” California Teachers Association Equity
and Human Rights Conference, San Francisco, CA, 2003.
147. Bernstein L. “Results of the Workshop on Early Reproductive Events and Breast Cancer Risk.”
Presentation to the Boards of Scientific Counselors and Scientific Advisors of the National Cancer
Institute. Bethesda, MD, 2003.
148. Bernstein L. “Lifestyle and Breast Cancer Risk: Opportunities for Intervention.” University of
North Carolina. Chapel Hill, NC, 2003.
149. Bernstein L. “Obesity, Physical Activity and Cancer: Opportunities for Intervention.” Annual
Meeting of the American Society for Preventive Oncology. Philadelphia, PA, 2003.
150. Bernstein L. “Breast Cancer Epidemiology: Insights and Innovation.” New Strategies in Breast
Cancer 2003. Phoenix, AZ, 2003.
151. Bernstein L. “Measurement issues in the collection of physical activity data.” Nutrition and
Chronic Disease Risk Workshop. Sponsored by NIH, Fred Hutchinson Cancer Research Center
and Harvard. Seattle, WA, 2003.
152. Bernstein L. Keynote: “Physical activity and cancer.” 25th Annual Scientific Congress of the
International Association of Cancer Registries, Honolulu, HI, 2003.
102
Leslie Bernstein, PhD
153. Bernstein L. Grand Rounds: “Early reproductive events and breast cancer risk: State of the
evidence on induced abortion – politics vs. science.” Norris Comprehensive Cancer Center, Los
Angeles, CA 2003.
154. Bernstein L. “Breast cancer: Defining opportunities for intervention.” Environmental and
Occupational Health Sciences Institute, Rutgers University, Cancer Institute of New Jersey and
UMDNJ-Robert Wood Johnson Medical School, 2003.
155. Bernstein L. “Physical activity and cancer.” Also Chair and Organizer, Plenary Session: Diet,
Obesity, and Physical Activity: Strength of the Science Underlying These Modifiable Causes of
Cancer. Second Annual International Conference on Frontiers in Cancer Prevention Research.
American Association for Cancer Research, Phoenix, AZ, 2003.
156. Bernstein L. “Induced abortion and breast cancer: Politics vs. science.” Department of
Obstetrics and Gynecology/Women’s and Children’s Hospital, Grand Rounds. Los Angeles, CA
2003.
157. Bernstein L. “The California Teachers Study Update: Who is at risk of breast cancer?” Equity
and Human Rights Conference, California Teachers Association. Anaheim, CA 2004.
158. Bernstein L. “Commentary: Energy Balance and Cancer.” 16th Annual California Cancer
Registry Conference: Surveillance, the Key to Cancer Control. Newport Beach, CA, 2004.
159. Bernstein L. “Effects of exercise and dietary factors - the impact of energy balance.” The Lynne
Cohen Foundation Symposium on the Emerging Role of Screening and Prevention in Women’s
Cancers. NYU Medical Center, New York, NY, 2004.
160. Bernstein L. “State of the Art: Exercise and Cancer Prevention.” Translational Cancer
Prevention Workshop, Haifa, Israel, 2004.
161. Bernstein L. “Physical Activity and Cancer.” CHS International Educational Conference on
Cancer Prevention, Dead Sea, Israel, 2004.
162. Bernstein L. “The Hormonal Basis for Breast Cancer: Tips for Teens.” Childrens Hospital of
Los Angeles, 2004.
163. Bernstein L. “Obesity, Physical Activity and Cancer.” 40th Annual Meeting of the American
Society of Clinical Oncology. Educational Session. New Orleans, 2004.
164. Bernstein L. “Obesity, Physical Activity and Breast Cancer Risk.” International Research
Conference on Food, Nutrition and Cancer. American Institute for Cancer Research. Washington,
DC, 2004.
165. Bernstein L. “Cancer Incidence in a Diverse Population: Etiologic Insights and Opportunities
for Prevention.” Disparities in Health in America: Working toward Social Justice. University of
Texas MD Anderson Cancer Center, Houston, TX, 2004.
166. Bernstein L. “’Do-it-yourself’ approaches to reducing breast cancer risk.” University of
California, San Francisco, Cancer Center Grand Rounds. San Francisco, 2004.
167. Bernstein L. “Physical activity and cancer prevention: Are we ready?” Harvard Center for
Cancer Prevention, Prevention Dialogues, Harvard School of Public Health. Boston, MA, 2005.
168. Bernstein L. “Radiation and chemotherapy: Do they increase the risk MI and stroke following
breast cancer?” Southern California Environmental Health Sciences Center Seminar. Los Angeles,
CA, 2005.
169. Bernstein L. “The California Teachers Study: the first five years of follow-up.” Epidemiology
and Genetics Research Program Visiting Scholar. National Cancer Institute. Bethesda, MD, 2005.
103
Leslie Bernstein, PhD
170. Bernstein L. “The risk of urogenital and breast cancer in users of estrogen.” Basic & Clinical
Pharmacology & Toxicology Symposium on Current Controversies in Pharmacoepidemiology.
Kolding, Denmark, 2005.
171. Bernstein L. “The California Teachers Study: formation and progress.” Breakthrough Breast
Cancer Meeting. London, England, 2005.
172. Bernstein L. “What is breast cancer? An epidemiologist’s perspective.” Department of Defense
Breast Cancer Research Era of Hope Meeting. Philadelphia PA, 2005.
173. Bernstein L. “Non-participation in epidemiologic studies: The threat we cannot ignore –
Community-based designs and experiences.” Joint Meeting of the Society for Epidemiologic
Research and the Canadian Society for Epidemiology and Biostatistics, Toronto, Canada, 2005.
174. Bernstein L. “Breast cancer epidemiology: A bridge to the critical questions.” AACR Special
Conference in Cancer Research: Advances in Breast Cancer Research: Genetics, Biology and
Clinical Applications. La Jolla, CA 2005.
175. Bernstein L. “Breast cancer prevention: Two steps forward, one step back.” Cutter Lecture,
Harvard University School of Public Health, Boston, MA 2005.
176. Bernstein L. “Lifestyle approaches to breast cancer risk reduction: Insights and opportunities.”
Plenary lecture. 28th Annual San Antonio Breast Cancer Symposium. San Antonio, TX 2005.
177. Bernstein L. “Does physical activity influence cancer outcomes?” AACR Special Conference in
Cancer Research: New Developments in the Epidemiology of Cancer Prognosis: Traditional and
molecular predictors of treatment response and survival. Charleston, SC, 2006.
178. Bernstein L. “Obesity, physical activity and cancer risk.” Distinguished Speaker Seminar. USC
Center for Transdisciplinary Research on Energetics and Cancer. Los Angeles, CA 2006.
179. Bernstein L. “Breast Cancer Risk Reduction: Insights and Opportunities.” Plenary Lecture.
Breast Cancer: From Gene to Cure. Amsterdam, the Netherlands, 2006.
180. Bernstein L. “The California Teachers Study: New approaches to old questions.” Boards of
Overseers and Directors, Breakthrough Breast Cancer Trust, London, England 2006.
181. Bernstein L. “Perspectives on the Etiology and Prevention of Breast Cancer.” Multidisciplinary
Research Colloquium in Aging, Andrus Gerontology Center, USC, Los Angeles, 2006.
182. Bernstein L. “Focus on the Host: Diet and Exercise.” Current Trends in Breast Cancer.
Updates from the 2005 San Antonio Breast Cancer Symposium. Grenwich, CT, 2006.
183. Bernstein L. “Obesity, Physical Inactivity and Cancer Risk: Etiologic Insights.” Keystone
Meeting; Molecular Targets in cancer Prevention. Tahoe City, CA 2006.
184. Bernstein L. “Impact of Health Behaviors on Breast Cancer Risk.” Cancer Genetics 2006:
Bridging Science and Practice. Fox Chase Cancer Center, Philadelphia, PA 2006.
185. Bernstein L. “Obesity and Cancer Risk: Etiologic Insights.” Environmental Health Sciences
Center, University of North Carolina, Chapel Hill, NC, 2006.
186. Bernstein L. “Prospects for the Prevention of Breast Cancer.” The Meadow Brook Lecture.
Southeast Michigan Center for Medical Education. Detroit, MI, 2006.
187. Bernstein L. “Reducing Breast Cancer Risk: Insights and Opportunities.” Grand Rounds.
Karmanos Cancer Institute, Detroit, MI, 2006.
188. Bernstein L. “Insights and Innovation: Results from the California Teachers Study.” The 16th
Annual CSP Educational Symposium, “Celebrating a Scientist: Ronald K. Ross, MD,” Los
Angeles, CA, 2006.
189. Bernstein L. “Pursuing lifestyle modification to lower cancer risk: the case of exercise activity.”
Epidemiology and Public Health Sciences Seminar Series. Wake Forest University, WinstonSalem, NC, 2006.
104
Leslie Bernstein, PhD
190. Bernstein L. “Physical activity and cancer: State of the evidence.” President’s Cancer Panel.
Minneapolis, MN, 2006.
191. Bernstein L. “Lifestyle approaches to breast cancer risk reduction: insights and opportunities –
The Breakthrough Generations Lecture.” The National Cancer Research Institute Cancer
Conference. Birmingham, England, 2006.
192. Bernstein L. “The science and politics of abortion and breast cancer.” Slone Memorial Lecture.
Slone Epidemiology Center at Boston University. Boston, MA, 2006.
193. Bernstein L. “Physical Activity and Cancer: Progress and "Opportunities."” AACR Frontiers in
Cancer Prevention Research. Boston, MA 2006.
194. Bernstein L. “Adopting an active lifestyle: Why exercise may lower women’s risk of breast
cancer.” Zero Breast Cancer Forum, Marin County, CA 2007.
195. Bernstein L. “The California Teachers Study: Design, insights and opportunities.” City of Hope
Comprehensive Cancer Center, Duarte, CA 2007.
196. Bernstein L. “Epidemiology and current standards in breast cancer prevention.” 7th Annual New
Strategies in Breast Cancer, Philadelphia, PA 2007.
197. Bernstein L. “Building teams and developing others.” Second WICR Leadership Development
Workshop, “Strategies for Success,” American Association for Cancer Research Annaul Meeting,
Los Angeles, CA 2007.
198. Bernstein L. “Making serendipity happen.” AFLAC Annual Dinner. American Association for
Cancer Research Annaul Meeting, Los Angeles, CA 2007.
199. Bernstein L. “Breast Cancer News: What’s Behind the Headlines?” National Breast Cancer
Coalition Annual Advocacy Conference, Washington DC, 2007.
200. Bernstein L “Reducing breast cancer risk: Insights and opportunities.” USC/Norris Auxiliary
Annual Award Luncheon, Los Angeles, CA 2007.
201. Bernstein L. “Breast cancer: Can Physical Activity and Nutrition Reduce Your Risk?" Los
Angeles YMCA Community Lecture, Los Angeles, CA 2007.
202. Bernstein L. “Breast Cancer Prevention: Learning from the Past, Mentoring the Future.” AACR
Frontiers in Cancer Prevention Research AACR-Prevent Cancer Foundation Award Lecture,
Philadelphia, PA, 2007.
203. Bernstein L. “Physical activity and breast cancer: Evolution of a hypothesis.” 30th Annual San
Antonio Breast Cancer Symposium Brinker Award Lecture, San Antonio, TX, 2007.
204. Bernstein L. “Reducing risk of breast cancer: Evolution of a hypothesis.” Presentation to the
Board of Trustees, City of Hope, Duarte, 2008.
205. Bernstein L. “Exercise and cancer risk: Tipping the energy balance.” Cancer Center Grand
Rounds, City of Hope, Duarte, 2008.
206. Bernstein L. “Exercise and cancer risk: Tipping the energy balance.” AACR–TREC–NCI
Conference on Energy Balance and Cancer: Mediators and Mechanisms, Lansdowne, VA, 2008.
207. Bernstein L. “Physical Activity.” In Modifiable Risk Factors for Cancer (chair/organizer of
educational session and speaker). American Association for Cancer Research Annual Meeting,
San Diego, CA. 2008.
208. Bernstein L. “Physical activity present and future: Reducing breast cancer risk and mortality.”
Era of Hope, Department of Defense Breast Cancer Research Program Meeting, Baltimore, MD,
2008.
209. Bernstein L. Judith P. Schlager Lecture: “Changing Breast Cancer Risk: A Population
Approach.” Breast Cancer: Current Controversies and New Horizons, Harvard Medical School,
Boston, MA, 2008.
105
Leslie Bernstein, PhD
210. Bernstein, L. “Making Serendipity Happen.” Breakthrough Breast Cancer Meeting, Oxford
University (St. Catherine College), Oxford, UK, 2008.
211. Bernstein L. “Breast Cancer: What Is Known? What Is Myth? What Can You Do to Reduce Your
Risk?” 8th Annual Women’s Health Conference, Pasadena, CA, 2008.
212. Bernstein L. “Can We Lower Breast Cancer Risk? Moving Biology + Intuition into Populationbased Approaches.” Grand Rounds, Breast and Prevention Research Programs, Washington
University, St. Louis, MO, 2008.
213. Bernstein L. “The California Teachers Study: Design, Insights, and Opportunities.” Delta Kappa
Gamma Professional Educators Sorority, Southern California Chapter, Gardena, CA 2008.
214. Bernstein L. “Restoring fitness after breast cancer.” Twelfth Annual Cincinnati Breast Cancer
Conference, “Reclaiming Control: Life after Breast Cancer.” Cincinnati, OH, 2008.
215. Bernstein L. “Obtaining tumor blocks for breast cancer cases” In “Advances and Challenges in
Multiple Cohorts,” 2008 Annual Meeting of the NCI Cohort Consortium, Bethesda, MD 2008.
216. Bernstein L. “Changing Breast Cancer Risk: Novel Population Approaches.” Grand Rounds,
School of Public Health, University of Michigan, Ann Arbor, MI, 2008.
217. Bernstein L. “Changing Lifestyle to Reduce Breast Cancer Risk: The Epidemiologic Evidence.”
Ninth Annual New Strategies in Breast Cancer Conference. Philadelphia, PA, 2009.
218. Bernstein L. “So What’s New in Breast Cancer.” Annual Advocacy Training Conference.
National Breast Cancer Coalition. Washington, DC, 2009.
219. Bernstein L. “Epidemiology of Breast Cancer: Moving Knowledge into Action.” The 2009
Breast Cancer Symposium. Mercy Hospitals of Bakersfield. Bakersfield, CA 2009.
220. Bernstein L. “Changing Lifestyle to Reduce Breast Cancer Risk and Improve Prognosis:
The Epidemiologic Evidence.” Grand Rounds, Memorial Sloan Kettering Comprehensive Cancer
Center, New York, NY 2009.
221. Bernstein L. “Identification of Risk Factors: Exercise and Breast Cancer, Positive Correlation.”
4th Annual Breast and GYN Cancers Course: Advancing Prevention, Diagnosis and Treatment.
Duarte, CA, 2009.
222. Bernstein L. “Physical Activity, Diet and Weight: Influences on Breast Cancer Incidence and
Outcomes .” Wellness Series, Breast Cancer Care & Research Fund, El Segundo, CA, 2009.
223. Bernstein L. “The California Teachers Study: Design, Opportunities, Results.” Annual Meeting
of the North American Association of Central Cancer Registries. San Diego, CA, 2009.
224. Bernstein L. “Identifying Population-Based Approaches to Breast Cancer Risk and Prognosis.”
Origins of Cancer Symposium. Van Andel Institute. Grand Rapids, MI, 2009.
225. Bernstein L. “Health Risks for Breast Cancer: Putting Prevention into Perspective.” Aspen
Cancer Conference Public Lecture. Aspen, CO, 2009.
226. Bernstein L. “Identification of Breast Cancer Risk Factors: Insights and Involvement“ Speak Out
to End Breast Cancer. National Breast Cancer Coalition, Newport Beach, CA 2009.
227. Bernstein L. “Cohort studies” in “Clinical Trials vs. Cohort Studies of Energy Balance on
Prognosis. TREC-FHCRC-NCI Conference on Energy Balance, Cancer Prognosis and Survivorship.
Seattle, WA, 2009.
228. Bernstein L. “Can we prevent ovarian cancer? Risk factor status and the potential for physical
activity.” 9th Annual City of Hope Women’s Cancer Conference. Las Vegas, NV, 2009.
229. Bernstein L. “Tipping the Energy Balance: Exercise and Cancer Risk and Prognosis.” The
Prevention of Cancer. UC San Francisco Diller Family Comprehensive Cancer Center Symposium.
San Francisco, CA 2009.
106
Leslie Bernstein, PhD
230. Bernstein L. "Reducing breast cancer risk through biology, epidemiology and serendipity.”
Rosalind E. Franklin Award Lecture, National Cancer Institute, Bethesda, MD 2010.
231. Bernstein L. “Physical Activity: A lifestyle approach to lower breast cancer risk and improve
prognosis.” New York University, New York City, NY 2010.
232. Bernstein L. “Can we lower breast cancer risk? Combining biology, epidemiology and
serendipity.” Reuel Stallones Memorial Lecture. University of Texas School of Public Health,
Houston, TX 2010.
233. Bernstein L. “The California Teachers Study: Optimizing design, opportunities and insights
through collaboration.” Department of Epidemiology, MD Anderson Comprehensive Cancer
Center. Houston, TX 2010.
234. Bernstein L. “The Health of Women (HOW) Study of the Love/Avon Army of Women.“
American Association for Cancer Research Annual Meeting, Washington DC, 2010.
235. Bernstein L. Co-Chair and Mentor. Professional Advancement Series: Women in Cancer
Research Career Mentoring. American Association for Cancer Research Annual Meeting,
Washington DC, 2010.
236. Bernstein L. “Changing lifestyle to reduce breast cancer risk and improve prognosis: The
epidemiologic evidence.” Grand Rounds. Tarzana Medical Center, Tarzana CA 2010.
237. Bernstein L. “Surviving Breast Cancer: Can we modify long-term prognosis?” Grand Rounds,
Wake Forest University Comprehensive Cancer Center, Wake Forest, NC 2010.
238. Bernstein L. “Changing Lifestyle to Reduce Breast Cancer Risk and Improve Prognosis:
The Epidemiologic Evidence.” CAPA Annual Meeting, Palm Springs, CA 2010.
239. Bernstein L. “The Current and Future State of Translational Research in Physical Activity and
Breast Cancer.” University of Texas San Antonio Cancer Research Center, San Antonio TX, 2010.
240. Bernstein L. “The Epidemiology of Breast Cancer: An Update on Opportunities for Prevention.”
7th International Symposium on the Intraductal Approach to Breast Cancer. Santa Monica, CA 2011.
241. Bernstein L. “Establishing and fostering successful mentoring relationships: How to take charge
of your career.” American Association for Cancer Research. 102nd Annual Meeting, Orlando FL,
2011.
242. Bernstein L. “Breast cancer prognosis: Does lifestyle (body size, physical activity, diet)
influence long-term outcomes after breast cancer?” Annual Advocacy Training Conference.
National Breast Cancer Coalition. Washington, DC, 2011.
243. Bernstein L. “Translating from primary prevention to secondary prevention: Can we reduce risk
of recurrence and death from breast cancer? Annual Advocacy Training Conference. National
Breast Cancer Coalition. Washington, DC, 2011.
244. Bernstein L. “Ask and you shall receive.” Mentoring Symposium. 3rd North American
Congress of Epidemiology, Montreal, Quebec, Canada, 2011.
245. Bernstein L. “Academic careers in epidemiology.” Pre-Conference Workshop: Career choices:
Figure out where to you want to work and how to get there. 3rd North American Congress of
Epidemiology, Montreal, Quebec, Canada, 2011.
246. Bernstein L. “Breast cancer epidemiology.” Manhattan Beach, CA 2011
247. Bernstein L. “Breast cancer epidemiology.” National Breast Cancer Coalition Project Lead for
Magazine Editors and Writers. New York, NY, 2011.
248. Bernstein L. “Preventing breast cancer: Do we know enough?” Keynote speaker. 11th Annual
Women’s Health Conference & Expo. Pasadena, CA, 2011.
249. Bernstein L. “The global breast cancer burden: Incidence, mortality and risk factors.” Forming
Alliances to Combat the Growing Global Burden of Breast Cancer. A Partnership of the U. S.
Department of State and the Avon Foundation for Women. Washington DC, 2011.
107
Leslie Bernstein, PhD
250. Bernstein L. “Tackling breast cancer risk and prognosis: Can we improve our game?” First
Geoffrey Howe Memorial Lecture. Columbia University School of Public Health, Department of
Epidemiology. New York, NY 2011.
251. Bernstein L. “Risk Reduction and Breast Cancer.” Southern California American College of
Surgeons Annual Meeting. Santa Barbara, CA 2012.
252. Bernstein L. Keynote: “Prevention, Lifestyle Changes and Breast Cancer: Can Risk Factors
Inform Prognosis? Palo Alto Medical Foundation Cancer and Primary Care Symposium, Palo
Alto, CA 2012.
253. Bernstein L. “The Career Development Plan: Taking charge of your career.” Roundtable leader.
American Association for Cancer Research Annual Meeting, Chicago, CA 2012.
254. Bernstein L. “Lifestyle Practices: Impact on Breast Cancer Risk & Prognosis.” Biobehavioral
Cancer Prevention and Control Training Program Annual Symposium, School of Public Health,
University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA 2012.
255. Bernstein L. “Lifestyle Practices: Impact on Breast Cancer Risk and Prognosis.” Dan L. Duncan
Cancer Center at Baylor College of Medicine, Houston, TX 2012.
256. Bernstein L. “The California Teachers Study.” Research Staff Organization Advance, City of
Hope, Lake Arrowhead, CA 2012.
257. Bernstein L. “Making Serendipity Happen.” Commencement Address. Louisiana State
University Health Sciences School (Medical, Dental, Nursing, Public Health, Allied Health
Sciences, and Basic Sciences), New Orleans, LA 2012.
258. Bernstein L. “The Impact of Obesity on Cancer Survivorship.” Cancer Survivorship Research:
Translating Science to Care. 2012 Conference. Arlington, VA 2012.
259. Bernstein L. “Risk of Developing Second Primary Breast Cancer Among Survivors of Breast
Cancer.” 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX,
2012.
260. Bernstein L. “Breast Cancer Prevention and Control: 40 Years of Progress.” 22nd Annual CSP
Educational Symposium, “Celebrating 40 Years of Cancer Surveillance in Los Angeles County”.
University of Southern California, Los Angeles, CA, 2013.
261. Bernstein L. “Using Registry Data for Etiologic Investigations.” Dee West Cancer
Epidemiology Symposium, “The Role of Population-based Cancer Registries in Cancer Prevention
and Control: A Cells-to-Society Approach.” Stanford University, Palo Alto, CA 2014.
262. Bernstein L. “Making Serendipity Happen: Identifying Opportunities to Reduce the Burden of
Breast Cancer.” Keck Graduate Institute, Claremont Colleges, 2014.
263. Bernstein L. “Impact of Energy Balance on Breast Cancer Survivorship.” 16th Annual Lynn
Sage Breast Cancer Symposium. Robert H. Lurie Comprehensive Cancer Center. Northwestern
University. Chicago, IL, 2014.
264. Bernstein L. “Ron Ross Oration: Reducing Breast Cancer Risk through Biology, Epidemiology,
Serendipity.” International Pacific Rim Breast and Prostate Cancer Symposium. Stevenson, WA,
2015.
108
Leslie Bernstein, PhD
Contributed Papers (Scientific Meetings)
1. Bernstein L. "Stereotypes of the elderly in drug advertising." Western Gerontological Society,
1978.
2. Bernstein L. "Risk Factors: perspectives in health and aging - epidemiologic research." Western
Gerontological Society, 1980.
3. Bernstein L, Anderson J, Pike MC. "Confidence intervals for the probability of survival in lifetable
analysis." American Statistical Association and the Biometric Society, 1980.
4. Wales J, Bernstein L, Kane R. "UCLA hospice evaluation study: preliminary results." American
Public Health Association, 1983.
5. Bernstein L. "Is hospice cost-effective? Who benefits? Randomized trial data." Gerontological
Society of America, 1983.
6. Bernstein L, Depue R, Ross RK, Henderson BE. "Higher pregnancy levels of estradiol and
sex-hormone binding globulin in hyperemetic women: a case-control study." Society for
Epidemiologic Research, 1986.
7. Preston-Martin S, Bernstein L, Pike MC, Henderson BE. "Risk factors for thyroid cancer among
young women." Society for Epidemiologic Research, 1986.
8. Preston-Martin S, Bernstein L, Pike MC, Henderson BE. "Reproductive factors associated with
increased risk of thyroid cancer in young women." American Public Health Association, 1986.
9. Preston D, Bernstein L, Sadun AA. "Distinguishing optic neuropathies with different parameters of
visual function." Association for Research in Vision and Ophthalmology, 1987.
10. Bernstein L, Pike MC, Ross RK, Lobo R, Henderson BE. "Cigarette smoking in pregnancy: effects
on maternal levels of estradiol and human chorionic gonadotropin." Society for Epidemiologic
Research, 1988.
11. Bernstein L, Levin D, Menck H, Ross RK. "AIDS-related secular trends in cancer in Los Angeles
County men: A comparison by marital status". California Cancer Registries Conference, 1988.
12. Rarick M, Sharma D, Gill PS, Bernstein L, Bernstein-Singer M, Levine A. "Miscellaneous
carcinomas developing in patients with HIV infection." International Conference on AIDS, 1989.
13. Bernstein L, Newton P, Ross RK. "Incidence of hairy cell leukemia in Los Angeles County,
California (USA)." International Association of Cancer Registries, 1989.
14. Bernstein L, Hartnett N, Henderson BE, Ross RK. "Cancer of the small intestine: etiologic clues
from the subsite distribution." International Association of Cancer Registries, 1990.
15. Slovak ML, Ho JP, Sheibani K, Brynes RK, Nathwani B, Bernstein L, Levine A. "Epidemiological
study of HIV-negative and HIV-positive intermediate and high grade B-cell lymphomas:
cytogenetic correlations." American Society of Human Genetics, 1990.
16. Bernstein L. "Childhood cancer in Los Angeles County: Opportunity for treatment on cooperative
group protocols." California Cancer Registries' Conference: Community Cancer Concerns: The
Registry Response. 1991.
17. Walker A, Bernstein L, Cozen W. "Increasing secular trends in ovarian and testicular germ cell
cancer incidence in Los Angeles County and associations with changes in potential risk factors."
California Cancer Registries' Conference: Community Cancer Concerns: The Registry Response.
1991.
18. Bernstein L, Hartnett N, Henderson BE, Ross RK. "Cancer of the small intestine." California
Cancer Registries' Conference: Community Cancer Concerns: The Registry Response. 1991.
109
Leslie Bernstein, PhD
19. Bernstein L, Halley J. "Childhood cancer in Los Angeles County: Access to cooperative group
protocols." Society for Epidemiologic Research, 1991.
20. Bernstein L. "Cancer risk among Latino Migrants to Los Angeles, California." International
Association of Cancer Registries, 1991.
21. Goodwin TM, Estrada S, Smith KA, Bernstein L, Artal R. "A prospective study of bioimpedance
analysis in normal and hypertensive pregnancies. Society of Perinatal Obstetricians, 1992.
22. Olalelye D, Sheng Z, Li XY, Halley J, Bernstein L, Rasheed S. "Prevalence of HIV-1 and HIV-2
infections in Nigeria, Africa." Keystone Symposia on Molecular and Cellular Biology, 1992.
23. Lindheim SR, Legro RS, Bernstein L, Stanczyk FZ, Vijod MA. "Behavioral stress responses in
premenopausal and postmenopausal women and the effects of estrogen." Society for Gynecologic
Investigation, 1992.
24. Walker A, Bernstein L. "The Kaposi's Sarcoma Epidemic in Los Angeles County, 1972-1989:
Cohort vs. cross sectional analysis." California Cancer Registries' Conference, 1992.
25. Levine AM, Shibata D, Sullivan-Halley J, Nathwani B, Brynes R, Slovak M, Bauch S, Riley L,
Weiss L, Levine P, Rasheed S, Bernstein L. “Case-control study of HIV- and HIV-associated
lymphoma in Los Angeles County.” American Society of Clinical Oncology, 1992.
26. Bernstein L, Ross RK. "Prior medication use and health history as risk factors for non-Hodgkin's
lymphoma." Society for Epidemiologic Research, 1992.
27. Levine AM, Shibata D, Weiss LM, Sullivan Halley J, Mahterian S, Riley CL, Ortega A, Nathwani B,
Bernstein L. “Molecular characteristics of intermediate/high grade lymphomas arising in
HIV-positive vs. HIV-negative patients: preliminary data from a population based study in the
county of Los Angeles.” American Society of Hematology, 1992.
28. Slovak ML, Weiss LM, Nathwani BN, Bernstein L, Levine AM. “Cytogenetic studies of
monocytoid B-cell lymphomas.” American Society of Hematology, 1992.
29. Walker AH, Bernstein L, Gill P, Gonsalves M, Radka S, Ross RK. “Serum levels of oncostatin M
in AIDS-related and classic Kaposi's sarcoma cases and controls.” California Cancer Registries
Conference, 1993.
30. Bernstein L, Henderson BE, Ross RK. “Physical exercise and reduction in risk of breast cancer in
young women.” Lancet Conference: The Challenge of Breast Cancer, 1994.
31. Bernstein GS, Grimes D, Walsh T, Frezieres R, Bernstein L, Coulson A. “Will U.S. women give the
IUD a second chance? An evaluation based on the first year experience of 1500 IUD users.” Annual
Meeting of the American Public Health Association, 1994.
32. Levine AM, Nathwani B, Mahterian S, Shibata D, Sullivan-Halley J, Bernstein L. “Role of
zidovudine (AZT) usage on subsequent development of lymphoma (NHL) in HIV-infected men.
American Society of Hematology, 1994.
33. Bernstein L, Nathwani B, Shibata D, Sullivan-Halley J, Levine AM. “History of transfusion and
increased risk of lymphoma in HIV-positive men.” American Society of Hematology, 1994.
34. Cozen W, Bernstein L, Mack T. “Risk of hemangiosarcoma and lymphangiosarcoma following
breast cancer”. California Association of Regional Cancer Registries, 7th Annual Conference, 1995.
35. Liu L, Deapen, Bernstein L. “Socioeconomic status and risk of cancer in Los Angeles County.”
North American Association of Central Cancer Registries Annual Conference, 1996.
36. Cozen W, Bernstein L, Mack TM. “Risk of breast cancer among Jewish women in Los Angeles
County.” California Association of Regional Cancer Registries Annual Conference, 1996.
110
Leslie Bernstein, PhD
37. Carpenter CL, Ross R, Paganini-Hill A, Bernstein L. “Lifetime physical activity and breast cancer
risk among postmenopausal women.” Society for Epidemiologic Research, 29th Annual Meeting,
1996.
38. Ursin G, Ross RK, Sullivan-Halley J, Hanisch R, Bernstein L. “Oral contraceptive use and breast
cancer risk in women aged 40 years or younger.” Society for Epidemiologic Research, 29th Annual
Meeting, 1996.
39. Longnecker MP, Bernstein L. Paganini-Hill A, Enger SM, Ross RK. “Risk factors for in situ breast
cancer in Los Angeles County.” Society for Epidemiologic Research, 29th Annual Meeting, 1996.
40. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. “Body size, lifetime physical activity, and
breast cancer risk among postmenopausal women.” 19th Annual San Antonio Breast Cancer
Symposium, 1996.
41. Bernstein L. “Tamoxifen therapy and risk of endometrial cancer following breast cancer.” 9th
Annual California Association of Regional Cancer Registries’ Conference, 1997.
42. Hamilton A, Ross R, Bernstein L, Masood R, Minor M, Gill P. “Risk factors for AIDs-KS and
classic-KS: clues for roles of cytokines.” National AIDS Malignancy Conference, 1997.
43. Enger S, Ross R, Henderson B, Bernstein L. “Breastfeeding history, pregnancy experience and risk
of breast cancer.” 9th Annual California Association of Regional Cancer Registries’ Conference,
1997.
44. Hamilton A, Ross RK, Bernstein L, Masood R, Minor M, Gill P. “Risk factors for AIDS-KS and
classic KS: clues for roles of cytokines.” 9th Annual California Association of Regional Cancer
Registries’ Conference, 1997.
45. Cozen W, Bernstein L, Mack T. “Risk patterns in non-Hodgkin’s lymphoma in Los Angeles:
variation by subtype provides clues to etiology.” 9th Annual California Association of Regional
Cancer Registries’ Conference, 1997.
46. Bernstein L. “Tamoxifen therapy and risk of endometrial cancer following breast cancer.” North
American Association of Central Cancer Registries Annual Conference, 1997.
47. Cozen W, Bernstein L, Mack T. “Risk patterns of non-Hodgkin’s lymphoma in Los Angeles:
variation by sutbtype.” North American Association of Central Cancer Registries Annual
Conference, 1997.
48. Enger S, Ross RK, Paganini-Hill A, Bernstein L. “Lifetime history of breastfeeding and
postmenopausal breast cancer.” 30th Annual Meeting, Society for Epidemiologic Research, 1997.
49. Koprowski C, Mack WJ, Ross RK, Henderson BE, Bernstein L. “Diet, body size and menarche in a
multiethnic cohort.” 30th Annual Meeting, Society for Epidemiologic Research, 1997.
50. Nelson R, Levine AM, Marks G, Bernstein L. “The effects of alcohol, tobacco and recreational drug
use on the risk of non-Hodgkin’s lymphoma unrelated to HIV infection: a case-control study.” 30th
Annual Meeting, Society for Epidemiologic Research, 1997.
51. Bernstein L, Ross RK, Deapen D, Lynch C, Cerhan J, Schwartz S, Liff J. “Tamoxifen therapy and
risk of endometrial cancer following breast cancer.” 13th International Conference, International
Society for Pharmacoepidemiology, 1997.
52. Levine AM, Zuckerman E, Zuckerman T, Nelson R, Govindrajan S, Valinluck B, Bernstein L.
“Lack of association between hepatitis C infection and development of AIDS-related lymphoma.”
American Society of Hematology, 1997.
53. Cozen W, Bernstein L, Mack T, Douer D. “Risk patterns of non-Hodgkin’s lymphoma in Los
Angeles: Variation by subtype.” American Society of Hematology, 1997.
111
Leslie Bernstein, PhD
54. Bernstein L, Cerhan J, Schwartz S, Liff J, Perlman J, Ford L. “The combined effects of ERT,
obesity and tamoxifen therapy for breast cancer on endometrial cancer risk.” 71st Annual Meeting,
American Epidemiological Society, 1998.
55. Haselkorn T, Mack W, Cozen W, Preston-Martin S, Warner N, Bernstein L. “Descriptive
epidemiology of thyroid carcinoma in Los Angeles County, California 1972-1995.” 10th Annual
Conference, California Association of Regional Cancer Registries, 1998.
56. Nelson R, Levine A, Bernstein L. “Drug use and the risk of AIDS-related non-Hodgkin’s
lymphoma.” Second National AIDS Malignancy Conference, 1998.
57. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. “Weight gain, family history, and breast
cancer risk among post-menopausal women.” 31st Annual Meeting, Society for Epidemiologic
Research, 1998.
58. Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L. “Breast cancer risk associated
with alcohol consumption depends on hormone receptor status.” 31st Annual Meeting, Society for
Epidemiologic Research, 1998.
59. Hill DA, Bernstein L. “Medical radiation and risk of breast cancer in young women.” 31st Annual
Meeting, Society for Epidemiologic Research, 1998.
60. Bernstein L, Nelson R, Levine A. “Reproductive factors and risk of intermediate or high grade nonHodgkin’s lymphoma in women.” 11th Annual California Cancer Registries Conference, 1999.
61. Gale RP, Cozen W, Wang FS, Bernstein L, Mack T. “Ethnic differences in incidence of chronic
lymphocytic leukemia in Los Angeles.” 11th Annual California Cancer Registries Conference, 1999.
62. Hill DA, Bernstein L, Preston-Martin S. “Medical radiation and risk of breast cancer in young
women.” Schilling Research Conference, The Environment and Cancer. American Cancer Society,
1999.
63. Enger SM, Ross RK, Paganini-Hill A, Carpenter C, Bernstein L. “Physical activity, obesity and
breast cancer hormone receptor status.” 32nd Annual Meeting, Society for Epidemiologic Research,
1999.
64. Carpenter C, Ross RK, Paganini-Hill A, Bernstein L. “Does family history increase
postmenopausal breast cancer risk by modification of known reproductive and lifestyle factors.”
The Biology and Genetics of Early Detection and Chemoprevention of Cancer. AACR Special
Conference in Cancer Research, 1999.
65. Nelson R, Levine A, Bernstein L. “Reproductive factors and risk of intermediate- or high-grade
non-Hodgkin’s lymphoma in women.” American Society of Hematology, 1999.
66. Croughan-Minihane M, Camarano L, Ernster V, Kerlikowske K, Zaloudek C, Black D, Martin
Cadieux M, Feigenbaum S, Nelson HP, Adamson GD, Deapen D, Bernstein L, Whittemore A.
“The risk of ovarian cancer associated with infertility and infertility treatment (The UCSF Fertility
Drugs and Ovarian Cancer Study).” American Society for Reproductive Medicine, 1999.
67. Hoggatt KJ, Horn-Ross PL, Bernstein L and the California Teachers Study. “Correlates of vitamin
supplement use in the California Teachers Study cohort.” 12th Annual California Cancer Registries
Conference, 2000.
68. Peel D, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross P, Nguyen D, Pinder R, Reynolds P,
Ross R, West D, Wright W, Ziogas A. “Collection of DNA in the California Teachers Study: A pilot
Study.” 92nd Annual Meeting of the American Association for Cancer Research, 2001.
112
Leslie Bernstein, PhD
69. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Sosnowska D, Forman D. “Role of
Heliocobacter pylori CagA plus strains and risk of adenocarcinoma of the stomach and esophagus.”
Digestive Disease Week and the 102nd Annual Meeting of the American Gastroenterological
Association, 2001.
70. Liu L, Bernstein L. “Childhood cancer patients’ access to cooperative group cancer programs: a
population-based study.” North American Association of Central Cancer Registries Annual Meeting,
2001.
71. McTiernan A, Irwin M, Baumgartner R, Bernstein L, Ballard-Barbash R. “Body mass and sex
hormones in postmenopausal breast cancer patients.” International Epidemiology Congress, 2001.
72. Enger SM, Bernstein L. “Reproductive factors and premenopausal breast cancer survival.”
International Epidemiology Congress, 2001.
73. Ursin G, Ma H, Wu AH, Bernstein L, Pike MC. “Mammographic density and breast cancer risk in
three ethnic groups.” 93rd Annual Meeting of the American Association for Cancer Research, 2002.
74. Peel D, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross P, Pinder R, Reynolds P, Ross R, West
D, Wright W, Ziogas AL. “Biospecimen collection in the California Teachers Cohort Study:
Comparison between Mouthwash and cheek-brush collection methods in the same group of
participants from a pilot study.” 93rd Annual Meeting of the American Association for Cancer
Research, 2002.
75. Newman LA, Rockhill B, Bondy ML, Abrams J, Berlin JA, Colditz GA, Bernstein L. “Validation
of the Gail breast cancer risk assessment model in African American women based on a multi-center
case-control study of 3,283 African American and 5,974 white American women.” Annual Meeting.
American Society of Clinical Oncology. 2002.
76. Baumgartner K, Hunt C, Bowen D, Baumgartner R, McTiernan, Bernstein L, Ballard-Barbash R.
“Weight change among women diagnosed with breast cancer and health related quality of life.”
Cancer Survivorship: Resilience across the Lifespan. NCI and ACS Conference 2002.
77. Irwin M, McTiernan A, Crumley D, Baumgartner R, Bernstein L, Gilliland F, Ballard-Barbash R,
LaCroix K, McVarish L, Tworoger S, Marshall S. “Physical activity levels across the breast cancer
experience: The Health, Eating, Activity, and Lifestyle (HEAL) Study.” Cancer Survivorship:
Resilience across the Lifespan. NCI and ACS Conference, 2002.
78. Ursin G, Ma H, Wu A, Bernstein L, Salane M, Parisky Y, Astrahan M, Pike MC.
“Mammographic density and breast cancer in three ethnic groups.” 35th Annual Meeting of the
Society for Epidemiologic Research, 2002.
79. Chen Z, Wu A, Gauderman J, Bernstein L, Pike MC, Ma H, Ursin G. “Ethnic differences in
mammographic density.” 35th Annual Meeting of the Society for Epidemiologic Research, 2002.
80. Press MF, Sauter G, Bernstein L, Zhou J, Li B, Mirlacher M, Villalobos I, Guzman R, Riva A,
Nabholtz JM, Slamon DJ. Comparison of HER-2/neu status determined by fluorescence in situ
hybridization (FISH) in the BCIRG central laboratories with HER-2/neu status determined by
immunochemistry or FISH in outside laboratories. San Antonio Breast Cancer Symposium, 2002.
81. Lillie E, Bernstein L, Gauderman J, Rivas G, Gangalang V, Krontiris T, Ursin G. “Polymorphism
in the androgen receptor genet and mammographic density.” Molecular and Genetic Epidemiology
of Cancer Meeting, American Association for Cancer Research, 2003.
82. Irwin M, McTiernan A, Bernstein L, Gilliland F, Baumgartner R, Ballard-Barbash R. “Obesity,
weight gain, and metabolic hormones in breast cancer survivors.” American Society for Preventive
Oncology, 2003.
113
Leslie Bernstein, PhD
83. Kendall AR, Mahue-Giangreco M, Crapenter CL, Ganz PA, Bernstein L. “Exercise and quality of
life in long-term breast cancer survivors.” 15th Annual California Cancer Registries Conference,
2003.
84. Carpenter CL, Ingles SA, Jaque SV, Schroeder ET, Wong HL, Bernstein L. “Association between
leptin-receptor gene polymorphism and obesity among postmenopausal women.” 94th Annual
Meeting of the American Association for Cancer Research, 2003.
85. Bernstein JL, Bernstein L, Thompson WD, Teitelbaum SL, Lynch CF, Boice JD, Rosenstein BS,
Borresen-Dale AL, Gatti RA, Concannon P, Haile RW. “ATM variants IVS10-6T>G and
7271T>G among women with unilateral and bilateral breast cancer.” 94th Annual Meeting of the
American Association for Cancer Research, 2003.
86. Cozen W, Ingles S, Gill PS, Masood R, Gauderman J, Martinez-Maza O, Bernstein L, Wang W,
Salam MT, Gage J, Gundell S, Stroud NJ, Danley K, Mack TM. “A low risk genotype for young
adult Hodgkin’s lymphoma.” 94th Annual Meeting of the American Association for Cancer
Research, 2003.
87. Mason HRC, Dwyer K, Murphy B, Browning P, Bernstein L. “Factors affecting breast cancer
treatment decison making in African-American and white women.” Annual Meeting of the
American Society of Clinical Oncology. 2003.
88. Newman LA, Gail MH, Selvan M, Bondy M, Rockhill B, Colditz G, Berlin J, Liff J, Abrams J,
Spirtas R, Bernstein L. “Proposed Revision of the Gail Breast Cancer (BC) Risk Assessment
Model.” Annual Meeting of the American Society of Clinical Oncology. Chicago, IL, 2003.
89. Patel AV, Press MF, Meeske K, Calle EE, Bernstein L. “Lifetime recreational physical activity
and risk of breast carcinoma in situ”. 36th Annual Meeting of the Society for Epidemiologic
Research, 2003.
90. Patel AV, Calle EE, Bernstein L, Wu AH, Thun MJ. “Recreational physical activity and risk of
postmenopausal breast cancer in a large cohort of US women.” 36th Annual Meeting of the Society
for Epidemiologic Research, 2003.
91. Bowen D, McTiernan A, Baumgartner K, Aiello E, Bernstein L, Malone K. “Relationship of posttraumatic growth to psychological and behavioral outcomes of surviving breast cancer.” American
Psychosocial Oncology Society, 2003.
92. Baumgartner K, Hunt WC, Baumgartner RN, Bernstein L, Gilliland FD, McTiernan A, BallardBarbash R. “Relationship of obesity with p53 and other tumor markers among Hispanic and nonHispanic white women.” Second Annual International Conference on Frontiers in Cancer
Prevention Research. American Association for Cancer Research, Phoenix, AZ, 2003.
93. Irwin M, Aiello E, Gilliland F, McTiernan A, Baumgartner R, Bernstein L, Ballard-Barbash R.
“The association between physical activity levels and mammographic breast density in pre- and
post-menopausal women: The Health, Eating, Activity and Lifestyle (HEAL) Study.” Second
Annual International Conference on Frontiers in Cancer Prevention Research. American
Association for Cancer Research, Phoenix, AZ, 2003.
94. Canchola AJ, Stewart SL, Bernstein L, West DW, Ross RK, Deapen D, Pinder R, Reynolds P,
Wright W, Anton-Culver H, Peel D, Ziogas A, Horn-Ross PL. “Cox regression using different
time scales.” WUSS (Western Users of SAS Software), 2003.
95. Lillie EO, Bernstein L, Ingles SA, Gauderman WJ, Rivas G, Gagalang V, Krontiris T, Ursin G.
“Polymorphism in the androgen receptor and mammographic density in women taking and not
taking estrogen and progestin therapy.” American Society for Human Genetics, 2003.
114
Leslie Bernstein, PhD
96. Teraoka SN, Bernstein JL, Bernstein L, Thompson WD, Teitelbaum SL, Lynch CF, Malone KE,
Boice JD, Rosenstein BS, Borresen-Dale AL, Gatti RA, Concannon P, Haile RW. “ATM variants
727IT>G and IVS10-6T>G among women with unilater and bilateral breast cancer.” American
Society for Human Genetics, 2003.
97. Press MF, Bernstein L, Zhou J-Y, Villalobos IE, Anderson S, Cobleigh MA, Vogel CL, Mass R.
“Low-level HER-2/neu gene amplification for fluorescence in situ hybridization and responsiveness
to single agent Herceptin ® immunotherapy among women with metastatic breast cancer.” 26th
Annual San Antonio Breast Cancer Symposium. San Antonio TX, 2003.
98. Carpenter CL, Ingles SA, Jaque V, Schroeder ET, Wong HL, Bernstein L. “Obesity and leptinreceptor gene polymorphisms among postmenopausal women.” FASEB Meeting, Washington DC,
2004.
99. Cozen W, Bernstein L, Wang Y, Danley K, Liu L, Mack T. “Changing trends in Hodgkin’s
lymphoma by age and socioeconomic status.” 16th Annual California Cancer Registry Conference:
Surveillance, the Key to Cancer Control. Newport Beach, CA, 2004.
100. Cockburn M, Wu A, Bernstein L. “Histology-specific trends support a major role in changing
constituents of tobacco smoke in increasing esophageal adenocarcinoma rates.” 16th Annual
California Cancer Registry Conference: Surveillance, the Key to Cancer Control. Newport Beach,
CA, 2004.
101. Patel A, Rodriguez C, Bernstein L, Chao A, Calle EE. “Obesity, location of weight gain, and risk
of pancreatic cancer in a large United States cohort.” 37th Annual Meeting, Society for
Epidemiologic Research, Salt Lake City, UT, 2004.
102. Geiger A, Bernstein L. “Stroke risk and tamoxifen therapy for breast cancer.” 37th Annual
Meeting, Society for Epidemiologic Research, Salt Lake City, UT, 2004.
103. Carpenter C, Ingles S, Jaque S, Bernstein L. “Leptin-receptor gene polymorphism: Effect
modification with age among obese postmenopausal women.” North American Association for the
Study of Obesity, 2004.
104. Geiger AM, Chen W, Bernstein L. “Myocardial infarction after tamoxifen therapy for breast
cancer.” 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 2004.
105. Geiger AM, Fischberg GM, Chen W, Bernstein L. “Stroke risk after tamoxifen therapy for breast
cancer.” 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 2004.
106. Smith A, Alfano C, Reeve B, Irwin M, Bernstein L, Baumgartner K, McTiernan A, BallardBarbash R. “Physical Activity and Psychosocial Quality of Life in Breast Cancer Survivors.” 29th
Annual Meeting of the American Society of Preventive Oncology. San Francisco, CA 2005.
107. Gill JK, Press MF, Patel A, Sullivan-Halley J, Bernstein L. “Oral contraceptives, alcohol, and
smoking: risk of in situ breast cancer.” 29th Annual Meeting of the American Society of
Preventive Oncology. San Francisco, CA 2005.
108. Alfano, C.M., McGregor, B.A., Kuniyuki, A., Reeve B.B., Baumgartner K.B., Bernstein L.,
Ballard-Barbash R., McTiernan A., Bowen D.J. “Hormone-related symptoms and health-related
quality of life in a multiethnic cohort of breast cancer survivors, 2 years post-diagnosis.” Second
annual meeting of the American Psychosocial Oncology Society, Phoenix, AZ, 2005.
109. Bernstein JL, Concannon P, Langholz B, Thompson WD, Bernstein L, Stovall M, Thomas DC.
“Multi-center screening of mutations in the ATM gene among women with breast cancer – The
WECARE Study.” Radiation Research Society, 2005.
115
Leslie Bernstein, PhD
110. Bellizzi KM, Reeve BB, Smith, AW, Bernstein L, Meeske K, McTiernan A, Baumgartner, KB.
“Examining the structure of the Posttraumatic Growth Inventory in breast cancer survivors.”
Positive Life Changes, Benefit-finding and Growth Following Illness Conference. Storrs, CT,
2005.
111. Press MF, Mass RD, Zhou JY, Sullivan-Halley J, Villalobos IE, Lieberman G, Flom KJ, Seelig S,
Slamon DJ, Bernstein L. “Association of topoisomerase II-alpha gene amplification with
responsiveness to anthracycline containing chemotherapy among women with metastatic breast
cancer entered in the H0648g pivotal clinical trial.” American Society for Clinical Oncology,
Orlando Fl, 2005.
112. Press MF, Mass RD, Zhou JY, Sullivan-Halley J, Villalobos IE, Lieberman G, Flom KJ, Seelig S,
Slamon DJ, Bernstein L. “Association of topoisomerase II-alpha gene amplification with
responsiveness to anthracycline containing chemotherapy among women with metastatic breast
cancer entered in the H0648g pivotal clinical trial.” Department of Defense Breast Cancer
Research Program, Era of Hope Meeting, Philadelphia, PA, 2005.
113. Lubin JH, Colt JS, Camann D, Davis S, Cerhan JR, Severson RK, Bernstein L, Hartge P.
“Epidemiologic evaluation of measurement data in the presence of detection limits.” International
Society for Environmental Epidemiology, 2005.
114. Wayne SJ, Neuhouser ML, Ulrich CM, Koprowski C, Baumgartner K, Baumgartner RN,
McTiernan A, Bernstein L, Ballard-Barbash R. “High intake of dietary fiber is associated with
high levels of serum sex hormone-binding globulin in postmenopausal breast cancer survivors: The
Health, Eating, Activity and Lifestyle (HEAL) Study. AACR Frontiers in Cancer Prevention
Meeting, 2005.
115. Rice C, Blair A, Spirtas R, Bernstein L, Stark AD, Heineman EF. “What is the contribution of
non-work related exposure to mesothelioma risk?” International Occupational Hygiene Association
6th International Conference, Pilanesberg National Park, South Africa, 2005.
116. Press MJ, Bernstein L, Sauter G, Zhou JY, Eiermann W, Pienkowski T, Crown J, Robert N, Bee
V, Taupin H, Villalobos I, Seelig S, Peatram M, Slamon DJ. “Topoisomerase II-alpha gene
amplification as a predictor of responsiveness to anthracycline-containing chemotherapy in the
Cancer International Research Group-006 clinical trial of trastuzumab (Herceptin) in the adjuvant
setting.” 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 2005.
117. Cozen W, Gebregziabher M, Vandenberg D, Conti D, Coetzee G, Bernstein L, Wang SS,
Rothman N, Hartge P. “Interleukin-g promoter and receptor polymorphisms, body mass index and
risk of multiple myeloma.” American Society for Hematology, 2005.
118. Mai PL, Sullivan-Halley J, Bernstein L, and the California Teachers Study Investigators.
“Physical activity and colon cancer risk in the California Teachers Study.” 30th Annual Meeting,
American Society for Preventive Oncology. Bethesda, MD 2006.
119. Bernstein J, Bernstein L, Langholz B, Thomas D, Stovall M, Capanu M, Thompson WD, Olson J,
Malone K, Lynch C, Anton-Culver H, Shore R, Boice J, Begg C, Wolitzer A, Gatti R, Rosenstein
B, Borreson-Dale AL, Copncannon P, Haile R. “The interaction of radiation, the ATM gene and
breast cancer.” Society for Epidemiologic Research, 2006.
120. Ma H, Hill CK, Bernstein L, Ross RK, Ursin G. “Low-dose medical radiation and breast cancer
risk in women under age 50 years overall and by estrogen and progesterone receptor status –
Results from a case-control and a case-case comparison.” Society for Epidemiologic Research,
2006.
116
Leslie Bernstein, PhD
121. Cozen W, Engels EA, Cerhan JR, Linet M, Bernstein L, Colt JS, Davis SS, Severson RK,
Martinez-Maza O, Hartge P. “Childhood crowding, atopy and risk of non-Hodgkin lymphoma.
American Society for Hematology, 2006.
122. Press MF, Sauter G, Buyse M, Bernstein L, Eiermann W, Pienkowski T, Bee V, Taupin H, Seelig
S, Slamon DJ. “Alteration of topoisomerase II-alpha gene in human breast cancer and its
association with responsiveness to anthracycline- based chemotherapy.” 43rd Annual Meeting,
American Society for Clinical Oncology, Chicago IL, 2007.
123. Lee E, McKean-Cowdin R, Ma H, Chen Z, Vandenberg D, Henderson BE, Bernstein L, Ursin G.
“Classification of unclassified variants in BRCA1/2 identified from a population-ased study of
young breast cancer patients.” 1st Scientific Conference on Familial Aspects of Breast Cancer. San
Antonio, TX, 2007.
124. Irwin M, Smith A, McTiernan A, Bernstein L, Cronin K, Baumgartner R, Gilliland F, BallardBarbash R. “Fasting C-peptide levels and breast cancer death in women with breast cancer: The
Health, Eating, Activity and Lifestyle (HEAL) Study.” AACR Frontiers in Cancer Prevention
Research Annual Meeting. Philadelphia, PA, 2007.
125. Prescott J, Sullivan-Halley J, Clarke CA, Cozen W, Bernstein L. “Reproductive factors, body
size and risk of non-Hodgkin lymphoma subtypes in the California Teachers Study.” AACR
Frontiers in Cancer Prevention Research Annual Meeting. Philadelphia, PA, 2007.
126. Lee JE, Männistö S, Spiegelman D, Hunter DJ, Bernstein L, van den Brandt PA, Buring JE, Cho
E, English D, Flood A, Freudenheim JL, Giles GG, Giovannucci E, Håkansson N, Horn-Ross PL,
Jacobs E, Leitzmann M, Marshall JR, McCullough ML, Miller AB, Rohan TE, Ross J, Schatzkin
A, Schouten LJ, Wolk A, Zhang SM, Smith-Warner SA. “Intakes of fruit and vegetables, and
carotenoids and risk of renal cell cancer in a pooled analysis of 13 prospective studies.” AACR
Frontiers in Cancer Prevention Research, Philadelphia, PA, 2007.
127. Wayne SJ, Koprowski C, Neuhouser ML, Ulrich CM, Bernstein L, Gilliland F, Wiggins C,
Baumgartner K, Baumgartner R, McTiernan A, Ballard-Barbash R. “Breast cancer survivors who
use selected herbal supplements have lower circulating estradiol and free estradiol: the Health,
Eating, Activity and Lifestyle Study.” 30th Annual San Antonio Breast Cancer Symposium, San
Antonio, TX, 2007.
128. Carpenter CL, Ganz PA, Bernstein L. ”Complementary and alternative therapies among longterm breast cancer survivors.” 30th Annual San Antonio Breast Cancer Symposium, San Antonio,
TX, 2007.
129. Geiger AM, Camacho F, Krajenta R, Buist DSM, Bernstein L, for the CRN Chemo-Stroke Study
Team. “Is stroke a late effect of chemotherapy?” American Society for Preventive Oncology
Annual Meeting, Bethesda, MD, 2008.
130. Zell JA, Ziogas A, Bernstein L, Clarke CA, Chang E, Cress R, Deapen D, Horn-Ross PL,
Neuhausen SL, Reynolds P, Stram DO, Ursin G, West DW, Anton-Culver H. “Family history of
colorectal cancer (CRC) predicts differential effects of non-steroidal anti-inflammatory drugs
(NSAIDs) on CRC risk.” American Society for Preventive Oncology Annual Meeting. Bethesda,
MD. 2008.
131. Largent J, Anton-Culver H, Neuhausen S, Ziogas A, Marshall S, Horn-Ross P, Clarke Dur C,
Chang E, Reynolds P, West D, Pinder R, Deapen D, Ursin G, Stram D, Cress R, Bernstein L.
“Hypertension, antihypertensive medication use and breast cancer risk in the California Teachers
Study.” American Association for Cancer Research Annual Meeting, San Diego, CA. 2008.
117
Leslie Bernstein, PhD
132. Cozen W, Hartge P, Engels EA, Cerhan JR, Severson RK, Davis S, Colt J, Ward MH, Linet MS,
Bernstein L, Rothman N, Wang SS. “The effect of immune response genotypes on non-Hodgkin
lymhoma risk is modified by a history of atopic conditions.” American Association for Cancer
Research Annual Meeting, San Diego, CA. 2008.
133. Duan L, Wu A, Sullivan-Halley J, Bernstein L. “Antacid drug use and risk of esophageal and
gastric adenocarcinomas in Los Angeles County.” American Association for Cancer Research
Annual Meeting, San Diego, CA. 2008.
134. Epstein M, Enger S, Sullivan-Halley J, Guzman R, Santiago A, Gasparyan A, Li B, Villalobos I,
Greiff JM, Polikoff J, Haque R, Bernstein L, Press M. “Association of estrogen receptor and HER2/neu status with responsiveness to adjuvant tamoxifen therapy in breast carcinoma patients.”
American Association for Cancer Research Annual Meeting, San Diego, CA. 2008.
135. Lee E, Ma H, Van Den Berg D, Bernstein L, Ursin G. ”The effect of oral contraceptives and
reproductive factors on breast cancer risk in BRCA1/2 carriers and non-carriers, results from a
population-based study.” American Association for Cancer Research Annual Meeting, San Diego,
CA. 2008.
136. Irwin ML, Smith A, Aiello E, Cronin K, McTiernan A, Bernstein L, Baumgartner R, Gilliland F,
Ballard-Barbash R. “Post-diagnosis mammographic density and risk of death in breast cancer
survivors: The Health, Eating, Activity, and Lifestyle (HEAL) study.” American Society for
Clinical Oncology Annual Meeting, Chicago, IL. 2008.
137. Pal SK, Rupta R, Somlo G, Hurria A, Chung CT, Luu TH, Bernstein L, Mortimer J. “Lack of
survival benefit in metastatic breast cancer with newer chemotherapy agents: The City of Hope
experience.” American Society for Clinical Oncology Annual Meeting, Chicago, IL. 2008.
138. Duggan C, Ballard-Barbash R, Baumgartner K, Baumgartner R, Bernstein L, Henderson K, Irwin
M, Sullivan-Halley J, Xiao L, McTiernan A. “Adiponectin and insulin: Associations with prognosis
in the Health, Eating, Activity and Lifestyle cohort.” Seventh TREC Centers Scientific Meeting.
Bethesda MD, 2008.
139. Marshall SF, Chang E, Clarke CA, Cress R, Deapen D, Horn-Ross PL, Largent J, Neuhausen S,
Reynolds P, Templeman C, Bernstein L. “Hormone therapy use before diagnosis and breast
cancer survival in the California Teachers Study.” San Antonio Breast Cancer Research
Symposium, 2008.
140. Lu Y, Prescott J,. Sullivan-Halley J, Cozen W, Henderson KD, Ma H, Clarke CA, Horn-Ross PL,
Ursin G, Bernstein L. “Body size, recreational physical activity and B-cell non-Hodgkin
lymphoma risk among women in the California Teachers Study.” 100th Annual Meeting, AACR,
Denver CO 2009.
141. West-Wright CN, Sullivan-Halley J, Henderson KD, Ursin G, Deapen D, Horn-Ross PL,
Bernstein L. “Long-term physical activity and survival after breast cancer: The California
Teacher's study.” 100th Annual Meeting, AACR, Denver CO 2009.
142. Lee E, Hsu C, Haiman CA, Horn-Ross P, Van Den Berg D, Bernstein L, Le Marchand L,
Henderson BE,. VW Setiawan, Ursin G. “Genetic variation in the progesterone receptor gene and
risk of endometrial cancer: a haplotype-based approach.” 100th Annual Meeting, AACR, Denver
CO 2009.
143. Razavi P, Pike MC, Horn-Ross PL, Bernstein L, Ursin G. “Long-term postmenopausal hormone
therapy and endometrial cancer.” 100th Annual Meeting, AACR, Denver CO 2009.
144. Henderson KD, Duan L, Ma H, Sullivan-HalleyJ, Bernstein L, The California Teachers Study
Investigators Group. “Current hormone therapy use is protective for colon cancer risk: The
California Teachers Study.” 100th Annual Meeting, AACR, Denver CO 2009.
118
Leslie Bernstein, PhD
145. Saxena T, Henderson KD, Sullivan-Halley J, Clarke CA, Marshall S, Bernstein L, Ursin G.
“Hormone therapy use and the risk of invasive breast cancer in the California Teachers Study.”
100th Annual Meeting, AACR, Denver CO 2009.
146. Davis-Dao C., Henderson KD, Sullivan-Halley J, Bernstein L. “Hormonal and reproductive
factors and risk of bladder cancer: the California Teachers Study.” Society for Epidemiologic
Research Annual Meeting, Anaheim, 2009.
147. West-Wright CN, Sullivan-Halley J, Henderson KD, Ursin G, Deapen D, Horn-Ross PL,
Bernstein L. “Long-term physical activity and survival after breast cancer: The California
Teacher's study.” Society for Epidemiologic Research Annual Meeting, Anaheim, 2009.
148. Lu Y, Prescott J, Sullivan-Halley J, Cozen W, Henderson KD, Ma H, Clarke CA, Horn-Ross PL,
Ursin G, Bernstein L. “Body size, recreational physical activity and B-cell non-Hodgkin
lymphoma risk among women in the California Teachers Study.” Society for Epidemiologic
Research Annual Meeting, Anaheim, 2009.
149. Cozen W, Hwang A, Hamilton AS, Bernstein L, Nathwani BN, Deapen DM, Mack TM. “Use of
tobacco and alcohol and risk of non-Hodgkin lymphoma in twins.” InterLymph Annual Meeting,
Vancouver BC, 2009.
150. Duggan C, Neuhouser M, Ulrich CM, Reding KW, Baumgartner RN, Baumgartner KB,
Bernstein L, Ballard-Barbash R, McTiernan A. “Associations of IGF-1 and IGFBP3 with
mortality in women with breast cancer.” NCI and TREC Conference: Energy Balance, Cancer
Prognosis, and Survivorship. Seattle WA, 2009.
151. Smith AW, Dunn M, Irwin ML, Alfano CM, Neuhauser M, George SM, McTiernan A, Bernstein
L, Baumgartner K, Baumgartner R, McKean-Cowdin R, Ballard-Barbash R. “Body weight and
survival in the HEAL breast cancer cohort.” NCI and TREC Conference: Energy Balance, Cancer
Prognosis, and Survivorship. Seattle WA, 2009.
152. Emaus A, Finstad SE, Veieroød MB, Tretli S, Selmer R, Furberg AS, Bernstein L, Schlichting E,
Thune I. “Physical activity, blood pressure and mortality in breast cancer patients.” NCI and TREC
Conference: Energy Balance, Cancer Prognosis, and Survivorship. Seattle WA, 2009.
153. George SM, Irwin ML, Smith AW, Neuhouser ML, McTiernan A, Alfano CM, Bernstein L,
Ulrich CM, Baumgartner KB, Albanes D, Reedy J, Mayne ST, Gail M, Ballard-Barbash R.
“Modifiable healthy lifestyle characteristics and disease-free survival after breast cancer in the
Health, Eating, Activity, and Lifestyle Study.” NCI and TREC Conference: Energy Balance,
Cancer Prognosis, and Survivorship. Seattle WA, 2009.
154. Clague J, Sullivan-Halley J, Bernstein L, and the California Teachers Study Steering Committee.
“Hormone therapy as a predictor of lung cancer risk and survival among postmenopausal women
enrolled in the California Teachers Study.” Frontiers in Cancer Prevention Research, American
Association for Cancer Research. Houston TX, 2009.
155. Reiner AS, Begg CB, Bernstein L, Haile RW, Knight JA, Lynch CF, John EM, Capanu M, Pike
MC, the WECARE Collaborative Group, Bernstein JL. “Family history of breast cancer and risk of
contralateral breast cancer.” Frontiers in Cancer Prevention Research, American Association for
Cancer Research. Houston TX, 2009.
156. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, Neuhausen SL, Stram DO,
Ursin G, Anton-Culver H. “Meat consumption, nonsteroidal anti-inflammatory drugs, and
colorectal cancer mortality in the California Teachers Study.” 2010 Gastrointestinal Cancers
Symposium. Orlando, FL, 2010.
119
Leslie Bernstein, PhD
157. Lu Y, Sullivan-Halley J, Henderson K, Ma H, Duan L, Wang S, Lacey J, Chang E, Deapen D,
Bernstein L. “Oral contraceptive, menopausal hormone therapy use and risk of non-Hodgkin
lymphoma in the California Teachers Study.” American Society for Preventive Oncology,
Bethesda, MD 2010.
158. Clague J, Reynolds P, Chang E, Henderson K, Ma H, Anton-Culver H, Bernstein L.
“Menopausal hormone therapy influences lung cancer survival but not lung cancer risk: Results
from the California Teachers Study.” American Society for Preventive Oncology, Bethesda, MD
2010.
159. Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L. “The roles of complementary and
alternative medicine in survival and quality of life among long-term breast cancer survivors:
Results of a prospective study.” American Society for Preventive Oncology, Bethesda, MD 2010.
160. Wang J, Colt JS, Thorne PS, Berhane KT, Severson RK, Davis S, Cerhan JR, Ward MH, Morton
LM, Hartge P, Bernstein L, Cozen W. “Household endotoxin and risk of non-Hodgkin
lymphoma.” American Association for Cancer Research Annual Meeting, Washington DC, 2010.
161. Duan L, Lacey J, Clarke-Dur C, West D, Bernstein L, Henderson K. “Medication use and ovary
cancer risk in the California Teachers Study.” American Association for Cancer Research Annual
Meeting, Washington DC, 2010.
162.
Dee A, McKean-Cowdin R, Neuhouser ML, Ulrich CM, Alfano CM, Baumgartner RN, McTiernan
A, Ballard-Barbash R, Bernstein L. “DEXA measures of body fat percentage and relation to acute
phase proteins among breast cancer survivors.” American Association for Cancer Research Annual
Meeting, Washington DC, 2010.
163. Horn-Ross PL, Canchola AJ, Bernstein L, Van Den Berg D, Ursin G. “Isothiocyanate-gene
interactions and endometrial cancer risk: the California Teachers Study.” American Association
for Cancer Research Annual Meeting, Washington DC, 2010.
164. Dieli-Conwright C, Sullivan-Halley J, Patel A, Press M, Malone K, Ursin G, Burkman R, Strom B,
Simon M, Bernstein L. “Lifetime recreational physical activity, hormone therapy use and breast
cancer risk in postmenopausal women.” American Association for Cancer Research Annual
Meeting, Washington DC, 2010.
165. Lu Y, Sullivan-Halley J, Henderson KD, Ma H, Duan L, Wang SS, Lacey J, Chang ET, Deapen D,
Bernstein L. “Oral contraceptive, menopausal hormone therapy use and risk of B-cell non-Hodgkin
lymphoma in the California Teachers Study.” American Association for Cancer Research Annual
Meeting, Washington DC, 2010.
166. Lu Y, Sullivan-Halley J, Chang ET, Henderson KD, Lacey J, Ma H, Bernstein L. “Recreational
physical activity and epithelial ovarian cancer risk in the California Teachers Study.” American
Association for Cancer Research Annual Meeting, Washington DC, 2010.
167.
Lee E, Conti D, Lee WH, Neuhausen SL, Bernstein L, Chang ET, Clarke CA, Horn-Ross PL, Ursin
G. “Genetic variations in the hormone pathway genes and breast cancer risk in the California
Teachers Study.” American Association for Cancer Research Annual Meeting, Washington DC,
2010.
168. Wang SS, Menashe I, Cerhan JR, Rothman N, Severson RK, Davis S, Chanock SJ, Bernstein L,
Hartge P, Morton L. “Genetic variants in chromosome 6p21.3 and risk of non-Hodgkin
lymphoma.” American Association for Cancer Research Annual Meeting, Washington DC, 2010.
169. Lu Y, Ma H, Sullivan-Halley J, Wang SS,. Henderson KD, Lacey Jr. JV, Bernstein L. “Oral
contraceptive use and survival among women with invasive breast cancer.” California Breast
Cancer Research Program, Sacramento CA 2010.
120
Leslie Bernstein, PhD
170. Setiawan VW, Karageorgi S, Deming S, Anderson K, Bernstein L, Brinton L, Cai H, Cerhan JR,
Chen C, Cozen W, Doherty JA, Freudenheim JL, Goodman MT, Horn-Ross P, Lissowska J, Lurie
G, Mack T, Matsuro RK, McCann SE, Moysich K, Pike MC, Rebbeck TR, Robien K, Shu XO,
Spurdle AB, Strom BL, The Australian National Endometrial Cancer Study Group, Ursin G, Xiang
YB, Webb PM, Weiss NS, Wentzensen N, Yang HP, DeVivo I. “Age at last birth and endometrial
cancer risk: Pooled analysis in the Epidemiology of Endometrial Cancer Consortium.” American
Association for Cancer Research. 102nd Annual Meeting, Orlando FL, 2011.
171. Lee E, McKean-Cowdin R, Ma H, Spicer D, Van Den Berg D, Bernstein L, Ursin G.
“Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation, results from a
population-based study of young women.” American Association for Cancer Research. 102nd
Annual Meeting, Orlando FL, 2011.
172. Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, Marchbanks PA, Spirtas R,
Burkman RT, Deapen D, Folger SG, Simon MS, Press MF, McDonald JA, Bernstein L. “Obesity
and mortality among black women and white women with invasive breast cancer.” American
Association for Cancer Research. 102nd Annual Meeting, Orlando FL, 2011.
173. Das N, Baumgartner KB, Kerber RA, Rai SN, Ulrich CM, Neuhouser ML, Bernstein L,
McTiernan A, Ballard-Barbash R, Baumgartner RN. “Associations between genetic variability in
folate metabolism and breast cancer survival.” American Association for Cancer Research. 102nd
Annual Meeting, Orlando FL, 2011.
174. Ma H, Sullivan-Halley J, Smith AW, Neuhouser ML, Meeske K, McKean-Cowdin R, Alfano
CM, George SM, Ballard-Barbash R, Bernstein L. “Estrogenic botanical supplements, healthrelated quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: A HEAL
Study report.” 3rd North American Congress of Epidemiology, Montreal, Quebec, Canada, 2011.
175. Dieli-Conwright CM, Lacey JV, Sullivan-Halley J, Chang E, Schumacher F, Neuhausen S, Ma H,
Deapen D, Henderson KD, Bernstein L. “Long-term and recent recreational activity and risk of
endometrial cancer: The California Teachers Study.” 3rd North American Congress of
Epidemiology, Montreal, Quebec, Canada, 2011.
176. Lacey JV, Chung N, Anton-Culver H, Wang S, Voutsinas J, Clarke C, Chang E, Ursin G, Deapen
D, Neuhausen S, Henderson K, Ma H, Dieli-Conwright C, Nelson D, Horn-Ross PL, Reynolds P,
Bernstein L. “Declining incidence of hospitalization for stroke after 2002 among women in
California.” 3rd North American Congress of Epidemiology, Montreal, Quebec, Canada, 2011.
177. Kruper L, Xu X, Henderson K, Bernstein L. “Variations in post-mastectomy reconstruction
rates: Invasive and in situ carcinoma.” American Society of Breast Surgeons Annual Meeting.
Washington DC, 2011.
178. Dieli-Conwright C, Bernstein L, Henderson KD. “Body mass index and risk of death among
breast cancer survivors: the California Teachers Study.” Endocrine Society Annual Meeting.
Boston, MA, 2011.
179. Whisnant Cash S, Ma H, Horn-Ross P, Reynolds P, Canchola A, Sullivan-Halley J, Beresford S,
Neuhouser M, Vaughan T, Heagerty P, Bernstein L. “Long-term physical activity and reduced risk
of invasive papillary thyroid cancer in the California Teachers Study.” 139th American Public
Health Association Annual Meeting, Washington DC, 2011.
180. Stover AM, Reeve BB, Piper B, Alfano C, Wilder Smith A, Mitchell S, Bernstein L,
Baumgartner KB, McTiernan A, Ballard-Barbash R. “Deriving clinically meaningful cut-points for
the Piper Fatigue Scale (PFS): Building a case-definition for cancer-related fatigue.” American
Society for Preventive Oncology. Chicago, IL 2012.
121
Leslie Bernstein, PhD
181. Lu Y, Wang S, Sullivan-halley J, Cozen W, Bernstein L. “Smoking, alcohol consumption and
body size measures and risk of B-cell non-Hodgkin lymphoma among women in Los Angeles.”
American Association for Research on Cancer Annual Meeting, Chicago IL, 2012.
182. Rand KA, Conti DV, Haiman CA, Van Den Berg DJ, Birmann BM, De Roos AJ, Severson RK,
Gebregziabher M, Ailawadhi S, Morbacher A, Lieber MR, Wang SS, Bernstein L, Edlund CK,
Rothman N, Chanock SJ, Kolonel LN, Colditz GA, Munshi N, Anderson KC, Cozen W.
“Polymorphisms in DNA repair genes and risk of multiple myeloma.” American Association for
Research on Cancer Annual Meeting, Chicago IL, 2012.
183. Ma H, Lu Y, Malone KE, Strom BL, Simon MS, Deapen DM, Sullivan-Halley J, Press MF,
Bernstein L. “Use of four biomarkers to evaluate survival disparity between black women and
white women 35 to 64 years of age at diagnosis with invasive breast cancer.” American Association
for Research on Cancer Annual Meeting, Chicago IL, 2012.
184. George SM, McTiernan A, Villasenor A, Alfano CM Irwin MI, Neuhouser ML, Baumgartner RN,
Bernstein L, Smith AW, Ballard-Barbash R. “Examination of lean body mass and physical activity
associations with bone mineral density among breast cancer survivors..” Cancer Survivorship
Research: Translating Science to Care. 2012 Conference. Arlington, VA, 2012.
185. Stover AM, Reeve BB, Piper BF, Alfano CM Simth AW, Mitchell SA, Bernstein L, Baumgartner
KB, McTiernan A, Ballard-Barbash R. “The Piper Fatigue Scale: Item reduction and psychometric
testing offer expanded opportunities for cancer care applications.” Cancer Survivorship Research:
Translating Science to Care. 2012 Conference. Arlington, VA, 2012.
186. Dee A, McTiernan A, Bernstein L, Baumgartner RN, BaumGartner KB, Ballard-Barbash R,
McKean-Cowdin R.. “Mammographic breast density and CYP1B1, COMT, and MTHFR
polymorphisms in postmenopausal breast cancer patients.” Cancer Survivorship Research:
Translating Science to Care. 2012 Conference. Arlington, VA, 2012.
187. Hurley S, Reynolds P, Goldberg D, Nelson DO, Lu Y, Henderson K, Bernstein L. “Risk of
colorectal cancer associated with active smoking among female teachers.” 140th American Public
Health Association Annual Meeting. San Francisco, CA 2012.
188. Vigen CP, Gomez SL, Sposto R, Lu Y, Kwan ML, John EM, Monroe KR, Keegan THM, ShariffMarco S, Kurian AW, Cheng I, Caan BJ, Lee VS, Roh JM, Sullivan Halley J, Bernstein L, Wu
AH. “The California Breast Cancer Survivorship Consortium (CBCSC): Prognostic factors
associated with racial/ethnic differences in breast cancer survival.” Eleventh Annual AACR
Internation Conferences: Frontiers in Cancer Prevention Research, Anaheim, CA 2012.
189. Togawa K, Sullivan-Halley J, Lu Y, Smith AW, Alfano C, Imayama I, McTiernan A, Neuhouser
ML, Ma H, Ballard-Barbash R, Bernstein L. “Risk factors for self-reported arm lymphedema
among female breast cancer survivors in Health, Eating, Activity and Lifestyle (HEAL) Study.”
Eleventh Annual AACR Internation Conferences: Frontiers in Cancer Prevention Research,
Anaheim, CA 2012.
190. Dee A, McKeanCowdin R, McTiernan A, Baumgartner RN, Baumgartner KB, Ballard-Barbash R,
Bernstein L. “Acute-phase proteins (C-reactive protein and Serum Amyloid A) and postdiagnosis
mammographic density in breast cancer survivors.” Eleventh Annual AACR Internation
Conferences: Frontiers in Cancer Prevention Research, Anaheim, CA 2012.
191. Imayama I, McTiernan A, Alfano CM, Neuhouser ML, George SM, Smith AW, Baumgartner RN,
Baumgartner KB, Bernstein L, Ballard-Barbash R. “Weight, inflammation, cancer-related
symptoms and health-related quality of life among breast cancer survivors.” Eleventh Annual
AACR Internation Conferences: Frontiers in Cancer Prevention Research, Anaheim, CA 2012.
122
Leslie Bernstein, PhD
192. Kwan ML, Caan BJ, Lee VS, John EM, govem SL, Shariff-Marco S, Keegan TH, Kurian AW,
Bernstein L, Lu Y, Cheng I, Monroe KR, Sposto R, Vigen C, Wu AH. “Body size and
racial/ethnic differences in breast cancer survival.” American Association for Cancer Research
Disparities Conference, San Diego, CA 2012.
193. Kruper L, Xu XX, Henderson K, Bernstein L. “Disparities in the Utilization of Reconstruction
after Mastectomy: The California Teachers Study.” 35th Annual CTRC-AACR San Antonio Breast
Cancer Symposium, San Antonio, TX 2012.
194. Lee E, Schumacher F, Wu AH, Bernstein L, Ursin G. Growth factor genes and change in
mammographic density after quitting estrogen and progestin hormone therapy in the California
Teachers Study. American Association for Research on Cancer Annual Meeting, Washington DC,
2013.
195. Ozhand A, McKean-Cowdin R, Bernstein L, Ballard-Barbash R, McTiernan A, Baumgartner KB.
Short term reduction in mammographic density predicts survival in breast cancer. American
Association for Research on Cancer Annual Meeting, Washington DC, 2013.
196. Togawa K, Sullivan-Halley J, Ma H, Bernstein L. Symptoms of arm lymphedema and healthrelated quality of life among female breast cancer survivors: Health, Eating, Activity, and Lifestyle
Study. American College of Epidemiology, Louisville, KY 2013. Best Student Poster.
197. Dieli-Conwright C, Tripathy D, Schroeder ET, Mortimer JE, Bernstein L. Metabolic syndrome
and breast cancer: Effects of a 16-week combined exercise intervention. American Institute for
Cancer Research, Bethesda MD, 2013.
198. Birmann BM, Rand KA, Conti DV, Van Den Berg DJ, Haiman CA, De Roos AJ, Severson RK,
Edlund CK, Ailawadi S, Gebregziabher M, Morbacher AM, Lieber MR, Wang SS, Bernstein L,
Henderson BE, Rothman N, Chanock SJ, Kolonel LN, Colditz GA, Munshi NC, Anderson KC,
Cozen W. Polymorphisms in IRS1 and IL6R and susceptibility to multiple myeloma. 55th ASH
annual Meeting, New Orleans, LA, 2013.
199. Lee E, Schumacher F, Neuhausen SL, Anton-Culver H, Ziogas A, Van Den Berg D, Bernstein L,
Ursin G. “Growth factor genes, interaction with hormone therapy use and breast cancer risk in the
California Teachers Study.” AACR Annual Meeting, San Diego, CA, 2014.
200. Benbow JL, Clarke CA, Park HL, Duffy CN, Chung NT, Brankin AE, Angell-Mendez K, Ziogas
A, Pinder R, Deapen D, Anton-Culver H, Neuhausen SL, Bernstein L, Wang SS, Lacey JV, Jr.
“Novel implementation of cloud computing and mobile technology to transform data collection and
management in cancer epidemiology.” AACR Annual Meeting, San Diego, CA 2014.
201. Feng Y, …Bernstein L, … et al. “A comprehensive examination of breast cancer risk loci in
African American women.” AACR Annual Meeting, San Diego CA 2014.
202. Lu Y, Luo J, Wang S, Ma H, Sullivan-Halley J, Reynolds P, Bernstein L. “Parents’ ages at birth
and risk of hormone-related cancer among women in the California Teachers Study.” AACR
Annual Meeting, San Diego, CA 2014.
203. Wang SS, Luo J, Sullivan-Halley J, Lu Y, Lacey JV, Cozen W, Bernstein L. “Menopausal
hormone therapy and B-cell non-Hodgkin lymphoma (NHL) risk in the Los Angeles County NHL
Case-Control Study.” AACR Annual Meeting, San Diego CA 2014.
204. Ma H, Xu X, Ursin G, Malone KE, Lu Y, Simon MS, McDonald J, Sullivan-Halley J, Press MF,
Bernstein L. Reduced risk of breast cancer associated with recreational physical activity varies by
HER2 status. Society for Epidemiological Research Annual Meeting, Seattle WA 2014.
205. Hwang AE, Yu Y, Hamilton A, Deapen D, Bernstein L, Nathwani B, Mack T, Cozen W.
Alcohol, smoking and non-Hodgkin lymphoma in twins. Society for Epidemiological Research
Annual Meeting, Seattle WA 2014.
123
Leslie Bernstein, PhD
206. Wentzensen NA….L Bernstein… et al.”Ovarian cancer risk factors by histologic subtypes:
evidence for etiologic heterogeneity.” AACR Annual Meeting, Philadelpha, PA, 2015.
207. Ma H, Clague J, Xu X, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park HL, Sullivan-Halley
J, Neuhausen S, Bernstein L. “Long-term and recent recreational physical activity reduces risk of
triple negative and other subtypes of invasive breast cancer in the California Teachers Study.”
AACR Annual Meeting, Philadelphia PA, 2015.
208. Lu Y, Luo J, Wang S, Sullivan-Halley J, Cozen W, Bernstein L. “Reproductive factors and risk
of B-cell non-Hodgkin lymphoma among women in Los Angeles.” AACR Annual Meeting,
Philadelphia PA, 2015.
124